DrugA,DrugB,Interaction,Mechanism,risk_level
Benzatropine,Budesonide,Benzatropine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Benzatropine,Bumadizone,Bumadizone may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Benzatropine,Bumetanide,Bumetanide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Benzatropine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Benzatropine.,decrease,no risk
Benzatropine,Buprenorphine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Buprenorphine.,increase,risk
Benzatropine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Benzatropine.,increase,risk
Benzatropine,Buserelin,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Buserelin.,increase,risk
Benzatropine,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Benzatropine.,increase,risk
Benzatropine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Benzatropine.,increase,risk
Benzatropine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Benzatropine.,increase,risk
Benzatropine,Butobarbital,The risk or severity of adverse effects can be increased when Benzatropine is combined with Butobarbital.,increase,risk
Benzatropine,Butorphanol,The risk or severity of adverse effects can be increased when Benzatropine is combined with Butorphanol.,increase,risk
Benzatropine,Butriptyline,The risk or severity of adverse effects can be increased when Benzatropine is combined with Butriptyline.,increase,risk
Benzatropine,Butylscopolamine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Butylscopolamine.,increase,risk
Benzatropine,Gabapentin enacarbil,Benzatropine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Benzatropine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gadobenic acid.,increase,risk
Benzatropine,Gadodiamide,Gadodiamide may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Benzatropine,Gadofosveset trisodium,Benzatropine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Benzatropine,Gadopentetic acid,Benzatropine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Benzatropine,Gadoteric acid,Benzatropine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Benzatropine,Gadoteridol,Benzatropine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Benzatropine,Galantamine,The therapeutic efficacy of Benzatropine can be decreased when used in combination with Galantamine.,decrease,no risk
Benzatropine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Benzatropine is combined with Gallamine triethiodide.,increase,risk
Benzatropine,Ganciclovir,Benzatropine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Benzatropine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gatifloxacin.,increase,risk
Benzatropine,Gefitinib,The metabolism of Benzatropine can be decreased when combined with Gefitinib.,decrease,no risk
Benzatropine,Gemcitabine,Benzatropine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Benzatropine,Gemfibrozil,Benzatropine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Benzatropine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gemifloxacin.,increase,risk
Benzatropine,Gentamicin,Benzatropine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Benzatropine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Benzatropine.,increase,risk
Benzatropine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gilteritinib.,increase,risk
Benzatropine,Gimeracil,Benzatropine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Benzatropine,Ginkgo biloba,The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Benzatropine,Givosiran,The serum concentration of Benzatropine can be increased when it is combined with Givosiran.,increase,no risk
Benzatropine,Glasdegib,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Glasdegib.,increase,risk
Benzatropine,Glipizide,Benzatropine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Benzatropine,Glucagon,Benzatropine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Benzatropine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Benzatropine.,decrease,no risk
Benzatropine,Glycerol phenylbutyrate,The metabolism of Benzatropine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Benzatropine,Glycopyrronium,The risk or severity of adverse effects can be increased when Benzatropine is combined with Glycopyrronium.,increase,risk
Ziprasidone,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Ziprasidone.,increase,risk
Ziprasidone,Balsalazide,The risk or severity of hypertension can be increased when Ziprasidone is combined with Balsalazide.,increase,risk
Ziprasidone,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Bedaquiline,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Ziprasidone.,increase,risk
Ziprasidone,Belladonna,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Belladonna.,increase,risk
Ziprasidone,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Benazepril,Ziprasidone may increase the antihypertensive activities of Benazepril.,increase,no risk
Ziprasidone,Bendroflumethiazide,Ziprasidone may increase the antihypertensive activities of Bendroflumethiazide.,increase,no risk
Ziprasidone,Benorilate,The risk or severity of hypertension can be increased when Ziprasidone is combined with Benorilate.,increase,risk
Ziprasidone,Benoxaprofen,The risk or severity of hypertension can be increased when Ziprasidone is combined with Benoxaprofen.,increase,risk
Ziprasidone,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Ziprasidone.,increase,risk
Ziprasidone,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ziprasidone.,increase,risk
Ziprasidone,Benzhydrocodone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Benzhydrocodone.,increase,risk
Ziprasidone,Benzocaine,The risk or severity of adverse effects can be increased when Benzocaine is combined with Ziprasidone.,increase,risk
Ziprasidone,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Ziprasidone.,increase,risk
Ziprasidone,Benzthiazide,The serum concentration of Benzthiazide can be increased when it is combined with Ziprasidone.,increase,no risk
Ziprasidone,Benzydamine,The risk or severity of hypertension can be increased when Ziprasidone is combined with Benzydamine.,increase,risk
Ziprasidone,Benzyl alcohol,The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ziprasidone.,increase,risk
Ziprasidone,Benzylpenicilloyl polylysine,Ziprasidone may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Ziprasidone,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Ziprasidone.,increase,risk
Ziprasidone,Berotralstat,The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Ziprasidone.,increase,risk
Ziprasidone,Besifloxacin,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Ziprasidone.,increase,risk
Ziprasidone,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Betaine,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Betaine.,decrease,no risk
Ziprasidone,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Betaxolol,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Ziprasidone.,increase,risk
Ziprasidone,Bethanidine,Ziprasidone may increase the antihypertensive activities of Bethanidine.,increase,no risk
Ziprasidone,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Bexarotene,The metabolism of Ziprasidone can be increased when combined with Bexarotene.,increase,no risk
Ziprasidone,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Bifonazole,The metabolism of Ziprasidone can be decreased when combined with Bifonazole.,decrease,no risk
Ziprasidone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ziprasidone.,increase,risk
Ziprasidone,Bimatoprost,Ziprasidone may increase the antihypertensive activities of Bimatoprost.,increase,no risk
Ziprasidone,Bimekizumab,The metabolism of Ziprasidone can be increased when combined with Bimekizumab.,increase,no risk
Ziprasidone,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Bismuth subcitrate potassium,Ziprasidone may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Ziprasidone,Bismuth subgallate,Ziprasidone may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Ziprasidone,Bismuth subnitrate,Ziprasidone may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Ziprasidone,Bisoprolol,Ziprasidone may increase the antihypertensive activities of Bisoprolol.,increase,no risk
Ziprasidone,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Boceprevir,The metabolism of Ziprasidone can be decreased when combined with Boceprevir.,decrease,no risk
Ziprasidone,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ziprasidone.,increase,risk
Ziprasidone,Bosentan,Ziprasidone may increase the antihypertensive activities of Bosentan.,increase,no risk
Ziprasidone,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Botulinum toxin type A.,increase,risk
Ziprasidone,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Ziprasidone.,increase,risk
Ziprasidone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ziprasidone.,increase,risk
Ziprasidone,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Ziprasidone.,increase,risk
Ziprasidone,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Brimonidine,The risk or severity of adverse effects can be increased when Brimonidine is combined with Ziprasidone.,increase,risk
Ziprasidone,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Ziprasidone.,increase,risk
Ziprasidone,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Ziprasidone.,increase,risk
Ziprasidone,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ziprasidone.,increase,risk
Ziprasidone,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Ziprasidone.,increase,risk
Ziprasidone,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ziprasidone.,increase,risk
Ziprasidone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ziprasidone.,increase,risk
Ziprasidone,Budesonide,The metabolism of Budesonide can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Bumadizone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Bumadizone.,increase,risk
Ziprasidone,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Ziprasidone.,increase,risk
Ziprasidone,Buprenorphine,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ziprasidone,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Ziprasidone.,increase,risk
Ziprasidone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ziprasidone.,increase,risk
Ziprasidone,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Ziprasidone.,increase,risk
Ziprasidone,Busulfan,The metabolism of Busulfan can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Ziprasidone.,increase,risk
Ziprasidone,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Ziprasidone.,increase,risk
Ziprasidone,Butamben,The risk or severity of adverse effects can be increased when Butamben is combined with Ziprasidone.,increase,risk
Ziprasidone,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Ziprasidone.,increase,risk
Ziprasidone,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Ziprasidone.,increase,risk
Ziprasidone,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Ziprasidone.,increase,risk
Ziprasidone,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Ziprasidone.,increase,risk
Ziprasidone,Butylscopolamine,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Butylscopolamine.,increase,risk
Ziprasidone,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Ziprasidone.,increase,risk
Ziprasidone,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Ziprasidone.,increase,risk
Ziprasidone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Ziprasidone.,increase,risk
Ziprasidone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ziprasidone.,increase,risk
Ziprasidone,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Ziprasidone.,increase,risk
Ziprasidone,Ganaxolone,The risk or severity of adverse effects can be increased when Ganaxolone is combined with Ziprasidone.,increase,risk
Ziprasidone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ziprasidone.,increase,risk
Ziprasidone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Ziprasidone.,increase,risk
Ziprasidone,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with Ziprasidone.,increase,risk
Ziprasidone,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Gilteritinib,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Ziprasidone,Ginkgo biloba,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ziprasidone,Glasdegib,The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Ziprasidone.,increase,risk
Ziprasidone,Glecaprevir,The metabolism of Ziprasidone can be decreased when combined with Glecaprevir.,decrease,no risk
Ziprasidone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Glofitamab,The serum concentration of Ziprasidone can be increased when it is combined with Glofitamab.,increase,no risk
Ziprasidone,Glucagon,Ziprasidone may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Ziprasidone,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Ziprasidone.,increase,risk
Ziprasidone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Glycerol phenylbutyrate,The metabolism of Ziprasidone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ziprasidone,Glycopyrronium,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Glycopyrronium.,increase,risk
Ziprasidone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Golimumab,The metabolism of Ziprasidone can be increased when combined with Golimumab.,increase,no risk
Ziprasidone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ziprasidone.,increase,risk
Ziprasidone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ziprasidone.,increase,risk
Ziprasidone,Grapefruit,The metabolism of Ziprasidone can be decreased when combined with Grapefruit.,decrease,no risk
Ziprasidone,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Ziprasidone.,increase,risk
Ziprasidone,Griseofulvin,The metabolism of Ziprasidone can be increased when combined with Griseofulvin.,increase,no risk
Ziprasidone,Guanabenz,Ziprasidone may increase the antihypertensive activities of Guanabenz.,increase,no risk
Ziprasidone,Guanadrel,Ziprasidone may increase the antihypertensive activities of Guanadrel.,increase,no risk
Ziprasidone,Guanethidine,Ziprasidone may increase the antihypertensive activities of Guanethidine.,increase,no risk
Ziprasidone,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Ziprasidone.,increase,risk
Ziprasidone,Guanoxan,Ziprasidone may increase the antihypertensive activities of Guanoxan.,increase,no risk
Ziprasidone,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Ziprasidone.,increase,risk
Ziprasidone,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Ziprasidone.,increase,risk
Ziprasidone,Haloperidol,The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Ziprasidone.,increase,risk
Ziprasidone,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Ziprasidone.,increase,risk
Ziprasidone,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Ziprasidone.,increase,risk
Ziprasidone,Hexocyclium,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Hexocyclium.,increase,risk
Ziprasidone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ziprasidone.,increase,risk
Ziprasidone,Homatropine,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Homatropine.,increase,risk
Ziprasidone,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Homatropine methylbromide.,increase,risk
Ziprasidone,Huperzine A,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Huperzine A.,decrease,no risk
Ziprasidone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Hydralazine,Ziprasidone may increase the antihypertensive activities of Hydralazine.,increase,no risk
Ziprasidone,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ziprasidone.,increase,risk
Ziprasidone,Hydrocodone,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ziprasidone,Hydrocortamate,The metabolism of Ziprasidone can be increased when combined with Hydrocortamate.,increase,no risk
Ziprasidone,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydroflumethiazide,Ziprasidone may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Ziprasidone,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ziprasidone.,increase,risk
Ziprasidone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Ziprasidone.,increase,risk
Ziprasidone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Hydroxyzine.,increase,risk
Ziprasidone,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ziprasidone.,increase,risk
Ziprasidone,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Ziprasidone.,increase,risk
Ziprasidone,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Ziprasidone.,increase,risk
Ziprasidone,Ketoconazole,The serum concentration of Ziprasidone can be increased when it is combined with Ketoconazole.,increase,no risk
Ziprasidone,Ketoprofen,The risk or severity of hypertension can be increased when Ziprasidone is combined with Ketoprofen.,increase,risk
Ziprasidone,Ketorolac,The risk or severity of hypertension can be increased when Ziprasidone is combined with Ketorolac.,increase,risk
Ziprasidone,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ziprasidone.,increase,risk
Ziprasidone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Ziprasidone.,increase,risk
Ziprasidone,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Ziprasidone.,increase,risk
Ziprasidone,Olaparib,The metabolism of Olaparib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ziprasidone is combined with Oliceridine.",increase,risk
Ziprasidone,Olmesartan,Ziprasidone may increase the antihypertensive activities of Olmesartan.,increase,no risk
Ziprasidone,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ziprasidone.,increase,risk
Ziprasidone,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Ziprasidone.,increase,no risk
Ziprasidone,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ziprasidone.,increase,risk
Ziprasidone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Ziprasidone.,increase,risk
Ziprasidone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Oritavancin,The metabolism of Ziprasidone can be increased when combined with Oritavancin.,increase,no risk
Ziprasidone,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ziprasidone.,increase,risk
Ziprasidone,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxaprozin,The risk or severity of hypertension can be increased when Ziprasidone is combined with Oxaprozin.,increase,risk
Ziprasidone,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxprenolol,The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxyphenbutazone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Oxyphenbutazone.,increase,risk
Ziprasidone,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Oxyphencyclimine.,increase,risk
Ziprasidone,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Ziprasidone.,increase,risk
Ziprasidone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ziprasidone.,increase,risk
Ziprasidone,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Ziprasidone.,increase,risk
Ziprasidone,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ziprasidone.,increase,risk
Ziprasidone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Quinapril,Ziprasidone may increase the antihypertensive activities of Quinapril.,increase,no risk
Ziprasidone,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Ziprasidone.,increase,no risk
Ziprasidone,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ziprasidone.,increase,risk
Ziprasidone,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Ziprasidone.,increase,risk
Ziprasidone,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Ziprasidone.,increase,risk
Ziprasidone,Quinupristin,The metabolism of Ziprasidone can be decreased when combined with Quinupristin.,decrease,no risk
Ziprasidone,Quizartinib,The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Quizartinib.,increase,risk
Ziprasidone,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ziprasidone.,increase,no risk
Ziprasidone,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Ziprasidone.,increase,risk
Ziprasidone,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Umeclidinium,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Umeclidinium.,increase,risk
Ziprasidone,Unoprostone,Ziprasidone may increase the antihypertensive activities of Unoprostone.,increase,no risk
Ziprasidone,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Ziprasidone.,increase,risk
Ziprasidone,Vadadustat,The serum concentration of Ziprasidone can be increased when it is combined with Vadadustat.,increase,no risk
Ziprasidone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Valproate bismuth.,increase,risk
Ziprasidone,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Ziprasidone.,increase,risk
Ziprasidone,Valsartan,Ziprasidone may increase the antihypertensive activities of Valsartan.,increase,no risk
Ziprasidone,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Ziprasidone.,increase,risk
Ziprasidone,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ziprasidone.,increase,risk
Ziprasidone,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Ziprasidone.,increase,risk
Ziprasidone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ziprasidone.,increase,risk
Ziprasidone,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ziprasidone.,increase,risk
Ziprasidone,Verapamil,The metabolism of Verapamil can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ziprasidone.,increase,risk
Ziprasidone,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Ziprasidone.,increase,risk
Ziprasidone,Vilanterol,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ziprasidone.,increase,risk
Ziprasidone,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Ziprasidone.,increase,risk
Ziprasidone,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Viloxazine,The risk or severity of adverse effects can be increased when Viloxazine is combined with Ziprasidone.,increase,risk
Ziprasidone,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vincristine,The metabolism of Vincristine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vindesine,The metabolism of Vindesine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Viomycin,Ziprasidone may increase the neurotoxic activities of Viomycin.,increase,no risk
Ziprasidone,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Ziprasidone.,increase,risk
Ziprasidone,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ziprasidone.,increase,risk
Ziprasidone,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Ziprasidone.,increase,risk
Ziprasidone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ziprasidone.,increase,no risk
Ziprasidone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ziprasidone.,increase,no risk
Ziprasidone,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ziprasidone,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Ziprasidone.,increase,risk
Ziprasidone,Zafirlukast,The metabolism of Ziprasidone can be decreased when combined with Zafirlukast.,decrease,no risk
Ziprasidone,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Ziprasidone.,increase,risk
Ziprasidone,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Ziconotide,The risk or severity of adverse effects can be increased when Ziconotide is combined with Ziprasidone.,increase,risk
Ziprasidone,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Zileuton,The metabolism of Zileuton can be decreased when combined with Ziprasidone.,decrease,no risk
Ziprasidone,Zimelidine,The risk or severity of adverse effects can be increased when Zimelidine is combined with Ziprasidone.,increase,risk
Ziprasidone,Zofenopril,Ziprasidone may increase the antihypertensive activities of Zofenopril.,increase,no risk
Ziprasidone,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Ziprasidone is combined with Zolmitriptan.,increase,risk
Ziprasidone,Zolpidem,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ziprasidone,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Ziprasidone.,increase,risk
Ziprasidone,Zopiclone,The risk or severity of adverse effects can be increased when Zopiclone is combined with Ziprasidone.,increase,risk
Ziprasidone,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Ziprasidone.,increase,risk
Ziprasidone,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Ziprasidone.,increase,risk
Ziprasidone,Zuranolone,The risk or severity of adverse effects can be increased when Zuranolone is combined with Ziprasidone.,increase,risk
Methysergide,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Bretylium,Methysergide may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Methysergide,Brexanolone,The risk or severity of CNS depression can be increased when Methysergide is combined with Brexanolone.,increase,risk
Methysergide,Brexpiprazole,Methysergide may increase the vasoconstricting activities of Brexpiprazole.,increase,no risk
Methysergide,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methysergide.,increase,no risk
Methysergide,Brivaracetam,The risk or severity of CNS depression can be increased when Methysergide is combined with Brivaracetam.,increase,risk
Methysergide,Bromazepam,The risk or severity of CNS depression can be increased when Methysergide is combined with Bromazepam.,increase,risk
Methysergide,Bromocriptine,Methysergide may increase the hypertensive and vasoconstricting activities of Bromocriptine.,increase,no risk
Methysergide,Bromperidol,The risk or severity of CNS depression can be increased when Methysergide is combined with Bromperidol.,increase,risk
Methysergide,Brompheniramine,The risk or severity of CNS depression can be increased when Methysergide is combined with Brompheniramine.,increase,risk
Methysergide,Budesonide,The metabolism of Methysergide can be increased when combined with Budesonide.,increase,no risk
Methysergide,Bumadizone,The risk or severity of hypertension can be increased when Methysergide is combined with Bumadizone.,increase,risk
Methysergide,Bupivacaine,The risk or severity of CNS depression can be increased when Methysergide is combined with Bupivacaine.,increase,risk
Methysergide,Buprenorphine,Methysergide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Methysergide,Bupropion,The risk or severity of CNS depression can be increased when Methysergide is combined with Bupropion.,increase,risk
Methysergide,Buspirone,The risk or severity of CNS depression can be increased when Methysergide is combined with Buspirone.,increase,risk
Methysergide,Busulfan,The metabolism of Busulfan can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Methysergide.,increase,risk
Methysergide,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Methysergide.,increase,risk
Methysergide,Butaperazine,The risk or severity of CNS depression can be increased when Methysergide is combined with Butaperazine.,increase,risk
Methysergide,Butobarbital,The risk or severity of CNS depression can be increased when Methysergide is combined with Butobarbital.,increase,risk
Methysergide,Butorphanol,The risk or severity of CNS depression can be increased when Methysergide is combined with Butorphanol.,increase,risk
Methysergide,Butriptyline,The risk or severity of CNS depression can be increased when Methysergide is combined with Butriptyline.,increase,risk
Methysergide,Gabapentin,The risk or severity of CNS depression can be increased when Methysergide is combined with Gabapentin.,increase,risk
Methysergide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Methysergide is combined with Gabapentin enacarbil.,increase,risk
Methysergide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Methysergide is combined with Gallamine triethiodide.,increase,risk
Methysergide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Methysergide is combined with Ganaxolone.",increase,risk
Methysergide,Gepirone,The risk or severity of CNS depression can be increased when Methysergide is combined with Gepirone.,increase,risk
Methysergide,Gilteritinib,The therapeutic efficacy of Methysergide can be decreased when used in combination with Gilteritinib.,decrease,no risk
Methysergide,Ginkgo biloba,The metabolism of Methysergide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Methysergide,Glecaprevir,The metabolism of Methysergide can be decreased when combined with Glecaprevir.,decrease,no risk
Methysergide,Glofitamab,The serum concentration of Methysergide can be increased when it is combined with Glofitamab.,increase,no risk
Methysergide,Glutethimide,The risk or severity of CNS depression can be increased when Methysergide is combined with Glutethimide.,increase,risk
Methysergide,Glyburide,The metabolism of Methysergide can be decreased when combined with Glyburide.,decrease,no risk
Methysergide,Glycerol phenylbutyrate,The metabolism of Methysergide can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Methysergide,Golimumab,The metabolism of Methysergide can be increased when combined with Golimumab.,increase,no risk
Methysergide,Granisetron,The risk or severity of CNS depression can be increased when Methysergide is combined with Granisetron.,increase,risk
Methysergide,Grapefruit,The metabolism of Methysergide can be decreased when combined with Grapefruit.,decrease,no risk
Methysergide,Griseofulvin,The metabolism of Methysergide can be increased when combined with Griseofulvin.,increase,no risk
Methysergide,Guanabenz,Methysergide may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Methysergide,Guanadrel,Methysergide may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Methysergide,Guanethidine,Methysergide may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Methysergide,Guanfacine,Methysergide may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Methysergide,Guanoxan,Methysergide may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Methysergide,Halazepam,The risk or severity of CNS depression can be increased when Methysergide is combined with Halazepam.,increase,risk
Methysergide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Methysergide.,increase,risk
Methysergide,Halothane,The risk or severity of CNS depression can be increased when Methysergide is combined with Halothane.,increase,risk
Methysergide,Hexafluronium,The risk or severity of CNS depression can be increased when Methysergide is combined with Hexafluronium.,increase,risk
Methysergide,Hydralazine,The metabolism of Methysergide can be decreased when combined with Hydralazine.,decrease,no risk
Methysergide,Hydrochlorothiazide,Methysergide may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Methysergide,Hydrocodone,Methysergide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Methysergide,Hydrocortamate,The metabolism of Methysergide can be increased when combined with Hydrocortamate.,increase,no risk
Methysergide,Hydrocortisone,The metabolism of Methysergide can be increased when combined with Hydrocortisone.,increase,no risk
Methysergide,Hydrocortisone acetate,The metabolism of Methysergide can be increased when combined with Hydrocortisone acetate.,increase,no risk
Methysergide,Hydrocortisone butyrate,The metabolism of Methysergide can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Methysergide,Hydrocortisone succinate,The metabolism of Methysergide can be increased when combined with Hydrocortisone succinate.,increase,no risk
Methysergide,Hydroflumethiazide,Methysergide may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Methysergide,Hydromorphone,The risk or severity of CNS depression can be increased when Methysergide is combined with Hydromorphone.,increase,risk
Methysergide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methysergide.,increase,no risk
Methysergide,Ketamine,The risk or severity of CNS depression can be increased when Methysergide is combined with Ketamine.,increase,risk
Methysergide,Ketazolam,The risk or severity of CNS depression can be increased when Methysergide is combined with Ketazolam.,increase,risk
Methysergide,Ketoconazole,The serum concentration of Methysergide can be increased when it is combined with Ketoconazole.,increase,no risk
Methysergide,Ketoprofen,The risk or severity of hypertension can be increased when Methysergide is combined with Ketoprofen.,increase,risk
Methysergide,Ketorolac,The risk or severity of hypertension can be increased when Methysergide is combined with Ketorolac.,increase,risk
Methysergide,Octreotide,The metabolism of Methysergide can be decreased when combined with Octreotide.,decrease,no risk
Methysergide,Olanzapine,The risk or severity of CNS depression can be increased when Methysergide is combined with Olanzapine.,increase,risk
Methysergide,Olaparib,The metabolism of Olaparib can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Methysergide is combined with Oliceridine.",increase,risk
Methysergide,Olmesartan,Methysergide may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Methysergide,Olodaterol,Methysergide may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Methysergide,Olutasidenib,The metabolism of Methysergide can be increased when combined with Olutasidenib.,increase,no risk
Methysergide,Omaveloxolone,The serum concentration of Methysergide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Methysergide,Ondansetron,The risk or severity of CNS depression can be increased when Methysergide is combined with Ondansetron.,increase,risk
Methysergide,Opium,The risk or severity of CNS depression can be increased when Methysergide is combined with Opium.,increase,risk
Methysergide,Orciprenaline,Methysergide may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Methysergide,Oritavancin,The metabolism of Methysergide can be increased when combined with Oritavancin.,increase,no risk
Methysergide,Orphenadrine,Methysergide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Methysergide,Osilodrostat,The metabolism of Methysergide can be decreased when combined with Osilodrostat.,decrease,no risk
Methysergide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Oxaprozin,The risk or severity of hypertension can be increased when Methysergide is combined with Oxaprozin.,increase,risk
Methysergide,Oxazepam,The risk or severity of CNS depression can be increased when Methysergide is combined with Oxazepam.,increase,risk
Methysergide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Methysergide is combined with Oxcarbazepine.,increase,risk
Methysergide,Oxitriptan,The risk or severity of CNS depression can be increased when Methysergide is combined with Oxitriptan.,increase,risk
Methysergide,Oxprenolol,Oxprenolol may increase the vasoconstricting activities of Methysergide.,increase,no risk
Methysergide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Methysergide is combined with Oxybuprocaine.,increase,risk
Methysergide,Oxybutynin,The metabolism of Methysergide can be decreased when combined with Oxybutynin.,decrease,no risk
Methysergide,Oxycodone,The risk or severity of CNS depression can be increased when Methysergide is combined with Oxycodone.,increase,risk
Methysergide,Oxymetazoline,Methysergide may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Methysergide,Oxymorphone,The risk or severity of CNS depression can be increased when Methysergide is combined with Oxymorphone.,increase,risk
Methysergide,Oxyphenbutazone,The risk or severity of hypertension can be increased when Methysergide is combined with Oxyphenbutazone.,increase,risk
Methysergide,Oxytocin,The risk or severity of hypertension can be increased when Methysergide is combined with Oxytocin.,increase,risk
Methysergide,Quazepam,The risk or severity of CNS depression can be increased when Methysergide is combined with Quazepam.,increase,risk
Methysergide,Quetiapine,The risk or severity of CNS depression can be increased when Methysergide is combined with Quetiapine.,increase,risk
Methysergide,Quinapril,Methysergide may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Methysergide,Quinidine,The metabolism of Quinidine can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Quinine,The risk or severity of CNS depression can be increased when Methysergide is combined with Quinine.,increase,risk
Methysergide,Quinupramine,The risk or severity of CNS depression can be increased when Methysergide is combined with Quinupramine.,increase,risk
Methysergide,Quinupristin,The metabolism of Methysergide can be decreased when combined with Quinupristin.,decrease,no risk
Methysergide,Urethane,The risk or severity of CNS depression can be increased when Methysergide is combined with Urethane.,increase,risk
Methysergide,Vadadustat,The serum concentration of Methysergide can be increased when it is combined with Vadadustat.,increase,no risk
Methysergide,Valdecoxib,The risk or severity of hypertension can be increased when Methysergide is combined with Valdecoxib.,increase,risk
Methysergide,Valproic acid,The risk or severity of CNS depression can be increased when Methysergide is combined with Valproic acid.,increase,risk
Methysergide,Valsartan,Methysergide may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Methysergide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Vecuronium,The risk or severity of CNS depression can be increased when Methysergide is combined with Vecuronium.,increase,risk
Methysergide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Venlafaxine,The risk or severity of CNS depression can be increased when Methysergide is combined with Venlafaxine.,increase,risk
Methysergide,Verapamil,The metabolism of Methysergide can be decreased when combined with Verapamil.,decrease,no risk
Methysergide,Vibegron,Methysergide may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Methysergide,Vigabatrin,The risk or severity of CNS depression can be increased when Methysergide is combined with Vigabatrin.,increase,risk
Methysergide,Vilanterol,Methysergide may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Methysergide,Vilazodone,Methysergide may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Methysergide,Viloxazine,The metabolism of Methysergide can be decreased when combined with Viloxazine.,decrease,no risk
Methysergide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Vincristine,The metabolism of Vincristine can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Vindesine,The metabolism of Vindesine can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Vitamin E,The metabolism of Methysergide can be increased when combined with Vitamin E.,increase,no risk
Methysergide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Voriconazole,The serum concentration of Methysergide can be increased when it is combined with Voriconazole.,increase,no risk
Methysergide,Vortioxetine,Methysergide may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Methysergide,Warfarin,The metabolism of Warfarin can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Xamoterol,Methysergide may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Methysergide,Xylometazoline,Methysergide may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Methysergide,Yohimbine,The risk or severity of CNS depression can be increased when Methysergide is combined with Yohimbine.,increase,risk
Methysergide,Zafirlukast,The metabolism of Methysergide can be decreased when combined with Zafirlukast.,decrease,no risk
Methysergide,Zaleplon,The risk or severity of CNS depression can be increased when Methysergide is combined with Zaleplon.,increase,risk
Methysergide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Methysergide.,decrease,no risk
Methysergide,Ziconotide,The risk or severity of CNS depression can be increased when Methysergide is combined with Ziconotide.,increase,risk
Methysergide,Zimelidine,The risk or severity of adverse effects can be increased when Methysergide is combined with Zimelidine.,increase,risk
Methysergide,Ziprasidone,The risk or severity of adverse effects can be increased when Methysergide is combined with Ziprasidone.,increase,risk
Methysergide,Zofenopril,Methysergide may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Methysergide,Zolmitriptan,Methysergide may increase the vasoconstricting activities of Zolmitriptan.,increase,no risk
Methysergide,Zolpidem,Methysergide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Methysergide,Zonisamide,The risk or severity of CNS depression can be increased when Methysergide is combined with Zonisamide.,increase,risk
Methysergide,Zopiclone,The risk or severity of adverse effects can be increased when Methysergide is combined with Zopiclone.,increase,risk
Methysergide,Zotepine,The risk or severity of CNS depression can be increased when Methysergide is combined with Zotepine.,increase,risk
Methysergide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Methysergide is combined with Zuclopenthixol.,increase,risk
Methysergide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Methysergide.,increase,risk
Cabergoline,Bifonazole,The metabolism of Cabergoline can be decreased when combined with Bifonazole.,decrease,no risk
Cabergoline,Bimekizumab,The metabolism of Cabergoline can be increased when combined with Bimekizumab.,increase,no risk
Cabergoline,Binimetinib,The serum concentration of Cabergoline can be increased when it is combined with Binimetinib.,increase,no risk
Cabergoline,Bisoprolol,Bisoprolol may increase the vasoconstricting activities of Cabergoline.,increase,no risk
Cabergoline,Boceprevir,The risk or severity of adverse effects can be increased when Boceprevir is combined with Cabergoline.,increase,risk
Cabergoline,Bortezomib,The serum concentration of Cabergoline can be increased when it is combined with Bortezomib.,increase,no risk
Cabergoline,Bosentan,The metabolism of Cabergoline can be increased when combined with Bosentan.,increase,no risk
Cabergoline,Bosutinib,The metabolism of Cabergoline can be decreased when combined with Bosutinib.,decrease,no risk
Cabergoline,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Cabergoline.,increase,risk
Cabergoline,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Cabergoline.,increase,risk
Cabergoline,Brentuximab vedotin,The serum concentration of Cabergoline can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Cabergoline,Bretylium,Cabergoline may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Cabergoline,Brexanolone,The risk or severity of CNS depression can be increased when Cabergoline is combined with Brexanolone.,increase,risk
Cabergoline,Brexpiprazole,The risk or severity of adverse effects can be decreased when Cabergoline is combined with Brexpiprazole.,decrease,risk
Cabergoline,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cabergoline.,increase,no risk
Cabergoline,Brivaracetam,The risk or severity of CNS depression can be increased when Cabergoline is combined with Brivaracetam.,increase,risk
Cabergoline,Bromazepam,The risk or severity of CNS depression can be increased when Cabergoline is combined with Bromazepam.,increase,risk
Cabergoline,Bromocriptine,The risk or severity of adverse effects can be decreased when Cabergoline is combined with Bromocriptine.,decrease,risk
Cabergoline,Bromperidol,The risk or severity of adverse effects can be increased when Cabergoline is combined with Bromperidol.,increase,risk
Cabergoline,Brompheniramine,The risk or severity of CNS depression can be increased when Cabergoline is combined with Brompheniramine.,increase,risk
Cabergoline,Budesonide,The metabolism of Cabergoline can be increased when combined with Budesonide.,increase,no risk
Cabergoline,Bumadizone,The risk or severity of hypertension can be increased when Cabergoline is combined with Bumadizone.,increase,risk
Cabergoline,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Cabergoline is combined with Bupivacaine.,increase,risk
Cabergoline,Buprenorphine,Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Cabergoline,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Cabergoline.,increase,risk
Cabergoline,Buspirone,The risk or severity of CNS depression can be increased when Cabergoline is combined with Buspirone.,increase,risk
Cabergoline,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Cabergoline.,increase,risk
Cabergoline,Butacaine,The risk or severity of methemoglobinemia can be increased when Cabergoline is combined with Butacaine.,increase,risk
Cabergoline,Butalbital,The metabolism of Cabergoline can be increased when combined with Butalbital.,increase,no risk
Cabergoline,Butamben,The risk or severity of methemoglobinemia can be increased when Cabergoline is combined with Butamben.,increase,risk
Cabergoline,Butaperazine,The risk or severity of adverse effects can be increased when Cabergoline is combined with Butaperazine.,increase,risk
Cabergoline,Butobarbital,The risk or severity of CNS depression can be increased when Cabergoline is combined with Butobarbital.,increase,risk
Cabergoline,Butorphanol,The risk or severity of CNS depression can be increased when Cabergoline is combined with Butorphanol.,increase,risk
Cabergoline,Butriptyline,The risk or severity of CNS depression can be increased when Cabergoline is combined with Butriptyline.,increase,risk
Cabergoline,Gabapentin,The risk or severity of CNS depression can be increased when Cabergoline is combined with Gabapentin.,increase,risk
Cabergoline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cabergoline is combined with Gabapentin enacarbil.,increase,risk
Cabergoline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Cabergoline is combined with Gallamine triethiodide.,increase,risk
Cabergoline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cabergoline is combined with Ganaxolone.",increase,risk
Cabergoline,Gemcitabine,The serum concentration of Cabergoline can be increased when it is combined with Gemcitabine.,increase,no risk
Cabergoline,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Cabergoline.,increase,no risk
Cabergoline,Gilteritinib,The therapeutic efficacy of Cabergoline can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cabergoline,Ginkgo biloba,The metabolism of Cabergoline can be decreased when combined with Ginkgo biloba.,decrease,no risk
Cabergoline,Glasdegib,The serum concentration of Cabergoline can be increased when it is combined with Glasdegib.,increase,no risk
Cabergoline,Glecaprevir,The serum concentration of Cabergoline can be increased when it is combined with Glecaprevir.,increase,no risk
Cabergoline,Glofitamab,The serum concentration of Cabergoline can be increased when it is combined with Glofitamab.,increase,no risk
Cabergoline,Glutethimide,The risk or severity of CNS depression can be increased when Cabergoline is combined with Glutethimide.,increase,risk
Cabergoline,Glyburide,The metabolism of Cabergoline can be decreased when combined with Glyburide.,decrease,no risk
Cabergoline,Glycerol phenylbutyrate,The metabolism of Cabergoline can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Cabergoline,Golimumab,The metabolism of Cabergoline can be increased when combined with Golimumab.,increase,no risk
Cabergoline,Granisetron,The risk or severity of CNS depression can be increased when Cabergoline is combined with Granisetron.,increase,risk
Cabergoline,Grapefruit,The serum concentration of Cabergoline can be increased when it is combined with Grapefruit.,increase,no risk
Cabergoline,Grazoprevir,The serum concentration of Cabergoline can be increased when it is combined with Grazoprevir.,increase,no risk
Cabergoline,Griseofulvin,The metabolism of Cabergoline can be increased when combined with Griseofulvin.,increase,no risk
Cabergoline,Guanabenz,Cabergoline may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Cabergoline,Guanadrel,Cabergoline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Cabergoline,Guanethidine,Cabergoline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Cabergoline,Guanfacine,Cabergoline may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Cabergoline,Guanoxan,Cabergoline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Cabergoline,Halazepam,The risk or severity of CNS depression can be increased when Cabergoline is combined with Halazepam.,increase,risk
Cabergoline,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Cabergoline.,increase,risk
Cabergoline,Halothane,The risk or severity of CNS depression can be increased when Cabergoline is combined with Halothane.,increase,risk
Cabergoline,Hexafluronium,The risk or severity of CNS depression can be increased when Cabergoline is combined with Hexafluronium.,increase,risk
Cabergoline,Hydralazine,The serum concentration of Cabergoline can be increased when it is combined with Hydralazine.,increase,no risk
Cabergoline,Hydrochlorothiazide,Cabergoline may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Cabergoline,Hydrocodone,Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cabergoline,Hydrocortamate,The metabolism of Cabergoline can be increased when combined with Hydrocortamate.,increase,no risk
Cabergoline,Hydrocortisone,The metabolism of Cabergoline can be increased when combined with Hydrocortisone.,increase,no risk
Cabergoline,Hydrocortisone acetate,The metabolism of Cabergoline can be increased when combined with Hydrocortisone acetate.,increase,no risk
Cabergoline,Hydrocortisone butyrate,The metabolism of Cabergoline can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Cabergoline,Hydrocortisone succinate,The metabolism of Cabergoline can be increased when combined with Hydrocortisone succinate.,increase,no risk
Cabergoline,Hydroflumethiazide,Cabergoline may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Cabergoline,Hydromorphone,The risk or severity of CNS depression can be increased when Cabergoline is combined with Hydromorphone.,increase,risk
Cabergoline,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cabergoline.,increase,no risk
Cabergoline,Ketamine,The risk or severity of CNS depression can be increased when Cabergoline is combined with Ketamine.,increase,risk
Cabergoline,Ketazolam,The serum concentration of Cabergoline can be increased when it is combined with Ketazolam.,increase,no risk
Cabergoline,Ketoconazole,The metabolism of Cabergoline can be decreased when combined with Ketoconazole.,decrease,no risk
Cabergoline,Ketoprofen,The risk or severity of hypertension can be increased when Cabergoline is combined with Ketoprofen.,increase,risk
Cabergoline,Ketorolac,The risk or severity of hypertension can be increased when Cabergoline is combined with Ketorolac.,increase,risk
Cabergoline,Octreotide,The serum concentration of Cabergoline can be increased when it is combined with Octreotide.,increase,no risk
Cabergoline,Olanzapine,The therapeutic efficacy of Cabergoline can be decreased when used in combination with Olanzapine.,decrease,no risk
Cabergoline,Olaparib,The metabolism of Cabergoline can be decreased when combined with Olaparib.,decrease,no risk
Cabergoline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cabergoline is combined with Oliceridine.",increase,risk
Cabergoline,Olmesartan,Cabergoline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Cabergoline,Olodaterol,Cabergoline may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Cabergoline,Olutasidenib,The metabolism of Cabergoline can be increased when combined with Olutasidenib.,increase,no risk
Cabergoline,Omadacycline,The serum concentration of Cabergoline can be increased when it is combined with Omadacycline.,increase,no risk
Cabergoline,Omaveloxolone,The serum concentration of Cabergoline can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cabergoline,Ombitasvir,The serum concentration of Cabergoline can be increased when it is combined with Ombitasvir.,increase,no risk
Cabergoline,Ondansetron,The risk or severity of CNS depression can be increased when Cabergoline is combined with Ondansetron.,increase,risk
Cabergoline,Opium,The risk or severity of CNS depression can be increased when Cabergoline is combined with Opium.,increase,risk
Cabergoline,Orciprenaline,Cabergoline may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Cabergoline,Oritavancin,The metabolism of Cabergoline can be increased when combined with Oritavancin.,increase,no risk
Cabergoline,Orphenadrine,Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cabergoline,Osilodrostat,The metabolism of Cabergoline can be decreased when combined with Osilodrostat.,decrease,no risk
Cabergoline,Osimertinib,The metabolism of Cabergoline can be decreased when combined with Osimertinib.,decrease,no risk
Cabergoline,Oxaprozin,The risk or severity of hypertension can be increased when Cabergoline is combined with Oxaprozin.,increase,risk
Cabergoline,Oxazepam,The risk or severity of CNS depression can be increased when Cabergoline is combined with Oxazepam.,increase,risk
Cabergoline,Oxcarbazepine,The metabolism of Cabergoline can be increased when combined with Oxcarbazepine.,increase,no risk
Cabergoline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cabergoline is combined with Oxetacaine.,increase,risk
Cabergoline,Oxitriptan,The risk or severity of CNS depression can be increased when Cabergoline is combined with Oxitriptan.,increase,risk
Cabergoline,Oxprenolol,Oxprenolol may increase the vasoconstricting activities of Cabergoline.,increase,no risk
Cabergoline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cabergoline is combined with Oxybuprocaine.,increase,risk
Cabergoline,Oxybutynin,The serum concentration of Cabergoline can be increased when it is combined with Oxybutynin.,increase,no risk
Cabergoline,Oxycodone,The risk or severity of CNS depression can be increased when Cabergoline is combined with Oxycodone.,increase,risk
Cabergoline,Oxymetazoline,Cabergoline may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Cabergoline,Oxymorphone,The risk or severity of CNS depression can be increased when Cabergoline is combined with Oxymorphone.,increase,risk
Cabergoline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Cabergoline is combined with Oxyphenbutazone.,increase,risk
Cabergoline,Quazepam,The risk or severity of CNS depression can be increased when Cabergoline is combined with Quazepam.,increase,risk
Cabergoline,Quetiapine,The therapeutic efficacy of Cabergoline can be decreased when used in combination with Quetiapine.,decrease,no risk
Cabergoline,Quinagolide,The risk or severity of adverse effects can be decreased when Cabergoline is combined with Quinagolide.,decrease,risk
Cabergoline,Quinapril,Cabergoline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Cabergoline,Quinidine,The serum concentration of Cabergoline can be increased when it is combined with Quinidine.,increase,no risk
Cabergoline,Quinine,The serum concentration of Cabergoline can be increased when it is combined with Quinine.,increase,no risk
Cabergoline,Quinupramine,The risk or severity of CNS depression can be increased when Cabergoline is combined with Quinupramine.,increase,risk
Cabergoline,Quinupristin,The metabolism of Cabergoline can be decreased when combined with Quinupristin.,decrease,no risk
Cabergoline,Quizartinib,The serum concentration of Cabergoline can be increased when it is combined with Quizartinib.,increase,no risk
Cabergoline,Ubrogepant,The serum concentration of Cabergoline can be increased when it is combined with Ubrogepant.,increase,no risk
Cabergoline,Umbralisib,The serum concentration of Cabergoline can be increased when it is combined with Umbralisib.,increase,no risk
Cabergoline,Umeclidinium,The serum concentration of Cabergoline can be increased when it is combined with Umeclidinium.,increase,no risk
Cabergoline,Urethane,The risk or severity of CNS depression can be increased when Cabergoline is combined with Urethane.,increase,risk
Cabergoline,Vadadustat,The serum concentration of Cabergoline can be increased when it is combined with Vadadustat.,increase,no risk
Cabergoline,Valdecoxib,The risk or severity of hypertension can be increased when Cabergoline is combined with Valdecoxib.,increase,risk
Cabergoline,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cabergoline is combined with Valproate bismuth.,increase,risk
Cabergoline,Valproic acid,The serum concentration of Cabergoline can be increased when it is combined with Valproic acid.,increase,no risk
Cabergoline,Valsartan,Cabergoline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Cabergoline,Vandetanib,The serum concentration of Cabergoline can be increased when it is combined with Vandetanib.,increase,no risk
Cabergoline,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Cabergoline.,decrease,no risk
Cabergoline,Vecuronium,The risk or severity of CNS depression can be increased when Cabergoline is combined with Vecuronium.,increase,risk
Cabergoline,Velpatasvir,The serum concentration of Cabergoline can be increased when it is combined with Velpatasvir.,increase,no risk
Cabergoline,Vemurafenib,The serum concentration of Cabergoline can be increased when it is combined with Vemurafenib.,increase,no risk
Cabergoline,Venetoclax,The serum concentration of Cabergoline can be increased when it is combined with Venetoclax.,increase,no risk
Cabergoline,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Cabergoline is combined with Venlafaxine.,increase,risk
Cabergoline,Verapamil,The serum concentration of Cabergoline can be increased when it is combined with Verapamil.,increase,no risk
Cabergoline,Vibegron,Cabergoline may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Cabergoline,Vigabatrin,The risk or severity of CNS depression can be increased when Cabergoline is combined with Vigabatrin.,increase,risk
Cabergoline,Vilanterol,Cabergoline may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Cabergoline,Vilazodone,Cabergoline may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Cabergoline,Viloxazine,The metabolism of Cabergoline can be decreased when combined with Viloxazine.,decrease,no risk
Cabergoline,Vinblastine,The metabolism of Cabergoline can be increased when combined with Vinblastine.,increase,no risk
Cabergoline,Vincristine,The serum concentration of Cabergoline can be increased when it is combined with Vincristine.,increase,no risk
Cabergoline,Vinflunine,The serum concentration of Cabergoline can be increased when it is combined with Vinflunine.,increase,no risk
Cabergoline,Vitamin E,The metabolism of Cabergoline can be increased when combined with Vitamin E.,increase,no risk
Cabergoline,Voclosporin,The serum concentration of Cabergoline can be increased when it is combined with Voclosporin.,increase,no risk
Cabergoline,Vorapaxar,The serum concentration of Cabergoline can be increased when it is combined with Vorapaxar.,increase,no risk
Cabergoline,Voriconazole,The serum concentration of Cabergoline can be increased when it is combined with Voriconazole.,increase,no risk
Cabergoline,Vortioxetine,Cabergoline may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Cabergoline,Voxelotor,The serum concentration of Cabergoline can be increased when it is combined with Voxelotor.,increase,no risk
Cabergoline,Voxilaprevir,The serum concentration of Cabergoline can be increased when it is combined with Voxilaprevir.,increase,no risk
Cabergoline,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Cabergoline.,increase,no risk
Cabergoline,Xamoterol,Cabergoline may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Cabergoline,Xylometazoline,Cabergoline may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Cabergoline,Yohimbine,The risk or severity of CNS depression can be increased when Cabergoline is combined with Yohimbine.,increase,risk
Cabergoline,Zafirlukast,The serum concentration of Cabergoline can be increased when it is combined with Zafirlukast.,increase,no risk
Cabergoline,Zaleplon,The risk or severity of CNS depression can be increased when Cabergoline is combined with Zaleplon.,increase,risk
Cabergoline,Ziconotide,The risk or severity of CNS depression can be increased when Cabergoline is combined with Ziconotide.,increase,risk
Cabergoline,Zimelidine,The metabolism of Cabergoline can be decreased when combined with Zimelidine.,decrease,no risk
Cabergoline,Ziprasidone,The risk or severity of adverse effects can be increased when Cabergoline is combined with Ziprasidone.,increase,risk
Cabergoline,Zofenopril,Cabergoline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Cabergoline,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Cabergoline is combined with Zolmitriptan.,increase,risk
Cabergoline,Zolpidem,Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cabergoline,Zonisamide,The serum concentration of Cabergoline can be increased when it is combined with Zonisamide.,increase,no risk
Cabergoline,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Cabergoline.,decrease,no risk
Cabergoline,Zotepine,The therapeutic efficacy of Cabergoline can be decreased when used in combination with Zotepine.,decrease,no risk
Cabergoline,Zuclopenthixol,The therapeutic efficacy of Cabergoline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Cabergoline,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cabergoline.,increase,risk
Dapsone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Gemfibrozil,The metabolism of Dapsone can be decreased when combined with Gemfibrozil.,decrease,no risk
Dapsone,Ginkgo biloba,The metabolism of Dapsone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dapsone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Glimepiride,The metabolism of Dapsone can be decreased when combined with Glimepiride.,decrease,no risk
Dapsone,Glipizide,The metabolism of Glipizide can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Glofitamab,The serum concentration of Dapsone can be increased when it is combined with Glofitamab.,increase,no risk
Dapsone,Glyburide,The metabolism of Dapsone can be decreased when combined with Glyburide.,decrease,no risk
Dapsone,Golimumab,The metabolism of Dapsone can be increased when combined with Golimumab.,increase,no risk
Dapsone,Halofantrine,The risk or severity of adverse effects can be increased when Halofantrine is combined with Dapsone.,increase,risk
Dapsone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dapsone.,increase,no risk
Dapsone,Halothane,The metabolism of Halothane can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydrocortisone,The metabolism of Dapsone can be increased when combined with Hydrocortisone.,increase,no risk
Dapsone,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Dapsone.,increase,risk
Dapsone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Hydroxyurea.,increase,risk
Dapsone,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Ketamine,The metabolism of Ketamine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Ketoconazole,The metabolism of Dapsone can be decreased when combined with Ketoconazole.,decrease,no risk
Dapsone,Ketoprofen,The metabolism of Dapsone can be decreased when combined with Ketoprofen.,decrease,no risk
Dapsone,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Olanzapine,The metabolism of Dapsone can be decreased when combined with Olanzapine.,decrease,no risk
Dapsone,Olaparib,The metabolism of Olaparib can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Omaveloxolone,The serum concentration of Dapsone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dapsone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Oritavancin,The metabolism of Dapsone can be decreased when combined with Oritavancin.,decrease,no risk
Dapsone,Osilodrostat,The metabolism of Dapsone can be decreased when combined with Osilodrostat.,decrease,no risk
Dapsone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Oxandrolone,The metabolism of Dapsone can be decreased when combined with Oxandrolone.,decrease,no risk
Dapsone,Oxcarbazepine,The metabolism of Dapsone can be increased when combined with Oxcarbazepine.,increase,no risk
Dapsone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Oxetacaine.,increase,risk
Dapsone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Oxybuprocaine.,increase,risk
Dapsone,Oxybutynin,The metabolism of Dapsone can be decreased when combined with Oxybutynin.,decrease,no risk
Dapsone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Dapsone.,increase,risk
Dapsone,Quinine,The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Quinine.,increase,risk
Dapsone,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Udenafil,The metabolism of Udenafil can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Vadadustat,The serum concentration of Dapsone can be increased when it is combined with Vadadustat.,increase,no risk
Dapsone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Valdecoxib,The metabolism of Dapsone can be decreased when combined with Valdecoxib.,decrease,no risk
Dapsone,Valproic acid,The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Valproic acid.,increase,risk
Dapsone,Valsartan,The metabolism of Dapsone can be decreased when combined with Valsartan.,decrease,no risk
Dapsone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Dapsone.,increase,risk
Dapsone,Venetoclax,The metabolism of Dapsone can be decreased when combined with Venetoclax.,decrease,no risk
Dapsone,Verapamil,The metabolism of Dapsone can be decreased when combined with Verapamil.,decrease,no risk
Dapsone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dapsone.,decrease,no risk
Dapsone,Viloxazine,The metabolism of Dapsone can be decreased when combined with Viloxazine.,decrease,no risk
Dapsone,Vincristine,The metabolism of Vincristine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Voriconazole,The metabolism of Dapsone can be decreased when combined with Voriconazole.,decrease,no risk
Dapsone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Warfarin,The metabolism of Warfarin can be increased when combined with Dapsone.,increase,no risk
Dapsone,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Zafirlukast,The metabolism of Dapsone can be decreased when combined with Zafirlukast.,decrease,no risk
Dapsone,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Zileuton,The metabolism of Zileuton can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Zimelidine,The metabolism of Dapsone can be decreased when combined with Zimelidine.,decrease,no risk
Dapsone,Ziprasidone,The metabolism of Dapsone can be decreased when combined with Ziprasidone.,decrease,no risk
Dapsone,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Dapsone.,decrease,no risk
Dapsone,Zopiclone,The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Zopiclone.,increase,risk
Phenytoin,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.,increase,no risk
Phenytoin,Balsalazide,The serum concentration of Phenytoin can be increased when it is combined with Balsalazide.,increase,no risk
Phenytoin,Baricitinib,The metabolism of Baricitinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bazedoxifene,The serum concentration of Bazedoxifene can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Beclomethasone dipropionate,The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Bedaquiline,The serum concentration of Bedaquiline can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Belinostat,The metabolism of Belinostat can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Belzutifan,The metabolism of Belzutifan can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Benorilate,The serum concentration of Phenytoin can be increased when it is combined with Benorilate.,increase,no risk
Phenytoin,Benoxaprofen,The serum concentration of Phenytoin can be increased when it is combined with Benoxaprofen.,increase,no risk
Phenytoin,Benperidol,The risk or severity of CNS depression can be increased when Phenytoin is combined with Benperidol.,increase,risk
Phenytoin,Bentonite,Bentonite can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Bentoquatam,Bentoquatam can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Benzatropine,The metabolism of Phenytoin can be decreased when combined with Benzatropine.,decrease,no risk
Phenytoin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Benzocaine.,increase,risk
Phenytoin,Benzphetamine,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Benzphetamine.,decrease,no risk
Phenytoin,Benzydamine,The serum concentration of Phenytoin can be increased when it is combined with Benzydamine.,increase,no risk
Phenytoin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Benzyl alcohol.,increase,risk
Phenytoin,Bepridil,The metabolism of Bepridil can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Berotralstat,The metabolism of Phenytoin can be decreased when combined with Berotralstat.,decrease,no risk
Phenytoin,Betamethasone,The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Betaxolol,The metabolism of Phenytoin can be decreased when combined with Betaxolol.,decrease,no risk
Phenytoin,Bexagliflozin,The metabolism of Bexagliflozin can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bexarotene,The metabolism of Phenytoin can be decreased when combined with Bexarotene.,decrease,no risk
Phenytoin,Bezafibrate,The metabolism of Phenytoin can be decreased when combined with Bezafibrate.,decrease,no risk
Phenytoin,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bictegravir,The metabolism of Bictegravir can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bifonazole,The metabolism of Phenytoin can be decreased when combined with Bifonazole.,decrease,no risk
Phenytoin,Bimekizumab,The metabolism of Phenytoin can be increased when combined with Bimekizumab.,increase,no risk
Phenytoin,Binimetinib,The metabolism of Binimetinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Biperiden,The metabolism of Phenytoin can be decreased when combined with Biperiden.,decrease,no risk
Phenytoin,Bismuth subsalicylate,The protein binding of Phenytoin can be decreased when combined with Bismuth subsalicylate.,decrease,no risk
Phenytoin,Bisoprolol,The metabolism of Bisoprolol can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bleomycin,The serum concentration of Phenytoin can be decreased when it is combined with Bleomycin.,decrease,no risk
Phenytoin,Boceprevir,The serum concentration of Boceprevir can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Borage oil,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Borage oil.,decrease,no risk
Phenytoin,Bortezomib,The metabolism of Bortezomib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bosentan,The metabolism of Phenytoin can be increased when combined with Bosentan.,increase,no risk
Phenytoin,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Phenytoin.,increase,risk
Phenytoin,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Brexanolone,The risk or severity of CNS depression can be increased when Phenytoin is combined with Brexanolone.,increase,risk
Phenytoin,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Brigatinib,The metabolism of Brigatinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.,increase,no risk
Phenytoin,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bromazepam,The serum concentration of Phenytoin can be increased when it is combined with Bromazepam.,increase,no risk
Phenytoin,Bromocriptine,The metabolism of Bromocriptine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Bromperidol,The risk or severity of CNS depression can be increased when Phenytoin is combined with Bromperidol.,increase,risk
Phenytoin,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Budesonide,The serum concentration of Budesonide can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Bumadizone,The serum concentration of Phenytoin can be increased when it is combined with Bumadizone.,increase,no risk
Phenytoin,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Bumetanide.",increase,risk
Phenytoin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Bupivacaine.,increase,risk
Phenytoin,Buprenorphine,Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Phenytoin,Bupropion,The metabolism of Phenytoin can be decreased when combined with Bupropion.,decrease,no risk
Phenytoin,Buspirone,The metabolism of Buspirone can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Busulfan,The serum concentration of Busulfan can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Phenytoin.,increase,risk
Phenytoin,Butacaine,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Butacaine.,increase,risk
Phenytoin,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Phenytoin.,increase,risk
Phenytoin,Butamben,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Butamben.,increase,risk
Phenytoin,Butaperazine,The serum concentration of Phenytoin can be increased when it is combined with Butaperazine.,increase,no risk
Phenytoin,Butobarbital,The risk or severity of CNS depression can be increased when Phenytoin is combined with Butobarbital.,increase,risk
Phenytoin,Butorphanol,The risk or severity of CNS depression can be increased when Phenytoin is combined with Butorphanol.,increase,risk
Phenytoin,Butriptyline,The risk or severity of CNS depression can be increased when Phenytoin is combined with Butriptyline.,increase,risk
Phenytoin,Gabapentin,The risk or severity of CNS depression can be increased when Phenytoin is combined with Gabapentin.,increase,risk
Phenytoin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Phenytoin is combined with Gabapentin enacarbil.,increase,risk
Phenytoin,Galantamine,The metabolism of Galantamine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Gamolenic acid,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Phenytoin,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ganciclovir.",increase,risk
Phenytoin,Gefitinib,The metabolism of Gefitinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Gemfibrozil,The metabolism of Phenytoin can be decreased when combined with Gemfibrozil.,decrease,no risk
Phenytoin,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ginkgo biloba,The metabolism of Phenytoin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Phenytoin,Givosiran,The serum concentration of Phenytoin can be increased when it is combined with Givosiran.,increase,no risk
Phenytoin,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Glecaprevir,The metabolism of Phenytoin can be decreased when combined with Glecaprevir.,decrease,no risk
Phenytoin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Glofitamab,The serum concentration of Phenytoin can be increased when it is combined with Glofitamab.,increase,no risk
Phenytoin,Glutethimide,The risk or severity of CNS depression can be increased when Phenytoin is combined with Glutethimide.,increase,risk
Phenytoin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Glycerin,The metabolism of Phenytoin can be increased when combined with Glycerin.,increase,no risk
Phenytoin,Glycerol phenylbutyrate,The metabolism of Phenytoin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Phenytoin,Glycol salicylate,The serum concentration of Phenytoin can be increased when it is combined with Glycol salicylate.,increase,no risk
Phenytoin,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Golimumab,The metabolism of Phenytoin can be increased when combined with Golimumab.,increase,no risk
Phenytoin,Granisetron,The metabolism of Granisetron can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Guanfacine,The metabolism of Guanfacine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Halazepam,The serum concentration of Phenytoin can be increased when it is combined with Halazepam.,increase,no risk
Phenytoin,Halcinonide,The serum concentration of Halcinonide can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Halofantrine,The metabolism of Phenytoin can be decreased when combined with Halofantrine.,decrease,no risk
Phenytoin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Phenytoin.,increase,risk
Phenytoin,Halothane,The serum concentration of Phenytoin can be increased when it is combined with Halothane.,increase,no risk
Phenytoin,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Phenytoin.,increase,no risk
Phenytoin,Hexafluronium,The risk or severity of CNS depression can be increased when Phenytoin is combined with Hexafluronium.,increase,risk
Phenytoin,Hyaluronidase,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Hyaluronidase.,decrease,no risk
Phenytoin,Hyaluronidase (human recombinant),The therapeutic efficacy of Phenytoin can be decreased when used in combination with Hyaluronidase (human recombinant).,decrease,no risk
Phenytoin,Hyaluronidase (ovine),The therapeutic efficacy of Phenytoin can be decreased when used in combination with Hyaluronidase (ovine).,decrease,no risk
Phenytoin,Hydrocodone,Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Phenytoin,Hydrocortisone,The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Hydromorphone,The risk or severity of CNS depression can be increased when Phenytoin is combined with Hydromorphone.,increase,risk
Phenytoin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Hydroxychloroquine,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Phenytoin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Hydroxyurea.,increase,risk
Phenytoin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.,increase,no risk
Phenytoin,Kaolin,Kaolin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Ketamine,The metabolism of Phenytoin can be decreased when combined with Ketamine.,decrease,no risk
Phenytoin,Ketazolam,The metabolism of Ketazolam can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ketoconazole,The serum concentration of Phenytoin can be increased when it is combined with Ketoconazole.,increase,no risk
Phenytoin,Ketoprofen,The serum concentration of Phenytoin can be increased when it is combined with Ketoprofen.,increase,no risk
Phenytoin,Ketorolac,The serum concentration of Phenytoin can be increased when it is combined with Ketorolac.,increase,no risk
Phenytoin,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ofloxacin.",increase,risk
Phenytoin,Olanzapine,The metabolism of Phenytoin can be decreased when combined with Olanzapine.,decrease,no risk
Phenytoin,Olaparib,The metabolism of Olaparib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Phenytoin is combined with Oliceridine.",increase,risk
Phenytoin,Olodaterol,The metabolism of Phenytoin can be decreased when combined with Olodaterol.,decrease,no risk
Phenytoin,Olsalazine,The protein binding of Phenytoin can be decreased when combined with Olsalazine.,decrease,no risk
Phenytoin,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Ombitasvir,The metabolism of Phenytoin can be decreased when combined with Ombitasvir.,decrease,no risk
Phenytoin,Omeprazole,The serum concentration of Phenytoin can be increased when it is combined with Omeprazole.,increase,no risk
Phenytoin,Ondansetron,The metabolism of Ondansetron can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Opicapone,The metabolism of Phenytoin can be decreased when combined with Opicapone.,decrease,no risk
Phenytoin,Opium,The metabolism of Opium can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Oritavancin,The metabolism of Phenytoin can be decreased when combined with Oritavancin.,decrease,no risk
Phenytoin,Orlistat,Orlistat can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Orphenadrine,Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Phenytoin,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ospemifene,The metabolism of Ospemifene can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Oxaliplatin,Oxaliplatin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Oxamniquine,The metabolism of Phenytoin can be decreased when combined with Oxamniquine.,decrease,no risk
Phenytoin,Oxandrolone,The metabolism of Phenytoin can be decreased when combined with Oxandrolone.,decrease,no risk
Phenytoin,Oxaprozin,The serum concentration of Phenytoin can be increased when it is combined with Oxaprozin.,increase,no risk
Phenytoin,Oxazepam,The serum concentration of Phenytoin can be increased when it is combined with Oxazepam.,increase,no risk
Phenytoin,Oxcarbazepine,The serum concentration of Phenytoin can be increased when it is combined with Oxcarbazepine.,increase,no risk
Phenytoin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Oxetacaine.,increase,risk
Phenytoin,Oxitriptan,The risk or severity of CNS depression can be increased when Phenytoin is combined with Oxitriptan.,increase,risk
Phenytoin,Oxprenolol,The risk or severity of CNS depression can be increased when Phenytoin is combined with Oxprenolol.,increase,risk
Phenytoin,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Oxybuprocaine.,increase,risk
Phenytoin,Oxybutynin,The metabolism of Phenytoin can be decreased when combined with Oxybutynin.,decrease,no risk
Phenytoin,Oxycodone,The metabolism of Oxycodone can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Oxymetholone,The therapeutic efficacy of Phenytoin can be increased when used in combination with Oxymetholone.,increase,no risk
Phenytoin,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Oxyphenbutazone,The serum concentration of Phenytoin can be increased when it is combined with Oxyphenbutazone.,increase,no risk
Phenytoin,Ozanimod,The metabolism of Phenytoin can be decreased when combined with Ozanimod.,decrease,no risk
Phenytoin,Quazepam,The metabolism of Quazepam can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Quetiapine,The metabolism of Quetiapine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Quinestrol,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Quinestrol.,decrease,no risk
Phenytoin,Quinidine,The serum concentration of Quinidine can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Quinine,The serum concentration of Quinine can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Quinupramine,The risk or severity of CNS depression can be increased when Phenytoin is combined with Quinupramine.,increase,risk
Phenytoin,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ubidecarenone.",increase,risk
Phenytoin,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Udenafil,The metabolism of Udenafil can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ulobetasol,The serum concentration of Ulobetasol can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Phenytoin.,decrease,no risk
Phenytoin,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Urethane,The risk or severity of CNS depression can be increased when Phenytoin is combined with Urethane.,increase,risk
Phenytoin,Vadadustat,The serum concentration of Phenytoin can be increased when it is combined with Vadadustat.,increase,no risk
Phenytoin,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Valdecoxib,The serum concentration of Phenytoin can be increased when it is combined with Valdecoxib.,increase,no risk
Phenytoin,Valganciclovir,The therapeutic efficacy of Phenytoin can be decreased when used in combination with Valganciclovir.,decrease,no risk
Phenytoin,Valproic acid,The serum concentration of Phenytoin can be decreased when it is combined with Valproic acid.,decrease,no risk
Phenytoin,Valsartan,The metabolism of Phenytoin can be decreased when combined with Valsartan.,decrease,no risk
Phenytoin,Vamorolone,The serum concentration of Vamorolone can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vardenafil,The metabolism of Vardenafil can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vayarin,The metabolism of Phenytoin can be decreased when combined with Vayarin.,decrease,no risk
Phenytoin,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Velpatasvir,The metabolism of Phenytoin can be decreased when combined with Velpatasvir.,decrease,no risk
Phenytoin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Venlafaxine,The metabolism of Phenytoin can be decreased when combined with Venlafaxine.,decrease,no risk
Phenytoin,Verapamil,The serum concentration of Verapamil can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Vericiguat,The metabolism of Vericiguat can be decreased when combined with Phenytoin.,decrease,no risk
Phenytoin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Phenytoin.,decrease,no risk
Phenytoin,Vigabatrin,The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.,decrease,no risk
Phenytoin,Vilanterol,The metabolism of Vilanterol can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vilazodone,The metabolism of Vilazodone can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Viloxazine,The metabolism of Phenytoin can be decreased when combined with Viloxazine.,decrease,no risk
Phenytoin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vincristine,The serum concentration of Vincristine can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Vindesine,The serum concentration of Phenytoin can be decreased when it is combined with Vindesine.,decrease,no risk
Phenytoin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vitamin D,The serum concentration of Vitamin D can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Vitamin E,The metabolism of Vitamin E can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Voclosporin,The metabolism of Voclosporin can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Phenytoin.,decrease,no risk
Phenytoin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Phenytoin.,decrease,no risk
Phenytoin,Voxilaprevir,The metabolism of Phenytoin can be decreased when combined with Voxilaprevir.,decrease,no risk
Phenytoin,Warfarin,The metabolism of Warfarin can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Phenytoin.,decrease,no risk
Phenytoin,Xylometazoline,The serum concentration of Phenytoin can be increased when it is combined with Xylometazoline.,increase,no risk
Phenytoin,Yohimbine,The metabolism of Yohimbine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Zafirlukast,The metabolism of Phenytoin can be decreased when combined with Zafirlukast.,decrease,no risk
Phenytoin,Zaleplon,The metabolism of Zaleplon can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Ziconotide,The risk or severity of CNS depression can be increased when Phenytoin is combined with Ziconotide.,increase,risk
Phenytoin,Zidovudine,The metabolism of Phenytoin can be decreased when combined with Zidovudine.,decrease,no risk
Phenytoin,Zileuton,The metabolism of Zileuton can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Zimelidine,The risk or severity of adverse effects can be increased when Phenytoin is combined with Zimelidine.,increase,risk
Phenytoin,Zinc,Zinc can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenytoin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Phenytoin,Ziprasidone,The risk or severity of adverse effects can be increased when Phenytoin is combined with Ziprasidone.,increase,risk
Phenytoin,Zolmitriptan,The risk or severity of CNS depression can be increased when Phenytoin is combined with Zolmitriptan.,increase,risk
Phenytoin,Zolpidem,Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Phenytoin,Zonisamide,Phenytoin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Phenytoin,Zopiclone,The metabolism of Phenytoin can be decreased when combined with Zopiclone.,decrease,no risk
Phenytoin,Zotepine,The metabolism of Zotepine can be increased when combined with Phenytoin.,increase,no risk
Phenytoin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Phenytoin.,increase,no risk
Medrysone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Medrysone.,increase,risk
Medrysone,Vadadustat,The serum concentration of Medrysone can be increased when it is combined with Vadadustat.,increase,no risk
Medrysone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Medrysone.,decrease,no risk
Medrysone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Vildagliptin.,increase,risk
Medrysone,Viloxazine,The metabolism of Medrysone can be decreased when combined with Viloxazine.,decrease,no risk
Medrysone,Voriconazole,The serum concentration of Medrysone can be increased when it is combined with Voriconazole.,increase,no risk
Doxycycline,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Doxycycline is combined with Botulinum toxin type B.,increase,risk
Doxycycline,Brivaracetam,Doxycycline may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Doxycycline,Bromazepam,Doxycycline may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Doxycycline,Bromotheophylline,Bromotheophylline may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doxycycline,Budesonide,Doxycycline may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Doxycycline,Bumadizone,Bumadizone may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Bumetanide,Bumetanide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doxycycline,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Bupivacaine.,increase,risk
Doxycycline,Bupropion,Doxycycline may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Doxycycline,Buspirone,Doxycycline may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Doxycycline,Butabarbital,The serum concentration of Doxycycline can be decreased when it is combined with Butabarbital.,decrease,no risk
Doxycycline,Butacaine,The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Butacaine.,increase,risk
Doxycycline,Butalbital,The serum concentration of Doxycycline can be decreased when it is combined with Butalbital.,decrease,no risk
Doxycycline,Butamben,The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Butamben.,increase,risk
Doxycycline,Gabapentin enacarbil,Doxycycline may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Doxycycline,Gadobenic acid,Doxycycline may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Doxycycline,Gadodiamide,Gadodiamide may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Gadofosveset trisodium,Doxycycline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Doxycycline,Gadopentetic acid,Doxycycline may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Doxycycline,Gadoteric acid,Doxycycline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Doxycycline,Gadoteridol,Doxycycline may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Doxycycline,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Doxycycline.,increase,no risk
Doxycycline,Ganciclovir,Doxycycline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Doxycycline,Gemcitabine,Doxycycline may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Doxycycline,Gemfibrozil,Doxycycline may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Doxycycline,Gentamicin,Doxycycline may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Doxycycline,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Doxycycline.,decrease,no risk
Doxycycline,Gimeracil,Doxycycline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Doxycycline,Givosiran,Givosiran may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Glipizide,Doxycycline may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Doxycycline,Glycerol phenylbutyrate,Doxycycline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Doxycycline,Golodirsen,Doxycycline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Doxycycline,Goserelin,Goserelin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Guanethidine,Doxycycline may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Doxycycline,Guanfacine,Doxycycline may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Doxycycline,Haloperidol,Doxycycline may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Doxycycline,Heparin,The risk or severity of bleeding can be increased when Doxycycline is combined with Heparin.,increase,risk
Doxycycline,Hetacillin,The therapeutic efficacy of Hetacillin can be decreased when used in combination with Doxycycline.,decrease,no risk
Doxycycline,Hydralazine,Doxycycline may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Doxycycline,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doxycycline,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doxycycline,Hydromorphone,Doxycycline may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Doxycycline,Hydrotalcite,The absorption of Doxycycline can be decreased when combined with Hydrotalcite.,decrease,no risk
Doxycycline,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Hydroxyethyl Starch,Doxycycline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Doxycycline,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Doxycycline.,decrease,no risk
Doxycycline,Kanamycin,Doxycycline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Doxycycline,Ketamine,Doxycycline may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Doxycycline,Ketazolam,Doxycycline may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Doxycycline,Ketoprofen,Ketoprofen may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Ketorolac,Ketorolac may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Octinoxate,Doxycycline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Doxycycline,Olsalazine,Olsalazine may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Omeprazole,Omeprazole can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Doxycycline,Opium,Doxycycline may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Doxycycline,Oseltamivir,Oseltamivir may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Doxycycline.,decrease,no risk
Doxycycline,Oxaprozin,Oxaprozin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Oxazepam,Doxycycline may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Doxycycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Oxetacaine.,increase,risk
Doxycycline,Oxybenzone,Doxycycline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Doxycycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Oxybuprocaine.,increase,risk
Doxycycline,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Oxyquinoline,Doxycycline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Doxycycline,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Doxycycline is combined with Oxytetracycline.,increase,risk
Doxycycline,Quetiapine,Doxycycline may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Doxycycline,Quinapril,Quinapril can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Doxycycline,Quinethazone,Quinethazone may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doxycycline,Quinidine,Doxycycline may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Doxycycline,Quinine,The risk or severity of neuromuscular blockade can be increased when Doxycycline is combined with Quinine.,increase,risk
Doxycycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Doxycycline.,decrease,no risk
Doxycycline,Urokinase,The risk or severity of bleeding can be increased when Doxycycline is combined with Urokinase.,increase,risk
Doxycycline,Vaborbactam,Doxycycline may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Doxycycline,Valaciclovir,Valaciclovir may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Valbenazine,Doxycycline may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Doxycycline,Valdecoxib,Valdecoxib may decrease the excretion rate of Doxycycline which could result in a higher serum level.,decrease,no risk
Doxycycline,Valganciclovir,Doxycycline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Doxycycline,Vancomycin,Doxycycline may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Doxycycline,Varenicline,Doxycycline may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Doxycycline,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Doxycycline.,increase,no risk
Doxycycline,Venlafaxine,Doxycycline may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Doxycycline,Verapamil,Doxycycline may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Doxycycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Doxycycline.,decrease,no risk
Doxycycline,Vilanterol,Doxycycline may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Doxycycline,Viloxazine,Doxycycline may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Doxycycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Doxycycline is combined with Viomycin.,increase,risk
Doxycycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Doxycycline.,increase,risk
Doxycycline,Vorapaxar,The risk or severity of bleeding can be increased when Doxycycline is combined with Vorapaxar.,increase,risk
Doxycycline,Vortioxetine,Doxycycline may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Doxycycline,Warfarin,The risk or severity of bleeding can be increased when Doxycycline is combined with Warfarin.,increase,risk
Doxycycline,Ximelagatran,The risk or severity of bleeding can be increased when Doxycycline is combined with Ximelagatran.,increase,risk
Doxycycline,Zaleplon,Doxycycline may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Doxycycline,Zanamivir,Doxycycline may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Doxycycline,Zinc ascorbate,The therapeutic efficacy of Doxycycline can be decreased when used in combination with Zinc ascorbate.,decrease,no risk
Doxycycline,Zonisamide,Zonisamide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Diethylstilbestrol,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Besilesomab,Diethylstilbestrol may increase the thrombogenic activities of Besilesomab.,increase,no risk
Diethylstilbestrol,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Betrixaban,Diethylstilbestrol may decrease the anticoagulant activities of Betrixaban.,decrease,no risk
Diethylstilbestrol,Bevacizumab,Diethylstilbestrol may increase the thrombogenic activities of Bevacizumab.,increase,no risk
Diethylstilbestrol,Bexarotene,The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Bexarotene.,decrease,no risk
Diethylstilbestrol,Bezafibrate,The metabolism of Diethylstilbestrol can be decreased when combined with Bezafibrate.,decrease,no risk
Diethylstilbestrol,Bezlotoxumab,Diethylstilbestrol may increase the thrombogenic activities of Bezlotoxumab.,increase,no risk
Diethylstilbestrol,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Bimekizumab,The metabolism of Diethylstilbestrol can be increased when combined with Bimekizumab.,increase,no risk
Diethylstilbestrol,Binimetinib,Diethylstilbestrol may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Bivalirudin,Diethylstilbestrol may decrease the anticoagulant activities of Bivalirudin.,decrease,no risk
Diethylstilbestrol,Blinatumomab,Diethylstilbestrol may increase the thrombogenic activities of Blinatumomab.,increase,no risk
Diethylstilbestrol,Boceprevir,The serum concentration of Diethylstilbestrol can be increased when it is combined with Boceprevir.,increase,no risk
Diethylstilbestrol,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Bosentan,The serum concentration of Diethylstilbestrol can be decreased when it is combined with Bosentan.,decrease,no risk
Diethylstilbestrol,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Brexanolone,The metabolism of Diethylstilbestrol can be increased when combined with Brexanolone.,increase,no risk
Diethylstilbestrol,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Brivaracetam,The metabolism of Diethylstilbestrol can be increased when combined with Brivaracetam.,increase,no risk
Diethylstilbestrol,Brodalumab,Diethylstilbestrol may increase the thrombogenic activities of Brodalumab.,increase,no risk
Diethylstilbestrol,Brolucizumab,Diethylstilbestrol may increase the thrombogenic activities of Brolucizumab.,increase,no risk
Diethylstilbestrol,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Bupropion,The metabolism of Bupropion can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Burosumab,Diethylstilbestrol may increase the thrombogenic activities of Burosumab.,increase,no risk
Diethylstilbestrol,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Butabarbital,The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Butabarbital.,decrease,no risk
Diethylstilbestrol,Butalbital,The metabolism of Diethylstilbestrol can be increased when combined with Butalbital.,increase,no risk
Diethylstilbestrol,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Gabapentin,The metabolism of Diethylstilbestrol can be increased when combined with Gabapentin.,increase,no risk
Diethylstilbestrol,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Galcanezumab,Diethylstilbestrol may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Diethylstilbestrol,Ganaxolone,The metabolism of Diethylstilbestrol can be increased when combined with Ganaxolone.,increase,no risk
Diethylstilbestrol,Gefitinib,Diethylstilbestrol may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Gemfibrozil,The metabolism of Diethylstilbestrol can be decreased when combined with Gemfibrozil.,decrease,no risk
Diethylstilbestrol,Gemtuzumab ozogamicin,Diethylstilbestrol may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Diethylstilbestrol,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Glasdegib,Diethylstilbestrol may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Glecaprevir,Diethylstilbestrol may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Glofitamab,The serum concentration of Diethylstilbestrol can be increased when it is combined with Glofitamab.,increase,no risk
Diethylstilbestrol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Glycerol phenylbutyrate,The metabolism of Diethylstilbestrol can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Diethylstilbestrol,Glycyrrhizic acid,Diethylstilbestrol may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Golimumab,The metabolism of Diethylstilbestrol can be increased when combined with Golimumab.,increase,no risk
Diethylstilbestrol,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Griseofulvin,The metabolism of Diethylstilbestrol can be increased when combined with Griseofulvin.,increase,no risk
Diethylstilbestrol,Guselkumab,Diethylstilbestrol may increase the thrombogenic activities of Guselkumab.,increase,no risk
Diethylstilbestrol,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Halothane,The metabolism of Halothane can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Hepatitis B immune globulin,Diethylstilbestrol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Diethylstilbestrol,Hetacillin,The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Hetacillin.,decrease,no risk
Diethylstilbestrol,Human cytomegalovirus immune globulin,Diethylstilbestrol may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Diethylstilbestrol,Human immunoglobulin G,Diethylstilbestrol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Diethylstilbestrol,Human Rho(D) immune globulin,Diethylstilbestrol may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Diethylstilbestrol,Human varicella-zoster immune globulin,Diethylstilbestrol may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Diethylstilbestrol,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Hydrocortamate,The metabolism of Diethylstilbestrol can be increased when combined with Hydrocortamate.,increase,no risk
Diethylstilbestrol,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Ketamine,The metabolism of Ketamine can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Ketoconazole,The metabolism of Diethylstilbestrol can be decreased when combined with Ketoconazole.,decrease,no risk
Diethylstilbestrol,Ketoprofen,The metabolism of Diethylstilbestrol can be decreased when combined with Ketoprofen.,decrease,no risk
Diethylstilbestrol,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Obiltoxaximab,Diethylstilbestrol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Diethylstilbestrol,Obinutuzumab,Diethylstilbestrol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Diethylstilbestrol,Ocrelizumab,Diethylstilbestrol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Diethylstilbestrol,Odesivimab,Diethylstilbestrol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Diethylstilbestrol,Ofatumumab,Diethylstilbestrol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Diethylstilbestrol,Ofloxacin,Diethylstilbestrol may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Olaratumab,Diethylstilbestrol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Diethylstilbestrol,Olmesartan,Olmesartan may decrease the excretion rate of Diethylstilbestrol which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Olutasidenib,The metabolism of Diethylstilbestrol can be increased when combined with Olutasidenib.,increase,no risk
Diethylstilbestrol,Omadacycline,The serum concentration of Diethylstilbestrol can be decreased when it is combined with Omadacycline.,decrease,no risk
Diethylstilbestrol,Omalizumab,Diethylstilbestrol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Diethylstilbestrol,Omaveloxolone,The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Diethylstilbestrol,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Diethylstilbestrol is combined with Ombitasvir.,increase,risk
Diethylstilbestrol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Opicapone,The metabolism of Diethylstilbestrol can be decreased when combined with Opicapone.,decrease,no risk
Diethylstilbestrol,Oritavancin,The metabolism of Diethylstilbestrol can be increased when combined with Oritavancin.,increase,no risk
Diethylstilbestrol,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Ospemifene,The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Ospemifene.,increase,risk
Diethylstilbestrol,Ouabain,The excretion of Ouabain can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Oxacillin,The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Oxacillin.,decrease,no risk
Diethylstilbestrol,Oxaliplatin,Diethylstilbestrol may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Oxcarbazepine,The metabolism of Diethylstilbestrol can be increased when combined with Oxcarbazepine.,increase,no risk
Diethylstilbestrol,Oxybutynin,The metabolism of Diethylstilbestrol can be decreased when combined with Oxybutynin.,decrease,no risk
Diethylstilbestrol,Oxytetracycline,The serum concentration of Diethylstilbestrol can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Diethylstilbestrol,Ozanimod,Diethylstilbestrol may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Quinine,The metabolism of Diethylstilbestrol can be decreased when combined with Quinine.,decrease,no risk
Diethylstilbestrol,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Ublituximab,Diethylstilbestrol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Diethylstilbestrol,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Urokinase,Diethylstilbestrol may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Diethylstilbestrol,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Diethylstilbestrol which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Ustekinumab,Diethylstilbestrol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Diethylstilbestrol,Vadadustat,The serum concentration of Diethylstilbestrol can be increased when it is combined with Vadadustat.,increase,no risk
Diethylstilbestrol,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Valproic acid,The metabolism of Diethylstilbestrol can be increased when combined with Valproic acid.,increase,no risk
Diethylstilbestrol,Valsartan,The metabolism of Valsartan can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Vedolizumab,Diethylstilbestrol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Diethylstilbestrol,Velpatasvir,Diethylstilbestrol may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Verapamil,The metabolism of Diethylstilbestrol can be decreased when combined with Verapamil.,decrease,no risk
Diethylstilbestrol,Vigabatrin,The metabolism of Diethylstilbestrol can be increased when combined with Vigabatrin.,increase,no risk
Diethylstilbestrol,Viloxazine,The metabolism of Diethylstilbestrol can be decreased when combined with Viloxazine.,decrease,no risk
Diethylstilbestrol,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Vitamin A,The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Vitamin A.,decrease,no risk
Diethylstilbestrol,Vitamin E,The metabolism of Diethylstilbestrol can be increased when combined with Vitamin E.,increase,no risk
Diethylstilbestrol,Vorapaxar,Diethylstilbestrol may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Diethylstilbestrol,Voriconazole,The metabolism of Diethylstilbestrol can be decreased when combined with Voriconazole.,decrease,no risk
Diethylstilbestrol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Voxilaprevir,Diethylstilbestrol may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Ximelagatran,Diethylstilbestrol may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Diethylstilbestrol,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Zaleplon,The metabolism of Diethylstilbestrol can be increased when combined with Zaleplon.,increase,no risk
Diethylstilbestrol,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Diethylstilbestrol.,increase,no risk
Diethylstilbestrol,Zidovudine,Diethylstilbestrol may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Diethylstilbestrol,Zileuton,The metabolism of Zileuton can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Zimelidine,The metabolism of Diethylstilbestrol can be decreased when combined with Zimelidine.,decrease,no risk
Diethylstilbestrol,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Ziprasidone,The metabolism of Diethylstilbestrol can be decreased when combined with Ziprasidone.,decrease,no risk
Diethylstilbestrol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Diethylstilbestrol,Zonisamide,The metabolism of Diethylstilbestrol can be increased when combined with Zonisamide.,increase,no risk
Diethylstilbestrol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Diethylstilbestrol.,decrease,no risk
Lymecycline,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Lymecycline.,increase,no risk
Lymecycline,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Gentamicin.,increase,risk
Lymecycline,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Lymecycline.,decrease,no risk
Lymecycline,Hetacillin,The therapeutic efficacy of Hetacillin can be decreased when used in combination with Lymecycline.,decrease,no risk
Lymecycline,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Lymecycline.,decrease,no risk
Lymecycline,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Kanamycin.,increase,risk
Lymecycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Lymecycline.,decrease,no risk
Lymecycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lymecycline is combined with Oxetacaine.,increase,risk
Lymecycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lymecycline is combined with Oxybuprocaine.,increase,risk
Lymecycline,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Oxytetracycline.,increase,risk
Lymecycline,Quinapril,Quinapril can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Quinidine,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Quinidine.,increase,risk
Lymecycline,Quinine,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Quinine.,increase,risk
Lymecycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Lymecycline.,decrease,no risk
Lymecycline,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Vancomycin.,increase,risk
Lymecycline,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Lymecycline.,increase,no risk
Lymecycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Lymecycline.,decrease,no risk
Lymecycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Viomycin.,increase,risk
Lymecycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Lymecycline is combined with Vitamin A.,increase,risk
Lymecycline,Warfarin,Lymecycline may increase the anticoagulant activities of Warfarin.,increase,no risk
Lymecycline,Zinc,Zinc can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lymecycline,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Clotrimazole,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Clotrimazole.,increase,no risk
Calcium acetate,Ofloxacin,Calcium acetate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium acetate,Omadacycline,The serum concentration of Omadacycline can be decreased when it is combined with Calcium acetate.,decrease,no risk
Calcium acetate,Ouabain,Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Ouabain.,increase,no risk
Calcium acetate,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Calcium acetate.,decrease,no risk
Calcium acetate,Oxytetracycline,The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium acetate.,decrease,no risk
Calcium acetate,Quinethazone,Quinethazone may decrease the excretion rate of Calcium acetate which could result in a higher serum level.,decrease,no risk
Calcium acetate,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium acetate.,decrease,no risk
Calcium acetate,Vitamin D,The risk or severity of adverse effects can be increased when Vitamin D is combined with Calcium acetate.,increase,risk
Calcium acetate,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Calcium acetate.,decrease,no risk
Calcium acetate,Ziconotide,The therapeutic efficacy of Ziconotide can be decreased when used in combination with Calcium acetate.,decrease,no risk
Calcium acetate,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium acetate.,decrease,no risk
Calcium acetate,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Calcium acetate.,decrease,no risk
Sulfanilamide,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Sulfanilamide.,increase,no risk
Sulfanilamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Benzocaine.,increase,risk
Sulfanilamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Benzyl alcohol.,increase,risk
Sulfanilamide,Benzylpenicillin,Sulfanilamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Sulfanilamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Bupivacaine.,increase,risk
Sulfanilamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Butacaine.,increase,risk
Sulfanilamide,Butamben,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Butamben.,increase,risk
Sulfanilamide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sulfanilamide.,increase,no risk
Sulfanilamide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sulfanilamide.,increase,no risk
Sulfanilamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Oxetacaine.,increase,risk
Sulfanilamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Oxybuprocaine.,increase,risk
Sulfanilamide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfanilamide.,decrease,no risk
Sulfanilamide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Sulfanilamide.,increase,no risk
Cycloserine,Quinupramine,Cycloserine may increase the neurotoxic activities of Quinupramine.,increase,no risk
Cycloserine,Valproate bismuth,Cycloserine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Cycloserine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cycloserine.,decrease,no risk
Cycloserine,Vincristine,Cycloserine may increase the neurotoxic activities of Vincristine.,increase,no risk
Cycloserine,Vinorelbine,Cycloserine may increase the neurotoxic activities of Vinorelbine.,increase,no risk
Cycloserine,Viomycin,Cycloserine may increase the neurotoxic activities of Viomycin.,increase,no risk
Cycloserine,Warfarin,The risk or severity of bleeding can be increased when Cycloserine is combined with Warfarin.,increase,risk
Cycloserine,Ziprasidone,Ziprasidone may increase the neurotoxic activities of Cycloserine.,increase,no risk
Cycloserine,Zotepine,Cycloserine may increase the neurotoxic activities of Zotepine.,increase,no risk
Cycloserine,Zuclopenthixol,Cycloserine may increase the neurotoxic activities of Zuclopenthixol.,increase,no risk
Anagrelide,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Anagrelide.,increase,risk
Anagrelide,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Bromocriptine,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Bromocriptine.,increase,risk
Anagrelide,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Anagrelide.,increase,risk
Anagrelide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Anagrelide.,increase,risk
Anagrelide,Bumadizone,The risk or severity of bleeding can be increased when Bumadizone is combined with Anagrelide.,increase,risk
Anagrelide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Bupivacaine.,increase,risk
Anagrelide,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Anagrelide.,increase,risk
Anagrelide,Busulfan,The risk or severity of bleeding can be increased when Anagrelide is combined with Busulfan.,increase,risk
Anagrelide,Butacaine,The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Butacaine.,increase,risk
Anagrelide,Butamben,The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Butamben.,increase,risk
Anagrelide,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Anagrelide.,increase,risk
Anagrelide,Butylscopolamine,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Butylscopolamine.,increase,risk
Anagrelide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Anagrelide.,increase,risk
Anagrelide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Anagrelide.,increase,risk
Anagrelide,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Gallamine triethiodide.,increase,risk
Anagrelide,Gatifloxacin,The metabolism of Anagrelide can be decreased when combined with Gatifloxacin.,decrease,no risk
Anagrelide,Gemcitabine,The risk or severity of bleeding can be increased when Anagrelide is combined with Gemcitabine.,increase,risk
Anagrelide,Gemfibrozil,The metabolism of Anagrelide can be decreased when combined with Gemfibrozil.,decrease,no risk
Anagrelide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Anagrelide.,increase,risk
Anagrelide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Anagrelide is combined with Gemtuzumab ozogamicin.,increase,risk
Anagrelide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Anagrelide.,increase,risk
Anagrelide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Anagrelide.,increase,risk
Anagrelide,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Anagrelide.,increase,no risk
Anagrelide,Givosiran,The serum concentration of Anagrelide can be increased when it is combined with Givosiran.,increase,no risk
Anagrelide,Glasdegib,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Glasdegib.,increase,risk
Anagrelide,Glofitamab,The serum concentration of Anagrelide can be increased when it is combined with Glofitamab.,increase,no risk
Anagrelide,Glucosamine,Glucosamine may increase the antiplatelet activities of Anagrelide.,increase,no risk
Anagrelide,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Anagrelide.,increase,risk
Anagrelide,Glycopyrronium,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Glycopyrronium.,increase,risk
Anagrelide,Golimumab,The metabolism of Anagrelide can be increased when combined with Golimumab.,increase,no risk
Anagrelide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Anagrelide.,increase,risk
Anagrelide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Anagrelide.,increase,risk
Anagrelide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Grepafloxacin.,increase,risk
Anagrelide,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Guanfacine,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Guanfacine.,increase,risk
Anagrelide,Halofantrine,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Halofantrine.,increase,risk
Anagrelide,Haloperidol,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Haloperidol.,increase,risk
Anagrelide,Heparin,The risk or severity of bleeding can be increased when Anagrelide is combined with Heparin.,increase,risk
Anagrelide,Hexocyclium,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Hexocyclium.,increase,risk
Anagrelide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Anagrelide.,increase,risk
Anagrelide,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Homatropine methylbromide.,increase,risk
Anagrelide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Anagrelide.,increase,risk
Anagrelide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Anagrelide.,increase,risk
Anagrelide,Hydroxyurea,The risk or severity of bleeding can be increased when Anagrelide is combined with Hydroxyurea.,increase,risk
Anagrelide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Hydroxyzine.,increase,risk
Anagrelide,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Anagrelide.,increase,risk
Anagrelide,Ketamine,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ketamine.,increase,risk
Anagrelide,Ketoconazole,The metabolism of Anagrelide can be decreased when combined with Ketoconazole.,decrease,no risk
Anagrelide,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Anagrelide.,increase,risk
Anagrelide,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Anagrelide.,increase,risk
Anagrelide,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Anagrelide.,increase,risk
Anagrelide,Obinutuzumab,The risk or severity of adverse effects can be increased when Anagrelide is combined with Obinutuzumab.,increase,risk
Anagrelide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Anagrelide.,increase,risk
Anagrelide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Anagrelide.,increase,risk
Anagrelide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Anagrelide.,increase,risk
Anagrelide,Olaparib,The risk or severity of bleeding can be increased when Anagrelide is combined with Olaparib.,increase,risk
Anagrelide,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Anagrelide.,increase,risk
Anagrelide,Olsalazine,The risk or severity of bleeding can be increased when Anagrelide is combined with Olsalazine.,increase,risk
Anagrelide,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Anagrelide.,increase,no risk
Anagrelide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anagrelide.,increase,risk
Anagrelide,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Anagrelide.,increase,risk
Anagrelide,Orciprenaline,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Orciprenaline.,increase,risk
Anagrelide,Orphenadrine,The metabolism of Anagrelide can be decreased when combined with Orphenadrine.,decrease,no risk
Anagrelide,Osilodrostat,The serum concentration of Anagrelide can be increased when it is combined with Osilodrostat.,increase,no risk
Anagrelide,Osimertinib,The serum concentration of Anagrelide can be decreased when it is combined with Osimertinib.,decrease,no risk
Anagrelide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Anagrelide.,increase,risk
Anagrelide,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Anagrelide.,increase,risk
Anagrelide,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Anagrelide.,increase,risk
Anagrelide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Oxetacaine.,increase,risk
Anagrelide,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Oxybuprocaine.,increase,risk
Anagrelide,Oxybutynin,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxybutynin.,increase,risk
Anagrelide,Oxymetazoline,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxymetazoline.,increase,risk
Anagrelide,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Anagrelide.,increase,risk
Anagrelide,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxyphencyclimine.,increase,risk
Anagrelide,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Anagrelide.,increase,risk
Anagrelide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Anagrelide.,increase,risk
Anagrelide,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Anagrelide.,increase,risk
Anagrelide,Quinidine,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quinidine.,increase,risk
Anagrelide,Quinine,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quinine.,increase,risk
Anagrelide,Quizartinib,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quizartinib.,increase,risk
Anagrelide,Umeclidinium,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Umeclidinium.,increase,risk
Anagrelide,Urokinase,Anagrelide may increase the anticoagulant activities of Urokinase.,increase,no risk
Anagrelide,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Anagrelide is combined with Ursodeoxycholic acid.,increase,risk
Anagrelide,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Anagrelide.,increase,risk
Anagrelide,Valproic acid,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Valproic acid.,increase,risk
Anagrelide,Vandetanib,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Vandetanib.,increase,risk
Anagrelide,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Anagrelide.,increase,risk
Anagrelide,Vemurafenib,The serum concentration of Anagrelide can be increased when it is combined with Vemurafenib.,increase,no risk
Anagrelide,Venlafaxine,The risk or severity of bleeding can be increased when Anagrelide is combined with Venlafaxine.,increase,risk
Anagrelide,Verapamil,The metabolism of Verapamil can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Anagrelide.,increase,risk
Anagrelide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Anagrelide.,increase,risk
Anagrelide,Viloxazine,The metabolism of Anagrelide can be decreased when combined with Viloxazine.,decrease,no risk
Anagrelide,Vinblastine,The risk or severity of bleeding can be increased when Anagrelide is combined with Vinblastine.,increase,risk
Anagrelide,Vindesine,The risk or severity of bleeding can be increased when Anagrelide is combined with Vindesine.,increase,risk
Anagrelide,Vinorelbine,The risk or severity of bleeding can be increased when Anagrelide is combined with Vinorelbine.,increase,risk
Anagrelide,Vitamin E,Vitamin E may increase the antiplatelet activities of Anagrelide.,increase,no risk
Anagrelide,Vorapaxar,The risk or severity of bleeding can be increased when Anagrelide is combined with Vorapaxar.,increase,risk
Anagrelide,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Anagrelide.,increase,risk
Anagrelide,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Anagrelide.,increase,risk
Anagrelide,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Anagrelide.,increase,risk
Anagrelide,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Warfarin,The risk or severity of bleeding can be increased when Anagrelide is combined with Warfarin.,increase,risk
Anagrelide,Xamoterol,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Xamoterol.,increase,risk
Anagrelide,Ximelagatran,The risk or severity of bleeding can be increased when Anagrelide is combined with Ximelagatran.,increase,risk
Anagrelide,Xylometazoline,The risk or severity of Tachycardia can be increased when Anagrelide is combined with Xylometazoline.,increase,risk
Anagrelide,Zidovudine,The risk or severity of bleeding can be increased when Anagrelide is combined with Zidovudine.,increase,risk
Anagrelide,Zileuton,The metabolism of Anagrelide can be decreased when combined with Zileuton.,decrease,no risk
Anagrelide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Anagrelide.,increase,risk
Anagrelide,Ziprasidone,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Ziprasidone.,increase,risk
Anagrelide,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Anagrelide.,increase,risk
Anagrelide,Zotepine,The metabolism of Zotepine can be decreased when combined with Anagrelide.,decrease,no risk
Anagrelide,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Zuclopenthixol.,increase,risk
Carmustine,Belumosudil,The risk or severity of adverse effects can be increased when Carmustine is combined with Belumosudil.,increase,risk
Carmustine,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Carmustine.,increase,risk
Carmustine,Bendamustine,The risk or severity of adverse effects can be increased when Carmustine is combined with Bendamustine.,increase,risk
Carmustine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Benorilate,Benorilate may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Benserazide,Carmustine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Carmustine,Benzatropine,Benzatropine may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Benznidazole,Carmustine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Carmustine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Benzocaine.,increase,risk
Carmustine,Benzthiazide,Benzthiazide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Benzydamine,Benzydamine may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Benzyl alcohol.,increase,risk
Carmustine,Bepotastine,Carmustine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Carmustine,Betamethasone,The risk or severity of adverse effects can be increased when Carmustine is combined with Betamethasone.,increase,risk
Carmustine,Betaxolol,The metabolism of Carmustine can be decreased when combined with Betaxolol.,decrease,no risk
Carmustine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Carmustine.,increase,risk
Carmustine,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Carmustine.,increase,risk
Carmustine,Bexarotene,The risk or severity of adverse effects can be increased when Carmustine is combined with Bexarotene.,increase,risk
Carmustine,Bicisate,Carmustine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Carmustine,Bimekizumab,The metabolism of Carmustine can be increased when combined with Bimekizumab.,increase,no risk
Carmustine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Bismuth subgallate,Carmustine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Carmustine,Bisoprolol,Carmustine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Carmustine,Bisoxatin,Carmustine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Carmustine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carmustine.,increase,risk
Carmustine,Bleomycin,The risk or severity of adverse effects can be increased when Carmustine is combined with Bleomycin.,increase,risk
Carmustine,Blinatumomab,The risk or severity of adverse effects can be increased when Carmustine is combined with Blinatumomab.,increase,risk
Carmustine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Carmustine.",decrease,no risk
Carmustine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Carmustine.,increase,risk
Carmustine,Bosutinib,The risk or severity of adverse effects can be increased when Carmustine is combined with Bosutinib.,increase,risk
Carmustine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Carmustine is combined with Brentuximab vedotin.,increase,risk
Carmustine,Brivaracetam,Carmustine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Carmustine,Brodalumab,The risk or severity of adverse effects can be increased when Carmustine is combined with Brodalumab.,increase,risk
Carmustine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Budesonide,The risk or severity of adverse effects can be increased when Carmustine is combined with Budesonide.,increase,risk
Carmustine,Bumadizone,Bumadizone may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Bumetanide,Bumetanide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Bupivacaine.,increase,risk
Carmustine,Bupropion,Carmustine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Carmustine,Buspirone,Carmustine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Carmustine,Busulfan,The risk or severity of adverse effects can be increased when Carmustine is combined with Busulfan.,increase,risk
Carmustine,Butabarbital,Butabarbital may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Butacaine,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Butacaine.,increase,risk
Carmustine,Butamben,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Butamben.,increase,risk
Carmustine,Gabapentin enacarbil,Carmustine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Carmustine,Gadobenic acid,Carmustine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Carmustine,Gadodiamide,Gadodiamide may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Gadofosveset trisodium,Carmustine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Carmustine,Gadopentetic acid,Carmustine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Carmustine,Gadoteric acid,Carmustine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Carmustine,Gadoteridol,Carmustine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Carmustine,Ganciclovir,Carmustine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Carmustine,Gatifloxacin,The metabolism of Carmustine can be decreased when combined with Gatifloxacin.,decrease,no risk
Carmustine,Gemcitabine,The risk or severity of adverse effects can be increased when Carmustine is combined with Gemcitabine.,increase,risk
Carmustine,Gemfibrozil,The metabolism of Carmustine can be decreased when combined with Gemfibrozil.,decrease,no risk
Carmustine,Gemifloxacin,The metabolism of Carmustine can be decreased when combined with Gemifloxacin.,decrease,no risk
Carmustine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carmustine.,increase,risk
Carmustine,Gentamicin,Carmustine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Carmustine,Gimeracil,Carmustine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Carmustine,Givosiran,The serum concentration of Carmustine can be increased when it is combined with Givosiran.,increase,no risk
Carmustine,Glatiramer,The risk or severity of adverse effects can be increased when Carmustine is combined with Glatiramer.,increase,risk
Carmustine,Glipizide,Carmustine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Carmustine,Glofitamab,The serum concentration of Carmustine can be increased when it is combined with Glofitamab.,increase,no risk
Carmustine,Glycerol phenylbutyrate,Carmustine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Carmustine,Golimumab,The metabolism of Carmustine can be increased when combined with Golimumab.,increase,no risk
Carmustine,Golodirsen,Carmustine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Carmustine,Goserelin,Goserelin may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Grepafloxacin,The metabolism of Carmustine can be decreased when combined with Grepafloxacin.,decrease,no risk
Carmustine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Guanethidine,Carmustine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Carmustine,Guanfacine,Carmustine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Carmustine,Guselkumab,The risk or severity of adverse effects can be increased when Carmustine is combined with Guselkumab.,increase,risk
Carmustine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Carmustine.,increase,risk
Carmustine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Carmustine.,increase,risk
Carmustine,Hydralazine,Carmustine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Carmustine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Carmustine is combined with Hydrocortisone acetate.,increase,risk
Carmustine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Carmustine is combined with Hydrocortisone butyrate.,increase,risk
Carmustine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Carmustine is combined with Hydrocortisone succinate.,increase,risk
Carmustine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Hydromorphone,Carmustine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Carmustine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Carmustine is combined with Hydroxychloroquine.,increase,risk
Carmustine,Hydroxyethyl Starch,Carmustine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Carmustine,Hydroxyurea,The risk or severity of adverse effects can be increased when Carmustine is combined with Hydroxyurea.,increase,risk
Carmustine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Kanamycin,Carmustine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Carmustine,Ketamine,Carmustine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Carmustine,Ketazolam,Carmustine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Carmustine,Ketoconazole,The metabolism of Carmustine can be decreased when combined with Ketoconazole.,decrease,no risk
Carmustine,Ketoprofen,Ketoprofen may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Ketorolac,Ketorolac may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Obeticholic acid,The metabolism of Carmustine can be decreased when combined with Obeticholic acid.,decrease,no risk
Carmustine,Obinutuzumab,The risk or severity of adverse effects can be increased when Carmustine is combined with Obinutuzumab.,increase,risk
Carmustine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Carmustine.,increase,no risk
Carmustine,Octinoxate,Carmustine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Carmustine,Ofatumumab,The risk or severity of adverse effects can be increased when Carmustine is combined with Ofatumumab.,increase,risk
Carmustine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Olaparib,The risk or severity of adverse effects can be increased when Carmustine is combined with Olaparib.,increase,risk
Carmustine,Olsalazine,Olsalazine may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Opium,Carmustine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Carmustine,Orphenadrine,The metabolism of Carmustine can be decreased when combined with Orphenadrine.,decrease,no risk
Carmustine,Oseltamivir,Oseltamivir may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Osilodrostat,The metabolism of Carmustine can be decreased when combined with Osilodrostat.,decrease,no risk
Carmustine,Osimertinib,The serum concentration of Carmustine can be decreased when it is combined with Osimertinib.,decrease,no risk
Carmustine,Ouabain,Ouabain may decrease the cardiotoxic activities of Carmustine.,decrease,no risk
Carmustine,Oxacillin,Carmustine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Carmustine,Oxaliplatin,The risk or severity of adverse effects can be increased when Carmustine is combined with Oxaliplatin.,increase,risk
Carmustine,Oxaprozin,Oxaprozin may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Oxazepam,Carmustine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Carmustine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Oxetacaine.,increase,risk
Carmustine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Oxybenzone,Carmustine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Carmustine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Oxybuprocaine.,increase,risk
Carmustine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Oxyquinoline,Carmustine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Carmustine,Ozanimod,The risk or severity of adverse effects can be increased when Carmustine is combined with Ozanimod.,increase,risk
Carmustine,Quetiapine,Carmustine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Carmustine,Quinethazone,Quinethazone may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Quinidine,The metabolism of Carmustine can be decreased when combined with Quinidine.,decrease,no risk
Carmustine,Quinine,The metabolism of Quinine can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Carmustine.,increase,risk
Carmustine,Upadacitinib,The risk or severity of adverse effects can be increased when Carmustine is combined with Upadacitinib.,increase,risk
Carmustine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Carmustine.,increase,risk
Carmustine,Vaborbactam,Carmustine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Carmustine,Valaciclovir,Valaciclovir may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Valbenazine,Carmustine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Carmustine,Valdecoxib,Valdecoxib may decrease the excretion rate of Carmustine which could result in a higher serum level.,decrease,no risk
Carmustine,Valganciclovir,Carmustine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Carmustine,Valproic acid,The metabolism of Carmustine can be decreased when combined with Valproic acid.,decrease,no risk
Carmustine,Vancomycin,Carmustine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Carmustine,Varenicline,Carmustine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Carmustine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Carmustine.,increase,risk
Carmustine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Vedolizumab,The risk or severity of adverse effects can be increased when Carmustine is combined with Vedolizumab.,increase,risk
Carmustine,Vemurafenib,The serum concentration of Carmustine can be increased when it is combined with Vemurafenib.,increase,no risk
Carmustine,Venlafaxine,Carmustine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Carmustine,Verapamil,The metabolism of Verapamil can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Carmustine.,decrease,no risk
Carmustine,Vilanterol,The risk or severity of adverse effects can be increased when Carmustine is combined with Vilanterol.,increase,risk
Carmustine,Viloxazine,The metabolism of Carmustine can be decreased when combined with Viloxazine.,decrease,no risk
Carmustine,Vinblastine,The risk or severity of adverse effects can be increased when Carmustine is combined with Vinblastine.,increase,risk
Carmustine,Vincristine,The risk or severity of adverse effects can be increased when Carmustine is combined with Vincristine.,increase,risk
Carmustine,Vindesine,The risk or severity of adverse effects can be increased when Carmustine is combined with Vindesine.,increase,risk
Carmustine,Vinorelbine,The risk or severity of adverse effects can be increased when Carmustine is combined with Vinorelbine.,increase,risk
Carmustine,Voclosporin,The risk or severity of adverse effects can be increased when Carmustine is combined with Voclosporin.,increase,risk
Carmustine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Carmustine.,increase,risk
Carmustine,Vorinostat,The risk or severity of adverse effects can be increased when Carmustine is combined with Vorinostat.,increase,risk
Carmustine,Vortioxetine,Carmustine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Carmustine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Warfarin,Carmustine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Carmustine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Carmustine.,increase,risk
Carmustine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Carmustine.,increase,risk
Carmustine,Zaleplon,Carmustine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Carmustine,Zanamivir,Carmustine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Carmustine,Zidovudine,The risk or severity of adverse effects can be increased when Carmustine is combined with Zidovudine.,increase,risk
Carmustine,Zileuton,The metabolism of Carmustine can be decreased when combined with Zileuton.,decrease,no risk
Carmustine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Carmustine.,decrease,no risk
Carmustine,Zonisamide,Zonisamide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carmustine,Zotepine,The metabolism of Zotepine can be decreased when combined with Carmustine.,decrease,no risk
Sulfisoxazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Gadobenic acid.,increase,risk
Sulfisoxazole,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Gatifloxacin,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Gatifloxacin.,increase,no risk
Sulfisoxazole,Gefapixant,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Gefapixant.,increase,no risk
Sulfisoxazole,Gemifloxacin,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Gemifloxacin.,increase,no risk
Sulfisoxazole,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Gilteritinib,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Gilteritinib.,increase,risk
Sulfisoxazole,Glasdegib,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Glasdegib.,increase,risk
Sulfisoxazole,Gliclazide,The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Gliclazide.,increase,risk
Sulfisoxazole,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Glipizide,The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Glipizide.,increase,risk
Sulfisoxazole,Gliquidone,The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Gliquidone.,increase,risk
Sulfisoxazole,Glyburide,The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Glyburide.,increase,risk
Sulfisoxazole,Glymidine,The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Glymidine.,increase,risk
Sulfisoxazole,Goserelin,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Goserelin.,decrease,no risk
Sulfisoxazole,Granisetron,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Granisetron.,increase,risk
Sulfisoxazole,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Grepafloxacin.,increase,risk
Sulfisoxazole,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Halofantrine,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Halofantrine.,increase,risk
Sulfisoxazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Haloperidol.,increase,risk
Sulfisoxazole,Halothane,The metabolism of Halothane can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Histrelin,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Histrelin.,decrease,no risk
Sulfisoxazole,Hydrochlorothiazide,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sulfisoxazole,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Hydroflumethiazide,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sulfisoxazole,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Hydroxychloroquine,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Sulfisoxazole,Hydroxyprogesterone caproate,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Sulfisoxazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Hydroxyzine.,increase,risk
Sulfisoxazole,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Octreotide,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Octreotide.,decrease,no risk
Sulfisoxazole,Ofloxacin,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Ofloxacin.,increase,no risk
Sulfisoxazole,Olanzapine,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Olanzapine.,decrease,no risk
Sulfisoxazole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Olsalazine,Olsalazine may increase the hypoglycemic activities of Sulfisoxazole.,increase,no risk
Sulfisoxazole,Ondansetron,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Ondansetron.,increase,risk
Sulfisoxazole,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Sulfisoxazole.,increase,no risk
Sulfisoxazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Oxatomide.,increase,risk
Sulfisoxazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sulfisoxazole is combined with Oxetacaine.,increase,risk
Sulfisoxazole,Oxprenolol,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Oxprenolol.,increase,no risk
Sulfisoxazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sulfisoxazole is combined with Oxybuprocaine.,increase,risk
Sulfisoxazole,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Sulfisoxazole.,increase,no risk
Sulfisoxazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Quetiapine,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Quetiapine.,decrease,no risk
Sulfisoxazole,Quinethazone,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Quinethazone.,decrease,no risk
Sulfisoxazole,Quinidine,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Quinidine.,increase,risk
Sulfisoxazole,Quinine,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Quinine.,increase,risk
Sulfisoxazole,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Quizartinib,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Quizartinib.,increase,risk
Sulfisoxazole,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Udenafil,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Udenafil.,increase,no risk
Sulfisoxazole,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Valdecoxib,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Valdecoxib.,increase,no risk
Sulfisoxazole,Valproic acid,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Valproic acid.,increase,risk
Sulfisoxazole,Valsartan,The metabolism of Valsartan can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Vandetanib,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Vandetanib.,increase,risk
Sulfisoxazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Vemurafenib,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Vemurafenib.,increase,risk
Sulfisoxazole,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Vildagliptin,The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Vildagliptin.,increase,risk
Sulfisoxazole,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Vorinostat,The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Vorinostat.,decrease,no risk
Sulfisoxazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Sulfisoxazole.,increase,risk
Sulfisoxazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Ziprasidone.,increase,risk
Sulfisoxazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sulfisoxazole.,decrease,no risk
Sulfisoxazole,Zonisamide,The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Zonisamide.,increase,no risk
Sulfisoxazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sulfisoxazole.,decrease,no risk
Metoprolol,Bemiparin,The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Bemiparin.,increase,risk
Metoprolol,Benazepril,Metoprolol may increase the hypotensive activities of Benazepril.,increase,no risk
Metoprolol,Bendroflumethiazide,The therapeutic efficacy of Metoprolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Metoprolol,Benorilate,Benorilate may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Benoxaprofen,Benoxaprofen may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Benserazide,Metoprolol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Metoprolol,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Benznidazole,Metoprolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Metoprolol,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Benzphetamine,The therapeutic efficacy of Metoprolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Metoprolol,Benzthiazide,The therapeutic efficacy of Metoprolol can be increased when used in combination with Benzthiazide.,increase,no risk
Metoprolol,Benzydamine,Benzydamine may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Bepotastine,Metoprolol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Metoprolol,Bepridil,Metoprolol may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Metoprolol,Beractant,Metoprolol may increase the bradycardic activities of Beractant.,increase,no risk
Metoprolol,Berotralstat,The metabolism of Metoprolol can be decreased when combined with Berotralstat.,decrease,no risk
Metoprolol,Betaine,Betaine may increase the bradycardic activities of Metoprolol.,increase,no risk
Metoprolol,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Metoprolol.,increase,no risk
Metoprolol,Bethanechol,The risk or severity of adverse effects can be increased when Metoprolol is combined with Bethanechol.,increase,risk
Metoprolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Bicisate,Metoprolol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Metoprolol,Bimatoprost,Metoprolol may increase the hypotensive activities of Bimatoprost.,increase,no risk
Metoprolol,Bimekizumab,The metabolism of Metoprolol can be increased when combined with Bimekizumab.,increase,no risk
Metoprolol,Bioallethrin,Metoprolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Metoprolol,Biperiden,The metabolism of Metoprolol can be decreased when combined with Biperiden.,decrease,no risk
Metoprolol,Bismuth subgallate,Metoprolol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Metoprolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Metoprolol.,increase,risk
Metoprolol,Bisoxatin,Metoprolol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Metoprolol,Bleomycin,Metoprolol may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Metoprolol,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Bosentan,Metoprolol may increase the hypotensive activities of Bosentan.,increase,no risk
Metoprolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Metoprolol.,increase,risk
Metoprolol,Bretylium,Metoprolol may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Metoprolol,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Metoprolol.,increase,no risk
Metoprolol,Brivaracetam,Metoprolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Metoprolol,Bromazepam,Metoprolol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Metoprolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Metoprolol is combined with Bromotheophylline.,increase,risk
Metoprolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Metoprolol.,increase,risk
Metoprolol,Budesonide,Metoprolol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Metoprolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Bumetanide,Bumetanide may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoprolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Metoprolol.,increase,no risk
Metoprolol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Bupropion,The metabolism of Metoprolol can be decreased when combined with Bupropion.,decrease,no risk
Metoprolol,Buspirone,The metabolism of Buspirone can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Butabarbital,Butabarbital may increase the hypotensive activities of Metoprolol.,increase,no risk
Metoprolol,Butalbital,Butalbital may increase the hypotensive activities of Metoprolol.,increase,no risk
Metoprolol,Butaperazine,The serum concentration of Metoprolol can be increased when it is combined with Butaperazine.,increase,no risk
Metoprolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Gabapentin enacarbil,Metoprolol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Metoprolol,Gadobenic acid,Metoprolol may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Metoprolol,Gadodiamide,Gadodiamide may decrease the excretion rate of Metoprolol which could result in a higher serum level.,decrease,no risk
Metoprolol,Gadofosveset trisodium,Metoprolol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Metoprolol,Gadopentetic acid,Metoprolol may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Metoprolol,Gadoteric acid,Metoprolol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Metoprolol,Gadoteridol,Metoprolol may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Metoprolol,Galantamine,The metabolism of Galantamine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Metoprolol.,increase,no risk
Metoprolol,Ganciclovir,Metoprolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Metoprolol,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Gemcitabine,Metoprolol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Metoprolol,Gemfibrozil,Metoprolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Metoprolol,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Metoprolol.,increase,no risk
Metoprolol,Gimeracil,Metoprolol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Metoprolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Metoprolol.,increase,no risk
Metoprolol,Givosiran,The serum concentration of Metoprolol can be increased when it is combined with Givosiran.,increase,no risk
Metoprolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Glucagon,The therapeutic efficacy of Metoprolol can be decreased when used in combination with Glucagon.,decrease,no risk
Metoprolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Glycerol phenylbutyrate,The metabolism of Metoprolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Metoprolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Golimumab,The metabolism of Metoprolol can be increased when combined with Golimumab.,increase,no risk
Metoprolol,Golodirsen,Metoprolol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Metoprolol,Goserelin,Goserelin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,decrease,no risk
Metoprolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Guanadrel,Guanadrel may increase the hypotensive activities of Metoprolol.,increase,no risk
Metoprolol,Guanethidine,Guanethidine may increase the hypotensive activities of Metoprolol.,increase,no risk
Metoprolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Guanoxan,Metoprolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Metoprolol,Halofantrine,The metabolism of Metoprolol can be decreased when combined with Halofantrine.,decrease,no risk
Metoprolol,Haloperidol,The serum concentration of Metoprolol can be increased when it is combined with Haloperidol.,increase,no risk
Metoprolol,Halothane,Halothane may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Heparin,The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Heparin.,increase,risk
Metoprolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Metoprolol.,increase,no risk
Metoprolol,Histamine,The serum concentration of Histamine can be increased when it is combined with Metoprolol.,increase,no risk
Metoprolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Metoprolol.,increase,risk
Metoprolol,Huperzine A,Huperzine A may increase the bradycardic activities of Metoprolol.,increase,no risk
Metoprolol,Hydralazine,Metoprolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Metoprolol,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Hydroflumethiazide,The therapeutic efficacy of Metoprolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Metoprolol,Hydromorphone,Metoprolol may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Metoprolol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,decrease,no risk
Metoprolol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Hydroxyethyl Starch,Metoprolol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Metoprolol,Hydroxyzine,The metabolism of Metoprolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Metoprolol,Hyoscyamine,Metoprolol may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Metoprolol,Kanamycin,Metoprolol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Metoprolol,Ketamine,Ketamine may increase the bradycardic activities of Metoprolol.,increase,no risk
Metoprolol,Ketazolam,Metoprolol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Metoprolol,Ketoconazole,The metabolism of Metoprolol can be decreased when combined with Ketoconazole.,decrease,no risk
Metoprolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Metoprolol.,increase,risk
Metoprolol,Obinutuzumab,Metoprolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Metoprolol,Octinoxate,Metoprolol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Metoprolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Metoprolol.,increase,no risk
Metoprolol,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Metoprolol.,increase,no risk
Metoprolol,Olmesartan,Metoprolol may increase the hypotensive activities of Olmesartan.,increase,no risk
Metoprolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Olsalazine,Olsalazine may decrease the excretion rate of Metoprolol which could result in a higher serum level.,decrease,no risk
Metoprolol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Opicapone,The risk or severity of adverse effects can be increased when Metoprolol is combined with Opicapone.,increase,risk
Metoprolol,Opium,The metabolism of Opium can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Oritavancin,The metabolism of Metoprolol can be decreased when combined with Oritavancin.,decrease,no risk
Metoprolol,Orphenadrine,The metabolism of Metoprolol can be decreased when combined with Orphenadrine.,decrease,no risk
Metoprolol,Oseltamivir,Oseltamivir may decrease the excretion rate of Metoprolol which could result in a higher serum level.,decrease,no risk
Metoprolol,Osilodrostat,The metabolism of Metoprolol can be decreased when combined with Osilodrostat.,decrease,no risk
Metoprolol,Ospemifene,The metabolism of Metoprolol can be decreased when combined with Ospemifene.,decrease,no risk
Metoprolol,Ouabain,Metoprolol may increase the bradycardic activities of Ouabain.,increase,no risk
Metoprolol,Oxacillin,Metoprolol may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Metoprolol,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Metoprolol.,increase,no risk
Metoprolol,Oxamniquine,The metabolism of Metoprolol can be decreased when combined with Oxamniquine.,decrease,no risk
Metoprolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Oxazepam,Metoprolol may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Metoprolol,Oxprenolol,Metoprolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Metoprolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Metoprolol is combined with Oxtriphylline.,increase,risk
Metoprolol,Oxybenzone,Metoprolol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Metoprolol,Oxybutynin,The metabolism of Metoprolol can be decreased when combined with Oxybutynin.,decrease,no risk
Metoprolol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Oxymetazoline,The therapeutic efficacy of Metoprolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Metoprolol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Oxyquinoline,Metoprolol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Metoprolol,Quetiapine,Quetiapine may increase the hypotensive activities of Metoprolol.,increase,no risk
Metoprolol,Quinapril,Metoprolol may increase the hypotensive activities of Quinapril.,increase,no risk
Metoprolol,Quinethazone,Quinethazone may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoprolol,Quinidine,Metoprolol may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Metoprolol,Quinine,The metabolism of Quinine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Ubidecarenone,The therapeutic efficacy of Ubidecarenone can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Udenafil,Udenafil may increase the antihypertensive activities of Metoprolol.,increase,no risk
Metoprolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Unoprostone,Metoprolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Metoprolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Metoprolol.,increase,risk
Metoprolol,Vaborbactam,Metoprolol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Metoprolol,Valaciclovir,Valaciclovir may decrease the excretion rate of Metoprolol which could result in a higher serum level.,decrease,no risk
Metoprolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Valganciclovir,Metoprolol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Metoprolol,Valsartan,Valsartan may increase the hypotensive activities of Metoprolol.,increase,no risk
Metoprolol,Vancomycin,Metoprolol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Metoprolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Metoprolol.,increase,no risk
Metoprolol,Varenicline,The excretion of Varenicline can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Vemurafenib,The metabolism of Metoprolol can be decreased when combined with Vemurafenib.,decrease,no risk
Metoprolol,Venlafaxine,The serum concentration of Metoprolol can be increased when it is combined with Venlafaxine.,increase,no risk
Metoprolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Metoprolol.,increase,risk
Metoprolol,Vericiguat,The risk or severity of adverse effects can be increased when Metoprolol is combined with Vericiguat.,increase,risk
Metoprolol,Vernakalant,Metoprolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Metoprolol,Verteporfin,Metoprolol may increase the photosensitizing activities of Verteporfin.,increase,no risk
Metoprolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Metoprolol.,increase,no risk
Metoprolol,Viloxazine,The metabolism of Metoprolol can be decreased when combined with Viloxazine.,decrease,no risk
Metoprolol,Vinblastine,The metabolism of Metoprolol can be decreased when combined with Vinblastine.,decrease,no risk
Metoprolol,Vinorelbine,The metabolism of Metoprolol can be decreased when combined with Vinorelbine.,decrease,no risk
Metoprolol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Warfarin,Metoprolol may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Metoprolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Metoprolol.,decrease,no risk
Metoprolol,Xylometazoline,Metoprolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Metoprolol,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Zaleplon,Metoprolol may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Metoprolol,Zanamivir,Metoprolol may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Metoprolol,Ziconotide,Metoprolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Metoprolol,Zimelidine,The serum concentration of Metoprolol can be increased when it is combined with Zimelidine.,increase,no risk
Metoprolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Metoprolol.,increase,no risk
Metoprolol,Zofenopril,Metoprolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Metoprolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Metoprolol.,decrease,no risk
Metoprolol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Metoprolol.,decrease,no risk
Metoprolol,Zonisamide,Metoprolol may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Metoprolol,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Metoprolol.,decrease,no risk
Dicoumarol,Benzylpenicilloyl polylysine,Benzylpenicilloyl polylysine may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Dicoumarol.,decrease,no risk
Dicoumarol,Betamethasone,Betamethasone may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Betamethasone phosphate,Betamethasone phosphate may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Betrixaban,The risk or severity of bleeding can be increased when Dicoumarol is combined with Betrixaban.,increase,risk
Dicoumarol,Bexarotene,The risk or severity of bleeding can be increased when Dicoumarol is combined with Bexarotene.,increase,risk
Dicoumarol,Bezafibrate,The risk or severity of bleeding can be increased when Bezafibrate is combined with Dicoumarol.,increase,risk
Dicoumarol,Bifonazole,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Bifonazole.,increase,no risk
Dicoumarol,Bimekizumab,The metabolism of Dicoumarol can be increased when combined with Bimekizumab.,increase,no risk
Dicoumarol,Bismuth subsalicylate,Bismuth subsalicylate may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dicoumarol.,increase,risk
Dicoumarol,Blinatumomab,The risk or severity of bleeding can be increased when Dicoumarol is combined with Blinatumomab.,increase,risk
Dicoumarol,Bortezomib,The risk or severity of bleeding can be increased when Dicoumarol is combined with Bortezomib.,increase,risk
Dicoumarol,Bosentan,The metabolism of Dicoumarol can be increased when combined with Bosentan.,increase,no risk
Dicoumarol,Bosutinib,The risk or severity of bleeding can be increased when Dicoumarol is combined with Bosutinib.,increase,risk
Dicoumarol,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Dicoumarol.,increase,risk
Dicoumarol,Brexpiprazole,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Dicoumarol.,increase,risk
Dicoumarol,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Dicoumarol.,increase,risk
Dicoumarol,Budesonide,Budesonide may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Dicoumarol.,increase,risk
Dicoumarol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Dicoumarol.,increase,risk
Dicoumarol,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Dicoumarol.,increase,risk
Dicoumarol,Busulfan,The risk or severity of bleeding can be increased when Dicoumarol is combined with Busulfan.,increase,risk
Dicoumarol,Butabarbital,The metabolism of Dicoumarol can be increased when combined with Butabarbital.,increase,no risk
Dicoumarol,Butalbital,The metabolism of Dicoumarol can be increased when combined with Butalbital.,increase,no risk
Dicoumarol,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Dicoumarol.,increase,risk
Dicoumarol,Gatifloxacin,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Gatifloxacin.,increase,no risk
Dicoumarol,Gefitinib,Gefitinib may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Gemcitabine,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Gemcitabine.,increase,no risk
Dicoumarol,Gemfibrozil,The metabolism of Dicoumarol can be decreased when combined with Gemfibrozil.,decrease,no risk
Dicoumarol,Gemifloxacin,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Gemifloxacin.,increase,no risk
Dicoumarol,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Dicoumarol is combined with Gemtuzumab ozogamicin.,increase,risk
Dicoumarol,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with Dicoumarol.,increase,risk
Dicoumarol,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with Dicoumarol.,increase,risk
Dicoumarol,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Dicoumarol.,increase,risk
Dicoumarol,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Dicoumarol.,increase,no risk
Dicoumarol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Dicoumarol.,increase,no risk
Dicoumarol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Dicoumarol.,increase,no risk
Dicoumarol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Dicoumarol.,increase,no risk
Dicoumarol,Glofitamab,The serum concentration of Dicoumarol can be increased when it is combined with Glofitamab.,increase,no risk
Dicoumarol,Glucagon,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Glucagon.,increase,no risk
Dicoumarol,Glutethimide,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Glutethimide.,decrease,no risk
Dicoumarol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Dicoumarol.,increase,no risk
Dicoumarol,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Dicoumarol.,increase,risk
Dicoumarol,Golimumab,The metabolism of Dicoumarol can be increased when combined with Golimumab.,increase,no risk
Dicoumarol,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with Dicoumarol.,increase,risk
Dicoumarol,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Dicoumarol.,increase,risk
Dicoumarol,Grepafloxacin,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Grepafloxacin.,increase,no risk
Dicoumarol,Griseofulvin,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Griseofulvin.,increase,no risk
Dicoumarol,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Haloprogin,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Haloprogin.,increase,no risk
Dicoumarol,Halothane,The metabolism of Halothane can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Hemin,Hemin may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Heparin,The risk or severity of bleeding can be increased when Dicoumarol is combined with Heparin.,increase,risk
Dicoumarol,Hetacillin,Hetacillin may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Hexetidine,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Hexetidine.,increase,no risk
Dicoumarol,Hydrochlorothiazide,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Dicoumarol,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Hydroflumethiazide,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Dicoumarol,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Hydroxyprogesterone caproate,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dicoumarol,Hydroxyurea,The risk or severity of bleeding can be increased when Dicoumarol is combined with Hydroxyurea.,increase,risk
Dicoumarol,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with Dicoumarol.,increase,risk
Dicoumarol,Ketamine,The metabolism of Ketamine can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Ketoconazole,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Ketoconazole.,increase,no risk
Dicoumarol,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Dicoumarol.,increase,risk
Dicoumarol,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Dicoumarol.,increase,risk
Dicoumarol,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Dicoumarol is combined with Obeticholic acid.,increase,risk
Dicoumarol,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Dicoumarol is combined with Obinutuzumab.,increase,risk
Dicoumarol,Ofloxacin,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Ofloxacin.,increase,no risk
Dicoumarol,Olanzapine,The metabolism of Dicoumarol can be decreased when combined with Olanzapine.,decrease,no risk
Dicoumarol,Olaparib,The risk or severity of bleeding can be increased when Dicoumarol is combined with Olaparib.,increase,risk
Dicoumarol,Olive oil,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Olive oil.,decrease,no risk
Dicoumarol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Olsalazine,Olsalazine may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Dicoumarol is combined with Omacetaxine mepesuccinate.,increase,risk
Dicoumarol,Omadacycline,Omadacycline may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Dicoumarol.,increase,risk
Dicoumarol,Omega-3-carboxylic acids,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Dicoumarol,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Dicoumarol.,increase,risk
Dicoumarol,Oritavancin,The metabolism of Dicoumarol can be decreased when combined with Oritavancin.,decrease,no risk
Dicoumarol,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Oxacillin,Oxacillin may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Dicoumarol.,increase,risk
Dicoumarol,Oxandrolone,The metabolism of Dicoumarol can be decreased when combined with Oxandrolone.,decrease,no risk
Dicoumarol,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Dicoumarol.,increase,risk
Dicoumarol,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Dicoumarol.,increase,risk
Dicoumarol,Oxymetholone,Oxymetholone may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Dicoumarol.,increase,risk
Dicoumarol,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Dicoumarol.,increase,risk
Dicoumarol,Quinestrol,Quinestrol may decrease the anticoagulant activities of Dicoumarol.,decrease,no risk
Dicoumarol,Quinidine,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Quinidine.,increase,no risk
Dicoumarol,Quinine,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Quinine.,increase,no risk
Dicoumarol,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Dicoumarol.,increase,risk
Dicoumarol,Quinupristin,The risk or severity of bleeding can be increased when Quinupristin is combined with Dicoumarol.,increase,risk
Dicoumarol,Ubidecarenone,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Ubidecarenone.,decrease,no risk
Dicoumarol,Ulipristal,The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Ulipristal.,decrease,no risk
Dicoumarol,Urokinase,Urokinase may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Dicoumarol is combined with Ursodeoxycholic acid.,increase,risk
Dicoumarol,Vadadustat,The serum concentration of Dicoumarol can be increased when it is combined with Vadadustat.,increase,no risk
Dicoumarol,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Dicoumarol.,increase,risk
Dicoumarol,Valproic acid,The metabolism of Dicoumarol can be decreased when combined with Valproic acid.,decrease,no risk
Dicoumarol,Valsartan,The metabolism of Dicoumarol can be decreased when combined with Valsartan.,decrease,no risk
Dicoumarol,Vamorolone,Vamorolone may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Vancomycin,The risk or severity of bleeding can be increased when Vancomycin is combined with Dicoumarol.,increase,risk
Dicoumarol,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Vemurafenib,The metabolism of Dicoumarol can be decreased when combined with Vemurafenib.,decrease,no risk
Dicoumarol,Venlafaxine,The risk or severity of bleeding can be increased when Dicoumarol is combined with Venlafaxine.,increase,risk
Dicoumarol,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Dicoumarol.,increase,risk
Dicoumarol,Viloxazine,The risk or severity of adverse effects can be increased when Viloxazine is combined with Dicoumarol.,increase,risk
Dicoumarol,Vinblastine,The risk or severity of bleeding can be increased when Dicoumarol is combined with Vinblastine.,increase,risk
Dicoumarol,Vindesine,The risk or severity of bleeding can be increased when Dicoumarol is combined with Vindesine.,increase,risk
Dicoumarol,Vinorelbine,The risk or severity of bleeding can be increased when Dicoumarol is combined with Vinorelbine.,increase,risk
Dicoumarol,Viomycin,The risk or severity of bleeding can be increased when Viomycin is combined with Dicoumarol.,increase,risk
Dicoumarol,Vitamin E,Vitamin E may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Dicoumarol.,decrease,no risk
Dicoumarol,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Dicoumarol.,increase,risk
Dicoumarol,Voriconazole,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Voriconazole.,increase,no risk
Dicoumarol,Vorinostat,Vorinostat may increase the anticoagulant activities of Dicoumarol.,increase,no risk
Dicoumarol,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Dicoumarol.,increase,risk
Dicoumarol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Warfarin,The metabolism of Dicoumarol can be increased when combined with Warfarin.,increase,no risk
Dicoumarol,Ximelagatran,The risk or severity of bleeding can be increased when Dicoumarol is combined with Ximelagatran.,increase,risk
Dicoumarol,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Dicoumarol.,increase,risk
Dicoumarol,Zafirlukast,The metabolism of Dicoumarol can be decreased when combined with Zafirlukast.,decrease,no risk
Dicoumarol,Zidovudine,The risk or severity of bleeding can be increased when Dicoumarol is combined with Zidovudine.,increase,risk
Dicoumarol,Zileuton,The metabolism of Zileuton can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Dicoumarol.,increase,risk
Dicoumarol,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Dicoumarol.,increase,risk
Dicoumarol,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dicoumarol.,increase,risk
Dicoumarol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dicoumarol.,decrease,no risk
Dicoumarol,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Dicoumarol.,increase,risk
Dicoumarol,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Dicoumarol.,increase,risk
Cefmenoxime,Gabapentin enacarbil,Cefmenoxime may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gadobenic acid,Cefmenoxime may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gadodiamide,Cefmenoxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gadofosveset trisodium,Cefmenoxime may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gadopentetic acid,Cefmenoxime may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gadoteric acid,Cefmenoxime may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gadoteridol,Cefmenoxime may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Ganciclovir,Cefmenoxime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gemcitabine,Cefmenoxime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gemfibrozil,Cefmenoxime may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gentamicin,Cefmenoxime may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Gimeracil,Cefmenoxime may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Givosiran.,increase,risk
Cefmenoxime,Glipizide,Cefmenoxime may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Glycerol phenylbutyrate,Cefmenoxime may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Golodirsen,Cefmenoxime may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Goserelin,Cefmenoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Guanethidine,Cefmenoxime may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Guanfacine,Cefmenoxime may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Haloperidol,Cefmenoxime may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefmenoxime.,decrease,no risk
Cefmenoxime,Hydralazine,Cefmenoxime may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Hydrochlorothiazide.,increase,risk
Cefmenoxime,Hydromorphone,Cefmenoxime may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Hydroxocobalamin,Cefmenoxime may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Hydroxyethyl Starch,Cefmenoxime may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Kanamycin,Cefmenoxime may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Ketamine,Cefmenoxime may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Ketazolam,Cefmenoxime may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Ketoprofen.,increase,risk
Cefmenoxime,Ketorolac,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Ketorolac.,increase,risk
Cefmenoxime,Octinoxate,Cefmenoxime may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Olsalazine.,increase,risk
Cefmenoxime,Opium,Cefmenoxime may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Oseltamivir,Cefmenoxime may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Oxacillin,Cefmenoxime may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefmenoxime.,increase,risk
Cefmenoxime,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Oxaprozin.,increase,risk
Cefmenoxime,Oxazepam,Cefmenoxime may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefmenoxime is combined with Oxetacaine.,increase,risk
Cefmenoxime,Oxybenzone,Cefmenoxime may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefmenoxime is combined with Oxybuprocaine.,increase,risk
Cefmenoxime,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Oxyphenbutazone.,increase,risk
Cefmenoxime,Oxyquinoline,Cefmenoxime may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Quetiapine,Cefmenoxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Quinidine,Cefmenoxime may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefmenoxime.,decrease,no risk
Cefmenoxime,Vaborbactam,Cefmenoxime may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Valaciclovir.,increase,risk
Cefmenoxime,Valbenazine,Cefmenoxime may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Valdecoxib.,increase,risk
Cefmenoxime,Valganciclovir,Cefmenoxime may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Vancomycin,Cefmenoxime may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Varenicline,Cefmenoxime may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Venlafaxine,Cefmenoxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Verapamil,Cefmenoxime may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefmenoxime.,decrease,no risk
Cefmenoxime,Vilanterol,Cefmenoxime may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Viloxazine,Cefmenoxime may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefmenoxime.,decrease,no risk
Cefmenoxime,Vortioxetine,Cefmenoxime may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Warfarin,Cefmenoxime may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefmenoxime.,decrease,no risk
Cefmenoxime,Zaleplon,Cefmenoxime may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Zanamivir,Cefmenoxime may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefmenoxime,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefmenoxime is combined with Zoledronic acid.,increase,risk
Cefmenoxime,Zonisamide,Cefmenoxime may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Ropinirole,Gabapentin,Gabapentin may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Gabapentin enacarbil,Gabapentin enacarbil may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Gallamine triethiodide,Gallamine triethiodide may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Ganaxolone,Ganaxolone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Gatifloxacin,The risk or severity of adverse effects can be increased when Gatifloxacin is combined with Ropinirole.,increase,risk
Ropinirole,Gemfibrozil,The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Ropinirole.,increase,risk
Ropinirole,Gemifloxacin,The risk or severity of adverse effects can be increased when Gemifloxacin is combined with Ropinirole.,increase,risk
Ropinirole,Gepirone,Gepirone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Givosiran,The serum concentration of Ropinirole can be increased when it is combined with Givosiran.,increase,no risk
Ropinirole,Glecaprevir,The risk or severity of adverse effects can be increased when Glecaprevir is combined with Ropinirole.,increase,risk
Ropinirole,Glofitamab,The serum concentration of Ropinirole can be increased when it is combined with Glofitamab.,increase,no risk
Ropinirole,Glutethimide,Glutethimide may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Golimumab,The metabolism of Ropinirole can be increased when combined with Golimumab.,increase,no risk
Ropinirole,Granisetron,Granisetron may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Grepafloxacin,The risk or severity of adverse effects can be increased when Grepafloxacin is combined with Ropinirole.,increase,risk
Ropinirole,Griseofulvin,The metabolism of Ropinirole can be increased when combined with Griseofulvin.,increase,no risk
Ropinirole,Guanabenz,Ropinirole may increase the hypotensive activities of Guanabenz.,increase,no risk
Ropinirole,Guanadrel,Ropinirole may increase the hypotensive activities of Guanadrel.,increase,no risk
Ropinirole,Guanethidine,Ropinirole may increase the hypotensive activities of Guanethidine.,increase,no risk
Ropinirole,Guanfacine,Guanfacine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Guanoxan,Ropinirole may increase the hypotensive activities of Guanoxan.,increase,no risk
Ropinirole,Halazepam,Halazepam may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Haloperidol,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Haloperidol.,decrease,no risk
Ropinirole,Halothane,Halothane may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Hexafluronium,Hexafluronium may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Hydralazine,The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydralazine.,increase,risk
Ropinirole,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydrochlorothiazide.,increase,risk
Ropinirole,Hydrocodone,Hydrocodone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydroflumethiazide.,increase,risk
Ropinirole,Hydromorphone,Hydromorphone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Hydroxyzine,Hydroxyzine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Ketamine,Ketamine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Ketazolam,Ketazolam may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Ketoconazole,The risk or severity of adverse effects can be increased when Ketoconazole is combined with Ropinirole.,increase,risk
Ropinirole,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Ropinirole.,increase,risk
Ropinirole,Obinutuzumab,The risk or severity of adverse effects can be increased when Ropinirole is combined with Obinutuzumab.,increase,risk
Ropinirole,Ofloxacin,The risk or severity of adverse effects can be increased when Ofloxacin is combined with Ropinirole.,increase,risk
Ropinirole,Olanzapine,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Olanzapine.,decrease,no risk
Ropinirole,Oliceridine,Oliceridine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Olmesartan,The risk or severity of adverse effects can be increased when Ropinirole is combined with Olmesartan.,increase,risk
Ropinirole,Ondansetron,Ondansetron may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Opicapone,The risk or severity of adverse effects can be increased when Ropinirole is combined with Opicapone.,increase,risk
Ropinirole,Opium,Opium may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Ropinirole.,increase,risk
Ropinirole,Osilodrostat,The risk or severity of adverse effects can be increased when Osilodrostat is combined with Ropinirole.,increase,risk
Ropinirole,Osimertinib,The serum concentration of Ropinirole can be decreased when it is combined with Osimertinib.,decrease,no risk
Ropinirole,Oxazepam,Oxazepam may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Oxcarbazepine,Oxcarbazepine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Oxitriptan,Oxitriptan may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Oxprenolol,Oxprenolol may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Oxybuprocaine,Oxybuprocaine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Oxycodone,Oxycodone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Oxymorphone,Oxymorphone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Quazepam,Quazepam may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Quetiapine,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Quetiapine.,decrease,no risk
Ropinirole,Quinagolide,The risk or severity of adverse effects can be decreased when Ropinirole is combined with Quinagolide.,decrease,risk
Ropinirole,Quinapril,The risk or severity of adverse effects can be increased when Ropinirole is combined with Quinapril.,increase,risk
Ropinirole,Quinestrol,Quinestrol may increase the excretion rate of Ropinirole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropinirole,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Ropinirole.,increase,risk
Ropinirole,Quinine,Quinine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Quinupramine,Quinupramine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Ropinirole.,increase,risk
Ropinirole,Urethane,Urethane may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Valproic acid,The risk or severity of adverse effects can be increased when Valproic acid is combined with Ropinirole.,increase,risk
Ropinirole,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Ropinirole.,increase,risk
Ropinirole,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Ropinirole.,increase,risk
Ropinirole,Vecuronium,Vecuronium may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Vemurafenib,The serum concentration of Ropinirole can be increased when it is combined with Vemurafenib.,increase,no risk
Ropinirole,Venlafaxine,Venlafaxine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Verapamil,The risk or severity of adverse effects can be increased when Ropinirole is combined with Verapamil.,increase,risk
Ropinirole,Vericiguat,The risk or severity of adverse effects can be increased when Ropinirole is combined with Vericiguat.,increase,risk
Ropinirole,Vigabatrin,Vigabatrin may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Vilazodone,Vilazodone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Viloxazine,The risk or severity of adverse effects can be increased when Viloxazine is combined with Ropinirole.,increase,risk
Ropinirole,Vortioxetine,Vortioxetine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Yohimbine,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Yohimbine.,decrease,no risk
Ropinirole,Zaleplon,Zaleplon may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Ziconotide,Ziconotide may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Zileuton,The metabolism of Ropinirole can be decreased when combined with Zileuton.,decrease,no risk
Ropinirole,Zimelidine,Zimelidine may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Ziprasidone,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Ziprasidone.,decrease,no risk
Ropinirole,Zofenopril,Ropinirole may increase the hypotensive activities of Zofenopril.,increase,no risk
Ropinirole,Zolmitriptan,Zolmitriptan may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Zolpidem,Zolpidem may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Zonisamide,Zonisamide may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Zopiclone,Zopiclone may increase the sedative activities of Ropinirole.,increase,no risk
Ropinirole,Zotepine,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Zotepine.,decrease,no risk
Ropinirole,Zuclopenthixol,The therapeutic efficacy of Ropinirole can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Ropinirole,Zuranolone,Zuranolone may increase the sedative activities of Ropinirole.,increase,no risk
Chlorotrianisene,Galcanezumab,Chlorotrianisene may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Chlorotrianisene,Gemtuzumab ozogamicin,Chlorotrianisene may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Chlorotrianisene,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Glofitamab,Chlorotrianisene may increase the thrombogenic activities of Glofitamab.,increase,no risk
Chlorotrianisene,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Golimumab,Chlorotrianisene may increase the thrombogenic activities of Golimumab.,increase,no risk
Chlorotrianisene,Guselkumab,Chlorotrianisene may increase the thrombogenic activities of Guselkumab.,increase,no risk
Chlorotrianisene,Heparin,Chlorotrianisene may decrease the anticoagulant activities of Heparin.,decrease,no risk
Chlorotrianisene,Hepatitis B immune globulin,Chlorotrianisene may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Chlorotrianisene,Human cytomegalovirus immune globulin,Chlorotrianisene may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Chlorotrianisene,Human immunoglobulin G,Chlorotrianisene may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Chlorotrianisene,Human Rho(D) immune globulin,Chlorotrianisene may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Chlorotrianisene,Human varicella-zoster immune globulin,Chlorotrianisene may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Chlorotrianisene,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Chlorotrianisene.,decrease,no risk
Chlorotrianisene,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Chlorotrianisene.,increase,no risk
Chlorotrianisene,Obiltoxaximab,Chlorotrianisene may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Chlorotrianisene,Obinutuzumab,Chlorotrianisene may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Chlorotrianisene,Ocrelizumab,Chlorotrianisene may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Chlorotrianisene,Odesivimab,Chlorotrianisene may increase the thrombogenic activities of Odesivimab.,increase,no risk
Chlorotrianisene,Ofatumumab,Chlorotrianisene may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Chlorotrianisene,Olaratumab,Chlorotrianisene may increase the thrombogenic activities of Olaratumab.,increase,no risk
Chlorotrianisene,Omalizumab,Chlorotrianisene may increase the thrombogenic activities of Omalizumab.,increase,no risk
Chlorotrianisene,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Chlorotrianisene is combined with Ombitasvir.,increase,risk
Chlorotrianisene,Ospemifene,The risk or severity of adverse effects can be increased when Chlorotrianisene is combined with Ospemifene.,increase,risk
Chlorotrianisene,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Chlorotrianisene is combined with Oxetacaine.,increase,risk
Chlorotrianisene,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Chlorotrianisene is combined with Oxybuprocaine.,increase,risk
Chlorotrianisene,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Chlorotrianisene.,increase,no risk
Chlorotrianisene,Ublituximab,Chlorotrianisene may increase the thrombogenic activities of Ublituximab.,increase,no risk
Chlorotrianisene,Urokinase,Chlorotrianisene may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Chlorotrianisene,Ustekinumab,Chlorotrianisene may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Chlorotrianisene,Valdecoxib,Valdecoxib may increase the thrombogenic activities of Chlorotrianisene.,increase,no risk
Chlorotrianisene,Vedolizumab,Chlorotrianisene may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Chlorotrianisene,Vorapaxar,Chlorotrianisene may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Chlorotrianisene,Warfarin,Chlorotrianisene may decrease the anticoagulant activities of Warfarin.,decrease,no risk
Chlorotrianisene,Ximelagatran,Chlorotrianisene may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Chlorotrianisene,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Chlorotrianisene.,decrease,no risk
Isradipine,Bacitracin,Bacitracin may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Isradipine.,increase,risk
Isradipine,Balsalazide,The therapeutic efficacy of Isradipine can be decreased when used in combination with Balsalazide.,decrease,no risk
Isradipine,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Bedaquiline.,increase,risk
Isradipine,Belantamab mafodotin,Isradipine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Isradipine,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bemiparin,The risk or severity of hyperkalemia can be increased when Isradipine is combined with Bemiparin.,increase,risk
Isradipine,Benazepril,Isradipine may increase the hypotensive activities of Benazepril.,increase,no risk
Isradipine,Bendroflumethiazide,The therapeutic efficacy of Isradipine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Isradipine,Benorilate,The therapeutic efficacy of Isradipine can be decreased when used in combination with Benorilate.,decrease,no risk
Isradipine,Benoxaprofen,The therapeutic efficacy of Isradipine can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Isradipine,Benserazide,Isradipine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Isradipine,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Isradipine.,increase,risk
Isradipine,Benznidazole,Isradipine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Isradipine,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Benzthiazide,The therapeutic efficacy of Isradipine can be increased when used in combination with Benzthiazide.,increase,no risk
Isradipine,Benzydamine,The therapeutic efficacy of Isradipine can be decreased when used in combination with Benzydamine.,decrease,no risk
Isradipine,Bepotastine,Isradipine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Isradipine,Bepridil,Isradipine may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Isradipine,Beractant,Isradipine may increase the bradycardic activities of Beractant.,increase,no risk
Isradipine,Berotralstat,The metabolism of Isradipine can be decreased when combined with Berotralstat.,decrease,no risk
Isradipine,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Isradipine.,increase,no risk
Isradipine,Bethanidine,Bethanidine may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Bexagliflozin.,increase,risk
Isradipine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bicisate,Isradipine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Isradipine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Isradipine.,increase,no risk
Isradipine,Bilastine,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Bilastine.,increase,risk
Isradipine,Bimatoprost,Isradipine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Isradipine,Bioallethrin,Isradipine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Isradipine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Isradipine.,decrease,no risk
Isradipine,Bismuth subgallate,Isradipine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Isradipine,Bisoprolol,The therapeutic efficacy of Isradipine can be increased when used in combination with Bisoprolol.,increase,no risk
Isradipine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Isradipine.,decrease,no risk
Isradipine,Bleomycin,Isradipine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Isradipine,Boceprevir,The serum concentration of Isradipine can be increased when it is combined with Boceprevir.,increase,no risk
Isradipine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bosentan,Bosentan may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bretylium,Isradipine may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Isradipine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Brimonidine,Brimonidine may increase the antihypertensive activities of Isradipine.,increase,no risk
Isradipine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bromazepam,Isradipine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Isradipine,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isradipine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Brompheniramine.,increase,risk
Isradipine,Buclizine,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Buclizine.,increase,risk
Isradipine,Budesonide,The metabolism of Budesonide can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bumadizone,The therapeutic efficacy of Isradipine can be decreased when used in combination with Bumadizone.,decrease,no risk
Isradipine,Bumetanide,Bumetanide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isradipine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Bupropion,Isradipine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Isradipine,Buserelin,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Buserelin.,increase,risk
Isradipine,Buspirone,The metabolism of Buspirone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Busulfan,The metabolism of Busulfan can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Butabarbital,Butabarbital may increase the hypotensive activities of Isradipine.,increase,no risk
Isradipine,Butalbital,Butalbital may increase the hypotensive activities of Isradipine.,increase,no risk
Isradipine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Gabapentin enacarbil,Isradipine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Isradipine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gadobenic acid.,increase,risk
Isradipine,Gadodiamide,Gadodiamide may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Gadofosveset trisodium,Isradipine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Isradipine,Gadopentetic acid,Isradipine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Isradipine,Gadoteric acid,Isradipine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Isradipine,Gadoteridol,Isradipine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Isradipine,Galantamine,The metabolism of Galantamine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Gallamine triethiodide,Isradipine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Isradipine,Ganciclovir,Isradipine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Isradipine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gatifloxacin.,increase,risk
Isradipine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Gemcitabine,Isradipine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Isradipine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gemifloxacin.,increase,risk
Isradipine,Gentamicin,Isradipine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Isradipine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Gimeracil,Isradipine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Isradipine,Givosiran,Givosiran may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Glasdegib,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Glasdegib.,increase,risk
Isradipine,Gliclazide,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Gliclazide.,increase,risk
Isradipine,Glimepiride,Glimepiride may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Glipizide,Isradipine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Isradipine,Gliquidone,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Gliquidone.,increase,risk
Isradipine,Glofitamab,The serum concentration of Isradipine can be increased when it is combined with Glofitamab.,increase,no risk
Isradipine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Isradipine.,decrease,no risk
Isradipine,Glyburide,Glyburide may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Isradipine.,decrease,no risk
Isradipine,Glycerol phenylbutyrate,Isradipine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Isradipine,Glycol salicylate,The therapeutic efficacy of Isradipine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Isradipine,Glycyrrhizic acid,Isradipine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Isradipine,Glymidine,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Glymidine.,increase,risk
Isradipine,Golodirsen,Isradipine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Isradipine,Goserelin,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Goserelin.,increase,risk
Isradipine,Granisetron,The metabolism of Granisetron can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Guanadrel,Guanadrel may increase the hypotensive activities of Isradipine.,increase,no risk
Isradipine,Guanethidine,Isradipine may increase the hypotensive activities of Guanethidine.,increase,no risk
Isradipine,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Guanoxan,Isradipine may increase the hypotensive activities of Guanoxan.,increase,no risk
Isradipine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Haloperidol,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Haloperidol.,increase,risk
Isradipine,Halothane,Halothane may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Heparin,The risk or severity of hyperkalemia can be increased when Isradipine is combined with Heparin.,increase,risk
Isradipine,Histrelin,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Histrelin.,increase,risk
Isradipine,Hydralazine,Isradipine may increase the hypotensive activities of Hydralazine.,increase,no risk
Isradipine,Hydrochlorothiazide,The therapeutic efficacy of Isradipine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Isradipine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydroflumethiazide,The therapeutic efficacy of Isradipine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Isradipine,Hydromorphone,Isradipine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Isradipine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Isradipine.,increase,risk
Isradipine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydroxyethyl Starch,Isradipine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Isradipine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Hydroxyzine.,increase,risk
Isradipine,Hyoscyamine,Isradipine may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Isradipine,Kanamycin,Isradipine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Isradipine,Ketamine,The metabolism of Ketamine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Ketoconazole,The metabolism of Isradipine can be decreased when combined with Ketoconazole.,decrease,no risk
Isradipine,Ketoprofen,The therapeutic efficacy of Isradipine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Isradipine,Ketorolac,The therapeutic efficacy of Isradipine can be decreased when used in combination with Ketorolac.,decrease,no risk
Isradipine,Obinutuzumab,Isradipine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Isradipine,Octinoxate,Isradipine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Isradipine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Isradipine.,increase,no risk
Isradipine,Ofloxacin,Isradipine may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Isradipine,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Isradipine.,increase,risk
Isradipine,Olaparib,The metabolism of Olaparib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Olmesartan,Olmesartan may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Olsalazine,Olsalazine may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Opicapone,The risk or severity of adverse effects can be increased when Isradipine is combined with Opicapone.,increase,risk
Isradipine,Opium,The metabolism of Opium can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Oseltamivir,Oseltamivir may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Isradipine.,increase,no risk
Isradipine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Oxacillin,Isradipine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Isradipine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Isradipine.,increase,risk
Isradipine,Oxaprozin,The therapeutic efficacy of Isradipine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Isradipine,Oxatomide,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Oxatomide.,increase,risk
Isradipine,Oxazepam,Isradipine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Isradipine,Oxprenolol,Isradipine may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Isradipine,Oxybenzone,Isradipine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Isradipine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Oxymetazoline,The therapeutic efficacy of Isradipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Isradipine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Oxyphenbutazone,The therapeutic efficacy of Isradipine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Isradipine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Isradipine.,decrease,no risk
Isradipine,Oxyquinoline,Isradipine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Isradipine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Isradipine.,increase,risk
Isradipine,Quazepam,The metabolism of Quazepam can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Quetiapine,Quetiapine may increase the hypotensive activities of Isradipine.,increase,no risk
Isradipine,Quinapril,Isradipine may increase the hypotensive activities of Quinapril.,increase,no risk
Isradipine,Quinethazone,Quinethazone may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isradipine,Quinidine,Isradipine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Isradipine,Quinine,The metabolism of Quinine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Quinupramine,Quinupramine may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Quizartinib,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Quizartinib.,increase,risk
Isradipine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Udenafil,The metabolism of Udenafil can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Unoprostone,Isradipine may increase the hypotensive activities of Unoprostone.,increase,no risk
Isradipine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Vaborbactam,Isradipine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Isradipine,Vadadustat,The serum concentration of Isradipine can be increased when it is combined with Vadadustat.,increase,no risk
Isradipine,Valaciclovir,Valaciclovir may decrease the excretion rate of Isradipine which could result in a higher serum level.,decrease,no risk
Isradipine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Valganciclovir,Isradipine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Isradipine,Valproic acid,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Valproic acid.,increase,risk
Isradipine,Valsartan,Valsartan may increase the hypotensive activities of Isradipine.,increase,no risk
Isradipine,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vancomycin,Isradipine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Isradipine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Varenicline,Isradipine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Isradipine,Vecuronium,Isradipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Isradipine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Isradipine.,increase,risk
Isradipine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Verapamil,Isradipine may increase the arrhythmogenic activities of Verapamil.,increase,no risk
Isradipine,Vericiguat,The risk or severity of adverse effects can be increased when Isradipine is combined with Vericiguat.,increase,risk
Isradipine,Vernakalant,Isradipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Isradipine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Isradipine.,increase,risk
Isradipine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Vildagliptin.,increase,risk
Isradipine,Viloxazine,The metabolism of Isradipine can be decreased when combined with Viloxazine.,decrease,no risk
Isradipine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vincristine,The metabolism of Vincristine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vindesine,The metabolism of Vindesine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Voriconazole,The serum concentration of Isradipine can be increased when it is combined with Voriconazole.,increase,no risk
Isradipine,Vorinostat,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Vorinostat.,increase,risk
Isradipine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Isradipine.,increase,no risk
Isradipine,Xamoterol,Xamoterol may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Xylometazoline,Isradipine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Isradipine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zanamivir,Isradipine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Isradipine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Ziconotide,Isradipine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Isradipine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zileuton,The metabolism of Zileuton can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zimelidine,The metabolism of Isradipine can be decreased when combined with Zimelidine.,decrease,no risk
Isradipine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ziprasidone.,increase,risk
Isradipine,Zofenopril,Isradipine may increase the hypotensive activities of Zofenopril.,increase,no risk
Isradipine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Isradipine.,decrease,no risk
Isradipine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zonisamide,Isradipine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Isradipine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zotepine,The metabolism of Zotepine can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Isradipine.,decrease,no risk
Isradipine,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Isradipine.,decrease,no risk
Diatrizoate,Gabapentin enacarbil,Diatrizoate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gadobenic acid,Diatrizoate may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gadodiamide,Gadodiamide may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gadofosveset trisodium,Diatrizoate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gadopentetic acid,Diatrizoate may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gadoteric acid,Diatrizoate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gadoteridol,Diatrizoate may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Diatrizoate,Ganciclovir,Diatrizoate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gemcitabine,Diatrizoate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gemfibrozil,Diatrizoate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gentamicin,Diatrizoate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Diatrizoate,Gimeracil,Diatrizoate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Diatrizoate,Givosiran,Givosiran may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Glipizide,Diatrizoate may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Diatrizoate,Glycerol phenylbutyrate,Diatrizoate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Golodirsen,Diatrizoate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Diatrizoate,Goserelin,Goserelin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Guanethidine,Diatrizoate may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Guanfacine,Diatrizoate may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Haloperidol,Diatrizoate may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Diatrizoate,Hydralazine,Diatrizoate may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Diatrizoate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Diatrizoate,Hydromorphone,Diatrizoate may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Diatrizoate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Hydroxyethyl Starch,Diatrizoate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Diatrizoate,Kanamycin,Diatrizoate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Diatrizoate,Ketamine,Diatrizoate may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Ketazolam,Diatrizoate may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Diatrizoate,Ketoprofen,Ketoprofen may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Ketorolac,Ketorolac may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Octinoxate,Diatrizoate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Olsalazine,Olsalazine may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Opium,Diatrizoate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oseltamivir,Oseltamivir may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oxacillin,Diatrizoate may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oxaprozin,Oxaprozin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oxazepam,Diatrizoate may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oxybenzone,Diatrizoate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Oxyquinoline,Diatrizoate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Diatrizoate,Quetiapine,Diatrizoate may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Quinethazone,Quinethazone may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Diatrizoate,Quinidine,Diatrizoate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Vaborbactam,Diatrizoate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Diatrizoate,Valaciclovir,Valaciclovir may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Valbenazine,Diatrizoate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Valdecoxib,Valdecoxib may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,decrease,no risk
Diatrizoate,Valganciclovir,Diatrizoate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Diatrizoate,Vancomycin,Diatrizoate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Diatrizoate,Varenicline,Diatrizoate may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Diatrizoate,Venlafaxine,Diatrizoate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Verapamil,Diatrizoate may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Diatrizoate,Vilanterol,Diatrizoate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Diatrizoate,Viloxazine,Diatrizoate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Vortioxetine,Diatrizoate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Diatrizoate,Warfarin,Diatrizoate may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Diatrizoate,Zaleplon,Diatrizoate may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Diatrizoate,Zanamivir,Diatrizoate may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Diatrizoate,Zonisamide,Zonisamide may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiramate,Benzphetamine,The risk or severity of CNS depression can be increased when Topiramate is combined with Benzphetamine.,increase,risk
Topiramate,Benzthiazide,The risk or severity of hypokalemia can be increased when Benzthiazide is combined with Topiramate.,increase,risk
Topiramate,Benzydamine,Benzydamine may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Benzyl alcohol.,increase,risk
Topiramate,Bepotastine,Topiramate may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Topiramate,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Topiramate.,increase,no risk
Topiramate,Bicisate,Topiramate may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Topiramate,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Topiramate.,decrease,no risk
Topiramate,Biperiden,The risk or severity of hyperthermia and oligohydrosis can be increased when Biperiden is combined with Topiramate.,increase,risk
Topiramate,Bismuth subgallate,Topiramate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Topiramate,Bisoprolol,Topiramate may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Topiramate,Bisoxatin,Topiramate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Topiramate,Bleomycin,Topiramate may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Topiramate,Borage oil,The therapeutic efficacy of Topiramate can be decreased when used in combination with Borage oil.,decrease,no risk
Topiramate,Bortezomib,The metabolism of Bortezomib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Bosutinib,The metabolism of Bosutinib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Topiramate.,increase,risk
Topiramate,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Topiramate.,increase,risk
Topiramate,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Topiramate.,increase,no risk
Topiramate,Brexanolone,The risk or severity of CNS depression can be increased when Topiramate is combined with Brexanolone.,increase,risk
Topiramate,Brexpiprazole,The risk or severity of CNS depression can be increased when Topiramate is combined with Brexpiprazole.,increase,risk
Topiramate,Brigatinib,The metabolism of Brigatinib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Topiramate.,increase,no risk
Topiramate,Brinzolamide,The risk or severity of adverse effects can be increased when Topiramate is combined with Brinzolamide.,increase,risk
Topiramate,Brivaracetam,The risk or severity of CNS depression can be increased when Topiramate is combined with Brivaracetam.,increase,risk
Topiramate,Bromazepam,The risk or severity of CNS depression can be increased when Topiramate is combined with Bromazepam.,increase,risk
Topiramate,Bromocriptine,The risk or severity of CNS depression can be increased when Topiramate is combined with Bromocriptine.,increase,risk
Topiramate,Bromotheophylline,Topiramate may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiramate,Bromperidol,The risk or severity of CNS depression can be increased when Topiramate is combined with Bromperidol.,increase,risk
Topiramate,Brompheniramine,The risk or severity of hyperthermia and oligohydrosis can be increased when Brompheniramine is combined with Topiramate.,increase,risk
Topiramate,Buclizine,The risk or severity of hyperthermia and oligohydrosis can be increased when Buclizine is combined with Topiramate.,increase,risk
Topiramate,Budesonide,Topiramate may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Topiramate,Bumadizone,Bumadizone may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Bumetanide,The risk or severity of hypokalemia can be increased when Bumetanide is combined with Topiramate.,increase,risk
Topiramate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Bupivacaine.,increase,risk
Topiramate,Buprenorphine,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Topiramate,Bupropion,The risk or severity of CNS depression can be increased when Topiramate is combined with Bupropion.,increase,risk
Topiramate,Buspirone,The risk or severity of CNS depression can be increased when Topiramate is combined with Buspirone.,increase,risk
Topiramate,Busulfan,The metabolism of Busulfan can be increased when combined with Topiramate.,increase,no risk
Topiramate,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Topiramate.,increase,risk
Topiramate,Butacaine,The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Butacaine.,increase,risk
Topiramate,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Topiramate.,increase,risk
Topiramate,Butamben,The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Butamben.,increase,risk
Topiramate,Butaperazine,The risk or severity of CNS depression can be increased when Topiramate is combined with Butaperazine.,increase,risk
Topiramate,Butobarbital,The risk or severity of CNS depression can be increased when Topiramate is combined with Butobarbital.,increase,risk
Topiramate,Butorphanol,The risk or severity of CNS depression can be increased when Topiramate is combined with Butorphanol.,increase,risk
Topiramate,Butriptyline,The risk or severity of CNS depression can be increased when Topiramate is combined with Butriptyline.,increase,risk
Topiramate,Butylscopolamine,The risk or severity of hyperthermia and oligohydrosis can be increased when Butylscopolamine is combined with Topiramate.,increase,risk
Topiramate,Gabapentin,The risk or severity of CNS depression can be increased when Topiramate is combined with Gabapentin.,increase,risk
Topiramate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Topiramate is combined with Gabapentin enacarbil.,increase,risk
Topiramate,Gadobenic acid,Topiramate may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Topiramate,Gadodiamide,Gadodiamide may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Gadofosveset trisodium,Topiramate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Topiramate,Gadopentetic acid,Topiramate may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Topiramate,Gadoteric acid,Topiramate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Topiramate,Gadoteridol,Topiramate may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Topiramate,Gallamine triethiodide,The risk or severity of hyperthermia and oligohydrosis can be increased when Gallamine triethiodide is combined with Topiramate.,increase,risk
Topiramate,Gamolenic acid,The therapeutic efficacy of Topiramate can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Topiramate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Topiramate is combined with Ganaxolone.",increase,risk
Topiramate,Ganciclovir,The therapeutic efficacy of Topiramate can be decreased when used in combination with Ganciclovir.,decrease,no risk
Topiramate,Gemcitabine,Topiramate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Topiramate,Gemfibrozil,Topiramate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Topiramate,Gentamicin,Topiramate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Topiramate,Gepirone,The risk or severity of CNS depression can be increased when Topiramate is combined with Gepirone.,increase,risk
Topiramate,Gestrinone,The metabolism of Gestrinone can be increased when combined with Topiramate.,increase,no risk
Topiramate,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Gimeracil,Topiramate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Topiramate,Givosiran,Givosiran may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Topiramate.,decrease,no risk
Topiramate,Glipizide,Topiramate may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Topiramate,Glutethimide,The risk or severity of CNS depression can be increased when Topiramate is combined with Glutethimide.,increase,risk
Topiramate,Glyburide,The serum concentration of Glyburide can be decreased when it is combined with Topiramate.,decrease,no risk
Topiramate,Glycerol phenylbutyrate,Topiramate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Topiramate,Glycopyrronium,The risk or severity of hyperthermia and oligohydrosis can be increased when Glycopyrronium is combined with Topiramate.,increase,risk
Topiramate,Golodirsen,Topiramate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Topiramate,Goserelin,Goserelin may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Granisetron,The risk or severity of CNS depression can be increased when Topiramate is combined with Granisetron.,increase,risk
Topiramate,Guanethidine,Topiramate may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Topiramate,Guanfacine,The risk or severity of CNS depression can be increased when Topiramate is combined with Guanfacine.,increase,risk
Topiramate,Halazepam,The risk or severity of CNS depression can be increased when Topiramate is combined with Halazepam.,increase,risk
Topiramate,Halofantrine,The therapeutic efficacy of Topiramate can be decreased when used in combination with Halofantrine.,decrease,no risk
Topiramate,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Topiramate.,increase,risk
Topiramate,Halothane,The risk or severity of CNS depression can be increased when Topiramate is combined with Halothane.,increase,risk
Topiramate,Hexafluronium,The risk or severity of CNS depression can be increased when Topiramate is combined with Hexafluronium.,increase,risk
Topiramate,Hexocyclium,The risk or severity of hyperthermia and oligohydrosis can be increased when Hexocyclium is combined with Topiramate.,increase,risk
Topiramate,Homatropine methylbromide,The risk or severity of hyperthermia and oligohydrosis can be increased when Homatropine methylbromide is combined with Topiramate.,increase,risk
Topiramate,Hydralazine,Topiramate may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Topiramate,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Hydrochlorothiazide is combined with Topiramate.,increase,risk
Topiramate,Hydrocodone,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Topiramate,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydroflumethiazide is combined with Topiramate.,increase,risk
Topiramate,Hydromorphone,The risk or severity of CNS depression can be increased when Topiramate is combined with Hydromorphone.,increase,risk
Topiramate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Hydroxychloroquine,The therapeutic efficacy of Topiramate can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Topiramate,Hydroxyethyl Starch,Topiramate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Topiramate,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Topiramate.,increase,no risk
Topiramate,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Topiramate.,increase,no risk
Topiramate,Hyoscyamine,The risk or severity of hyperthermia and oligohydrosis can be increased when Hyoscyamine is combined with Topiramate.,increase,risk
Topiramate,Kanamycin,Topiramate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Topiramate,Ketamine,The risk or severity of CNS depression can be increased when Topiramate is combined with Ketamine.,increase,risk
Topiramate,Ketazolam,The risk or severity of CNS depression can be increased when Topiramate is combined with Ketazolam.,increase,risk
Topiramate,Ketoprofen,Ketoprofen may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Ketorolac,Ketorolac may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Octinoxate,Topiramate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Topiramate,Olanzapine,The risk or severity of hyperthermia and oligohydrosis can be increased when Olanzapine is combined with Topiramate.,increase,risk
Topiramate,Olaparib,The metabolism of Olaparib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Topiramate is combined with Oliceridine.",increase,risk
Topiramate,Olsalazine,Olsalazine may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Topiramate.,decrease,no risk
Topiramate,Ondansetron,The risk or severity of CNS depression can be increased when Topiramate is combined with Ondansetron.,increase,risk
Topiramate,Opium,The risk or severity of CNS depression can be increased when Topiramate is combined with Opium.,increase,risk
Topiramate,Orlistat,Orlistat can cause a decrease in the absorption of Topiramate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Topiramate,Orphenadrine,The risk or severity of hyperthermia and oligohydrosis can be increased when Orphenadrine is combined with Topiramate.,increase,risk
Topiramate,Oseltamivir,Oseltamivir may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Osimertinib,The metabolism of Osimertinib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Oxacillin,Topiramate may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Topiramate,Oxaprozin,Oxaprozin may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Oxazepam,The risk or severity of CNS depression can be increased when Topiramate is combined with Oxazepam.,increase,risk
Topiramate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Topiramate is combined with Oxcarbazepine.,increase,risk
Topiramate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Oxetacaine.,increase,risk
Topiramate,Oxitriptan,The risk or severity of CNS depression can be increased when Topiramate is combined with Oxitriptan.,increase,risk
Topiramate,Oxprenolol,The risk or severity of CNS depression can be increased when Topiramate is combined with Oxprenolol.,increase,risk
Topiramate,Oxtriphylline,Topiramate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiramate,Oxybenzone,Topiramate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Topiramate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Oxybuprocaine.,increase,risk
Topiramate,Oxybutynin,The risk or severity of hyperthermia and oligohydrosis can be increased when Oxybutynin is combined with Topiramate.,increase,risk
Topiramate,Oxycodone,The risk or severity of CNS depression can be increased when Topiramate is combined with Oxycodone.,increase,risk
Topiramate,Oxymorphone,The risk or severity of CNS depression can be increased when Topiramate is combined with Oxymorphone.,increase,risk
Topiramate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Oxyphencyclimine,The risk or severity of hyperthermia and oligohydrosis can be increased when Oxyphencyclimine is combined with Topiramate.,increase,risk
Topiramate,Oxyphenonium,The risk or severity of hyperthermia and oligohydrosis can be increased when Oxyphenonium is combined with Topiramate.,increase,risk
Topiramate,Oxyquinoline,Topiramate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Topiramate,Quazepam,The risk or severity of CNS depression can be increased when Topiramate is combined with Quazepam.,increase,risk
Topiramate,Quetiapine,The risk or severity of hyperthermia and oligohydrosis can be increased when Quetiapine is combined with Topiramate.,increase,risk
Topiramate,Quinethazone,The risk or severity of hypokalemia can be increased when Quinethazone is combined with Topiramate.,increase,risk
Topiramate,Quinidine,The risk or severity of hyperthermia and oligohydrosis can be increased when Quinidine is combined with Topiramate.,increase,risk
Topiramate,Quinine,The risk or severity of CNS depression can be increased when Topiramate is combined with Quinine.,increase,risk
Topiramate,Quinupramine,The risk or severity of CNS depression can be increased when Topiramate is combined with Quinupramine.,increase,risk
Topiramate,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Topiramate.,decrease,no risk
Topiramate,Ulipristal,The metabolism of Ulipristal can be increased when combined with Topiramate.,increase,no risk
Topiramate,Umeclidinium,The risk or severity of hyperthermia and oligohydrosis can be increased when Umeclidinium is combined with Topiramate.,increase,risk
Topiramate,Urethane,The risk or severity of CNS depression can be increased when Topiramate is combined with Urethane.,increase,risk
Topiramate,Vaborbactam,Topiramate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Topiramate,Valaciclovir,Valaciclovir may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Valbenazine,Topiramate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Topiramate,Valdecoxib,Valdecoxib may decrease the excretion rate of Topiramate which could result in a higher serum level.,decrease,no risk
Topiramate,Valganciclovir,The therapeutic efficacy of Topiramate can be decreased when used in combination with Valganciclovir.,decrease,no risk
Topiramate,Valproic acid,The risk or severity of adverse effects can be increased when Topiramate is combined with Valproic acid.,increase,risk
Topiramate,Vancomycin,Topiramate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Topiramate,Vandetanib,The metabolism of Vandetanib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Varenicline,Topiramate may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Topiramate,Vecuronium,The risk or severity of CNS depression can be increased when Topiramate is combined with Vecuronium.,increase,risk
Topiramate,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Venetoclax,The metabolism of Venetoclax can be increased when combined with Topiramate.,increase,no risk
Topiramate,Venlafaxine,The risk or severity of CNS depression can be increased when Topiramate is combined with Venlafaxine.,increase,risk
Topiramate,Verapamil,Topiramate may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Topiramate,Vigabatrin,The risk or severity of CNS depression can be increased when Topiramate is combined with Vigabatrin.,increase,risk
Topiramate,Vilanterol,Topiramate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Topiramate,Vilazodone,The risk or severity of CNS depression can be increased when Topiramate is combined with Vilazodone.,increase,risk
Topiramate,Viloxazine,The risk or severity of CNS depression can be increased when Topiramate is combined with Viloxazine.,increase,risk
Topiramate,Vinblastine,The metabolism of Vinblastine can be increased when combined with Topiramate.,increase,no risk
Topiramate,Vincristine,The metabolism of Vincristine can be increased when combined with Topiramate.,increase,no risk
Topiramate,Vindesine,The metabolism of Vindesine can be increased when combined with Topiramate.,increase,no risk
Topiramate,Vinflunine,The metabolism of Vinflunine can be increased when combined with Topiramate.,increase,no risk
Topiramate,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Topiramate.,increase,no risk
Topiramate,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Topiramate.,increase,no risk
Topiramate,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Topiramate.,decrease,no risk
Topiramate,Vortioxetine,The risk or severity of CNS depression can be increased when Topiramate is combined with Vortioxetine.,increase,risk
Topiramate,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Topiramate.,decrease,no risk
Topiramate,Warfarin,The metabolism of Warfarin can be increased when combined with Topiramate.,increase,no risk
Topiramate,Yohimbine,The risk or severity of CNS depression can be increased when Topiramate is combined with Yohimbine.,increase,risk
Topiramate,Zaleplon,The risk or severity of CNS depression can be increased when Topiramate is combined with Zaleplon.,increase,risk
Topiramate,Zanamivir,Topiramate may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Topiramate,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Topiramate.,increase,no risk
Topiramate,Ziconotide,The risk or severity of CNS depression can be increased when Topiramate is combined with Ziconotide.,increase,risk
Topiramate,Zimelidine,The risk or severity of adverse effects can be increased when Topiramate is combined with Zimelidine.,increase,risk
Topiramate,Ziprasidone,The risk or severity of hyperthermia and oligohydrosis can be increased when Ziprasidone is combined with Topiramate.,increase,risk
Topiramate,Zolmitriptan,The risk or severity of CNS depression can be increased when Topiramate is combined with Zolmitriptan.,increase,risk
Topiramate,Zolpidem,Topiramate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Topiramate,Zonisamide,The risk or severity of adverse effects can be increased when Topiramate is combined with Zonisamide.,increase,risk
Topiramate,Zopiclone,The risk or severity of adverse effects can be increased when Topiramate is combined with Zopiclone.,increase,risk
Topiramate,Zotepine,The risk or severity of CNS depression can be increased when Topiramate is combined with Zotepine.,increase,risk
Topiramate,Zuclopenthixol,The risk or severity of CNS depression can be increased when Topiramate is combined with Zuclopenthixol.,increase,risk
Topiramate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Topiramate.,increase,risk
Cefmetazole,Gabapentin enacarbil,Cefmetazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gadobenic acid,Cefmetazole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gadodiamide,Cefmetazole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gadofosveset trisodium,Cefmetazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gadopentetic acid,Cefmetazole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gadoteric acid,Cefmetazole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gadoteridol,Cefmetazole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefmetazole,Ganciclovir,Cefmetazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gemcitabine,Cefmetazole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gemfibrozil,Cefmetazole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gentamicin,Cefmetazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Gimeracil,Cefmetazole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefmetazole,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Givosiran.,increase,risk
Cefmetazole,Glipizide,Cefmetazole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefmetazole,Glycerol phenylbutyrate,Cefmetazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefmetazole,Golodirsen,Cefmetazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefmetazole,Goserelin,Cefmetazole may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Guanethidine,Cefmetazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Guanfacine,Cefmetazole may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Haloperidol,Cefmetazole may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefmetazole,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefmetazole.,decrease,no risk
Cefmetazole,Hydralazine,Cefmetazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Hydrochlorothiazide.,increase,risk
Cefmetazole,Hydromorphone,Cefmetazole may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefmetazole,Hydroxocobalamin,Cefmetazole may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Hydroxyethyl Starch,Cefmetazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefmetazole,Kanamycin,Cefmetazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Ketamine,Cefmetazole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Ketazolam,Cefmetazole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefmetazole,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Ketoprofen.,increase,risk
Cefmetazole,Ketorolac,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Ketorolac.,increase,risk
Cefmetazole,Octinoxate,Cefmetazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefmetazole,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Olsalazine.,increase,risk
Cefmetazole,Opium,Cefmetazole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefmetazole,Oseltamivir,Cefmetazole may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefmetazole,Oxacillin,Cefmetazole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefmetazole.,increase,risk
Cefmetazole,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Oxaprozin.,increase,risk
Cefmetazole,Oxazepam,Cefmetazole may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefmetazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefmetazole is combined with Oxetacaine.,increase,risk
Cefmetazole,Oxybenzone,Cefmetazole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefmetazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefmetazole is combined with Oxybuprocaine.,increase,risk
Cefmetazole,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Oxyphenbutazone.,increase,risk
Cefmetazole,Oxyquinoline,Cefmetazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefmetazole,Quetiapine,Cefmetazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Quinidine,Cefmetazole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefmetazole.,decrease,no risk
Cefmetazole,Vaborbactam,Cefmetazole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefmetazole,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Valaciclovir.,increase,risk
Cefmetazole,Valbenazine,Cefmetazole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Valdecoxib.,increase,risk
Cefmetazole,Valganciclovir,Cefmetazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefmetazole,Vancomycin,Cefmetazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Varenicline,Cefmetazole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefmetazole,Venlafaxine,Cefmetazole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Verapamil,Cefmetazole may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefmetazole,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefmetazole.,decrease,no risk
Cefmetazole,Vilanterol,Cefmetazole may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefmetazole,Viloxazine,Cefmetazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefmetazole.,decrease,no risk
Cefmetazole,Vortioxetine,Cefmetazole may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefmetazole,Warfarin,Cefmetazole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefmetazole,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefmetazole.,decrease,no risk
Cefmetazole,Zaleplon,Cefmetazole may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefmetazole,Zanamivir,Cefmetazole may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefmetazole,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefmetazole is combined with Zoledronic acid.,increase,risk
Cefmetazole,Zonisamide,Cefmetazole may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Olmesartan,Glimepiride,Olmesartan may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Olmesartan,Glipizide,Olmesartan may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Olmesartan,Glyburide,Olmesartan may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Olmesartan,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Glycol salicylate.",increase,risk
Olmesartan,Glycyrrhizic acid,Olmesartan may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Olmesartan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Guanadrel,Guanadrel may increase the hypotensive activities of Olmesartan.,increase,no risk
Olmesartan,Guanethidine,Olmesartan may increase the hypotensive activities of Guanethidine.,increase,no risk
Olmesartan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Guanoxan,Olmesartan may increase the hypotensive activities of Guanoxan.,increase,no risk
Olmesartan,Halothane,Halothane may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Olmesartan.,increase,risk
Olmesartan,Hydralazine,Olmesartan may increase the hypotensive activities of Hydralazine.,increase,no risk
Olmesartan,Hydroflumethiazide,The therapeutic efficacy of Olmesartan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Olmesartan,Ketoconazole,Olmesartan may decrease the excretion rate of Ketoconazole which could result in a higher serum level.,decrease,no risk
Olmesartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Ketoprofen.",increase,risk
Olmesartan,Ketorolac,The therapeutic efficacy of Olmesartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Olmesartan,Obeticholic acid,The risk or severity of adverse effects can be increased when Olmesartan is combined with Obeticholic acid.,increase,risk
Olmesartan,Obinutuzumab,Olmesartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Olmesartan,Ofloxacin,Olmesartan may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Olmesartan,Olanzapine,The risk or severity of adverse effects can be increased when Olmesartan is combined with Olanzapine.,increase,risk
Olmesartan,Olodaterol,Olodaterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Opicapone,The risk or severity of adverse effects can be increased when Olmesartan is combined with Opicapone.,increase,risk
Olmesartan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Oxaprozin.",increase,risk
Olmesartan,Oxprenolol,Olmesartan may increase the hypotensive activities of Oxprenolol.,increase,no risk
Olmesartan,Oxymetazoline,The therapeutic efficacy of Olmesartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Olmesartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Oxyphenbutazone.",increase,risk
Olmesartan,Quetiapine,Quetiapine may increase the hypotensive activities of Olmesartan.,increase,no risk
Olmesartan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Olmesartan.",increase,risk
Olmesartan,Quinidine,The risk or severity of liver damage can be increased when Olmesartan is combined with Quinidine.,increase,risk
Olmesartan,Quinine,Quinine may increase the hypotensive activities of Olmesartan.,increase,no risk
Olmesartan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Udenafil,Udenafil may increase the antihypertensive activities of Olmesartan.,increase,no risk
Olmesartan,Unoprostone,Olmesartan may increase the hypotensive activities of Unoprostone.,increase,no risk
Olmesartan,Ursodeoxycholic acid,Olmesartan may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Olmesartan,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Valdecoxib.",increase,risk
Olmesartan,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Olmesartan.",increase,risk
Olmesartan,Vardenafil,Vardenafil may increase the antihypertensive activities of Olmesartan.,increase,no risk
Olmesartan,Verapamil,The risk or severity of adverse effects can be increased when Olmesartan is combined with Verapamil.,increase,risk
Olmesartan,Vericiguat,The risk or severity of adverse effects can be increased when Olmesartan is combined with Vericiguat.,increase,risk
Olmesartan,Vilanterol,Vilanterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Vilazodone,Vilazodone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Vinblastine,Olmesartan may decrease the excretion rate of Vinblastine which could result in a higher serum level.,decrease,no risk
Olmesartan,Vincristine,Olmesartan may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Olmesartan,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Xamoterol,Xamoterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Yohimbine,Yohimbine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Olmesartan.,increase,no risk
Olmesartan,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Olmesartan.",increase,risk
Olmesartan,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olmesartan,Zonisamide,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Zonisamide.,increase,risk
Olmesartan,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Theophylline,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Brivaracetam,Brivaracetam may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Theophylline,Bromazepam,The metabolism of Theophylline can be decreased when combined with Bromazepam.,decrease,no risk
Theophylline,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Budesonide,The metabolism of Theophylline can be increased when combined with Budesonide.,increase,no risk
Theophylline,Bupivacaine,The metabolism of Theophylline can be decreased when combined with Bupivacaine.,decrease,no risk
Theophylline,Buprenorphine,The metabolism of Theophylline can be decreased when combined with Buprenorphine.,decrease,no risk
Theophylline,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Theophylline.,increase,risk
Theophylline,Buspirone,The metabolism of Theophylline can be decreased when combined with Buspirone.,decrease,no risk
Theophylline,Butabarbital,The serum concentration of Theophylline can be decreased when it is combined with Butabarbital.,decrease,no risk
Theophylline,Butalbital,The metabolism of Theophylline can be increased when combined with Butalbital.,increase,no risk
Theophylline,Gabapentin,Gabapentin may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Theophylline,Galantamine,The metabolism of Theophylline can be decreased when combined with Galantamine.,decrease,no risk
Theophylline,Ganaxolone,Ganaxolone may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Theophylline,Gatifloxacin,The metabolism of Theophylline can be decreased when combined with Gatifloxacin.,decrease,no risk
Theophylline,Gefitinib,The metabolism of Theophylline can be decreased when combined with Gefitinib.,decrease,no risk
Theophylline,Gemfibrozil,The metabolism of Theophylline can be decreased when combined with Gemfibrozil.,decrease,no risk
Theophylline,Gemifloxacin,The metabolism of Theophylline can be decreased when combined with Gemifloxacin.,decrease,no risk
Theophylline,Gestrinone,Gestrinone may decrease the excretion rate of Theophylline which could result in a higher serum level.,decrease,no risk
Theophylline,Gilteritinib,The metabolism of Theophylline can be decreased when combined with Gilteritinib.,decrease,no risk
Theophylline,Ginkgo biloba,The metabolism of Theophylline can be decreased when combined with Ginkgo biloba.,decrease,no risk
Theophylline,Givosiran,The serum concentration of Theophylline can be increased when it is combined with Givosiran.,increase,no risk
Theophylline,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Glecaprevir,The metabolism of Theophylline can be decreased when combined with Glecaprevir.,decrease,no risk
Theophylline,Glofitamab,The serum concentration of Theophylline can be increased when it is combined with Glofitamab.,increase,no risk
Theophylline,Glyburide,The metabolism of Theophylline can be decreased when combined with Glyburide.,decrease,no risk
Theophylline,Glycerin,The metabolism of Theophylline can be increased when combined with Glycerin.,increase,no risk
Theophylline,Glycerol phenylbutyrate,The metabolism of Theophylline can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Theophylline,Golimumab,The metabolism of Theophylline can be increased when combined with Golimumab.,increase,no risk
Theophylline,Grapefruit,The serum concentration of Theophylline can be increased when it is combined with Grapefruit.,increase,no risk
Theophylline,Grepafloxacin,The metabolism of Theophylline can be decreased when combined with Grepafloxacin.,decrease,no risk
Theophylline,Griseofulvin,The metabolism of Theophylline can be increased when combined with Griseofulvin.,increase,no risk
Theophylline,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The serum concentration of Theophylline can be increased when it is combined with Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen.,increase,no risk
Theophylline,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Theophylline.,decrease,no risk
Theophylline,Halofantrine,The metabolism of Theophylline can be decreased when combined with Halofantrine.,decrease,no risk
Theophylline,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Theophylline.,increase,no risk
Theophylline,Halothane,The metabolism of Theophylline can be decreased when combined with Halothane.,decrease,no risk
Theophylline,Hepatitis A Vaccine,The serum concentration of Theophylline can be increased when it is combined with Hepatitis A Vaccine.,increase,no risk
Theophylline,Hepatitis B Vaccine (Recombinant),The serum concentration of Theophylline can be increased when it is combined with Hepatitis B Vaccine (Recombinant).,increase,no risk
Theophylline,Human adenovirus e serotype 4 strain cl-68578 antigen,The serum concentration of Theophylline can be increased when it is combined with Human adenovirus e serotype 4 strain cl-68578 antigen.,increase,no risk
Theophylline,Human interferon beta,The metabolism of Theophylline can be decreased when combined with Human interferon beta.,decrease,no risk
Theophylline,Hydralazine,The serum concentration of Theophylline can be increased when it is combined with Hydralazine.,increase,no risk
Theophylline,Hydrocodone,The metabolism of Theophylline can be decreased when combined with Hydrocodone.,decrease,no risk
Theophylline,Hydrocortamate,The metabolism of Theophylline can be increased when combined with Hydrocortamate.,increase,no risk
Theophylline,Hydrocortisone,The metabolism of Theophylline can be increased when combined with Hydrocortisone.,increase,no risk
Theophylline,Hydrocortisone acetate,The metabolism of Theophylline can be increased when combined with Hydrocortisone acetate.,increase,no risk
Theophylline,Hydrocortisone butyrate,The metabolism of Theophylline can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Theophylline,Hydrocortisone succinate,The metabolism of Theophylline can be increased when combined with Hydrocortisone succinate.,increase,no risk
Theophylline,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Theophylline.,increase,risk
Theophylline,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Theophylline.,increase,risk
Theophylline,Hydroxyzine,The metabolism of Theophylline can be decreased when combined with Hydroxyzine.,decrease,no risk
Theophylline,Janssen COVID-19 Vaccine,The serum concentration of Theophylline can be increased when it is combined with Janssen COVID-19 Vaccine.,increase,no risk
Theophylline,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The serum concentration of Theophylline can be increased when it is combined with Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated).,increase,no risk
Theophylline,Ketamine,The metabolism of Ketamine can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Ketazolam,The serum concentration of Theophylline can be increased when it is combined with Ketazolam.,increase,no risk
Theophylline,Ketoconazole,The metabolism of Theophylline can be decreased when combined with Ketoconazole.,decrease,no risk
Theophylline,Ketoprofen,The metabolism of Theophylline can be decreased when combined with Ketoprofen.,decrease,no risk
Theophylline,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Theophylline.,increase,risk
Theophylline,Octreotide,The serum concentration of Theophylline can be increased when it is combined with Octreotide.,increase,no risk
Theophylline,Ofloxacin,The metabolism of Theophylline can be decreased when combined with Ofloxacin.,decrease,no risk
Theophylline,Olaparib,The metabolism of Theophylline can be decreased when combined with Olaparib.,decrease,no risk
Theophylline,Oliceridine,The metabolism of Theophylline can be decreased when combined with Oliceridine.,decrease,no risk
Theophylline,Olodaterol,Theophylline may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Theophylline,Olutasidenib,The metabolism of Theophylline can be increased when combined with Olutasidenib.,increase,no risk
Theophylline,Omaveloxolone,The serum concentration of Theophylline can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Theophylline,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Ondansetron,The metabolism of Theophylline can be decreased when combined with Ondansetron.,decrease,no risk
Theophylline,Opium,The metabolism of Theophylline can be decreased when combined with Opium.,decrease,no risk
Theophylline,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Theophylline.,increase,risk
Theophylline,Oritavancin,The metabolism of Theophylline can be increased when combined with Oritavancin.,increase,no risk
Theophylline,Orphenadrine,The metabolism of Theophylline can be decreased when combined with Orphenadrine.,decrease,no risk
Theophylline,Osilodrostat,The serum concentration of Theophylline can be increased when it is combined with Osilodrostat.,increase,no risk
Theophylline,Osimertinib,The serum concentration of Theophylline can be decreased when it is combined with Osimertinib.,decrease,no risk
Theophylline,Ospemifene,The metabolism of Theophylline can be decreased when combined with Ospemifene.,decrease,no risk
Theophylline,Oxamniquine,The metabolism of Theophylline can be decreased when combined with Oxamniquine.,decrease,no risk
Theophylline,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Theophylline.,decrease,no risk
Theophylline,Oxcarbazepine,The metabolism of Theophylline can be increased when combined with Oxcarbazepine.,increase,no risk
Theophylline,Oxprenolol,The metabolism of Theophylline can be decreased when combined with Oxprenolol.,decrease,no risk
Theophylline,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Oxybutynin,The serum concentration of Theophylline can be increased when it is combined with Oxybutynin.,increase,no risk
Theophylline,Oxycodone,The metabolism of Theophylline can be decreased when combined with Oxycodone.,decrease,no risk
Theophylline,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Theophylline.,increase,risk
Theophylline,Oxymorphone,The metabolism of Theophylline can be decreased when combined with Oxymorphone.,decrease,no risk
Theophylline,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Theophylline.,decrease,no risk
Theophylline,Quetiapine,The metabolism of Theophylline can be decreased when combined with Quetiapine.,decrease,no risk
Theophylline,Quinidine,The serum concentration of Theophylline can be increased when it is combined with Quinidine.,increase,no risk
Theophylline,Quinine,The serum concentration of Theophylline can be increased when it is combined with Quinine.,increase,no risk
Theophylline,Quinupristin,The metabolism of Theophylline can be decreased when combined with Quinupristin.,decrease,no risk
Theophylline,Umeclidinium,The metabolism of Theophylline can be decreased when combined with Umeclidinium.,decrease,no risk
Theophylline,Vadadustat,The serum concentration of Theophylline can be increased when it is combined with Vadadustat.,increase,no risk
Theophylline,Valbenazine,The metabolism of Theophylline can be decreased when combined with Valbenazine.,decrease,no risk
Theophylline,Valproic acid,The serum concentration of Theophylline can be increased when it is combined with Valproic acid.,increase,no risk
Theophylline,Varicella zoster vaccine (live/attenuated),The serum concentration of Theophylline can be increased when it is combined with Varicella zoster vaccine (live/attenuated).,increase,no risk
Theophylline,Varicella zoster vaccine (recombinant),The serum concentration of Theophylline can be increased when it is combined with Varicella zoster vaccine (recombinant).,increase,no risk
Theophylline,Vayarin,The metabolism of Theophylline can be decreased when combined with Vayarin.,decrease,no risk
Theophylline,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Vemurafenib,The serum concentration of Theophylline can be increased when it is combined with Vemurafenib.,increase,no risk
Theophylline,Venetoclax,The metabolism of Theophylline can be decreased when combined with Venetoclax.,decrease,no risk
Theophylline,Venlafaxine,The metabolism of Theophylline can be decreased when combined with Venlafaxine.,decrease,no risk
Theophylline,Verapamil,The serum concentration of Theophylline can be increased when it is combined with Verapamil.,increase,no risk
Theophylline,Vernakalant,The metabolism of Theophylline can be decreased when combined with Vernakalant.,decrease,no risk
Theophylline,Vibrio cholerae CVD 103-HgR strain live antigen,The serum concentration of Theophylline can be increased when it is combined with Vibrio cholerae CVD 103-HgR strain live antigen.,increase,no risk
Theophylline,Vigabatrin,Vigabatrin may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Theophylline,Vilanterol,The risk or severity of hypokalemia can be increased when Theophylline is combined with Vilanterol.,increase,risk
Theophylline,Vilazodone,The metabolism of Theophylline can be decreased when combined with Vilazodone.,decrease,no risk
Theophylline,Viloxazine,The metabolism of Theophylline can be decreased when combined with Viloxazine.,decrease,no risk
Theophylline,Vinblastine,The metabolism of Theophylline can be increased when combined with Vinblastine.,increase,no risk
Theophylline,Vinorelbine,The metabolism of Theophylline can be decreased when combined with Vinorelbine.,decrease,no risk
Theophylline,Vitamin E,The metabolism of Theophylline can be increased when combined with Vitamin E.,increase,no risk
Theophylline,Vorapaxar,The metabolism of Theophylline can be decreased when combined with Vorapaxar.,decrease,no risk
Theophylline,Voriconazole,The metabolism of Theophylline can be decreased when combined with Voriconazole.,decrease,no risk
Theophylline,Vortioxetine,The metabolism of Theophylline can be decreased when combined with Vortioxetine.,decrease,no risk
Theophylline,Voxelotor,The serum concentration of Theophylline can be increased when it is combined with Voxelotor.,increase,no risk
Theophylline,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Warfarin,The metabolism of Theophylline can be increased when combined with Warfarin.,increase,no risk
Theophylline,Yellow fever vaccine,The serum concentration of Theophylline can be increased when it is combined with Yellow fever vaccine.,increase,no risk
Theophylline,Yohimbine,The metabolism of Theophylline can be decreased when combined with Yohimbine.,decrease,no risk
Theophylline,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Theophylline.,decrease,no risk
Theophylline,Zaleplon,Zaleplon may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Theophylline,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Zileuton,The serum concentration of Theophylline can be increased when it is combined with Zileuton.,increase,no risk
Theophylline,Zimelidine,The metabolism of Theophylline can be decreased when combined with Zimelidine.,decrease,no risk
Theophylline,Ziprasidone,The metabolism of Theophylline can be decreased when combined with Ziprasidone.,decrease,no risk
Theophylline,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Zolpidem,The metabolism of Theophylline can be decreased when combined with Zolpidem.,decrease,no risk
Theophylline,Zonisamide,Zonisamide may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Theophylline,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Zotepine,The metabolism of Zotepine can be decreased when combined with Theophylline.,decrease,no risk
Theophylline,Zuclopenthixol,The metabolism of Theophylline can be decreased when combined with Zuclopenthixol.,decrease,no risk
Argatroban,Gemcitabine,The risk or severity of bleeding can be increased when Argatroban is combined with Gemcitabine.,increase,risk
Argatroban,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Argatroban is combined with Gemtuzumab ozogamicin.,increase,risk
Argatroban,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Argatroban.,increase,risk
Argatroban,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Argatroban.,increase,no risk
Argatroban,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Argatroban.,increase,risk
Argatroban,Hemin,Hemin may increase the anticoagulant activities of Argatroban.,increase,no risk
Argatroban,Heparin,The risk or severity of bleeding can be increased when Argatroban is combined with Heparin.,increase,risk
Argatroban,Hydrochlorothiazide,The therapeutic efficacy of Argatroban can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Argatroban,Hydroflumethiazide,The therapeutic efficacy of Argatroban can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Argatroban,Hydroxyprogesterone caproate,The therapeutic efficacy of Argatroban can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Argatroban,Hydroxyurea,The risk or severity of bleeding can be increased when Argatroban is combined with Hydroxyurea.,increase,risk
Argatroban,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Argatroban.,increase,risk
Argatroban,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Argatroban.,increase,risk
Argatroban,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Argatroban is combined with Obeticholic acid.,increase,risk
Argatroban,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Argatroban is combined with Obinutuzumab.,increase,risk
Argatroban,Olaparib,The risk or severity of bleeding can be increased when Argatroban is combined with Olaparib.,increase,risk
Argatroban,Olive oil,The therapeutic efficacy of Argatroban can be decreased when used in combination with Olive oil.,decrease,no risk
Argatroban,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Argatroban.,increase,risk
Argatroban,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Argatroban is combined with Omacetaxine mepesuccinate.,increase,risk
Argatroban,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Argatroban.,increase,no risk
Argatroban,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Argatroban.,increase,risk
Argatroban,Omega-3-carboxylic acids,The therapeutic efficacy of Argatroban can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Argatroban,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Argatroban.,increase,risk
Argatroban,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Argatroban.,increase,risk
Argatroban,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Argatroban.,increase,risk
Argatroban,Quinestrol,Quinestrol may decrease the anticoagulant activities of Argatroban.,decrease,no risk
Argatroban,Quinidine,The therapeutic efficacy of Argatroban can be increased when used in combination with Quinidine.,increase,no risk
Argatroban,Quinine,The therapeutic efficacy of Argatroban can be increased when used in combination with Quinine.,increase,no risk
Argatroban,Ulipristal,The therapeutic efficacy of Argatroban can be decreased when used in combination with Ulipristal.,decrease,no risk
Argatroban,Urokinase,Urokinase may increase the anticoagulant activities of Argatroban.,increase,no risk
Argatroban,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Argatroban is combined with Ursodeoxycholic acid.,increase,risk
Argatroban,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Argatroban.,increase,risk
Argatroban,Venlafaxine,The risk or severity of bleeding can be increased when Argatroban is combined with Venlafaxine.,increase,risk
Argatroban,Vinblastine,The risk or severity of bleeding can be increased when Argatroban is combined with Vinblastine.,increase,risk
Argatroban,Vindesine,The risk or severity of bleeding can be increased when Argatroban is combined with Vindesine.,increase,risk
Argatroban,Vinorelbine,The risk or severity of bleeding can be increased when Argatroban is combined with Vinorelbine.,increase,risk
Argatroban,Vitamin E,Vitamin E may increase the anticoagulant activities of Argatroban.,increase,no risk
Argatroban,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Argatroban.,decrease,no risk
Argatroban,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Argatroban.,increase,risk
Argatroban,Vorinostat,The risk or severity of bleeding can be increased when Argatroban is combined with Vorinostat.,increase,risk
Argatroban,Warfarin,The risk or severity of bleeding can be increased when Argatroban is combined with Warfarin.,increase,risk
Argatroban,Ximelagatran,The risk or severity of bleeding can be increased when Argatroban is combined with Ximelagatran.,increase,risk
Argatroban,Zidovudine,The risk or severity of bleeding can be increased when Argatroban is combined with Zidovudine.,increase,risk
Argatroban,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Argatroban.,increase,risk
Liothyronine,Bismuth subgallate,Liothyronine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Liothyronine,Bismuth subsalicylate,The therapeutic efficacy of Liothyronine can be increased when used in combination with Bismuth subsalicylate.,increase,no risk
Liothyronine,Bisoprolol,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Bisoprolol.,decrease,no risk
Liothyronine,Bisoxatin,Liothyronine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Liothyronine,Bleomycin,Liothyronine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Liothyronine,Bosutinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Bosutinib.,decrease,no risk
Liothyronine,Brigatinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Brigatinib.,decrease,no risk
Liothyronine,Brivaracetam,Liothyronine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Liothyronine,Bromazepam,Liothyronine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Liothyronine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Bromotheophylline,Liothyronine may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Liothyronine,Budesonide,Liothyronine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Liothyronine,Bumadizone,Bumadizone may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Bumetanide,The excretion of Bumetanide can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Bupropion,Liothyronine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Liothyronine,Buspirone,Liothyronine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Liothyronine,Butabarbital,Butabarbital may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Butriptyline,The risk or severity of Cardiac Arrhythmia can be increased when Liothyronine is combined with Butriptyline.,increase,risk
Liothyronine,Gabapentin enacarbil,Liothyronine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Liothyronine,Gadobenic acid,Liothyronine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Liothyronine,Gadodiamide,Gadodiamide may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Gadofosveset trisodium,Liothyronine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Liothyronine,Gadopentetic acid,Liothyronine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Liothyronine,Gadoteric acid,Liothyronine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Liothyronine,Gadoteridol,Liothyronine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Liothyronine,Ganciclovir,Liothyronine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Liothyronine,Gefitinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Gefitinib.,decrease,no risk
Liothyronine,Gemcitabine,Liothyronine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Liothyronine,Gemfibrozil,The metabolism of Liothyronine can be decreased when combined with Gemfibrozil.,decrease,no risk
Liothyronine,Gentamicin,Liothyronine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Liothyronine,Gilteritinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Liothyronine,Gimeracil,Liothyronine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Liothyronine,Givosiran,Givosiran may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Glecaprevir,The metabolism of Liothyronine can be decreased when combined with Glecaprevir.,decrease,no risk
Liothyronine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Glycerol phenylbutyrate,Liothyronine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Liothyronine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Golodirsen,Liothyronine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Liothyronine,Goserelin,Goserelin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Guanethidine,Liothyronine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Liothyronine,Guanfacine,Liothyronine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Liothyronine,Haloperidol,Liothyronine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Liothyronine,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Liothyronine.,increase,no risk
Liothyronine,Hydralazine,Liothyronine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Liothyronine,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Liothyronine,Hydromorphone,Liothyronine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Liothyronine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Hydroxyethyl Starch,Liothyronine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Liothyronine,Kanamycin,Liothyronine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Liothyronine,Ketamine,The risk or severity of hypertension and Tachycardia can be increased when Ketamine is combined with Liothyronine.,increase,risk
Liothyronine,Ketazolam,Liothyronine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Liothyronine,Ketoconazole,The metabolism of Liothyronine can be decreased when combined with Ketoconazole.,decrease,no risk
Liothyronine,Ketoprofen,Ketoprofen may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Ketorolac,Ketorolac may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Octinoxate,Liothyronine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Liothyronine,Olsalazine,The therapeutic efficacy of Liothyronine can be increased when used in combination with Olsalazine.,increase,no risk
Liothyronine,Ombitasvir,The metabolism of Liothyronine can be decreased when combined with Ombitasvir.,decrease,no risk
Liothyronine,Opium,Liothyronine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Liothyronine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Liothyronine.,increase,risk
Liothyronine,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Osimertinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Osimertinib.,decrease,no risk
Liothyronine,Ouabain,The excretion of Liothyronine can be decreased when combined with Ouabain.,decrease,no risk
Liothyronine,Oxacillin,Liothyronine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Liothyronine,Oxandrolone,The therapeutic efficacy of Liothyronine can be increased when used in combination with Oxandrolone.,increase,no risk
Liothyronine,Oxaprozin,Oxaprozin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Oxazepam,Liothyronine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Liothyronine,Oxprenolol,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Liothyronine,Oxtriphylline,Liothyronine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Liothyronine,Oxybenzone,Liothyronine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Liothyronine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Liothyronine.,increase,risk
Liothyronine,Oxymetholone,The therapeutic efficacy of Liothyronine can be increased when used in combination with Oxymetholone.,increase,no risk
Liothyronine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Oxyquinoline,Liothyronine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Liothyronine,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Quetiapine,Liothyronine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Liothyronine,Quinapril,The excretion of Quinapril can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Quinestrol,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Quinestrol.,decrease,no risk
Liothyronine,Quinethazone,Quinethazone may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Liothyronine,Quinidine,Liothyronine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Liothyronine,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Liothyronine is combined with Quinupramine.,increase,risk
Liothyronine,Quizartinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Quizartinib.,decrease,no risk
Liothyronine,Vaborbactam,Liothyronine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Liothyronine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Liothyronine.,increase,no risk
Liothyronine,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Valbenazine,Liothyronine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Liothyronine,Valdecoxib,Valdecoxib may decrease the excretion rate of Liothyronine which could result in a higher serum level.,decrease,no risk
Liothyronine,Valganciclovir,Liothyronine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Liothyronine,Valproic acid,The excretion of Valproic acid can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Valsartan,The excretion of Liothyronine can be decreased when combined with Valsartan.,decrease,no risk
Liothyronine,Vancomycin,Liothyronine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Liothyronine,Vandetanib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Vandetanib.,decrease,no risk
Liothyronine,Varenicline,Liothyronine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Liothyronine,Vasopressin,Liothyronine may increase the vasoconstricting activities of Vasopressin.,increase,no risk
Liothyronine,Velpatasvir,The excretion of Liothyronine can be decreased when combined with Velpatasvir.,decrease,no risk
Liothyronine,Vemurafenib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Vemurafenib.,decrease,no risk
Liothyronine,Venetoclax,The excretion of Liothyronine can be decreased when combined with Venetoclax.,decrease,no risk
Liothyronine,Venlafaxine,Liothyronine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Liothyronine,Verapamil,Liothyronine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Liothyronine,Vilanterol,Liothyronine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Liothyronine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Liothyronine.,decrease,no risk
Liothyronine,Viloxazine,Liothyronine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Liothyronine,Vinblastine,The excretion of Liothyronine can be decreased when combined with Vinblastine.,decrease,no risk
Liothyronine,Vincristine,The excretion of Liothyronine can be decreased when combined with Vincristine.,decrease,no risk
Liothyronine,Vortioxetine,Liothyronine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Liothyronine,Voxilaprevir,The excretion of Liothyronine can be decreased when combined with Voxilaprevir.,decrease,no risk
Liothyronine,Warfarin,The risk or severity of bleeding can be increased when Liothyronine is combined with Warfarin.,increase,risk
Liothyronine,Xylometazoline,Liothyronine may increase the vasoconstricting activities of Xylometazoline.,increase,no risk
Liothyronine,Zaleplon,Liothyronine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Liothyronine,Zanamivir,Liothyronine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Liothyronine,Zanubrutinib,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Liothyronine,Zidovudine,The excretion of Zidovudine can be decreased when combined with Liothyronine.,decrease,no risk
Liothyronine,Zimelidine,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Zimelidine.,decrease,no risk
Liothyronine,Zonisamide,Zonisamide may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Disopyramide,Bacitracin,Bacitracin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Baclofen,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Baclofen.,decrease,no risk
Disopyramide,Balsalazide,Balsalazide may increase the hypoglycemic activities of Disopyramide.,increase,no risk
Disopyramide,Baricitinib,Disopyramide may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Disopyramide,Beclomethasone dipropionate,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Disopyramide.,increase,risk
Disopyramide,Bedaquiline,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Bedaquiline.,increase,risk
Disopyramide,Belinostat,The metabolism of Disopyramide can be increased when combined with Belinostat.,increase,no risk
Disopyramide,Belladonna,The risk or severity of adverse effects can be increased when Disopyramide is combined with Belladonna.,increase,risk
Disopyramide,Benazepril,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Disopyramide.,increase,risk
Disopyramide,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Bendroflumethiazide,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Disopyramide,Benorilate,Benorilate may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Benserazide,Disopyramide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Disopyramide,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Disopyramide.,increase,risk
Disopyramide,Benzhydrocodone,The risk or severity of adverse effects can be increased when Disopyramide is combined with Benzhydrocodone.,increase,risk
Disopyramide,Benznidazole,Disopyramide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Disopyramide,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Benzphetamine,The risk or severity of Tachycardia can be increased when Disopyramide is combined with Benzphetamine.,increase,risk
Disopyramide,Benzthiazide,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Benzthiazide.,decrease,no risk
Disopyramide,Benzydamine,Benzydamine may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Bepotastine,Disopyramide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Disopyramide,Bepridil,Disopyramide may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Disopyramide,Berotralstat,The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Disopyramide.,increase,risk
Disopyramide,Betaine,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Betaine.,decrease,no risk
Disopyramide,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Disopyramide.,increase,risk
Disopyramide,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Disopyramide.,increase,risk
Disopyramide,Betaxolol,Disopyramide may increase the bradycardic activities of Betaxolol.,increase,no risk
Disopyramide,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Disopyramide.,increase,risk
Disopyramide,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Disopyramide.,increase,no risk
Disopyramide,Bicisate,Disopyramide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Disopyramide,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Disopyramide.,increase,risk
Disopyramide,Bimekizumab,The metabolism of Disopyramide can be increased when combined with Bimekizumab.,increase,no risk
Disopyramide,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Bioallethrin,Disopyramide may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Disopyramide,Biperiden,The risk or severity of adverse effects can be increased when Disopyramide is combined with Biperiden.,increase,risk
Disopyramide,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Disopyramide.,decrease,no risk
Disopyramide,Bismuth subgallate,Disopyramide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Disopyramide,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Disopyramide.,increase,no risk
Disopyramide,Bisoprolol,The therapeutic efficacy of Disopyramide can be increased when used in combination with Bisoprolol.,increase,no risk
Disopyramide,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Disopyramide.,decrease,no risk
Disopyramide,Bleomycin,Disopyramide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Disopyramide,Boceprevir,The metabolism of Disopyramide can be decreased when combined with Boceprevir.,decrease,no risk
Disopyramide,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Disopyramide.,increase,risk
Disopyramide,Bosentan,The therapeutic efficacy of Disopyramide can be increased when used in combination with Bosentan.,increase,no risk
Disopyramide,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Disopyramide is combined with Botulinum toxin type A.,increase,risk
Disopyramide,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Disopyramide is combined with Botulinum toxin type B.,increase,risk
Disopyramide,Bretylium,Disopyramide may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Disopyramide,Brexpiprazole,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Disopyramide,Brivaracetam,Disopyramide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Disopyramide,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Bromocriptine,The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Bromocriptine.,increase,risk
Disopyramide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Disopyramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Disopyramide,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Disopyramide.,increase,risk
Disopyramide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Disopyramide.,increase,risk
Disopyramide,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Disopyramide.,increase,risk
Disopyramide,Bumadizone,Bumadizone may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Bumetanide,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Bumetanide.,decrease,no risk
Disopyramide,Buprenorphine,The risk or severity of adverse effects can be increased when Disopyramide is combined with Buprenorphine.,increase,risk
Disopyramide,Bupropion,Disopyramide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Disopyramide,Buserelin,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Buserelin.,decrease,no risk
Disopyramide,Buspirone,Disopyramide may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Disopyramide,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Disopyramide.,increase,risk
Disopyramide,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Disopyramide.,increase,risk
Disopyramide,Butobarbital,The risk or severity of adverse effects can be increased when Disopyramide is combined with Butobarbital.,increase,risk
Disopyramide,Butorphanol,The risk or severity of adverse effects can be increased when Disopyramide is combined with Butorphanol.,increase,risk
Disopyramide,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Disopyramide.,increase,risk
Disopyramide,Butylscopolamine,The risk or severity of adverse effects can be increased when Disopyramide is combined with Butylscopolamine.,increase,risk
Disopyramide,Gabapentin enacarbil,Disopyramide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Disopyramide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Disopyramide.,increase,risk
Disopyramide,Gadodiamide,Gadodiamide may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Gadofosveset trisodium,Disopyramide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Disopyramide,Gadopentetic acid,Disopyramide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Disopyramide,Gadoteric acid,Disopyramide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Disopyramide,Gadoteridol,Disopyramide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Disopyramide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Disopyramide.,increase,risk
Disopyramide,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Disopyramide is combined with Gallamine triethiodide.,increase,risk
Disopyramide,Ganciclovir,The risk or severity of adverse effects can be increased when Disopyramide is combined with Ganciclovir.,increase,risk
Disopyramide,Gatifloxacin,The therapeutic efficacy of Disopyramide can be increased when used in combination with Gatifloxacin.,increase,no risk
Disopyramide,Gefapixant,The therapeutic efficacy of Disopyramide can be increased when used in combination with Gefapixant.,increase,no risk
Disopyramide,Gemcitabine,Disopyramide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Disopyramide,Gemfibrozil,The metabolism of Disopyramide can be decreased when combined with Gemfibrozil.,decrease,no risk
Disopyramide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Disopyramide.,increase,risk
Disopyramide,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Disopyramide.,increase,no risk
Disopyramide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Disopyramide.,increase,risk
Disopyramide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Disopyramide.,increase,risk
Disopyramide,Gimeracil,Disopyramide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Disopyramide,Ginkgo biloba,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Disopyramide,Givosiran,The serum concentration of Disopyramide can be increased when it is combined with Givosiran.,increase,no risk
Disopyramide,Glasdegib,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Glasdegib.,increase,risk
Disopyramide,Gliclazide,The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Gliclazide.,increase,risk
Disopyramide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Disopyramide.,increase,risk
Disopyramide,Glipizide,The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Glipizide.,increase,risk
Disopyramide,Gliquidone,The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Gliquidone.,increase,risk
Disopyramide,Glofitamab,The serum concentration of Disopyramide can be increased when it is combined with Glofitamab.,increase,no risk
Disopyramide,Glucagon,Disopyramide may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Disopyramide,Glyburide,The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Glyburide.,increase,risk
Disopyramide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Disopyramide.,decrease,no risk
Disopyramide,Glycerol phenylbutyrate,Disopyramide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Disopyramide,Glycopyrronium,The risk or severity of adverse effects can be increased when Disopyramide is combined with Glycopyrronium.,increase,risk
Disopyramide,Glymidine,The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Glymidine.,increase,risk
Disopyramide,Golimumab,The metabolism of Disopyramide can be increased when combined with Golimumab.,increase,no risk
Disopyramide,Golodirsen,Disopyramide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Disopyramide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Disopyramide.,increase,risk
Disopyramide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Disopyramide.,increase,risk
Disopyramide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Grepafloxacin.,increase,risk
Disopyramide,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Guanethidine,Disopyramide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Disopyramide,Guanfacine,The risk or severity of adverse effects can be increased when Disopyramide is combined with Guanfacine.,increase,risk
Disopyramide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Disopyramide.,increase,risk
Disopyramide,Halofantrine,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Halofantrine.,increase,risk
Disopyramide,Haloperidol,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Haloperidol.,increase,risk
Disopyramide,Hexafluronium,The risk or severity of adverse effects can be increased when Disopyramide is combined with Hexafluronium.,increase,risk
Disopyramide,Hexocyclium,The risk or severity of adverse effects can be increased when Disopyramide is combined with Hexocyclium.,increase,risk
Disopyramide,Histamine,The serum concentration of Histamine can be increased when it is combined with Disopyramide.,increase,no risk
Disopyramide,Histrelin,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Histrelin.,decrease,no risk
Disopyramide,Homatropine,The risk or severity of adverse effects can be increased when Disopyramide is combined with Homatropine.,increase,risk
Disopyramide,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Disopyramide is combined with Homatropine methylbromide.,increase,risk
Disopyramide,Huperzine A,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Huperzine A.,decrease,no risk
Disopyramide,Hydralazine,Disopyramide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Disopyramide,Hydrochlorothiazide,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Disopyramide,Hydrocodone,The risk or severity of adverse effects can be increased when Disopyramide is combined with Hydrocodone.,increase,risk
Disopyramide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Disopyramide.,increase,risk
Disopyramide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Disopyramide.,increase,risk
Disopyramide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Disopyramide.,increase,risk
Disopyramide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Disopyramide.,increase,risk
Disopyramide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Disopyramide.,increase,risk
Disopyramide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Disopyramide.,increase,risk
Disopyramide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Disopyramide.,increase,risk
Disopyramide,Hydroflumethiazide,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Disopyramide,Hydromorphone,The risk or severity of adverse effects can be increased when Disopyramide is combined with Hydromorphone.,increase,risk
Disopyramide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Hydroxychloroquine,The therapeutic efficacy of Disopyramide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Disopyramide,Hydroxyethyl Starch,Disopyramide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Disopyramide,Hydroxyprogesterone caproate,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Disopyramide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Hydroxyzine.,increase,risk
Disopyramide,Hyoscyamine,Disopyramide may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Disopyramide,Kanamycin,Disopyramide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Disopyramide,Ketamine,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Ketamine.,decrease,no risk
Disopyramide,Ketazolam,Disopyramide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Disopyramide,Ketoconazole,The metabolism of Disopyramide can be decreased when combined with Ketoconazole.,decrease,no risk
Disopyramide,Ketoprofen,Ketoprofen may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Ketorolac,Ketorolac may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Obeticholic acid,The metabolism of Disopyramide can be decreased when combined with Obeticholic acid.,decrease,no risk
Disopyramide,Octinoxate,Disopyramide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Disopyramide,Octreotide,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Octreotide.,decrease,no risk
Disopyramide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Disopyramide.,increase,risk
Disopyramide,Olanzapine,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Olanzapine.,decrease,no risk
Disopyramide,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Disopyramide is combined with Oliceridine.",increase,risk
Disopyramide,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Disopyramide.,increase,risk
Disopyramide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Disopyramide.,increase,no risk
Disopyramide,Omaveloxolone,The serum concentration of Disopyramide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Disopyramide,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Disopyramide.,increase,risk
Disopyramide,Opium,The risk or severity of adverse effects can be increased when Disopyramide is combined with Opium.,increase,risk
Disopyramide,Orciprenaline,The risk or severity of Tachycardia can be increased when Disopyramide is combined with Orciprenaline.,increase,risk
Disopyramide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Disopyramide.,increase,risk
Disopyramide,Oseltamivir,Oseltamivir may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Osilodrostat,The metabolism of Disopyramide can be decreased when combined with Osilodrostat.,decrease,no risk
Disopyramide,Osimertinib,The serum concentration of Disopyramide can be decreased when it is combined with Osimertinib.,decrease,no risk
Disopyramide,Oxacillin,Disopyramide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Disopyramide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Disopyramide.,increase,risk
Disopyramide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Disopyramide.,increase,no risk
Disopyramide,Oxaprozin,Oxaprozin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Disopyramide.,increase,risk
Disopyramide,Oxazepam,Disopyramide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Disopyramide,Oxprenolol,Disopyramide may increase the bradycardic activities of Oxprenolol.,increase,no risk
Disopyramide,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Disopyramide.,decrease,no risk
Disopyramide,Oxybenzone,Disopyramide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Disopyramide,Oxybutynin,The risk or severity of adverse effects can be increased when Disopyramide is combined with Oxybutynin.,increase,risk
Disopyramide,Oxycodone,The risk or severity of adverse effects can be increased when Disopyramide is combined with Oxycodone.,increase,risk
Disopyramide,Oxymetazoline,The risk or severity of Tachycardia can be increased when Disopyramide is combined with Oxymetazoline.,increase,risk
Disopyramide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Disopyramide.,increase,no risk
Disopyramide,Oxymorphone,The risk or severity of adverse effects can be increased when Disopyramide is combined with Oxymorphone.,increase,risk
Disopyramide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Disopyramide which could result in a higher serum level.,decrease,no risk
Disopyramide,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Disopyramide is combined with Oxyphencyclimine.,increase,risk
Disopyramide,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Disopyramide.,decrease,no risk
Disopyramide,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Disopyramide.,increase,risk
Disopyramide,Oxyquinoline,Disopyramide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Disopyramide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Disopyramide.,increase,risk
Disopyramide,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Disopyramide.,increase,risk
Disopyramide,Quinethazone,The therapeutic efficacy of Disopyramide can be decreased when used in combination with Quinethazone.,decrease,no risk
Disopyramide,Quinidine,Disopyramide may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Disopyramide,Quinine,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Quinine.,increase,risk
Disopyramide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Disopyramide.,decrease,no risk
Disopyramide,Quizartinib,The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Quizartinib.,increase,risk
Lidocaine,Bacampicillin,The risk or severity of methemoglobinemia can be increased when Bacampicillin is combined with Lidocaine.,increase,risk
Lidocaine,Bacitracin,The risk or severity of methemoglobinemia can be increased when Bacitracin is combined with Lidocaine.,increase,risk
Lidocaine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.,increase,no risk
Lidocaine,Beclomethasone dipropionate,The metabolism of Lidocaine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Lidocaine,Bedaquiline,The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Lidocaine.,increase,risk
Lidocaine,Belinostat,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Lidocaine.,increase,risk
Lidocaine,Belzutifan,The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Lidocaine.,increase,risk
Lidocaine,Bendamustine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Lidocaine.,increase,risk
Lidocaine,Benperidol,The risk or severity of CNS depression can be increased when Lidocaine is combined with Benperidol.,increase,risk
Lidocaine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Benzocaine.,increase,risk
Lidocaine,Benzphetamine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Benzphetamine.,increase,risk
Lidocaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Lidocaine.,increase,risk
Lidocaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Lidocaine.,increase,risk
Lidocaine,Bepridil,Lidocaine may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Lidocaine,Berotralstat,The metabolism of Lidocaine can be decreased when combined with Berotralstat.,decrease,no risk
Lidocaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Lidocaine.,increase,risk
Lidocaine,Betamethasone,The metabolism of Lidocaine can be increased when combined with Betamethasone.,increase,no risk
Lidocaine,Betamethasone phosphate,The metabolism of Lidocaine can be increased when combined with Betamethasone phosphate.,increase,no risk
Lidocaine,Betaxolol,The serum concentration of Lidocaine can be increased when it is combined with Betaxolol.,increase,no risk
Lidocaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Lidocaine.,increase,risk
Lidocaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Lidocaine.,increase,risk
Lidocaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Lidocaine.,increase,risk
Lidocaine,Bimekizumab,The metabolism of Lidocaine can be increased when combined with Bimekizumab.,increase,no risk
Lidocaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Lidocaine.,increase,risk
Lidocaine,Bioallethrin,Lidocaine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Lidocaine,Biperiden,The metabolism of Lidocaine can be decreased when combined with Biperiden.,decrease,no risk
Lidocaine,Bisoprolol,The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.,increase,no risk
Lidocaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Lidocaine.,increase,risk
Lidocaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Lidocaine.,increase,risk
Lidocaine,Boceprevir,The metabolism of Lidocaine can be decreased when combined with Boceprevir.,decrease,no risk
Lidocaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Lidocaine.,increase,risk
Lidocaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Lidocaine.,increase,risk
Lidocaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Lidocaine.,increase,risk
Lidocaine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Lidocaine.,increase,risk
Lidocaine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Lidocaine.,increase,risk
Lidocaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Lidocaine.,increase,risk
Lidocaine,Bretylium,Lidocaine may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Lidocaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Lidocaine.,increase,risk
Lidocaine,Brexpiprazole,The risk or severity of CNS depression can be increased when Lidocaine is combined with Brexpiprazole.,increase,risk
Lidocaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Lidocaine.,increase,risk
Lidocaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Lidocaine.,increase,risk
Lidocaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.,increase,no risk
Lidocaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Lidocaine.,increase,risk
Lidocaine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Lidocaine.,increase,risk
Lidocaine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Bromperidol,The risk or severity of CNS depression can be increased when Lidocaine is combined with Bromperidol.,increase,risk
Lidocaine,Brompheniramine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Brompheniramine.,increase,risk
Lidocaine,Budesonide,The metabolism of Lidocaine can be increased when combined with Budesonide.,increase,no risk
Lidocaine,Buprenorphine,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Lidocaine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Lidocaine.,increase,risk
Lidocaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Lidocaine.,increase,risk
Lidocaine,Buspirone,The risk or severity of CNS depression can be increased when Lidocaine is combined with Buspirone.,increase,risk
Lidocaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Lidocaine.,increase,risk
Lidocaine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Lidocaine.,increase,risk
Lidocaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Butacaine.,increase,risk
Lidocaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Lidocaine.,increase,risk
Lidocaine,Butamben,The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Butamben.,increase,risk
Lidocaine,Butaperazine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Butaperazine.,increase,risk
Lidocaine,Butobarbital,The risk or severity of CNS depression can be increased when Lidocaine is combined with Butobarbital.,increase,risk
Lidocaine,Butorphanol,The risk or severity of CNS depression can be increased when Lidocaine is combined with Butorphanol.,increase,risk
Lidocaine,Butriptyline,The risk or severity of CNS depression can be increased when Lidocaine is combined with Butriptyline.,increase,risk
Lidocaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Lidocaine.,increase,risk
Lidocaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lidocaine is combined with Gabapentin enacarbil.,increase,risk
Lidocaine,Galantamine,The metabolism of Galantamine can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Lidocaine is combined with Gallamine triethiodide.,increase,risk
Lidocaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lidocaine is combined with Ganaxolone.",increase,risk
Lidocaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Lidocaine.,increase,risk
Lidocaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Lidocaine.,increase,risk
Lidocaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Lidocaine.,increase,risk
Lidocaine,Gemfibrozil,The metabolism of Lidocaine can be decreased when combined with Gemfibrozil.,decrease,no risk
Lidocaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Lidocaine.,increase,risk
Lidocaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Lidocaine.,increase,risk
Lidocaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Lidocaine.,increase,risk
Lidocaine,Gepirone,The risk or severity of CNS depression can be increased when Lidocaine is combined with Gepirone.,increase,risk
Lidocaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Lidocaine.,increase,risk
Lidocaine,Givosiran,The serum concentration of Lidocaine can be increased when it is combined with Givosiran.,increase,no risk
Lidocaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Lidocaine.,increase,risk
Lidocaine,Glofitamab,The serum concentration of Lidocaine can be increased when it is combined with Glofitamab.,increase,no risk
Lidocaine,Glutethimide,The risk or severity of CNS depression can be increased when Lidocaine is combined with Glutethimide.,increase,risk
Lidocaine,Glyburide,The metabolism of Glyburide can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Glycerol phenylbutyrate,The metabolism of Lidocaine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Lidocaine,Golimumab,The metabolism of Lidocaine can be increased when combined with Golimumab.,increase,no risk
Lidocaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Lidocaine.,increase,risk
Lidocaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Lidocaine.,increase,risk
Lidocaine,Granisetron,The risk or severity of CNS depression can be increased when Lidocaine is combined with Granisetron.,increase,risk
Lidocaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Lidocaine.,increase,risk
Lidocaine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Guanfacine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Guanfacine.,increase,risk
Lidocaine,Halazepam,The risk or severity of CNS depression can be increased when Lidocaine is combined with Halazepam.,increase,risk
Lidocaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Lidocaine.,increase,risk
Lidocaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Lidocaine.,increase,risk
Lidocaine,Halothane,The risk or severity of CNS depression can be increased when Lidocaine is combined with Halothane.,increase,risk
Lidocaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Lidocaine.,increase,risk
Lidocaine,Hexafluronium,The risk or severity of CNS depression can be increased when Lidocaine is combined with Hexafluronium.,increase,risk
Lidocaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Lidocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Lidocaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Lidocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Lidocaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Lidocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Lidocaine,Hydrocodone,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lidocaine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Hydromorphone,The risk or severity of CNS depression can be increased when Lidocaine is combined with Hydromorphone.,increase,risk
Lidocaine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Lidocaine.,increase,risk
Lidocaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Lidocaine.,increase,risk
Lidocaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Lidocaine.,increase,risk
Lidocaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.,increase,no risk
Lidocaine,Hyoscyamine,Lidocaine may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Lidocaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Lidocaine.,increase,risk
Lidocaine,Ketamine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Ketamine.,increase,risk
Lidocaine,Ketazolam,The risk or severity of CNS depression can be increased when Lidocaine is combined with Ketazolam.,increase,risk
Lidocaine,Ketoconazole,The metabolism of Lidocaine can be decreased when combined with Ketoconazole.,decrease,no risk
Lidocaine,Obeticholic acid,The metabolism of Lidocaine can be decreased when combined with Obeticholic acid.,decrease,no risk
Lidocaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Lidocaine.,increase,risk
Lidocaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Lidocaine.,increase,risk
Lidocaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Lidocaine.,increase,risk
Lidocaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Lidocaine.,increase,risk
Lidocaine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Lidocaine.,increase,risk
Lidocaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Lidocaine.,increase,risk
Lidocaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lidocaine is combined with Oliceridine.",increase,risk
Lidocaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Lidocaine.,increase,risk
Lidocaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Lidocaine.,increase,risk
Lidocaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Lidocaine.,increase,risk
Lidocaine,Omaveloxolone,The serum concentration of Lidocaine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lidocaine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Opium,The risk or severity of CNS depression can be increased when Lidocaine is combined with Opium.,increase,risk
Lidocaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Lidocaine.,increase,risk
Lidocaine,Orphenadrine,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lidocaine,Osilodrostat,The metabolism of Lidocaine can be decreased when combined with Osilodrostat.,decrease,no risk
Lidocaine,Osimertinib,The serum concentration of Lidocaine can be decreased when it is combined with Osimertinib.,decrease,no risk
Lidocaine,Ospemifene,The metabolism of Lidocaine can be decreased when combined with Ospemifene.,decrease,no risk
Lidocaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Lidocaine.,increase,risk
Lidocaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Lidocaine.,increase,risk
Lidocaine,Oxamniquine,The metabolism of Lidocaine can be decreased when combined with Oxamniquine.,decrease,no risk
Lidocaine,Oxazepam,The risk or severity of CNS depression can be increased when Lidocaine is combined with Oxazepam.,increase,risk
Lidocaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Lidocaine.,increase,risk
Lidocaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Oxetacaine.,increase,risk
Lidocaine,Oxitriptan,The risk or severity of CNS depression can be increased when Lidocaine is combined with Oxitriptan.,increase,risk
Lidocaine,Oxprenolol,The serum concentration of Lidocaine can be increased when it is combined with Oxprenolol.,increase,no risk
Lidocaine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Oxybuprocaine.,increase,risk
Lidocaine,Oxybutynin,The metabolism of Lidocaine can be decreased when combined with Oxybutynin.,decrease,no risk
Lidocaine,Oxycodone,The risk or severity of CNS depression can be increased when Lidocaine is combined with Oxycodone.,increase,risk
Lidocaine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Lidocaine.,increase,risk
Lidocaine,Oxymorphone,The risk or severity of CNS depression can be increased when Lidocaine is combined with Oxymorphone.,increase,risk
Lidocaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Lidocaine.,increase,risk
Lidocaine,Quazepam,The risk or severity of CNS depression can be increased when Lidocaine is combined with Quazepam.,increase,risk
Lidocaine,Quetiapine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Quetiapine.,increase,risk
Lidocaine,Quinidine,Lidocaine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Lidocaine,Quinine,The metabolism of Lidocaine can be decreased when combined with Quinine.,decrease,no risk
Lidocaine,Quinupramine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Quinupramine.,increase,risk
Lidocaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Lidocaine.,increase,risk
Lidocaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Lidocaine.,increase,risk
Lidocaine,Udenafil,The metabolism of Udenafil can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Lidocaine.,increase,risk
Lidocaine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Lidocaine.,increase,risk
Lidocaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Lidocaine.,increase,risk
Lidocaine,Vadadustat,The serum concentration of Lidocaine can be increased when it is combined with Vadadustat.,increase,no risk
Lidocaine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Lidocaine.,increase,risk
Lidocaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Lidocaine.,increase,risk
Lidocaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Lidocaine.,increase,risk
Lidocaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Lidocaine.,increase,risk
Lidocaine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Vasopressin,The risk or severity of hypertension can be increased when Vasopressin is combined with Lidocaine.,increase,risk
Lidocaine,Vecuronium,The risk or severity of CNS depression can be increased when Lidocaine is combined with Vecuronium.,increase,risk
Lidocaine,Vemurafenib,The serum concentration of Lidocaine can be increased when it is combined with Vemurafenib.,increase,no risk
Lidocaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Lidocaine.,increase,risk
Lidocaine,Venlafaxine,The metabolism of Lidocaine can be decreased when combined with Venlafaxine.,decrease,no risk
Lidocaine,Verapamil,Lidocaine may increase the arrhythmogenic activities of Verapamil.,increase,no risk
Lidocaine,Vernakalant,Lidocaine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Lidocaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Lidocaine.,increase,risk
Lidocaine,Vilazodone,The metabolism of Lidocaine can be decreased when combined with Vilazodone.,decrease,no risk
Lidocaine,Viloxazine,The metabolism of Lidocaine can be decreased when combined with Viloxazine.,decrease,no risk
Lidocaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Lidocaine.,increase,risk
Lidocaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Lidocaine.,increase,risk
Lidocaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Lidocaine.,increase,risk
Lidocaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Lidocaine.,increase,risk
Lidocaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Lidocaine.,increase,risk
Lidocaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Lidocaine.,increase,risk
Lidocaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Lidocaine.,increase,risk
Lidocaine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Voriconazole,The metabolism of Lidocaine can be decreased when combined with Voriconazole.,decrease,no risk
Lidocaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Lidocaine.,increase,risk
Lidocaine,Vortioxetine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Vortioxetine.,increase,risk
Lidocaine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Warfarin,The metabolism of Warfarin can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Lidocaine.,increase,risk
Lidocaine,Yohimbine,The risk or severity of CNS depression can be increased when Lidocaine is combined with Yohimbine.,increase,risk
Lidocaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Lidocaine.,increase,risk
Lidocaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Lidocaine.,increase,risk
Lidocaine,Ziconotide,Lidocaine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Lidocaine,Zileuton,The metabolism of Zileuton can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Zimelidine,The risk or severity of adverse effects can be increased when Lidocaine is combined with Zimelidine.,increase,risk
Lidocaine,Ziprasidone,The risk or severity of adverse effects can be increased when Lidocaine is combined with Ziprasidone.,increase,risk
Lidocaine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Zolpidem,Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Lidocaine,Zonisamide,Lidocaine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Lidocaine,Zopiclone,The risk or severity of adverse effects can be increased when Lidocaine is combined with Zopiclone.,increase,risk
Lidocaine,Zotepine,The metabolism of Zotepine can be decreased when combined with Lidocaine.,decrease,no risk
Lidocaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Lidocaine is combined with Zuclopenthixol.,increase,risk
Lidocaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Lidocaine.,increase,risk
Pamidronic acid,Gabapentin enacarbil,Pamidronic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gadobenic acid,Pamidronic acid may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gadodiamide,Pamidronic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gadofosveset trisodium,Pamidronic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gadopentetic acid,Pamidronic acid may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gadoteric acid,Pamidronic acid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gadoteridol,Pamidronic acid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Ganciclovir.",increase,risk
Pamidronic acid,Gemcitabine,Pamidronic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Gemfibrozil.",increase,risk
Pamidronic acid,Gentamicin,Pamidronic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Gimeracil,Pamidronic acid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Givosiran,The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Givosiran.,increase,risk
Pamidronic acid,Glipizide,Pamidronic acid may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Glycerol phenylbutyrate,Pamidronic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Glycol salicylate is combined with Pamidronic acid.,increase,risk
Pamidronic acid,Golodirsen,Pamidronic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Goserelin,Pamidronic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Guanethidine,Pamidronic acid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Guanfacine,Pamidronic acid may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Haloperidol,Pamidronic acid may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Human calcitonin,The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Pamidronic acid.,increase,risk
Pamidronic acid,Hydralazine,Pamidronic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Hydrochlorothiazide.,increase,risk
Pamidronic acid,Hydromorphone,Pamidronic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Hydrotalcite,The serum concentration of Pamidronic acid can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Pamidronic acid,Hydroxocobalamin,Pamidronic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Hydroxyethyl Starch,Pamidronic acid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Kanamycin,Pamidronic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Ketamine,Pamidronic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Ketazolam,Pamidronic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Pamidronic acid,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Pamidronic acid.,increase,risk
Pamidronic acid,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Pamidronic acid.,increase,risk
Clemastine,Gabapentin,The risk or severity of CNS depression can be increased when Clemastine is combined with Gabapentin.,increase,risk
Clemastine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Clemastine is combined with Gabapentin enacarbil.,increase,risk
Clemastine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Clemastine.,increase,risk
Clemastine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Clemastine.,increase,risk
Clemastine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Clemastine is combined with Gallamine triethiodide.,increase,risk
Clemastine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clemastine is combined with Ganaxolone.",increase,risk
Clemastine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Clemastine.,increase,risk
Clemastine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Clemastine.,decrease,no risk
Clemastine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Clemastine.,increase,risk
Clemastine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Clemastine.,increase,risk
Clemastine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Clemastine.,increase,risk
Clemastine,Glasdegib,The risk or severity of QTc prolongation can be increased when Clemastine is combined with Glasdegib.,increase,risk
Clemastine,Glutethimide,The risk or severity of CNS depression can be increased when Clemastine is combined with Glutethimide.,increase,risk
Clemastine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clemastine.,increase,risk
Clemastine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Clemastine.,increase,risk
Clemastine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Clemastine is combined with Grepafloxacin.,increase,risk
Clemastine,Guanfacine,The risk or severity of CNS depression can be increased when Clemastine is combined with Guanfacine.,increase,risk
Clemastine,Halazepam,The risk or severity of CNS depression can be increased when Clemastine is combined with Halazepam.,increase,risk
Clemastine,Halofantrine,The risk or severity of QTc prolongation can be increased when Clemastine is combined with Halofantrine.,increase,risk
Clemastine,Haloperidol,The risk or severity of QTc prolongation can be increased when Clemastine is combined with Haloperidol.,increase,risk
Clemastine,Halothane,The risk or severity of CNS depression can be increased when Clemastine is combined with Halothane.,increase,risk
Clemastine,Hexafluronium,The risk or severity of CNS depression can be increased when Clemastine is combined with Hexafluronium.,increase,risk
Clemastine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Clemastine.,increase,risk
Clemastine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clemastine.,decrease,no risk
Clemastine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Clemastine.,decrease,no risk
Clemastine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Clemastine.,decrease,no risk
Clemastine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Clemastine.,increase,risk
Clemastine,Hydrocodone,Clemastine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Clemastine,Hydromorphone,The risk or severity of CNS depression can be increased when Clemastine is combined with Hydromorphone.,increase,risk
Clemastine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Clemastine.,increase,risk
Clemastine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Clemastine is combined with Hydroxyzine.,increase,risk
Clemastine,Hyoscyamine,Clemastine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Clemastine,Ketamine,The risk or severity of CNS depression can be increased when Clemastine is combined with Ketamine.,increase,risk
Clemastine,Ketazolam,The risk or severity of CNS depression can be increased when Clemastine is combined with Ketazolam.,increase,risk
Clemastine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Clemastine.,increase,risk
Clemastine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Clemastine.,increase,risk
Clemastine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Clemastine.,increase,risk
Clemastine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Clemastine.,increase,risk
Clemastine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Clemastine is combined with Oliceridine.",increase,risk
Clemastine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Clemastine.,increase,risk
Clemastine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Clemastine.,increase,risk
Clemastine,Opium,The risk or severity of CNS depression can be increased when Clemastine is combined with Opium.,increase,risk
Clemastine,Orphenadrine,Clemastine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Clemastine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Clemastine.,increase,risk
Clemastine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Clemastine.,increase,risk
Clemastine,Oxazepam,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxazepam.,increase,risk
Clemastine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxcarbazepine.,increase,risk
Clemastine,Oxitriptan,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxitriptan.,increase,risk
Clemastine,Oxprenolol,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxprenolol.,increase,risk
Clemastine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxybuprocaine.,increase,risk
Clemastine,Oxycodone,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxycodone.,increase,risk
Clemastine,Oxymorphone,The risk or severity of CNS depression can be increased when Clemastine is combined with Oxymorphone.,increase,risk
Clemastine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Clemastine.,increase,risk
Acarbose,Gatifloxacin,The therapeutic efficacy of Acarbose can be increased when used in combination with Gatifloxacin.,increase,no risk
Acarbose,Gefapixant,The therapeutic efficacy of Acarbose can be increased when used in combination with Gefapixant.,increase,no risk
Acarbose,Gemifloxacin,The therapeutic efficacy of Acarbose can be increased when used in combination with Gemifloxacin.,increase,no risk
Acarbose,Gliclazide,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Gliclazide.,increase,risk
Acarbose,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Acarbose.,increase,risk
Acarbose,Glipizide,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Glipizide.,increase,risk
Acarbose,Gliquidone,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Gliquidone.,increase,risk
Acarbose,Glyburide,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Glyburide.,increase,risk
Acarbose,Glymidine,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Glymidine.,increase,risk
Acarbose,Goserelin,The therapeutic efficacy of Acarbose can be decreased when used in combination with Goserelin.,decrease,no risk
Acarbose,Grepafloxacin,The therapeutic efficacy of Acarbose can be increased when used in combination with Grepafloxacin.,increase,no risk
Acarbose,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Acarbose.,increase,risk
Acarbose,Haloperidol,The therapeutic efficacy of Acarbose can be decreased when used in combination with Haloperidol.,decrease,no risk
Acarbose,Histrelin,The therapeutic efficacy of Acarbose can be decreased when used in combination with Histrelin.,decrease,no risk
Acarbose,Hydrochlorothiazide,The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Acarbose,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Acarbose.,increase,risk
Acarbose,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Acarbose.,increase,risk
Acarbose,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Acarbose.,increase,risk
Acarbose,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Acarbose.,increase,risk
Acarbose,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Acarbose.,increase,risk
Acarbose,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Acarbose.,increase,risk
Acarbose,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Acarbose.,increase,risk
Acarbose,Hydroflumethiazide,The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Acarbose,Hydroxychloroquine,The therapeutic efficacy of Acarbose can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Acarbose,Hydroxyprogesterone caproate,The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Acarbose,Ketotifen,The risk or severity of thrombocytopenia can be increased when Acarbose is combined with Ketotifen.,increase,risk
Acarbose,Octreotide,The therapeutic efficacy of Acarbose can be decreased when used in combination with Octreotide.,decrease,no risk
Acarbose,Ofloxacin,The therapeutic efficacy of Acarbose can be increased when used in combination with Ofloxacin.,increase,no risk
Acarbose,Olanzapine,The therapeutic efficacy of Acarbose can be decreased when used in combination with Olanzapine.,decrease,no risk
Acarbose,Olsalazine,Olsalazine may increase the hypoglycemic activities of Acarbose.,increase,no risk
Acarbose,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Acarbose.,increase,no risk
Acarbose,Oxprenolol,The therapeutic efficacy of Acarbose can be increased when used in combination with Oxprenolol.,increase,no risk
Acarbose,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Acarbose.,increase,no risk
Acarbose,Quetiapine,The therapeutic efficacy of Acarbose can be decreased when used in combination with Quetiapine.,decrease,no risk
Acarbose,Quinethazone,The therapeutic efficacy of Acarbose can be decreased when used in combination with Quinethazone.,decrease,no risk
Acarbose,Quinine,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Quinine.,increase,risk
Acarbose,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Acarbose.,decrease,no risk
Acarbose,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Acarbose.,increase,risk
Acarbose,Udenafil,The therapeutic efficacy of Acarbose can be increased when used in combination with Udenafil.,increase,no risk
Acarbose,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Acarbose.,increase,risk
Acarbose,Valdecoxib,The therapeutic efficacy of Acarbose can be increased when used in combination with Valdecoxib.,increase,no risk
Acarbose,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Acarbose.,increase,risk
Acarbose,Vemurafenib,The therapeutic efficacy of Acarbose can be increased when used in combination with Vemurafenib.,increase,no risk
Acarbose,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Acarbose.,increase,risk
Acarbose,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Acarbose.,increase,risk
Acarbose,Vildagliptin,The risk or severity of hypoglycemia can be increased when Acarbose is combined with Vildagliptin.,increase,risk
Acarbose,Vorinostat,The therapeutic efficacy of Acarbose can be decreased when used in combination with Vorinostat.,decrease,no risk
Acarbose,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Acarbose.,increase,risk
Acarbose,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Acarbose.,increase,risk
Acarbose,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Acarbose.,increase,risk
Acarbose,Ziprasidone,The therapeutic efficacy of Acarbose can be decreased when used in combination with Ziprasidone.,decrease,no risk
Acarbose,Zonisamide,The therapeutic efficacy of Acarbose can be increased when used in combination with Zonisamide.,increase,no risk
Venlafaxine,Bacitracin,Bacitracin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Venlafaxine,Balsalazide,Venlafaxine may increase the antiplatelet activities of Balsalazide.,increase,no risk
Venlafaxine,Baricitinib,Venlafaxine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Venlafaxine.,increase,risk
Venlafaxine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Benorilate,Benorilate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Benperidol,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Benperidol.,increase,risk
Venlafaxine,Benserazide,Venlafaxine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Venlafaxine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Benznidazole,Venlafaxine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Venlafaxine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Venlafaxine.,increase,risk
Venlafaxine,Benzthiazide,Benzthiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Benzydamine,Benzydamine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Bepotastine,Venlafaxine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bepridil,The metabolism of Bepridil can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Berotralstat,The metabolism of Venlafaxine can be decreased when combined with Berotralstat.,decrease,no risk
Venlafaxine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Bethanidine,Venlafaxine may increase the tachycardic activities of Bethanidine.,increase,no risk
Venlafaxine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Venlafaxine.,increase,risk
Venlafaxine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Bexagliflozin.,increase,risk
Venlafaxine,Bicisate,Venlafaxine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bimekizumab,The metabolism of Venlafaxine can be increased when combined with Bimekizumab.,increase,no risk
Venlafaxine,Binimetinib,Venlafaxine may increase the excretion rate of Binimetinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Biperiden,The metabolism of Venlafaxine can be decreased when combined with Biperiden.,decrease,no risk
Venlafaxine,Bismuth subgallate,Venlafaxine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bisoprolol,Venlafaxine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bisoxatin,Venlafaxine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Venlafaxine.,increase,risk
Venlafaxine,Bleomycin,Venlafaxine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Venlafaxine,Boceprevir,The metabolism of Venlafaxine can be decreased when combined with Boceprevir.,decrease,no risk
Venlafaxine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Venlafaxine.,increase,risk
Venlafaxine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Venlafaxine.,increase,risk
Venlafaxine,Brexanolone,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Brexanolone.,increase,risk
Venlafaxine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Brigatinib,Venlafaxine may increase the excretion rate of Brigatinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Venlafaxine,Brivaracetam,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Brivaracetam.,increase,risk
Venlafaxine,Bromazepam,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Bromazepam.,increase,risk
Venlafaxine,Bromocriptine,Venlafaxine may increase the tachycardic activities of Bromocriptine.,increase,no risk
Venlafaxine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Bromperidol,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Bromperidol.,increase,risk
Venlafaxine,Brompheniramine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Brompheniramine.,increase,risk
Venlafaxine,Buclizine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Buclizine.,increase,risk
Venlafaxine,Budesonide,Venlafaxine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bumadizone,Bumadizone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Bumetanide,Bumetanide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Buprenorphine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Venlafaxine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Venlafaxine.,increase,risk
Venlafaxine,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Venlafaxine.,increase,risk
Venlafaxine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Venlafaxine.,increase,risk
Venlafaxine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Venlafaxine.,increase,risk
Venlafaxine,Butaperazine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Butaperazine.,increase,risk
Venlafaxine,Butobarbital,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Butobarbital.,increase,risk
Venlafaxine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Venlafaxine.,increase,risk
Venlafaxine,Butriptyline,The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Venlafaxine.,increase,risk
Venlafaxine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Butylscopolamine.,increase,risk
Venlafaxine,Gabapentin,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gabapentin.,increase,risk
Venlafaxine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gabapentin enacarbil.,increase,risk
Venlafaxine,Gadobenic acid,Venlafaxine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gadodiamide,Gadodiamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gadofosveset trisodium,Venlafaxine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gadopentetic acid,Venlafaxine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gadoteric acid,Venlafaxine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gadoteridol,Venlafaxine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Venlafaxine,Galantamine,The metabolism of Galantamine can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gallamine triethiodide.,increase,risk
Venlafaxine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Venlafaxine is combined with Ganaxolone.",increase,risk
Venlafaxine,Ganciclovir,Venlafaxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gatifloxacin.,increase,risk
Venlafaxine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Gemcitabine,Venlafaxine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gemfibrozil,Venlafaxine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gentamicin,Venlafaxine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Venlafaxine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Venlafaxine.,increase,risk
Venlafaxine,Gilteritinib,The therapeutic efficacy of Venlafaxine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Venlafaxine,Gimeracil,Venlafaxine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Venlafaxine,Givosiran,The serum concentration of Venlafaxine can be increased when it is combined with Givosiran.,increase,no risk
Venlafaxine,Glasdegib,Venlafaxine may increase the excretion rate of Glasdegib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Glecaprevir,Venlafaxine may increase the excretion rate of Glecaprevir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Gliclazide,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gliclazide.,increase,risk
Venlafaxine,Glimepiride,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glimepiride.,increase,risk
Venlafaxine,Glipizide,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glipizide.,increase,risk
Venlafaxine,Gliquidone,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gliquidone.,increase,risk
Venlafaxine,Glofitamab,The serum concentration of Venlafaxine can be increased when it is combined with Glofitamab.,increase,no risk
Venlafaxine,Glutethimide,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Glutethimide.,increase,risk
Venlafaxine,Glyburide,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glyburide.,increase,risk
Venlafaxine,Glycerol phenylbutyrate,The metabolism of Venlafaxine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Venlafaxine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Glycopyrronium.,increase,risk
Venlafaxine,Glymidine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glymidine.,increase,risk
Venlafaxine,Golimumab,The metabolism of Venlafaxine can be increased when combined with Golimumab.,increase,no risk
Venlafaxine,Golodirsen,Venlafaxine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Venlafaxine,Goserelin,Goserelin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Venlafaxine.,increase,risk
Venlafaxine,Guanabenz,Venlafaxine may increase the tachycardic activities of Guanabenz.,increase,no risk
Venlafaxine,Guanethidine,Venlafaxine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Guanfacine,Venlafaxine may increase the tachycardic activities of Guanfacine.,increase,no risk
Venlafaxine,Halazepam,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Halazepam.,increase,risk
Venlafaxine,Halofantrine,The metabolism of Venlafaxine can be decreased when combined with Halofantrine.,decrease,no risk
Venlafaxine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Venlafaxine.,increase,no risk
Venlafaxine,Halothane,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Halothane.,increase,risk
Venlafaxine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Venlafaxine.,increase,risk
Venlafaxine,Hexafluronium,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Hexafluronium.,increase,risk
Venlafaxine,Hexocyclium,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Hexocyclium.,increase,risk
Venlafaxine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Homatropine methylbromide.,increase,risk
Venlafaxine,Hydralazine,Venlafaxine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Hydrocodone,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Venlafaxine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Venlafaxine.,increase,risk
Venlafaxine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Venlafaxine.,increase,risk
Venlafaxine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Venlafaxine.,increase,risk
Venlafaxine,Hydroxyethyl Starch,Venlafaxine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Venlafaxine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Venlafaxine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Hyoscyamine.,increase,risk
Venlafaxine,Kanamycin,Venlafaxine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Venlafaxine,Ketamine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ketamine.,increase,risk
Venlafaxine,Ketazolam,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ketazolam.,increase,risk
Venlafaxine,Ketoconazole,The serum concentration of Venlafaxine can be increased when it is combined with Ketoconazole.,increase,no risk
Venlafaxine,Ketoprofen,Venlafaxine may increase the antiplatelet activities of Ketoprofen.,increase,no risk
Venlafaxine,Ketorolac,Venlafaxine may increase the antiplatelet activities of Ketorolac.,increase,no risk
Venlafaxine,Octinoxate,Venlafaxine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Venlafaxine,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Venlafaxine.,increase,risk
Venlafaxine,Olanzapine,The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Venlafaxine.,increase,risk
Venlafaxine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Venlafaxine is combined with Oliceridine.",increase,risk
Venlafaxine,Olodaterol,Venlafaxine may increase the tachycardic activities of Olodaterol.,increase,no risk
Venlafaxine,Olsalazine,Olsalazine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Omaveloxolone,The serum concentration of Venlafaxine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Venlafaxine,Ombitasvir,Venlafaxine may increase the excretion rate of Ombitasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Venlafaxine.,increase,risk
Venlafaxine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Venlafaxine.,increase,risk
Venlafaxine,Orciprenaline,Venlafaxine may increase the tachycardic activities of Orciprenaline.,increase,no risk
Venlafaxine,Oritavancin,The metabolism of Venlafaxine can be decreased when combined with Oritavancin.,decrease,no risk
Venlafaxine,Orphenadrine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Venlafaxine,Oseltamivir,Oseltamivir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Osilodrostat,The metabolism of Venlafaxine can be decreased when combined with Osilodrostat.,decrease,no risk
Venlafaxine,Osimertinib,Venlafaxine may increase the excretion rate of Osimertinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Ospemifene,The metabolism of Venlafaxine can be decreased when combined with Ospemifene.,decrease,no risk
Venlafaxine,Oxacillin,Venlafaxine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Venlafaxine,Oxaliplatin,Venlafaxine may increase the excretion rate of Oxaliplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Oxamniquine,The metabolism of Venlafaxine can be decreased when combined with Oxamniquine.,decrease,no risk
Venlafaxine,Oxaprozin,Venlafaxine may increase the antiplatelet activities of Oxaprozin.,increase,no risk
Venlafaxine,Oxazepam,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxazepam.,increase,risk
Venlafaxine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxcarbazepine.,increase,risk
Venlafaxine,Oxitriptan,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxitriptan.,increase,risk
Venlafaxine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Oxybenzone,Venlafaxine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Venlafaxine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxybuprocaine.,increase,risk
Venlafaxine,Oxybutynin,The metabolism of Venlafaxine can be decreased when combined with Oxybutynin.,decrease,no risk
Venlafaxine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Venlafaxine.,increase,risk
Venlafaxine,Oxymetazoline,Venlafaxine may increase the tachycardic activities of Oxymetazoline.,increase,no risk
Venlafaxine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Venlafaxine.,increase,risk
Venlafaxine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Oxyphencyclimine.,increase,risk
Venlafaxine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Venlafaxine.,increase,risk
Venlafaxine,Oxyquinoline,Venlafaxine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Venlafaxine,Ozanimod,Venlafaxine may increase the excretion rate of Ozanimod which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Quazepam,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Quazepam.,increase,risk
Venlafaxine,Quetiapine,The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Venlafaxine.,increase,risk
Venlafaxine,Quinethazone,Quinethazone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Quinidine,The metabolism of Venlafaxine can be decreased when combined with Quinidine.,decrease,no risk
Venlafaxine,Quinine,The metabolism of Quinine can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Venlafaxine.,increase,risk
Venlafaxine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Ubidecarenone.,increase,risk
Venlafaxine,Ubrogepant,Venlafaxine may increase the excretion rate of Ubrogepant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Urethane,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Urethane.,increase,risk
Venlafaxine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Venlafaxine.,increase,risk
Venlafaxine,Vaborbactam,Venlafaxine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Venlafaxine,Vadadustat,The serum concentration of Venlafaxine can be increased when it is combined with Vadadustat.,increase,no risk
Venlafaxine,Valaciclovir,Valaciclovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Valdecoxib,Valdecoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Venlafaxine,Valganciclovir,Venlafaxine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Venlafaxine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Venlafaxine.,increase,risk
Venlafaxine,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Venlafaxine.,increase,risk
Venlafaxine,Vancomycin,Venlafaxine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Venlafaxine,Varenicline,Venlafaxine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Venlafaxine,Vecuronium,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Vecuronium.,increase,risk
Venlafaxine,Velpatasvir,Venlafaxine may increase the excretion rate of Velpatasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Vemurafenib,Venlafaxine may increase the excretion rate of Vemurafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Venetoclax,The metabolism of Venlafaxine can be decreased when combined with Venetoclax.,decrease,no risk
Venlafaxine,Verapamil,The metabolism of Venlafaxine can be decreased when combined with Verapamil.,decrease,no risk
Venlafaxine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Venlafaxine.,decrease,no risk
Venlafaxine,Vibegron,Venlafaxine may increase the tachycardic activities of Vibegron.,increase,no risk
Venlafaxine,Vigabatrin,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Vigabatrin.,increase,risk
Venlafaxine,Vilanterol,Venlafaxine may increase the tachycardic activities of Vilanterol.,increase,no risk
Venlafaxine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Venlafaxine.,increase,risk
Venlafaxine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Vildagliptin.,increase,risk
Venlafaxine,Viloxazine,The metabolism of Venlafaxine can be decreased when combined with Viloxazine.,decrease,no risk
Venlafaxine,Vinblastine,The metabolism of Venlafaxine can be decreased when combined with Vinblastine.,decrease,no risk
Venlafaxine,Vincristine,Venlafaxine may increase the excretion rate of Vincristine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Vinorelbine,The metabolism of Venlafaxine can be decreased when combined with Vinorelbine.,decrease,no risk
Venlafaxine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Venlafaxine.,increase,risk
Venlafaxine,Voriconazole,The risk or severity of adverse effects can be increased when Voriconazole is combined with Venlafaxine.,increase,risk
Venlafaxine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Venlafaxine.,increase,risk
Venlafaxine,Voxilaprevir,Venlafaxine may increase the excretion rate of Voxilaprevir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Venlafaxine.,increase,risk
Venlafaxine,Xamoterol,Venlafaxine may increase the tachycardic activities of Xamoterol.,increase,no risk
Venlafaxine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Venlafaxine.,increase,risk
Venlafaxine,Xylometazoline,Venlafaxine may increase the tachycardic activities of Xylometazoline.,increase,no risk
Venlafaxine,Yohimbine,The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Venlafaxine.,increase,risk
Venlafaxine,Zaleplon,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Zaleplon.,increase,risk
Venlafaxine,Zanamivir,Venlafaxine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Venlafaxine,Ziconotide,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ziconotide.,increase,risk
Venlafaxine,Zidovudine,Venlafaxine may increase the excretion rate of Zidovudine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Venlafaxine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Venlafaxine.,increase,risk
Venlafaxine,Ziprasidone,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ziprasidone.,increase,risk
Venlafaxine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Zolmitriptan.,increase,risk
Venlafaxine,Zolpidem,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Venlafaxine,Zonisamide,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Zonisamide.,increase,risk
Venlafaxine,Zopiclone,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zopiclone.,increase,risk
Venlafaxine,Zotepine,The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Venlafaxine.,increase,risk
Venlafaxine,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Venlafaxine.,increase,risk
Venlafaxine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Venlafaxine.,increase,risk
Conjugated estrogens,Bacitracin,Bacitracin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Baclofen,Baclofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Balsalazide,Balsalazide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bamlanivimab,Conjugated estrogens may increase the thrombogenic activities of Bamlanivimab.,increase,no risk
Conjugated estrogens,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Conjugated estrogens.,increase,no risk
Conjugated estrogens,Basiliximab,Conjugated estrogens may increase the thrombogenic activities of Basiliximab.,increase,no risk
Conjugated estrogens,Beclomethasone dipropionate,Beclomethasone dipropionate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Belantamab mafodotin,Conjugated estrogens may increase the thrombogenic activities of Belantamab mafodotin.,increase,no risk
Conjugated estrogens,Belimumab,Conjugated estrogens may increase the thrombogenic activities of Belimumab.,increase,no risk
Conjugated estrogens,Belinostat,The metabolism of Conjugated estrogens can be increased when combined with Belinostat.,increase,no risk
Conjugated estrogens,Belumosudil,Belumosudil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bemiparin,Conjugated estrogens may decrease the anticoagulant activities of Bemiparin.,decrease,no risk
Conjugated estrogens,Bempedoic acid,The excretion of Conjugated estrogens can be decreased when combined with Bempedoic acid.,decrease,no risk
Conjugated estrogens,Benazepril,The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Benazepril.,increase,risk
Conjugated estrogens,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conjugated estrogens,Benorilate,Benorilate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Benralizumab,Conjugated estrogens may increase the thrombogenic activities of Benralizumab.,increase,no risk
Conjugated estrogens,Benserazide,Conjugated estrogens may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Benzatropine,Benzatropine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Benznidazole,Conjugated estrogens may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Benzoic acid,The excretion of Conjugated estrogens can be decreased when combined with Benzoic acid.,decrease,no risk
Conjugated estrogens,Benzthiazide,Benzthiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conjugated estrogens,Benzydamine,Benzydamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Bepotastine,Conjugated estrogens may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Berotralstat,The metabolism of Conjugated estrogens can be decreased when combined with Berotralstat.,decrease,no risk
Conjugated estrogens,Besilesomab,Conjugated estrogens may increase the thrombogenic activities of Besilesomab.,increase,no risk
Conjugated estrogens,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Conjugated estrogens.,increase,no risk
Conjugated estrogens,Betaxolol,The metabolism of Conjugated estrogens can be decreased when combined with Betaxolol.,decrease,no risk
Conjugated estrogens,Betrixaban,Conjugated estrogens may decrease the anticoagulant activities of Betrixaban.,decrease,no risk
Conjugated estrogens,Bevacizumab,Conjugated estrogens may increase the thrombogenic activities of Bevacizumab.,increase,no risk
Conjugated estrogens,Bezafibrate,The excretion of Conjugated estrogens can be decreased when combined with Bezafibrate.,decrease,no risk
Conjugated estrogens,Bezlotoxumab,Conjugated estrogens may increase the thrombogenic activities of Bezlotoxumab.,increase,no risk
Conjugated estrogens,Bicisate,Conjugated estrogens may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bimekizumab,The metabolism of Conjugated estrogens can be increased when combined with Bimekizumab.,increase,no risk
Conjugated estrogens,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Bismuth subgallate,Conjugated estrogens may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bisoprolol,Conjugated estrogens may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bisoxatin,Conjugated estrogens may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bivalirudin,Conjugated estrogens may decrease the anticoagulant activities of Bivalirudin.,decrease,no risk
Conjugated estrogens,Bleomycin,Conjugated estrogens may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Blinatumomab,Conjugated estrogens may increase the thrombogenic activities of Blinatumomab.,increase,no risk
Conjugated estrogens,Boceprevir,The metabolism of Conjugated estrogens can be decreased when combined with Boceprevir.,decrease,no risk
Conjugated estrogens,Bortezomib,The metabolism of Conjugated estrogens can be decreased when combined with Bortezomib.,decrease,no risk
Conjugated estrogens,Bosentan,The excretion of Bosentan can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Brentuximab vedotin,Conjugated estrogens may increase the thrombogenic activities of Brentuximab vedotin.,increase,no risk
Conjugated estrogens,Brigatinib,Brigatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Conjugated estrogens.,increase,no risk
Conjugated estrogens,Brivaracetam,Conjugated estrogens may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Brodalumab,Conjugated estrogens may increase the thrombogenic activities of Brodalumab.,increase,no risk
Conjugated estrogens,Brolucizumab,Conjugated estrogens may increase the thrombogenic activities of Brolucizumab.,increase,no risk
Conjugated estrogens,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Bromotheophylline,Bromotheophylline may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Conjugated estrogens,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Conjugated estrogens.,increase,no risk
Conjugated estrogens,Bumadizone,Bumadizone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bumetanide,The excretion of Bumetanide can be decreased when combined with Conjugated estrogens.,decrease,no risk
Conjugated estrogens,Buprenorphine,Buprenorphine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Bupropion,Conjugated estrogens may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Burosumab,Conjugated estrogens may increase the thrombogenic activities of Burosumab.,increase,no risk
Conjugated estrogens,Buspirone,Conjugated estrogens may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Butabarbital,Butabarbital may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,decrease,no risk
Conjugated estrogens,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Conjugated estrogens.,increase,no risk
Travoprost,Balsalazide,The therapeutic efficacy of Travoprost can be decreased when used in combination with Balsalazide.,decrease,no risk
Travoprost,Benorilate,The therapeutic efficacy of Travoprost can be decreased when used in combination with Benorilate.,decrease,no risk
Travoprost,Benoxaprofen,The therapeutic efficacy of Travoprost can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Travoprost,Benzydamine,The therapeutic efficacy of Travoprost can be decreased when used in combination with Benzydamine.,decrease,no risk
Travoprost,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Travoprost.,decrease,no risk
Travoprost,Bumadizone,The therapeutic efficacy of Travoprost can be decreased when used in combination with Bumadizone.,decrease,no risk
Travoprost,Glycol salicylate,The therapeutic efficacy of Travoprost can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Travoprost,Ketoprofen,The therapeutic efficacy of Travoprost can be decreased when used in combination with Ketoprofen.,decrease,no risk
Travoprost,Ketorolac,The therapeutic efficacy of Travoprost can be decreased when used in combination with Ketorolac.,decrease,no risk
Travoprost,Oxaprozin,The therapeutic efficacy of Travoprost can be decreased when used in combination with Oxaprozin.,decrease,no risk
Travoprost,Oxyphenbutazone,The therapeutic efficacy of Travoprost can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Travoprost,Valdecoxib,The therapeutic efficacy of Travoprost can be decreased when used in combination with Valdecoxib.,decrease,no risk
Amcinonide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Amcinonide.,increase,risk
Amcinonide,Vadadustat,The serum concentration of Amcinonide can be increased when it is combined with Vadadustat.,increase,no risk
Amcinonide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Amcinonide.,decrease,no risk
Amcinonide,Vildagliptin,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Vildagliptin.,increase,risk
Amcinonide,Viloxazine,The metabolism of Amcinonide can be decreased when combined with Viloxazine.,decrease,no risk
Amcinonide,Voriconazole,The serum concentration of Amcinonide can be increased when it is combined with Voriconazole.,increase,no risk
Atomoxetine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Atomoxetine.,decrease,no risk
Atomoxetine,Bepotastine,Atomoxetine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bepridil,The metabolism of Atomoxetine can be decreased when combined with Bepridil.,decrease,no risk
Atomoxetine,Berotralstat,The metabolism of Atomoxetine can be decreased when combined with Berotralstat.,decrease,no risk
Atomoxetine,Betaxolol,Atomoxetine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Atomoxetine,Bethanidine,Atomoxetine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Atomoxetine,Bicalutamide,The metabolism of Atomoxetine can be decreased when combined with Bicalutamide.,decrease,no risk
Atomoxetine,Bicisate,Atomoxetine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bilastine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Bilastine.,increase,risk
Atomoxetine,Bimekizumab,The metabolism of Atomoxetine can be increased when combined with Bimekizumab.,increase,no risk
Atomoxetine,Biperiden,The metabolism of Atomoxetine can be decreased when combined with Biperiden.,decrease,no risk
Atomoxetine,Bismuth subgallate,Atomoxetine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bisoprolol,Atomoxetine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Atomoxetine,Bisoxatin,Atomoxetine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bleomycin,Atomoxetine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Atomoxetine.,increase,risk
Atomoxetine,Bosentan,Atomoxetine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Atomoxetine,Bretylium,Atomoxetine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Atomoxetine,Brexpiprazole,The risk or severity of hypertension can be increased when Atomoxetine is combined with Brexpiprazole.,increase,risk
Atomoxetine,Brivaracetam,Atomoxetine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bromazepam,Atomoxetine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bromocriptine,The risk or severity of hypertension can be increased when Atomoxetine is combined with Bromocriptine.,increase,risk
Atomoxetine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Atomoxetine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Brompheniramine.,increase,risk
Atomoxetine,Buclizine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Buclizine.,increase,risk
Atomoxetine,Budesonide,Atomoxetine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Atomoxetine,Bumadizone,The risk or severity of hypertension can be increased when Atomoxetine is combined with Bumadizone.,increase,risk
Atomoxetine,Bumetanide,Bumetanide may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Atomoxetine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Atomoxetine.,decrease,no risk
Atomoxetine,Buprenorphine,The metabolism of Atomoxetine can be decreased when combined with Buprenorphine.,decrease,no risk
Atomoxetine,Bupropion,The metabolism of Atomoxetine can be decreased when combined with Bupropion.,decrease,no risk
Atomoxetine,Buserelin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Buserelin.,increase,risk
Atomoxetine,Buspirone,The risk or severity of hypertension can be increased when Atomoxetine is combined with Buspirone.,increase,risk
Atomoxetine,Butabarbital,Butabarbital may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Butriptyline,The risk or severity of hypertension can be increased when Atomoxetine is combined with Butriptyline.,increase,risk
Atomoxetine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Butylscopolamine.,increase,risk
Atomoxetine,Gabapentin enacarbil,Atomoxetine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Gadobenic acid.,increase,risk
Atomoxetine,Gadodiamide,Gadodiamide may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gadofosveset trisodium,Atomoxetine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gadopentetic acid,Atomoxetine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gadoteric acid,Atomoxetine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gadoteridol,Atomoxetine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Atomoxetine,Galantamine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Galantamine.,increase,risk
Atomoxetine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Gallamine triethiodide.,increase,risk
Atomoxetine,Ganciclovir,Atomoxetine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Gatifloxacin.,increase,risk
Atomoxetine,Gefitinib,The metabolism of Atomoxetine can be decreased when combined with Gefitinib.,decrease,no risk
Atomoxetine,Gemcitabine,Atomoxetine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gemfibrozil,Atomoxetine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Gemifloxacin.,increase,risk
Atomoxetine,Gentamicin,Atomoxetine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Atomoxetine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Atomoxetine.,increase,risk
Atomoxetine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Gilteritinib.,increase,risk
Atomoxetine,Gimeracil,Atomoxetine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Atomoxetine,Givosiran,The serum concentration of Atomoxetine can be increased when it is combined with Givosiran.,increase,no risk
Atomoxetine,Glasdegib,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Glasdegib.,increase,risk
Atomoxetine,Glipizide,Atomoxetine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Atomoxetine,Glycerol phenylbutyrate,The metabolism of Atomoxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Atomoxetine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Glycopyrronium.,increase,risk
Atomoxetine,Golimumab,The metabolism of Atomoxetine can be increased when combined with Golimumab.,increase,no risk
Atomoxetine,Golodirsen,Atomoxetine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Atomoxetine,Goserelin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Goserelin.,increase,risk
Atomoxetine,Granisetron,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Granisetron.,increase,risk
Atomoxetine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Grepafloxacin.,increase,risk
Atomoxetine,Guanabenz,Atomoxetine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Atomoxetine,Guanadrel,Atomoxetine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Atomoxetine,Guanethidine,Atomoxetine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Atomoxetine,Guanfacine,Atomoxetine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Atomoxetine,Guanoxan,Atomoxetine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Atomoxetine,Halofantrine,The metabolism of Atomoxetine can be decreased when combined with Halofantrine.,decrease,no risk
Atomoxetine,Haloperidol,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Haloperidol.,increase,risk
Atomoxetine,Halothane,The risk or severity of hypertension can be increased when Atomoxetine is combined with Halothane.,increase,risk
Atomoxetine,Hexocyclium,The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Hexocyclium.,increase,risk
Atomoxetine,Histrelin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Histrelin.,increase,risk
Atomoxetine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Homatropine methylbromide.,increase,risk
Atomoxetine,Hydralazine,Atomoxetine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Atomoxetine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Atomoxetine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Atomoxetine,Hydromorphone,Atomoxetine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Atomoxetine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Hydroxychloroquine,The metabolism of Atomoxetine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Atomoxetine,Hydroxyethyl Starch,Atomoxetine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Atomoxetine,Hydroxyurea,The metabolism of Atomoxetine can be decreased when combined with Hydroxyurea.,decrease,no risk
Atomoxetine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Hydroxyzine.,increase,risk
Atomoxetine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Hyoscyamine.,increase,risk
Atomoxetine,Kanamycin,Atomoxetine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Atomoxetine,Ketamine,Atomoxetine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Ketazolam,Atomoxetine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Atomoxetine,Ketoconazole,The metabolism of Atomoxetine can be decreased when combined with Ketoconazole.,decrease,no risk
Atomoxetine,Ketoprofen,The risk or severity of hypertension can be increased when Atomoxetine is combined with Ketoprofen.,increase,risk
Atomoxetine,Ketorolac,The risk or severity of hypertension can be increased when Atomoxetine is combined with Ketorolac.,increase,risk
Atomoxetine,Octinoxate,Atomoxetine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Atomoxetine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Atomoxetine.,increase,risk
Atomoxetine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Ofloxacin.,increase,risk
Atomoxetine,Olanzapine,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Olanzapine.,increase,risk
Atomoxetine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Atomoxetine.,decrease,no risk
Atomoxetine,Olmesartan,Atomoxetine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Atomoxetine,Olodaterol,Atomoxetine may increase the tachycardic activities of Olodaterol.,increase,no risk
Atomoxetine,Olsalazine,Olsalazine may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Ondansetron,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Ondansetron.,increase,risk
Atomoxetine,Opium,Atomoxetine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Atomoxetine,Orciprenaline,Atomoxetine may increase the tachycardic activities of Orciprenaline.,increase,no risk
Atomoxetine,Oritavancin,The metabolism of Atomoxetine can be decreased when combined with Oritavancin.,decrease,no risk
Atomoxetine,Orphenadrine,The metabolism of Atomoxetine can be decreased when combined with Orphenadrine.,decrease,no risk
Atomoxetine,Oseltamivir,Oseltamivir may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,decrease,no risk
Atomoxetine,Osilodrostat,The metabolism of Atomoxetine can be decreased when combined with Osilodrostat.,decrease,no risk
Atomoxetine,Ospemifene,The metabolism of Atomoxetine can be decreased when combined with Ospemifene.,decrease,no risk
Atomoxetine,Oxacillin,Atomoxetine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Atomoxetine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Atomoxetine.,increase,risk
Atomoxetine,Oxamniquine,The metabolism of Atomoxetine can be decreased when combined with Oxamniquine.,decrease,no risk
Atomoxetine,Oxaprozin,The risk or severity of hypertension can be increased when Atomoxetine is combined with Oxaprozin.,increase,risk
Atomoxetine,Oxatomide,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Oxatomide.,increase,risk
Atomoxetine,Oxazepam,Atomoxetine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Atomoxetine,Oxprenolol,The metabolism of Atomoxetine can be decreased when combined with Oxprenolol.,decrease,no risk
Atomoxetine,Oxybenzone,Atomoxetine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Atomoxetine,Oxybutynin,The metabolism of Atomoxetine can be decreased when combined with Oxybutynin.,decrease,no risk
Atomoxetine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Atomoxetine.,decrease,no risk
Atomoxetine,Oxymetazoline,The risk or severity of hypertension can be increased when Atomoxetine is combined with Oxymetazoline.,increase,risk
Atomoxetine,Oxymetholone,The metabolism of Atomoxetine can be decreased when combined with Oxymetholone.,decrease,no risk
Atomoxetine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Atomoxetine.,decrease,no risk
Atomoxetine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Atomoxetine is combined with Oxyphenbutazone.,increase,risk
Atomoxetine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Oxyphencyclimine.,increase,risk
Atomoxetine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Atomoxetine.,increase,risk
Atomoxetine,Oxyquinoline,Atomoxetine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Atomoxetine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Atomoxetine.,increase,risk
Atomoxetine,Quetiapine,The risk or severity of hypertension can be increased when Atomoxetine is combined with Quetiapine.,increase,risk
Atomoxetine,Quinapril,Atomoxetine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Atomoxetine,Quinethazone,Quinethazone may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Atomoxetine,Quinidine,The metabolism of Atomoxetine can be decreased when combined with Quinidine.,decrease,no risk
Atomoxetine,Quinine,The metabolism of Atomoxetine can be decreased when combined with Quinine.,decrease,no risk
Atomoxetine,Quinupramine,The risk or severity of hypertension can be increased when Atomoxetine is combined with Quinupramine.,increase,risk
Atomoxetine,Quizartinib,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Quizartinib.,increase,risk
Bleomycin,Bisoxatin,Bleomycin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Bleomycin,Blinatumomab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Blinatumomab.,increase,risk
Bleomycin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Bleomycin.",decrease,no risk
Bleomycin,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Bleomycin.,increase,risk
Bleomycin,Bosutinib,The risk or severity of adverse effects can be increased when Bleomycin is combined with Bosutinib.,increase,risk
Bleomycin,Brentuximab vedotin,The risk or severity of pulmonary toxicity can be increased when Brentuximab vedotin is combined with Bleomycin.,increase,risk
Bleomycin,Brivaracetam,Bleomycin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Bleomycin,Brodalumab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Brodalumab.,increase,risk
Bleomycin,Bromazepam,Bleomycin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Bleomycin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bleomycin,Budesonide,The risk or severity of adverse effects can be increased when Bleomycin is combined with Budesonide.,increase,risk
Bleomycin,Bumadizone,Bumadizone may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Bumetanide,Bumetanide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bleomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Bupivacaine.,increase,risk
Bleomycin,Bupropion,Bleomycin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Bleomycin,Buspirone,Bleomycin may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Bleomycin,Busulfan,The risk or severity of adverse effects can be increased when Bleomycin is combined with Busulfan.,increase,risk
Bleomycin,Butabarbital,Butabarbital may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Butacaine.,increase,risk
Bleomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Butamben.,increase,risk
Bleomycin,Gabapentin enacarbil,Bleomycin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Bleomycin,Gadobenic acid,Bleomycin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Bleomycin,Gadodiamide,Gadodiamide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Gadofosveset trisodium,Bleomycin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Bleomycin,Gadopentetic acid,Bleomycin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Bleomycin,Gadoteric acid,Bleomycin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Bleomycin,Gadoteridol,Bleomycin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Bleomycin,Ganciclovir,Bleomycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Bleomycin,Gemcitabine,The risk or severity of pulmonary toxicity can be increased when Gemcitabine is combined with Bleomycin.,increase,risk
Bleomycin,Gemfibrozil,Bleomycin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Bleomycin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bleomycin.,increase,risk
Bleomycin,Gentamicin,Bleomycin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Bleomycin,Gimeracil,Bleomycin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Bleomycin,Givosiran,Givosiran may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Glatiramer,The risk or severity of adverse effects can be increased when Bleomycin is combined with Glatiramer.,increase,risk
Bleomycin,Glipizide,Bleomycin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Bleomycin,Glycerol phenylbutyrate,Bleomycin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Bleomycin,Golimumab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Golimumab.,increase,risk
Bleomycin,Golodirsen,Bleomycin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Bleomycin,Goserelin,Goserelin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Guanethidine,Bleomycin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Bleomycin,Guanfacine,Bleomycin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Bleomycin,Guselkumab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Guselkumab.,increase,risk
Bleomycin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Haloperidol,Bleomycin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Bleomycin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Bleomycin.,increase,risk
Bleomycin,Hydralazine,Bleomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Bleomycin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bleomycin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Bleomycin is combined with Hydrocortisone acetate.,increase,risk
Bleomycin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Bleomycin is combined with Hydrocortisone butyrate.,increase,risk
Bleomycin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Bleomycin is combined with Hydrocortisone succinate.,increase,risk
Bleomycin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bleomycin,Hydromorphone,Bleomycin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Bleomycin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Bleomycin is combined with Hydroxychloroquine.,increase,risk
Bleomycin,Hydroxyethyl Starch,Bleomycin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Bleomycin,Hydroxyurea,The risk or severity of adverse effects can be increased when Bleomycin is combined with Hydroxyurea.,increase,risk
Bleomycin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Kanamycin,Bleomycin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Ketamine,Bleomycin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Bleomycin,Ketazolam,Bleomycin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Bleomycin,Ketoprofen,Ketoprofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Ketorolac,Ketorolac may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Obinutuzumab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Obinutuzumab.,increase,risk
Bleomycin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Bleomycin.,increase,no risk
Bleomycin,Octinoxate,Bleomycin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Bleomycin,Ofatumumab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ofatumumab.,increase,risk
Bleomycin,Olaparib,The risk or severity of adverse effects can be increased when Bleomycin is combined with Olaparib.,increase,risk
Bleomycin,Olsalazine,Olsalazine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Opium,Bleomycin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Bleomycin,Oseltamivir,Oseltamivir may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Ouabain,Ouabain may decrease the cardiotoxic activities of Bleomycin.,decrease,no risk
Bleomycin,Oxacillin,Bleomycin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Bleomycin,Oxaliplatin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Oxaliplatin.,increase,risk
Bleomycin,Oxaprozin,Oxaprozin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Oxazepam,Bleomycin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Bleomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Oxetacaine.,increase,risk
Bleomycin,Oxybenzone,Bleomycin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Bleomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Oxybuprocaine.,increase,risk
Bleomycin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Oxyquinoline,Bleomycin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Bleomycin,Ozanimod,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ozanimod.,increase,risk
Bleomycin,Quetiapine,Bleomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Bleomycin,Quinethazone,Quinethazone may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bleomycin,Quinidine,Bleomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Bleomycin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Bleomycin.,increase,risk
Bleomycin,Upadacitinib,The risk or severity of adverse effects can be increased when Bleomycin is combined with Upadacitinib.,increase,risk
Bleomycin,Vaborbactam,Bleomycin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Bleomycin,Valaciclovir,Valaciclovir may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Valbenazine,Bleomycin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Bleomycin,Valdecoxib,Valdecoxib may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Valganciclovir,Bleomycin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Bleomycin,Valproic acid,The serum concentration of Valproic acid can be decreased when it is combined with Bleomycin.,decrease,no risk
Bleomycin,Vancomycin,Bleomycin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Varenicline,Bleomycin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Bleomycin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Bleomycin.,increase,risk
Bleomycin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Vedolizumab,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vedolizumab.,increase,risk
Bleomycin,Venlafaxine,Venlafaxine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Bleomycin,Verapamil,Bleomycin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Bleomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Bleomycin.,decrease,no risk
Bleomycin,Vilanterol,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vilanterol.,increase,risk
Bleomycin,Viloxazine,Bleomycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Bleomycin,Vinblastine,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vinblastine.,increase,risk
Bleomycin,Vincristine,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vincristine.,increase,risk
Bleomycin,Vindesine,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vindesine.,increase,risk
Bleomycin,Vinorelbine,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vinorelbine.,increase,risk
Bleomycin,Voclosporin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Voclosporin.,increase,risk
Bleomycin,Vorinostat,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vorinostat.,increase,risk
Bleomycin,Vortioxetine,Bleomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Bleomycin,Warfarin,Bleomycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Bleomycin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Bleomycin.,increase,risk
Bleomycin,Zaleplon,Bleomycin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Bleomycin,Zanamivir,Bleomycin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Bleomycin,Zidovudine,The risk or severity of adverse effects can be increased when Bleomycin is combined with Zidovudine.,increase,risk
Bleomycin,Zinc ascorbate,The therapeutic efficacy of Bleomycin can be decreased when used in combination with Zinc ascorbate.,decrease,no risk
Bleomycin,Zonisamide,Zonisamide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorambucil,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Gemcitabine,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Gemcitabine.,increase,risk
Chlorambucil,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Chlorambucil.,increase,risk
Chlorambucil,Glatiramer,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Glatiramer.,increase,risk
Chlorambucil,Golimumab,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Golimumab.,increase,risk
Chlorambucil,Guselkumab,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Guselkumab.,increase,risk
Chlorambucil,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Chlorambucil.,increase,risk
Chlorambucil,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Chlorambucil.,increase,risk
Chlorambucil,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Chlorambucil.,increase,risk
Chlorambucil,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Hydrocortisone acetate.,increase,risk
Chlorambucil,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Hydrocortisone butyrate.,increase,risk
Chlorambucil,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Hydrocortisone succinate.,increase,risk
Chlorambucil,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Chlorambucil.,increase,risk
Chlorambucil,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Chlorambucil.,increase,risk
Chlorambucil,Hydroxyurea,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Hydroxyurea.,increase,risk
Chlorambucil,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Obinutuzumab,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Obinutuzumab.,increase,risk
Chlorambucil,Ocrelizumab,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Ocrelizumab.,increase,risk
Chlorambucil,Ofatumumab,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Ofatumumab.,increase,risk
Chlorambucil,Olaparib,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Olaparib.,increase,risk
Chlorambucil,Oxaliplatin,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Oxaliplatin.,increase,risk
Chlorambucil,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Chlorambucil is combined with Oxetacaine.,increase,risk
Chlorambucil,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Chlorambucil is combined with Oxybuprocaine.,increase,risk
Chlorambucil,Ozanimod,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Ozanimod.,increase,risk
Chlorambucil,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Chlorambucil.,increase,risk
Chlorambucil,Upadacitinib,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Upadacitinib.,increase,risk
Chlorambucil,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Chlorambucil.,increase,risk
Chlorambucil,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Chlorambucil.,increase,risk
Chlorambucil,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Vedolizumab,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vedolizumab.,increase,risk
Chlorambucil,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Vilanterol,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vilanterol.,increase,risk
Chlorambucil,Vinblastine,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vinblastine.,increase,risk
Chlorambucil,Vincristine,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vincristine.,increase,risk
Chlorambucil,Vindesine,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vindesine.,increase,risk
Chlorambucil,Vinorelbine,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vinorelbine.,increase,risk
Chlorambucil,Voclosporin,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Voclosporin.,increase,risk
Chlorambucil,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Chlorambucil.,increase,risk
Chlorambucil,Vorinostat,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vorinostat.,increase,risk
Chlorambucil,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Chlorambucil.,increase,risk
Chlorambucil,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Chlorambucil.,increase,risk
Chlorambucil,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Chlorambucil.,increase,risk
Chlorambucil,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Chlorambucil.,decrease,no risk
Chlorambucil,Zidovudine,The risk or severity of adverse effects can be increased when Chlorambucil is combined with Zidovudine.,increase,risk
Chlorambucil,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Chlorambucil.,decrease,no risk
Etomidate,Bethanidine,Etomidate may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Etomidate,Bicisate,Etomidate may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Etomidate,Biperiden,The risk or severity of Tachycardia can be increased when Etomidate is combined with Biperiden.,increase,risk
Etomidate,Bismuth subgallate,Etomidate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Etomidate,Bisoprolol,The therapeutic efficacy of Etomidate can be decreased when used in combination with Bisoprolol.,decrease,no risk
Etomidate,Bisoxatin,Etomidate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Etomidate,Bleomycin,Bleomycin may decrease the excretion rate of Etomidate which could result in a higher serum level.,decrease,no risk
Etomidate,Bosentan,Etomidate may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Etomidate,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Etomidate.,increase,risk
Etomidate,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Etomidate.,increase,risk
Etomidate,Bretylium,Etomidate may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Etomidate,Brexanolone,The risk or severity of CNS depression can be increased when Etomidate is combined with Brexanolone.,increase,risk
Etomidate,Brexpiprazole,The therapeutic efficacy of Etomidate can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Etomidate,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Etomidate.,increase,no risk
Etomidate,Brivaracetam,The risk or severity of CNS depression can be increased when Etomidate is combined with Brivaracetam.,increase,risk
Etomidate,Bromazepam,The risk or severity of CNS depression can be increased when Etomidate is combined with Bromazepam.,increase,risk
Etomidate,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Etomidate.,increase,no risk
Etomidate,Bromotheophylline,Bromotheophylline may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etomidate,Bromperidol,The risk or severity of CNS depression can be increased when Etomidate is combined with Bromperidol.,increase,risk
Etomidate,Brompheniramine,The risk or severity of CNS depression can be increased when Etomidate is combined with Brompheniramine.,increase,risk
Etomidate,Buclizine,The risk or severity of Tachycardia can be increased when Etomidate is combined with Buclizine.,increase,risk
Etomidate,Budesonide,Etomidate may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Etomidate,Bumadizone,The risk or severity of hypertension can be increased when Etomidate is combined with Bumadizone.,increase,risk
Etomidate,Bumetanide,Bumetanide may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etomidate,Bupivacaine,The risk or severity of CNS depression can be increased when Etomidate is combined with Bupivacaine.,increase,risk
Etomidate,Buprenorphine,Etomidate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Etomidate,Bupropion,The risk or severity of CNS depression can be increased when Etomidate is combined with Bupropion.,increase,risk
Etomidate,Buspirone,The risk or severity of CNS depression can be increased when Etomidate is combined with Buspirone.,increase,risk
Etomidate,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Etomidate.,increase,risk
Etomidate,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Etomidate.,increase,risk
Etomidate,Butaperazine,The risk or severity of CNS depression can be increased when Etomidate is combined with Butaperazine.,increase,risk
Etomidate,Butobarbital,The risk or severity of CNS depression can be increased when Etomidate is combined with Butobarbital.,increase,risk
Etomidate,Butorphanol,The risk or severity of CNS depression can be increased when Etomidate is combined with Butorphanol.,increase,risk
Etomidate,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Etomidate.,increase,risk
Etomidate,Butylscopolamine,The risk or severity of Tachycardia can be increased when Etomidate is combined with Butylscopolamine.,increase,risk
Etomidate,Kanamycin,Etomidate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Etomidate,Ketamine,The risk or severity of CNS depression can be increased when Etomidate is combined with Ketamine.,increase,risk
Etomidate,Ketazolam,The risk or severity of CNS depression can be increased when Etomidate is combined with Ketazolam.,increase,risk
Etomidate,Ketoprofen,The risk or severity of hypertension can be increased when Etomidate is combined with Ketoprofen.,increase,risk
Etomidate,Ketorolac,The risk or severity of hypertension can be increased when Etomidate is combined with Ketorolac.,increase,risk
Etomidate,Octinoxate,Etomidate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Etomidate,Olanzapine,The therapeutic efficacy of Etomidate can be decreased when used in combination with Olanzapine.,decrease,no risk
Etomidate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Etomidate is combined with Oliceridine.",increase,risk
Etomidate,Olmesartan,Etomidate may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Etomidate,Olodaterol,The risk or severity of hypertension can be increased when Etomidate is combined with Olodaterol.,increase,risk
Etomidate,Olsalazine,Olsalazine may decrease the excretion rate of Etomidate which could result in a higher serum level.,decrease,no risk
Etomidate,Ondansetron,The risk or severity of CNS depression can be increased when Etomidate is combined with Ondansetron.,increase,risk
Etomidate,Opium,The risk or severity of CNS depression can be increased when Etomidate is combined with Opium.,increase,risk
Etomidate,Orciprenaline,The risk or severity of hypertension can be increased when Etomidate is combined with Orciprenaline.,increase,risk
Etomidate,Orphenadrine,Etomidate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Etomidate,Oseltamivir,Oseltamivir may decrease the excretion rate of Etomidate which could result in a higher serum level.,decrease,no risk
Etomidate,Oxacillin,Etomidate may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Etomidate,Oxaprozin,The risk or severity of hypertension can be increased when Etomidate is combined with Oxaprozin.,increase,risk
Etomidate,Oxazepam,The risk or severity of CNS depression can be increased when Etomidate is combined with Oxazepam.,increase,risk
Etomidate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Etomidate is combined with Oxcarbazepine.,increase,risk
Etomidate,Oxitriptan,The risk or severity of CNS depression can be increased when Etomidate is combined with Oxitriptan.,increase,risk
Etomidate,Oxprenolol,The therapeutic efficacy of Etomidate can be decreased when used in combination with Oxprenolol.,decrease,no risk
Etomidate,Oxybenzone,Etomidate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Etomidate,Oxybuprocaine,The risk or severity of CNS depression can be increased when Etomidate is combined with Oxybuprocaine.,increase,risk
Etomidate,Oxybutynin,The risk or severity of Tachycardia can be increased when Etomidate is combined with Oxybutynin.,increase,risk
Etomidate,Oxycodone,The risk or severity of CNS depression can be increased when Etomidate is combined with Oxycodone.,increase,risk
Etomidate,Oxymetazoline,The risk or severity of hypertension can be increased when Etomidate is combined with Oxymetazoline.,increase,risk
Etomidate,Oxymorphone,The risk or severity of CNS depression can be increased when Etomidate is combined with Oxymorphone.,increase,risk
Etomidate,Oxyphenbutazone,The risk or severity of hypertension can be increased when Etomidate is combined with Oxyphenbutazone.,increase,risk
Etomidate,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Etomidate is combined with Oxyphencyclimine.,increase,risk
Etomidate,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Etomidate.,increase,risk
Etomidate,Oxyquinoline,Etomidate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Etomidate,Quazepam,The risk or severity of CNS depression can be increased when Etomidate is combined with Quazepam.,increase,risk
Etomidate,Quetiapine,The therapeutic efficacy of Etomidate can be decreased when used in combination with Quetiapine.,decrease,no risk
Etomidate,Quinapril,Etomidate may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Etomidate,Quinethazone,Quinethazone may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etomidate,Quinidine,Etomidate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Etomidate,Quinine,The risk or severity of CNS depression can be increased when Etomidate is combined with Quinine.,increase,risk
Etomidate,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Etomidate.,increase,risk
Etomidate,Umeclidinium,The risk or severity of Tachycardia can be increased when Etomidate is combined with Umeclidinium.,increase,risk
Etomidate,Urethane,The risk or severity of CNS depression can be increased when Etomidate is combined with Urethane.,increase,risk
Etomidate,Vaborbactam,Etomidate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Etomidate,Valaciclovir,Valaciclovir may decrease the excretion rate of Etomidate which could result in a higher serum level.,decrease,no risk
Etomidate,Valbenazine,Etomidate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Etomidate,Valdecoxib,The risk or severity of hypertension can be increased when Etomidate is combined with Valdecoxib.,increase,risk
Etomidate,Valganciclovir,Etomidate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Etomidate,Valproic acid,The risk or severity of CNS depression can be increased when Etomidate is combined with Valproic acid.,increase,risk
Etomidate,Valsartan,Etomidate may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Etomidate,Vancomycin,Etomidate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Etomidate,Varenicline,Etomidate may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Etomidate,Vecuronium,The risk or severity of CNS depression can be increased when Etomidate is combined with Vecuronium.,increase,risk
Etomidate,Venlafaxine,Venlafaxine may increase the tachycardic activities of Etomidate.,increase,no risk
Etomidate,Verapamil,Etomidate may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Etomidate,Vigabatrin,The risk or severity of CNS depression can be increased when Etomidate is combined with Vigabatrin.,increase,risk
Etomidate,Vilanterol,The risk or severity of hypertension can be increased when Etomidate is combined with Vilanterol.,increase,risk
Etomidate,Vilazodone,The risk or severity of CNS depression can be increased when Etomidate is combined with Vilazodone.,increase,risk
Etomidate,Viloxazine,The risk or severity of CNS depression can be increased when Etomidate is combined with Viloxazine.,increase,risk
Etomidate,Vortioxetine,The risk or severity of CNS depression can be increased when Etomidate is combined with Vortioxetine.,increase,risk
Etomidate,Warfarin,Etomidate may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Etomidate,Xamoterol,The risk or severity of hypertension can be increased when Etomidate is combined with Xamoterol.,increase,risk
Etomidate,Xylometazoline,The risk or severity of hypertension can be increased when Etomidate is combined with Xylometazoline.,increase,risk
Etomidate,Yohimbine,The risk or severity of CNS depression can be increased when Etomidate is combined with Yohimbine.,increase,risk
Etomidate,Zaleplon,The risk or severity of CNS depression can be increased when Etomidate is combined with Zaleplon.,increase,risk
Etomidate,Zanamivir,Etomidate may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Etomidate,Ziconotide,The risk or severity of CNS depression can be increased when Etomidate is combined with Ziconotide.,increase,risk
Etomidate,Zimelidine,The risk or severity of adverse effects can be increased when Etomidate is combined with Zimelidine.,increase,risk
Etomidate,Ziprasidone,The risk or severity of adverse effects can be increased when Etomidate is combined with Ziprasidone.,increase,risk
Etomidate,Zofenopril,Etomidate may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Etomidate,Zolmitriptan,The risk or severity of CNS depression can be increased when Etomidate is combined with Zolmitriptan.,increase,risk
Etomidate,Zolpidem,Etomidate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Etomidate,Zonisamide,The risk or severity of CNS depression can be increased when Etomidate is combined with Zonisamide.,increase,risk
Etomidate,Zopiclone,The risk or severity of adverse effects can be increased when Etomidate is combined with Zopiclone.,increase,risk
Etomidate,Zotepine,The risk or severity of CNS depression can be increased when Etomidate is combined with Zotepine.,increase,risk
Etomidate,Zuclopenthixol,The therapeutic efficacy of Etomidate can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Etomidate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Etomidate.,increase,risk
Raltitrexed,Gemcitabine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Gemcitabine.,increase,risk
Raltitrexed,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Raltitrexed.,increase,risk
Raltitrexed,Glatiramer,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Glatiramer.,increase,risk
Raltitrexed,Glucarpidase,The serum concentration of the active metabolites of Raltitrexed can be reduced when Raltitrexed is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
Raltitrexed,Golimumab,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Golimumab.,increase,risk
Raltitrexed,Guselkumab,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Guselkumab.,increase,risk
Raltitrexed,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Raltitrexed.,increase,risk
Raltitrexed,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Raltitrexed.,increase,risk
Raltitrexed,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Raltitrexed.,increase,risk
Raltitrexed,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Hydrocortisone acetate.,increase,risk
Raltitrexed,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Hydrocortisone butyrate.,increase,risk
Raltitrexed,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Hydrocortisone succinate.,increase,risk
Raltitrexed,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Raltitrexed.,increase,risk
Raltitrexed,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Hydroxychloroquine.,increase,risk
Raltitrexed,Hydroxyurea,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Hydroxyurea.,increase,risk
Raltitrexed,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Obinutuzumab,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Obinutuzumab.,increase,risk
Raltitrexed,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Raltitrexed.,increase,no risk
Raltitrexed,Ofatumumab,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Ofatumumab.,increase,risk
Raltitrexed,Olaparib,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Olaparib.,increase,risk
Raltitrexed,Oxaliplatin,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Oxaliplatin.,increase,risk
Raltitrexed,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Raltitrexed is combined with Oxetacaine.,increase,risk
Raltitrexed,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Raltitrexed is combined with Oxybuprocaine.,increase,risk
Raltitrexed,Ozanimod,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Ozanimod.,increase,risk
Raltitrexed,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Raltitrexed.,increase,risk
Raltitrexed,Upadacitinib,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Upadacitinib.,increase,risk
Raltitrexed,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Raltitrexed.,increase,risk
Raltitrexed,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Raltitrexed.,increase,risk
Raltitrexed,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Vedolizumab,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vedolizumab.,increase,risk
Raltitrexed,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Raltitrexed.,decrease,no risk
Raltitrexed,Vilanterol,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vilanterol.,increase,risk
Raltitrexed,Vinblastine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vinblastine.,increase,risk
Raltitrexed,Vincristine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vincristine.,increase,risk
Raltitrexed,Vindesine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vindesine.,increase,risk
Raltitrexed,Vinorelbine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vinorelbine.,increase,risk
Raltitrexed,Voclosporin,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Voclosporin.,increase,risk
Raltitrexed,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Raltitrexed.,increase,risk
Raltitrexed,Vorinostat,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vorinostat.,increase,risk
Raltitrexed,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Raltitrexed.,increase,risk
Raltitrexed,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Raltitrexed.,increase,risk
Raltitrexed,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Raltitrexed.,increase,risk
Raltitrexed,Zidovudine,The risk or severity of adverse effects can be increased when Raltitrexed is combined with Zidovudine.,increase,risk
Etonogestrel,Boceprevir,The serum concentration of Etonogestrel can be increased when it is combined with Boceprevir.,increase,no risk
Etonogestrel,Bosentan,The serum concentration of Etonogestrel can be decreased when it is combined with Bosentan.,decrease,no risk
Etonogestrel,Brexanolone,The metabolism of Etonogestrel can be increased when combined with Brexanolone.,increase,no risk
Etonogestrel,Brivaracetam,The metabolism of Etonogestrel can be increased when combined with Brivaracetam.,increase,no risk
Etonogestrel,Bromazepam,Etonogestrel may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Etonogestrel,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Bromotheophylline,Bromotheophylline may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etonogestrel,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Bumadizone,Bumadizone may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Bumetanide,Bumetanide may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etonogestrel,Bupropion,Etonogestrel may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Etonogestrel,Buspirone,Etonogestrel may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Etonogestrel,Butabarbital,Butabarbital may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Butalbital,The metabolism of Etonogestrel can be increased when combined with Butalbital.,increase,no risk
Etonogestrel,Gabapentin,The metabolism of Etonogestrel can be increased when combined with Gabapentin.,increase,no risk
Etonogestrel,Gabapentin enacarbil,Etonogestrel may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gadobenic acid,Etonogestrel may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gadodiamide,Gadodiamide may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gadofosveset trisodium,Etonogestrel may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gadopentetic acid,Etonogestrel may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gadoteric acid,Etonogestrel may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gadoteridol,Etonogestrel may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Etonogestrel,Ganaxolone,The metabolism of Etonogestrel can be increased when combined with Ganaxolone.,increase,no risk
Etonogestrel,Ganciclovir,Etonogestrel may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gemcitabine,Etonogestrel may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gemfibrozil,Etonogestrel may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gentamicin,Etonogestrel may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gimeracil,Etonogestrel may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Etonogestrel,Givosiran,Givosiran may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Glofitamab,The serum concentration of Etonogestrel can be increased when it is combined with Glofitamab.,increase,no risk
Etonogestrel,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Glycerol phenylbutyrate,The metabolism of Etonogestrel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Etonogestrel,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Golodirsen,Etonogestrel may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Etonogestrel,Goserelin,Goserelin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Griseofulvin,The metabolism of Etonogestrel can be increased when combined with Griseofulvin.,increase,no risk
Etonogestrel,Guanethidine,Etonogestrel may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Guanfacine,Etonogestrel may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Hetacillin,The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Hetacillin.,decrease,no risk
Etonogestrel,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Etonogestrel is combined with Human C1-esterase inhibitor.,increase,risk
Etonogestrel,Hydralazine,Etonogestrel may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etonogestrel,Hydrocortamate,The metabolism of Etonogestrel can be increased when combined with Hydrocortamate.,increase,no risk
Etonogestrel,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etonogestrel,Hydromorphone,Etonogestrel may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Etonogestrel,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Hydroxyethyl Starch,Etonogestrel may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Etonogestrel,Kanamycin,Etonogestrel may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Etonogestrel,Ketamine,Etonogestrel may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Ketazolam,Etonogestrel may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Etonogestrel,Ketoconazole,The metabolism of Etonogestrel can be decreased when combined with Ketoconazole.,decrease,no risk
Etonogestrel,Ketoprofen,Ketoprofen may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Ketorolac,Ketorolac may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Octinoxate,Etonogestrel may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Etonogestrel,Olsalazine,Olsalazine may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Olutasidenib,The metabolism of Etonogestrel can be increased when combined with Olutasidenib.,increase,no risk
Etonogestrel,Omadacycline,The serum concentration of Etonogestrel can be decreased when it is combined with Omadacycline.,decrease,no risk
Etonogestrel,Omaveloxolone,The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Etonogestrel,Opium,Etonogestrel may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oritavancin,The metabolism of Etonogestrel can be increased when combined with Oritavancin.,increase,no risk
Etonogestrel,Oseltamivir,Oseltamivir may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oxacillin,The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Oxacillin.,decrease,no risk
Etonogestrel,Oxaprozin,Oxaprozin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oxazepam,Etonogestrel may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oxcarbazepine,The metabolism of Etonogestrel can be increased when combined with Oxcarbazepine.,increase,no risk
Etonogestrel,Oxybenzone,Etonogestrel may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oxyquinoline,Etonogestrel may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Etonogestrel,Oxytetracycline,The serum concentration of Etonogestrel can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Etonogestrel,Quetiapine,Etonogestrel may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Quinethazone,Quinethazone may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etonogestrel,Quinidine,Etonogestrel may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Ulipristal,The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Ulipristal.,decrease,no risk
Etonogestrel,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Vaborbactam,Etonogestrel may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Etonogestrel,Vadadustat,The serum concentration of Etonogestrel can be increased when it is combined with Vadadustat.,increase,no risk
Etonogestrel,Valaciclovir,Valaciclovir may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Valbenazine,Etonogestrel may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Valdecoxib,Valdecoxib may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Valganciclovir,Etonogestrel may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Etonogestrel,Valproic acid,The metabolism of Etonogestrel can be increased when combined with Valproic acid.,increase,no risk
Etonogestrel,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Etonogestrel.,increase,no risk
Etonogestrel,Vancomycin,Etonogestrel may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Etonogestrel,Varenicline,Etonogestrel may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Etonogestrel,Vemurafenib,The metabolism of Etonogestrel can be increased when combined with Vemurafenib.,increase,no risk
Etonogestrel,Venetoclax,The metabolism of Etonogestrel can be decreased when combined with Venetoclax.,decrease,no risk
Etonogestrel,Venlafaxine,Venlafaxine may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,decrease,no risk
Etonogestrel,Verapamil,The metabolism of Etonogestrel can be decreased when combined with Verapamil.,decrease,no risk
Etonogestrel,Vigabatrin,The metabolism of Etonogestrel can be increased when combined with Vigabatrin.,increase,no risk
Etonogestrel,Vilanterol,Etonogestrel may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Etonogestrel,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Viloxazine,The metabolism of Etonogestrel can be decreased when combined with Viloxazine.,decrease,no risk
Etonogestrel,Vinblastine,The metabolism of Etonogestrel can be increased when combined with Vinblastine.,increase,no risk
Etonogestrel,Vitamin E,The metabolism of Etonogestrel can be increased when combined with Vitamin E.,increase,no risk
Etonogestrel,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Voriconazole,The metabolism of Etonogestrel can be decreased when combined with Voriconazole.,decrease,no risk
Etonogestrel,Vortioxetine,Etonogestrel may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Etonogestrel,Warfarin,Etonogestrel may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Etonogestrel,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Etonogestrel.,decrease,no risk
Etonogestrel,Zaleplon,The metabolism of Etonogestrel can be increased when combined with Zaleplon.,increase,no risk
Etonogestrel,Zanamivir,Etonogestrel may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Etonogestrel,Zimelidine,The metabolism of Etonogestrel can be decreased when combined with Zimelidine.,decrease,no risk
Etonogestrel,Ziprasidone,The metabolism of Etonogestrel can be decreased when combined with Ziprasidone.,decrease,no risk
Morphine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Morphine.,increase,no risk
Morphine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Boceprevir,The metabolism of Morphine can be decreased when combined with Boceprevir.,decrease,no risk
Morphine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Morphine.,increase,no risk
Morphine,Bosentan,Morphine may increase the hypotensive activities of Bosentan.,increase,no risk
Morphine,Bosutinib,The metabolism of Morphine can be decreased when combined with Bosutinib.,decrease,no risk
Morphine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Morphine.,increase,risk
Morphine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Morphine.,increase,risk
Morphine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Morphine.,increase,no risk
Morphine,Bretylium,The risk or severity of adverse effects can be increased when Morphine is combined with Bretylium.,increase,risk
Morphine,Brexanolone,The risk or severity of CNS depression can be increased when Morphine is combined with Brexanolone.,increase,risk
Morphine,Brexpiprazole,The risk or severity of CNS depression can be increased when Morphine is combined with Brexpiprazole.,increase,risk
Morphine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Morphine.,decrease,no risk
Morphine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Morphine.,increase,no risk
Morphine,Brivaracetam,The risk or severity of CNS depression can be increased when Morphine is combined with Brivaracetam.,increase,risk
Morphine,Bromazepam,The risk or severity of adverse effects can be increased when Morphine is combined with Bromazepam.,increase,risk
Morphine,Bromocriptine,The risk or severity of CNS depression can be increased when Morphine is combined with Bromocriptine.,increase,risk
Morphine,Bromotheophylline,The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Bromperidol,The risk or severity of CNS depression can be increased when Morphine is combined with Bromperidol.,increase,risk
Morphine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Morphine.,increase,risk
Morphine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Morphine.,increase,risk
Morphine,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Bupivacaine,The risk or severity of CNS depression can be increased when Morphine is combined with Bupivacaine.,increase,risk
Morphine,Buprenorphine,Morphine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Morphine,Bupropion,The risk or severity of CNS depression can be increased when Morphine is combined with Bupropion.,increase,risk
Morphine,Buspirone,The risk or severity of CNS depression can be increased when Morphine is combined with Buspirone.,increase,risk
Morphine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Morphine.,increase,risk
Morphine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Morphine.,increase,risk
Morphine,Butaperazine,The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Morphine.,increase,risk
Morphine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Morphine.,increase,risk
Morphine,Butorphanol,The therapeutic efficacy of Morphine can be decreased when used in combination with Butorphanol.,decrease,no risk
Morphine,Butriptyline,The risk or severity of CNS depression can be increased when Morphine is combined with Butriptyline.,increase,risk
Morphine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Morphine.,increase,risk
Morphine,Gabapentin,The serum concentration of Gabapentin can be increased when it is combined with Morphine.,increase,no risk
Morphine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Morphine is combined with Gabapentin enacarbil.,increase,risk
Morphine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Morphine.,increase,risk
Morphine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Morphine is combined with Ganaxolone.",increase,risk
Morphine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Morphine.,increase,no risk
Morphine,Gemfibrozil,The metabolism of Morphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Morphine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Morphine.,increase,risk
Morphine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Morphine.,increase,no risk
Morphine,Glasdegib,The serum concentration of Morphine can be increased when it is combined with Glasdegib.,increase,no risk
Morphine,Glecaprevir,The serum concentration of Morphine can be increased when it is combined with Glecaprevir.,increase,no risk
Morphine,Glofitamab,The serum concentration of Morphine can be increased when it is combined with Glofitamab.,increase,no risk
Morphine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Glutethimide,The risk or severity of CNS depression can be increased when Morphine is combined with Glutethimide.,increase,risk
Morphine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Morphine.,increase,risk
Morphine,Golimumab,The metabolism of Morphine can be increased when combined with Golimumab.,increase,no risk
Morphine,Granisetron,The risk or severity of CNS depression can be increased when Morphine is combined with Granisetron.,increase,risk
Morphine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Morphine.,increase,no risk
Morphine,Guanabenz,Morphine may increase the hypotensive activities of Guanabenz.,increase,no risk
Morphine,Guanadrel,Morphine may increase the hypotensive activities of Guanadrel.,increase,no risk
Morphine,Guanethidine,Morphine may increase the hypotensive activities of Guanethidine.,increase,no risk
Morphine,Guanfacine,The risk or severity of CNS depression can be increased when Morphine is combined with Guanfacine.,increase,risk
Morphine,Guanoxan,Morphine may increase the hypotensive activities of Guanoxan.,increase,no risk
Morphine,Halazepam,The risk or severity of adverse effects can be increased when Morphine is combined with Halazepam.,increase,risk
Morphine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Morphine.,decrease,no risk
Morphine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Morphine.,increase,risk
Morphine,Halothane,The therapeutic efficacy of Morphine can be increased when used in combination with Halothane.,increase,no risk
Morphine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Morphine.,increase,risk
Morphine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Morphine.,increase,risk
Morphine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Morphine.,increase,risk
Morphine,Hydralazine,The risk or severity of adverse effects can be increased when Morphine is combined with Hydralazine.,increase,risk
Morphine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Hydrocodone,Morphine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Morphine,Hydrocortisone,The metabolism of Morphine can be increased when combined with Hydrocortisone.,increase,no risk
Morphine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Hydromorphone,The risk or severity of adverse effects can be increased when Morphine is combined with Hydromorphone.,increase,risk
Morphine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Morphine.,decrease,no risk
Morphine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Morphine.,increase,no risk
Morphine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Morphine.,increase,risk
Morphine,Ketamine,The risk or severity of CNS depression can be increased when Morphine is combined with Ketamine.,increase,risk
Morphine,Ketazolam,The risk or severity of adverse effects can be increased when Morphine is combined with Ketazolam.,increase,risk
Morphine,Ketoconazole,The metabolism of Morphine can be decreased when combined with Ketoconazole.,decrease,no risk
Morphine,Ketoprofen,The metabolism of Morphine can be decreased when combined with Ketoprofen.,decrease,no risk
Morphine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Morphine.,decrease,no risk
Morphine,Obinutuzumab,The risk or severity of adverse effects can be increased when Morphine is combined with Obinutuzumab.,increase,risk
Morphine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Morphine.,increase,risk
Morphine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Morphine is combined with Oliceridine.",increase,risk
Morphine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Morphine.,increase,risk
Morphine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Morphine.,decrease,no risk
Morphine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Morphine.,increase,no risk
Morphine,Omaveloxolone,The serum concentration of Morphine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Morphine,Ombitasvir,The metabolism of Morphine can be decreased when combined with Ombitasvir.,decrease,no risk
Morphine,Ondansetron,The risk or severity of CNS depression can be increased when Morphine is combined with Ondansetron.,increase,risk
Morphine,Opicapone,The risk or severity of adverse effects can be increased when Morphine is combined with Opicapone.,increase,risk
Morphine,Opium,The risk or severity of adverse effects can be increased when Morphine is combined with Opium.,increase,risk
Morphine,Orphenadrine,Morphine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Morphine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Morphine.,increase,no risk
Morphine,Oxazepam,The risk or severity of adverse effects can be increased when Morphine is combined with Oxazepam.,increase,risk
Morphine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Morphine is combined with Oxcarbazepine.,increase,risk
Morphine,Oxitriptan,The risk or severity of CNS depression can be increased when Morphine is combined with Oxitriptan.,increase,risk
Morphine,Oxprenolol,The risk or severity of CNS depression can be increased when Morphine is combined with Oxprenolol.,increase,risk
Morphine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Morphine is combined with Oxybuprocaine.,increase,risk
Morphine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Morphine.,increase,risk
Morphine,Oxycodone,The risk or severity of adverse effects can be increased when Morphine is combined with Oxycodone.,increase,risk
Morphine,Oxymorphone,The risk or severity of adverse effects can be increased when Morphine is combined with Oxymorphone.,increase,risk
Morphine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Morphine.,increase,risk
Morphine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Morphine.,decrease,no risk
Morphine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Morphine.,increase,risk
Morphine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Morphine.,decrease,no risk
Ropivacaine,Bacampicillin,The risk or severity of methemoglobinemia can be increased when Bacampicillin is combined with Ropivacaine.,increase,risk
Ropivacaine,Bacitracin,The risk or severity of methemoglobinemia can be increased when Bacitracin is combined with Ropivacaine.,increase,risk
Ropivacaine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.,increase,no risk
Ropivacaine,Balsalazide,Balsalazide may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Baricitinib,Ropivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bedaquiline,The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Ropivacaine.,increase,risk
Ropivacaine,Belinostat,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Ropivacaine.,increase,risk
Ropivacaine,Belzutifan,The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Ropivacaine.,increase,risk
Ropivacaine,Benazepril,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Benazepril.,increase,risk
Ropivacaine,Bendamustine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Ropivacaine.,increase,risk
Ropivacaine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Benorilate,Benorilate may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Benperidol,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Benperidol.,increase,risk
Ropivacaine,Benserazide,Ropivacaine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ropivacaine,Benzatropine,Benzatropine may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Benznidazole,Ropivacaine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ropivacaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Benzocaine.,increase,risk
Ropivacaine,Benzphetamine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Benzphetamine.,increase,risk
Ropivacaine,Benzthiazide,Benzthiazide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Benzydamine,Benzydamine may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Benzyl alcohol.,increase,risk
Ropivacaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Ropivacaine.,increase,risk
Ropivacaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Ropivacaine.,increase,risk
Ropivacaine,Bepotastine,Ropivacaine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bepridil,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bepridil.,increase,risk
Ropivacaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Ropivacaine.,increase,risk
Ropivacaine,Betaxolol,The metabolism of Ropivacaine can be decreased when combined with Betaxolol.,decrease,no risk
Ropivacaine,Bethanidine,Ropivacaine may increase the hypotensive activities of Bethanidine.,increase,no risk
Ropivacaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Ropivacaine.,increase,risk
Ropivacaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Ropivacaine.,increase,risk
Ropivacaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Ropivacaine.,increase,risk
Ropivacaine,Bicisate,Ropivacaine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bimekizumab,The metabolism of Ropivacaine can be increased when combined with Bimekizumab.,increase,no risk
Ropivacaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Bismuth subgallate,Ropivacaine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bisoprolol,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bisoprolol.,increase,risk
Ropivacaine,Bisoxatin,Ropivacaine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Ropivacaine.,increase,risk
Ropivacaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Ropivacaine.,increase,risk
Ropivacaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Ropivacaine.,increase,risk
Ropivacaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Ropivacaine.,increase,risk
Ropivacaine,Bosentan,Ropivacaine may increase the hypotensive activities of Bosentan.,increase,no risk
Ropivacaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ropivacaine.,increase,risk
Ropivacaine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ropivacaine.,increase,risk
Ropivacaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Ropivacaine.,increase,risk
Ropivacaine,Bretylium,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bretylium.,increase,risk
Ropivacaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Ropivacaine.,increase,risk
Ropivacaine,Brexpiprazole,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Brexpiprazole.,increase,risk
Ropivacaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Ropivacaine.,increase,risk
Ropivacaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.,increase,no risk
Ropivacaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Ropivacaine.,increase,risk
Ropivacaine,Bromazepam,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Bromazepam.,increase,risk
Ropivacaine,Bromocriptine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Bromocriptine.,increase,risk
Ropivacaine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Bromperidol,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Bromperidol.,increase,risk
Ropivacaine,Brompheniramine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Brompheniramine.,increase,risk
Ropivacaine,Budesonide,Ropivacaine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bumadizone,Bumadizone may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Bumetanide,Bumetanide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Bupivacaine.,increase,risk
Ropivacaine,Buprenorphine,Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ropivacaine,Bupropion,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Bupropion.,increase,risk
Ropivacaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Ropivacaine.,increase,risk
Ropivacaine,Buspirone,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Buspirone.,increase,risk
Ropivacaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Ropivacaine.,increase,risk
Ropivacaine,Butabarbital,Butabarbital may increase the hypotensive activities of Ropivacaine.,increase,no risk
Ropivacaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Butacaine.,increase,risk
Ropivacaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Ropivacaine.,increase,risk
Ropivacaine,Butamben,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Butamben.,increase,risk
Ropivacaine,Butaperazine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Butaperazine.,increase,risk
Ropivacaine,Butobarbital,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Butobarbital.,increase,risk
Ropivacaine,Butorphanol,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Butorphanol.,increase,risk
Ropivacaine,Butriptyline,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Butriptyline.,increase,risk
Ropivacaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Ropivacaine.,increase,risk
Ropivacaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Gabapentin enacarbil.,increase,risk
Ropivacaine,Gadobenic acid,Ropivacaine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gadodiamide,Gadodiamide may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gadofosveset trisodium,Ropivacaine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gadopentetic acid,Ropivacaine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gadoteric acid,Ropivacaine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gadoteridol,Ropivacaine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Gallamine triethiodide.,increase,risk
Ropivacaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ropivacaine is combined with Ganaxolone.",increase,risk
Ropivacaine,Ganciclovir,Ropivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ropivacaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Ropivacaine.,increase,risk
Ropivacaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Ropivacaine.,increase,risk
Ropivacaine,Gemfibrozil,The metabolism of Ropivacaine can be decreased when combined with Gemfibrozil.,decrease,no risk
Ropivacaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Ropivacaine.,increase,risk
Ropivacaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Ropivacaine.,increase,risk
Ropivacaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Ropivacaine.,increase,risk
Ropivacaine,Gepirone,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Gepirone.,increase,risk
Ropivacaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Gimeracil,Ropivacaine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ropivacaine,Givosiran,The serum concentration of Ropivacaine can be increased when it is combined with Givosiran.,increase,no risk
Ropivacaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Ropivacaine.,increase,risk
Ropivacaine,Glipizide,Ropivacaine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ropivacaine,Glofitamab,The serum concentration of Ropivacaine can be increased when it is combined with Glofitamab.,increase,no risk
Ropivacaine,Glutethimide,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Glutethimide.,increase,risk
Ropivacaine,Glycerol phenylbutyrate,Ropivacaine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ropivacaine,Golimumab,The metabolism of Ropivacaine can be increased when combined with Golimumab.,increase,no risk
Ropivacaine,Golodirsen,Ropivacaine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ropivacaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Ropivacaine.,increase,risk
Ropivacaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Ropivacaine.,increase,risk
Ropivacaine,Granisetron,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Granisetron.,increase,risk
Ropivacaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Ropivacaine.,increase,risk
Ropivacaine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Ropivacaine.,decrease,no risk
Ropivacaine,Guanadrel,Ropivacaine may increase the hypotensive activities of Guanadrel.,increase,no risk
Ropivacaine,Guanethidine,Ropivacaine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Guanfacine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Guanfacine.,increase,risk
Ropivacaine,Guanoxan,Ropivacaine may increase the hypotensive activities of Guanoxan.,increase,no risk
Ropivacaine,Halazepam,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Halazepam.,increase,risk
Ropivacaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Ropivacaine.,increase,risk
Ropivacaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ropivacaine.,increase,risk
Ropivacaine,Halothane,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Halothane.,increase,risk
Ropivacaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Ropivacaine.,increase,risk
Ropivacaine,Hexafluronium,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Hexafluronium.,increase,risk
Ropivacaine,Hydralazine,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Hydralazine.,increase,risk
Ropivacaine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Hydrocodone,Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ropivacaine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Hydromorphone,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Hydromorphone.,increase,risk
Ropivacaine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Ropivacaine.,increase,risk
Ropivacaine,Hydroxyethyl Starch,Ropivacaine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ropivacaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Ropivacaine.,increase,risk
Ropivacaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Ropivacaine.,increase,risk
Ropivacaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.,increase,no risk
Ropivacaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Ropivacaine.,increase,risk
Ropivacaine,Ketamine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Ketamine.,increase,risk
Ropivacaine,Ketazolam,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Ketazolam.,increase,risk
Ropivacaine,Ketoconazole,The metabolism of Ropivacaine can be decreased when combined with Ketoconazole.,decrease,no risk
Ropivacaine,Ketoprofen,Ketoprofen may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Ketorolac,Ketorolac may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Obeticholic acid,The metabolism of Ropivacaine can be decreased when combined with Obeticholic acid.,decrease,no risk
Ropivacaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Ropivacaine.,increase,risk
Ropivacaine,Octinoxate,Ropivacaine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ropivacaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Ropivacaine.,increase,risk
Ropivacaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Ropivacaine.,increase,risk
Ropivacaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Ropivacaine.,increase,risk
Ropivacaine,Olanzapine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Olanzapine.,increase,risk
Ropivacaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Ropivacaine.,increase,risk
Ropivacaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Ropivacaine.,increase,risk
Ropivacaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ropivacaine is combined with Oliceridine.",increase,risk
Ropivacaine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Ropivacaine.,increase,risk
Ropivacaine,Olsalazine,Olsalazine may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Ropivacaine.,increase,risk
Ropivacaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Ropivacaine.,increase,risk
Ropivacaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Ropivacaine.,increase,risk
Ropivacaine,Ondansetron,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Ondansetron.,increase,risk
Ropivacaine,Opicapone,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Opicapone.,increase,risk
Ropivacaine,Opium,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Opium.,increase,risk
Ropivacaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Ropivacaine.,increase,risk
Ropivacaine,Orphenadrine,Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ropivacaine,Oseltamivir,Oseltamivir may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Osilodrostat,The metabolism of Ropivacaine can be decreased when combined with Osilodrostat.,decrease,no risk
Ropivacaine,Osimertinib,The serum concentration of Ropivacaine can be decreased when it is combined with Osimertinib.,decrease,no risk
Ropivacaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Ropivacaine.,increase,risk
Ropivacaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Ropivacaine.,increase,risk
Ropivacaine,Oxaprozin,Oxaprozin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Oxazepam,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Oxazepam.,increase,risk
Ropivacaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Ropivacaine.,increase,risk
Ropivacaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Oxetacaine.,increase,risk
Ropivacaine,Oxitriptan,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Oxitriptan.,increase,risk
Ropivacaine,Oxprenolol,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Oxprenolol.,increase,risk
Ropivacaine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ropivacaine.,decrease,no risk
Ropivacaine,Oxybenzone,Ropivacaine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ropivacaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Oxybuprocaine.,increase,risk
Ropivacaine,Oxycodone,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Oxycodone.,increase,risk
Ropivacaine,Oxymorphone,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Oxymorphone.,increase,risk
Ropivacaine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Oxyquinoline,Ropivacaine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ropivacaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Ropivacaine.,increase,risk
Ropivacaine,Quazepam,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Quazepam.,increase,risk
Ropivacaine,Quetiapine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Quetiapine.,increase,risk
Ropivacaine,Quinapril,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Quinapril.,increase,risk
Ropivacaine,Quinethazone,Quinethazone may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ropivacaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Ropivacaine.,increase,risk
Ropivacaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Ropivacaine.,increase,risk
Ropivacaine,Quinupramine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Quinupramine.,increase,risk
Ropivacaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Ropivacaine.,increase,risk
Ropivacaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Ropivacaine.,increase,risk
Ropivacaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Ropivacaine.,increase,risk
Ropivacaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Ropivacaine.,increase,risk
Ropivacaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Ropivacaine.,increase,risk
Ropivacaine,Vaborbactam,Ropivacaine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ropivacaine,Valaciclovir,Valaciclovir may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Valbenazine,Ropivacaine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Valdecoxib,Valdecoxib may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,decrease,no risk
Ropivacaine,Valganciclovir,Ropivacaine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ropivacaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Ropivacaine.,increase,risk
Ropivacaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Ropivacaine.,increase,risk
Ropivacaine,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Ropivacaine.,increase,risk
Ropivacaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Ropivacaine.,increase,risk
Ropivacaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Ropivacaine.,increase,risk
Ropivacaine,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Ropivacaine.,increase,risk
Ropivacaine,Varenicline,Ropivacaine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ropivacaine,Vecuronium,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Vecuronium.,increase,risk
Ropivacaine,Vemurafenib,The serum concentration of Ropivacaine can be increased when it is combined with Vemurafenib.,increase,no risk
Ropivacaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Ropivacaine.,increase,risk
Ropivacaine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ropivacaine.,increase,risk
Ropivacaine,Verapamil,The metabolism of Verapamil can be decreased when combined with Ropivacaine.,decrease,no risk
Ropivacaine,Vericiguat,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Vericiguat.,increase,risk
Ropivacaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Ropivacaine.,increase,risk
Ropivacaine,Vilanterol,Ropivacaine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ropivacaine,Vilazodone,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Vilazodone.,increase,risk
Ropivacaine,Viloxazine,The metabolism of Ropivacaine can be decreased when combined with Viloxazine.,decrease,no risk
Ropivacaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Ropivacaine.,increase,risk
Ropivacaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Ropivacaine.,increase,risk
Ropivacaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Ropivacaine.,increase,risk
Ropivacaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Ropivacaine.,increase,risk
Ropivacaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Ropivacaine.,increase,risk
Ropivacaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Ropivacaine.,increase,risk
Ropivacaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Ropivacaine.,increase,risk
Ropivacaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Ropivacaine.,increase,risk
Ropivacaine,Vortioxetine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Vortioxetine.,increase,risk
Ropivacaine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ropivacaine.,decrease,no risk
Ropivacaine,Warfarin,Ropivacaine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ropivacaine,Yohimbine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Yohimbine.,increase,risk
Ropivacaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Ropivacaine.,increase,risk
Ropivacaine,Zanamivir,Ropivacaine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ropivacaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Ropivacaine.,increase,risk
Ropivacaine,Ziconotide,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Ziconotide.,increase,risk
Ropivacaine,Zileuton,The metabolism of Ropivacaine can be decreased when combined with Zileuton.,decrease,no risk
Ropivacaine,Zimelidine,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zimelidine.,increase,risk
Ropivacaine,Ziprasidone,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ziprasidone.,increase,risk
Ropivacaine,Zofenopril,Ropivacaine may increase the hypotensive activities of Zofenopril.,increase,no risk
Ropivacaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Zolmitriptan.,increase,risk
Ropivacaine,Zolpidem,Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ropivacaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Ropivacaine.,increase,risk
Ropivacaine,Zopiclone,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zopiclone.,increase,risk
Ropivacaine,Zotepine,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Zotepine.,increase,risk
Ropivacaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Ropivacaine is combined with Zuclopenthixol.,increase,risk
Ropivacaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ropivacaine.,increase,risk
Bupivacaine,Belinostat,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Bupivacaine.,increase,risk
Bupivacaine,Belzutifan,The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Bupivacaine.,increase,risk
Bupivacaine,Benazepril,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Benazepril.,increase,risk
Bupivacaine,Bendamustine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Bupivacaine.,increase,risk
Bupivacaine,Bendroflumethiazide,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Bendroflumethiazide.,increase,risk
Bupivacaine,Benperidol,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Benperidol.,increase,risk
Bupivacaine,Benzatropine,The metabolism of Bupivacaine can be decreased when combined with Benzatropine.,decrease,no risk
Bupivacaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Benzocaine.,increase,risk
Bupivacaine,Benzphetamine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Benzphetamine.,increase,risk
Bupivacaine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Benzyl alcohol.,increase,risk
Bupivacaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Bupivacaine.,increase,risk
Bupivacaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Bupivacaine.,increase,risk
Bupivacaine,Bepridil,The metabolism of Bupivacaine can be decreased when combined with Bepridil.,decrease,no risk
Bupivacaine,Berotralstat,The metabolism of Bupivacaine can be decreased when combined with Berotralstat.,decrease,no risk
Bupivacaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Bupivacaine.,increase,risk
Bupivacaine,Betaxolol,The serum concentration of Bupivacaine can be increased when it is combined with Betaxolol.,increase,no risk
Bupivacaine,Bethanidine,Bupivacaine may increase the hypotensive activities of Bethanidine.,increase,no risk
Bupivacaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Bupivacaine.,increase,risk
Bupivacaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Bupivacaine.,increase,risk
Bupivacaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Bupivacaine.,increase,risk
Bupivacaine,Bimekizumab,The metabolism of Bupivacaine can be increased when combined with Bimekizumab.,increase,no risk
Bupivacaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Biperiden,The metabolism of Bupivacaine can be decreased when combined with Biperiden.,decrease,no risk
Bupivacaine,Bisoprolol,The serum concentration of Bupivacaine can be increased when it is combined with Bisoprolol.,increase,no risk
Bupivacaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Bupivacaine.,increase,risk
Bupivacaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Bupivacaine.,increase,risk
Bupivacaine,Boceprevir,The metabolism of Bupivacaine can be decreased when combined with Boceprevir.,decrease,no risk
Bupivacaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Bupivacaine.,increase,risk
Bupivacaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Bupivacaine.,increase,risk
Bupivacaine,Bosentan,Bupivacaine may increase the hypotensive activities of Bosentan.,increase,no risk
Bupivacaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Bupivacaine.,increase,risk
Bupivacaine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Bupivacaine.,increase,risk
Bupivacaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Bupivacaine.,increase,risk
Bupivacaine,Bretylium,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Bretylium.,increase,risk
Bupivacaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Bupivacaine.,increase,risk
Bupivacaine,Brexpiprazole,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Brexpiprazole.,increase,risk
Bupivacaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Bupivacaine.,increase,risk
Bupivacaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.,increase,no risk
Bupivacaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Bupivacaine.,increase,risk
Bupivacaine,Bromazepam,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Bromazepam.,increase,risk
Bupivacaine,Bromocriptine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Bromocriptine.,increase,risk
Bupivacaine,Bromperidol,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Bromperidol.,increase,risk
Bupivacaine,Brompheniramine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Brompheniramine.,increase,risk
Bupivacaine,Bumetanide,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Bumetanide.,increase,risk
Bupivacaine,Buprenorphine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Bupivacaine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Bupivacaine.,increase,risk
Bupivacaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Bupivacaine.,increase,risk
Bupivacaine,Buspirone,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Buspirone.,increase,risk
Bupivacaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Bupivacaine.,increase,risk
Bupivacaine,Butabarbital,Butabarbital may increase the hypotensive activities of Bupivacaine.,increase,no risk
Bupivacaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Butacaine.,increase,risk
Bupivacaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Bupivacaine.,increase,risk
Bupivacaine,Butamben,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Butamben.,increase,risk
Bupivacaine,Butaperazine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Butaperazine.,increase,risk
Bupivacaine,Butobarbital,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Butobarbital.,increase,risk
Bupivacaine,Butorphanol,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Butorphanol.,increase,risk
Bupivacaine,Butriptyline,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Butriptyline.,increase,risk
Bupivacaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Bupivacaine.,increase,risk
Bupivacaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Gabapentin enacarbil.,increase,risk
Bupivacaine,Galantamine,The metabolism of Galantamine can be decreased when combined with Bupivacaine.,decrease,no risk
Bupivacaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Gallamine triethiodide.,increase,risk
Bupivacaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Bupivacaine is combined with Ganaxolone.",increase,risk
Bupivacaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Bupivacaine.,increase,risk
Bupivacaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Bupivacaine.,increase,risk
Bupivacaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Bupivacaine.,increase,risk
Bupivacaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Bupivacaine.,increase,risk
Bupivacaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Bupivacaine.,increase,risk
Bupivacaine,Gepirone,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Gepirone.,increase,risk
Bupivacaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Givosiran,The serum concentration of Bupivacaine can be increased when it is combined with Givosiran.,increase,no risk
Bupivacaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Bupivacaine.,increase,risk
Bupivacaine,Glofitamab,The serum concentration of Bupivacaine can be increased when it is combined with Glofitamab.,increase,no risk
Bupivacaine,Glutethimide,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Glutethimide.,increase,risk
Bupivacaine,Glycerol phenylbutyrate,The metabolism of Bupivacaine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bupivacaine,Golimumab,The metabolism of Bupivacaine can be increased when combined with Golimumab.,increase,no risk
Bupivacaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Bupivacaine.,increase,risk
Bupivacaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Bupivacaine.,increase,risk
Bupivacaine,Granisetron,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Granisetron.,increase,risk
Bupivacaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Bupivacaine.,increase,risk
Bupivacaine,Guanabenz,Bupivacaine may increase the hypotensive activities of Guanabenz.,increase,no risk
Bupivacaine,Guanadrel,Bupivacaine may increase the hypotensive activities of Guanadrel.,increase,no risk
Bupivacaine,Guanethidine,Bupivacaine may increase the hypotensive activities of Guanethidine.,increase,no risk
Bupivacaine,Guanfacine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Guanfacine.,increase,risk
Bupivacaine,Guanoxan,Bupivacaine may increase the hypotensive activities of Guanoxan.,increase,no risk
Bupivacaine,Halazepam,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Halazepam.,increase,risk
Bupivacaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Bupivacaine.,increase,risk
Bupivacaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Bupivacaine.,increase,risk
Bupivacaine,Halothane,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Halothane.,increase,risk
Bupivacaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Bupivacaine.,increase,risk
Bupivacaine,Hexafluronium,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Hexafluronium.,increase,risk
Bupivacaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Bupivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Bupivacaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Bupivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Bupivacaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Bupivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Bupivacaine,Hydralazine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydralazine.,increase,risk
Bupivacaine,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydrochlorothiazide.,increase,risk
Bupivacaine,Hydrocodone,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Bupivacaine,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydroflumethiazide.,increase,risk
Bupivacaine,Hydromorphone,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Hydromorphone.,increase,risk
Bupivacaine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Bupivacaine.,increase,risk
Bupivacaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Bupivacaine.,increase,risk
Bupivacaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Bupivacaine.,increase,risk
Bupivacaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.,increase,no risk
Bupivacaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Bupivacaine.,increase,risk
Bupivacaine,Ketamine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ketamine.,increase,risk
Bupivacaine,Ketazolam,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ketazolam.,increase,risk
Bupivacaine,Ketoconazole,The metabolism of Bupivacaine can be decreased when combined with Ketoconazole.,decrease,no risk
Bupivacaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Bupivacaine.,increase,risk
Bupivacaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Bupivacaine.,increase,risk
Bupivacaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Bupivacaine.,increase,risk
Bupivacaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Bupivacaine.,increase,risk
Bupivacaine,Olanzapine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Olanzapine.,increase,risk
Bupivacaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Bupivacaine.,increase,risk
Bupivacaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Bupivacaine.,increase,risk
Bupivacaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Bupivacaine is combined with Oliceridine.",increase,risk
Bupivacaine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Bupivacaine.,increase,risk
Bupivacaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Bupivacaine.,increase,risk
Bupivacaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Bupivacaine.,increase,risk
Bupivacaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Bupivacaine.,increase,risk
Bupivacaine,Omaveloxolone,The serum concentration of Bupivacaine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Bupivacaine,Ondansetron,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ondansetron.,increase,risk
Bupivacaine,Opicapone,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Opicapone.,increase,risk
Bupivacaine,Opium,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Opium.,increase,risk
Bupivacaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Bupivacaine.,increase,risk
Bupivacaine,Orphenadrine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Bupivacaine,Osilodrostat,The metabolism of Bupivacaine can be decreased when combined with Osilodrostat.,decrease,no risk
Bupivacaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Ospemifene,The metabolism of Bupivacaine can be decreased when combined with Ospemifene.,decrease,no risk
Bupivacaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Bupivacaine.,increase,risk
Bupivacaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Bupivacaine.,increase,risk
Bupivacaine,Oxamniquine,The metabolism of Bupivacaine can be decreased when combined with Oxamniquine.,decrease,no risk
Bupivacaine,Oxazepam,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Oxazepam.,increase,risk
Bupivacaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Bupivacaine.,increase,risk
Bupivacaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Oxetacaine.,increase,risk
Bupivacaine,Oxitriptan,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Oxitriptan.,increase,risk
Bupivacaine,Oxprenolol,The serum concentration of Bupivacaine can be increased when it is combined with Oxprenolol.,increase,no risk
Bupivacaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Oxybuprocaine.,increase,risk
Bupivacaine,Oxybutynin,The metabolism of Bupivacaine can be decreased when combined with Oxybutynin.,decrease,no risk
Bupivacaine,Oxycodone,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Oxycodone.,increase,risk
Bupivacaine,Oxymorphone,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Oxymorphone.,increase,risk
Bupivacaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Bupivacaine.,increase,risk
Bupivacaine,Quazepam,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Quazepam.,increase,risk
Bupivacaine,Quetiapine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Quetiapine.,increase,risk
Bupivacaine,Quinapril,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Quinapril.,increase,risk
Bupivacaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Bupivacaine.,increase,risk
Bupivacaine,Quinine,The metabolism of Bupivacaine can be decreased when combined with Quinine.,decrease,no risk
Bupivacaine,Quinupramine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Quinupramine.,increase,risk
Bupivacaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Bupivacaine.,increase,risk
Bupivacaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Bupivacaine.,increase,risk
Bupivacaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Bupivacaine.,increase,risk
Bupivacaine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Bupivacaine.,decrease,no risk
Bupivacaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Bupivacaine.,increase,risk
Bupivacaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Bupivacaine.,increase,risk
Bupivacaine,Vadadustat,The serum concentration of Bupivacaine can be increased when it is combined with Vadadustat.,increase,no risk
Bupivacaine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Bupivacaine.,decrease,no risk
Bupivacaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Bupivacaine.,increase,risk
Bupivacaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Bupivacaine.,increase,risk
Bupivacaine,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Bupivacaine.,increase,risk
Bupivacaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Bupivacaine.,increase,risk
Bupivacaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Bupivacaine.,increase,risk
Bupivacaine,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Bupivacaine.,increase,risk
Bupivacaine,Vecuronium,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Vecuronium.,increase,risk
Bupivacaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Bupivacaine.,increase,risk
Bupivacaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Bupivacaine.,increase,risk
Bupivacaine,Venlafaxine,The metabolism of Bupivacaine can be decreased when combined with Venlafaxine.,decrease,no risk
Bupivacaine,Verapamil,The metabolism of Bupivacaine can be decreased when combined with Verapamil.,decrease,no risk
Bupivacaine,Vericiguat,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Vericiguat.,increase,risk
Bupivacaine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Bupivacaine.,decrease,no risk
Bupivacaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Bupivacaine.,increase,risk
Bupivacaine,Vilazodone,The metabolism of Bupivacaine can be decreased when combined with Vilazodone.,decrease,no risk
Bupivacaine,Viloxazine,The metabolism of Bupivacaine can be decreased when combined with Viloxazine.,decrease,no risk
Bupivacaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Bupivacaine.,increase,risk
Bupivacaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Bupivacaine.,increase,risk
Bupivacaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Bupivacaine.,increase,risk
Bupivacaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Bupivacaine.,increase,risk
Bupivacaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Bupivacaine.,increase,risk
Bupivacaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Bupivacaine.,increase,risk
Bupivacaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Bupivacaine.,increase,risk
Bupivacaine,Voriconazole,The metabolism of Bupivacaine can be decreased when combined with Voriconazole.,decrease,no risk
Bupivacaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Bupivacaine.,increase,risk
Bupivacaine,Vortioxetine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Vortioxetine.,increase,risk
Bupivacaine,Yohimbine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Yohimbine.,increase,risk
Bupivacaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Bupivacaine.,increase,risk
Bupivacaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Bupivacaine.,increase,risk
Bupivacaine,Ziconotide,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ziconotide.,increase,risk
Bupivacaine,Zimelidine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zimelidine.,increase,risk
Bupivacaine,Ziprasidone,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Ziprasidone.,increase,risk
Bupivacaine,Zofenopril,Bupivacaine may increase the hypotensive activities of Zofenopril.,increase,no risk
Bupivacaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Zolmitriptan.,increase,risk
Bupivacaine,Zolpidem,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Bupivacaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Bupivacaine.,increase,risk
Bupivacaine,Zopiclone,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zopiclone.,increase,risk
Bupivacaine,Zotepine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Zotepine.,increase,risk
Bupivacaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Zuclopenthixol.,increase,risk
Bupivacaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Bupivacaine.,increase,risk
Dapiprazole,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dapiprazole.,increase,no risk
Dapiprazole,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dapiprazole is combined with Ganaxolone.",increase,risk
Dapiprazole,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dapiprazole.,increase,risk
Dapiprazole,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dapiprazole is combined with Oliceridine.",increase,risk
Dapiprazole,Ziconotide,The risk or severity of CNS depression can be increased when Dapiprazole is combined with Ziconotide.,increase,risk
Dapiprazole,Ziprasidone,The risk or severity of adverse effects can be increased when Dapiprazole is combined with Ziprasidone.,increase,risk
Dapiprazole,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dapiprazole.,increase,risk
Penciclovir,Gatifloxacin,The metabolism of Penciclovir can be decreased when combined with Gatifloxacin.,decrease,no risk
Penciclovir,Gemfibrozil,The metabolism of Penciclovir can be decreased when combined with Gemfibrozil.,decrease,no risk
Penciclovir,Gemifloxacin,The metabolism of Penciclovir can be decreased when combined with Gemifloxacin.,decrease,no risk
Penciclovir,Givosiran,The serum concentration of Penciclovir can be increased when it is combined with Givosiran.,increase,no risk
Penciclovir,Glofitamab,The serum concentration of Penciclovir can be increased when it is combined with Glofitamab.,increase,no risk
Penciclovir,Golimumab,The metabolism of Penciclovir can be increased when combined with Golimumab.,increase,no risk
Penciclovir,Grepafloxacin,The metabolism of Penciclovir can be decreased when combined with Grepafloxacin.,decrease,no risk
Penciclovir,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Penciclovir.,decrease,no risk
Penciclovir,Ketoconazole,The metabolism of Penciclovir can be decreased when combined with Ketoconazole.,decrease,no risk
Penciclovir,Obeticholic acid,The metabolism of Penciclovir can be decreased when combined with Obeticholic acid.,decrease,no risk
Penciclovir,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Orphenadrine,The metabolism of Penciclovir can be decreased when combined with Orphenadrine.,decrease,no risk
Penciclovir,Osilodrostat,The metabolism of Penciclovir can be decreased when combined with Osilodrostat.,decrease,no risk
Penciclovir,Osimertinib,The serum concentration of Penciclovir can be decreased when it is combined with Osimertinib.,decrease,no risk
Penciclovir,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Quinidine,The metabolism of Penciclovir can be decreased when combined with Quinidine.,decrease,no risk
Penciclovir,Quinine,The metabolism of Quinine can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Valproic acid,The metabolism of Penciclovir can be decreased when combined with Valproic acid.,decrease,no risk
Penciclovir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Penciclovir.,decrease,no risk
Penciclovir,Vemurafenib,The serum concentration of Penciclovir can be increased when it is combined with Vemurafenib.,increase,no risk
Penciclovir,Verapamil,The metabolism of Verapamil can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Penciclovir.,decrease,no risk
Penciclovir,Viloxazine,The metabolism of Penciclovir can be decreased when combined with Viloxazine.,decrease,no risk
Penciclovir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Warfarin,The metabolism of Warfarin can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Penciclovir.,decrease,no risk
Penciclovir,Zileuton,The metabolism of Penciclovir can be decreased when combined with Zileuton.,decrease,no risk
Penciclovir,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Penciclovir.,decrease,no risk
Penciclovir,Zotepine,The metabolism of Zotepine can be decreased when combined with Penciclovir.,decrease,no risk
Tenofovir disoproxil,Budesonide,Tenofovir disoproxil may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Bumadizone,Bumadizone may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Bumetanide,Bumetanide may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Bupropion,Tenofovir disoproxil may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Buspirone,Tenofovir disoproxil may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Butabarbital,Tenofovir disoproxil may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gabapentin enacarbil,Tenofovir disoproxil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gadobenic acid,Tenofovir disoproxil may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gadodiamide,Tenofovir disoproxil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gadofosveset trisodium,Tenofovir disoproxil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gadopentetic acid,Tenofovir disoproxil may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gadoteric acid,Tenofovir disoproxil may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Gadoteridol,Tenofovir disoproxil may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Ganciclovir,The excretion of Tenofovir disoproxil can be decreased when combined with Ganciclovir.,decrease,no risk
Tenofovir disoproxil,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Gemfibrozil,The excretion of Tenofovir disoproxil can be decreased when combined with Gemfibrozil.,decrease,no risk
Tenofovir disoproxil,Gentamicin,Gentamicin may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Gimeracil,Tenofovir disoproxil may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Givosiran,Givosiran may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Glasdegib,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Glasdegib.,increase,no risk
Tenofovir disoproxil,Glecaprevir,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Glecaprevir.,increase,no risk
Tenofovir disoproxil,Glipizide,Tenofovir disoproxil may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Glyburide,The excretion of Tenofovir disoproxil can be decreased when combined with Glyburide.,decrease,no risk
Tenofovir disoproxil,Glycerol phenylbutyrate,Tenofovir disoproxil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Glycol salicylate,Glycol salicylate may decrease the excretion rate of Tenofovir disoproxil which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Golodirsen,Tenofovir disoproxil may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Goserelin,Tenofovir disoproxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Guanethidine,Tenofovir disoproxil may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Guanfacine,Tenofovir disoproxil may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Guanidine,The excretion of Tenofovir disoproxil can be decreased when combined with Guanidine.,decrease,no risk
Tenofovir disoproxil,Haloperidol,Tenofovir disoproxil may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Tenofovir disoproxil.,decrease,no risk
Tenofovir disoproxil,Hydralazine,Tenofovir disoproxil may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Hydrochlorothiazide,Hydrochlorothiazide may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tenofovir disoproxil,Hydromorphone,Tenofovir disoproxil may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Hydroxocobalamin,Tenofovir disoproxil may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Hydroxyethyl Starch,Tenofovir disoproxil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Kanamycin,Kanamycin may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Ketamine,Tenofovir disoproxil may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Ketazolam,Tenofovir disoproxil may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Ketoconazole,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ketoconazole.,increase,no risk
Tenofovir disoproxil,Ketoprofen,Ketoprofen may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Ketorolac,Ketorolac may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Octinoxate,Tenofovir disoproxil may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Ofloxacin,The excretion of Tenofovir disoproxil can be decreased when combined with Ofloxacin.,decrease,no risk
Tenofovir disoproxil,Olsalazine,The risk or severity of nephrotoxicity can be increased when Tenofovir disoproxil is combined with Olsalazine.,increase,risk
Tenofovir disoproxil,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Opium,Tenofovir disoproxil may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Oseltamivir,Tenofovir disoproxil may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Ouabain,The excretion of Tenofovir disoproxil can be decreased when combined with Ouabain.,decrease,no risk
Tenofovir disoproxil,Oxacillin,Tenofovir disoproxil may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Tenofovir disoproxil.,increase,risk
Tenofovir disoproxil,Oxaprozin,Oxaprozin may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Oxazepam,Tenofovir disoproxil may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Oxcarbazepine,The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Tenofovir disoproxil,Oxybenzone,Tenofovir disoproxil may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Oxyphenbutazone,Oxyphenbutazone may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Oxyquinoline,Tenofovir disoproxil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Oxytetracycline,The excretion of Tenofovir disoproxil can be decreased when combined with Oxytetracycline.,decrease,no risk
Tenofovir disoproxil,Quetiapine,Tenofovir disoproxil may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Quinethazone,Quinethazone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tenofovir disoproxil,Quinidine,Tenofovir disoproxil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Quinine,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Quinine.,increase,no risk
Tenofovir disoproxil,Quizartinib,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Quizartinib.,increase,no risk
Tenofovir disoproxil,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Umbralisib,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Umbralisib.,increase,no risk
Tenofovir disoproxil,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Vaborbactam,Tenofovir disoproxil may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Vadadustat,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vadadustat.,increase,no risk
Tenofovir disoproxil,Valaciclovir,Valaciclovir may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Valbenazine,Tenofovir disoproxil may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Valdecoxib,Valdecoxib may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Valganciclovir,Tenofovir disoproxil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Valproic acid,The excretion of Tenofovir disoproxil can be decreased when combined with Valproic acid.,decrease,no risk
Tenofovir disoproxil,Vancomycin,Vancomycin may increase the nephrotoxic activities of Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Vandetanib,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vandetanib.,increase,no risk
Tenofovir disoproxil,Vardenafil,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vardenafil.,increase,no risk
Tenofovir disoproxil,Varenicline,Tenofovir disoproxil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Tenofovir disoproxil.,decrease,no risk
Tenofovir disoproxil,Velpatasvir,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Velpatasvir.,increase,no risk
Tenofovir disoproxil,Vemurafenib,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vemurafenib.,increase,no risk
Tenofovir disoproxil,Venetoclax,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Venetoclax.,increase,no risk
Tenofovir disoproxil,Venlafaxine,Tenofovir disoproxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Verapamil,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Verapamil.,increase,no risk
Tenofovir disoproxil,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tenofovir disoproxil.,decrease,no risk
Tenofovir disoproxil,Vilanterol,Tenofovir disoproxil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Viloxazine,Tenofovir disoproxil may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Tenofovir disoproxil.,increase,no risk
Tenofovir disoproxil,Voclosporin,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Voclosporin.,increase,no risk
Tenofovir disoproxil,Vorapaxar,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vorapaxar.,increase,no risk
Tenofovir disoproxil,Vortioxetine,Tenofovir disoproxil may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Voxilaprevir,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Voxilaprevir.,increase,no risk
Tenofovir disoproxil,Warfarin,Tenofovir disoproxil may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Tenofovir disoproxil.,decrease,no risk
Tenofovir disoproxil,Zaleplon,Tenofovir disoproxil may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Zanamivir,Tenofovir disoproxil may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Tenofovir disoproxil,Zidovudine,The excretion of Tenofovir disoproxil can be decreased when combined with Zidovudine.,decrease,no risk
Tenofovir disoproxil,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Zoledronic acid.,increase,risk
Tenofovir disoproxil,Zonisamide,The serum concentration of Tenofovir disoproxil can be increased when it is combined with Zonisamide.,increase,no risk
Flucloxacillin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Flucloxacillin.,increase,no risk
Flucloxacillin,Gatifloxacin,The serum concentration of Gatifloxacin can be increased when it is combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Gemifloxacin,The serum concentration of Gemifloxacin can be increased when it is combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Gentamicin,The serum concentration of Gentamicin can be decreased when it is combined with Flucloxacillin.,decrease,no risk
Flucloxacillin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Glimepiride,Glimepiride may decrease the excretion rate of Flucloxacillin which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Glipizide,Flucloxacillin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Glyburide,Glyburide may decrease the excretion rate of Flucloxacillin which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Glycyrrhizic acid,Flucloxacillin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Kanamycin,The serum concentration of Kanamycin can be decreased when it is combined with Flucloxacillin.,decrease,no risk
Flucloxacillin,Ketoconazole,Ketoconazole may decrease the excretion rate of Flucloxacillin which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Ofloxacin,Flucloxacillin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Olaparib,The metabolism of Olaparib can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Flucloxacillin.,decrease,no risk
Flucloxacillin,Olmesartan,Olmesartan may decrease the excretion rate of Flucloxacillin which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Omadacycline,The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Omadacycline.,decrease,no risk
Flucloxacillin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Flucloxacillin is combined with Oxetacaine.,increase,risk
Flucloxacillin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Flucloxacillin is combined with Oxybuprocaine.,increase,risk
Flucloxacillin,Oxytetracycline,The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Oxytetracycline.,decrease,no risk
Flucloxacillin,Quinidine,The metabolism of Quinidine can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Flucloxacillin which could result in a higher serum level.,decrease,no risk
Flucloxacillin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Flucloxacillin.,increase,no risk
Flucloxacillin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Flucloxacillin.,decrease,no risk
Flucloxacillin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vincristine,The metabolism of Vincristine can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vindesine,The metabolism of Vindesine can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Warfarin,The metabolism of Warfarin can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Flucloxacillin.,increase,no risk
Flucloxacillin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Flucloxacillin.,decrease,no risk
Tranexamic acid,Beroctocog alfa,Tranexamic acid may increase the thrombogenic activities of Beroctocog alfa.,increase,no risk
Tranexamic acid,Gestrinone,Gestrinone may increase the thrombogenic activities of Tranexamic acid.,increase,no risk
Tranexamic acid,Hydrogen peroxide,Tranexamic acid may increase the thrombogenic activities of Hydrogen peroxide.,increase,no risk
Tranexamic acid,Hydroxyprogesterone caproate,Hydroxyprogesterone caproate may increase the thrombogenic activities of Tranexamic acid.,increase,no risk
Tranexamic acid,Ulipristal,Ulipristal may increase the thrombogenic activities of Tranexamic acid.,increase,no risk
Tranexamic acid,Urokinase,The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Urokinase.,decrease,no risk
Tranexamic acid,Von Willebrand factor human,Tranexamic acid may increase the thrombogenic activities of Von Willebrand factor human.,increase,no risk
Ertapenem,Gabapentin enacarbil,Ertapenem may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ertapenem,Gadobenic acid,Ertapenem may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ertapenem,Gadodiamide,Gadodiamide may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Gadofosveset trisodium,Ertapenem may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ertapenem,Gadopentetic acid,Ertapenem may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ertapenem,Gadoteric acid,Ertapenem may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ertapenem,Gadoteridol,Ertapenem may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ertapenem,Ganciclovir,Ertapenem may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ertapenem,Gemcitabine,Ertapenem may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ertapenem,Gemfibrozil,Ertapenem may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ertapenem,Gentamicin,Ertapenem may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ertapenem,Gimeracil,Ertapenem may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ertapenem,Givosiran,Givosiran may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Glipizide,Ertapenem may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ertapenem,Glycerol phenylbutyrate,Ertapenem may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ertapenem,Golodirsen,Ertapenem may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ertapenem,Goserelin,Goserelin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Guanethidine,Ertapenem may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ertapenem,Guanfacine,Ertapenem may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ertapenem,Haloperidol,Ertapenem may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ertapenem,Hydralazine,Ertapenem may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ertapenem,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ertapenem,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ertapenem,Hydromorphone,Ertapenem may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ertapenem,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Hydroxyethyl Starch,Ertapenem may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ertapenem,Kanamycin,Ertapenem may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ertapenem,Ketamine,Ertapenem may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ertapenem,Ketazolam,Ertapenem may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ertapenem,Ketoprofen,Ketoprofen may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Ketorolac,Ketorolac may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Octinoxate,Ertapenem may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ertapenem,Olsalazine,Olsalazine may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Opium,Ertapenem may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ertapenem,Oseltamivir,Oseltamivir may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Oxacillin,Ertapenem may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ertapenem,Oxaprozin,Oxaprozin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Oxazepam,Ertapenem may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ertapenem,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ertapenem is combined with Oxetacaine.,increase,risk
Ertapenem,Oxybenzone,Ertapenem may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ertapenem,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ertapenem is combined with Oxybuprocaine.,increase,risk
Ertapenem,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Oxyquinoline,Ertapenem may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ertapenem,Quetiapine,Ertapenem may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ertapenem,Quinethazone,Quinethazone may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ertapenem,Quinidine,Ertapenem may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ertapenem,Vaborbactam,Ertapenem may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ertapenem,Valaciclovir,Valaciclovir may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Valbenazine,Ertapenem may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ertapenem,Valdecoxib,Valdecoxib may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Valganciclovir,Ertapenem may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ertapenem,Valproic acid,The serum concentration of Valproic acid can be decreased when it is combined with Ertapenem.,decrease,no risk
Ertapenem,Vancomycin,Ertapenem may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ertapenem,Varenicline,Ertapenem may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ertapenem,Venlafaxine,Venlafaxine may decrease the excretion rate of Ertapenem which could result in a higher serum level.,decrease,no risk
Ertapenem,Verapamil,Ertapenem may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ertapenem,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ertapenem.,decrease,no risk
Ertapenem,Vilanterol,Ertapenem may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ertapenem,Viloxazine,Ertapenem may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ertapenem,Vortioxetine,Ertapenem may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ertapenem,Warfarin,Ertapenem may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ertapenem,Zaleplon,Ertapenem may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ertapenem,Zanamivir,Ertapenem may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ertapenem,Zonisamide,Zonisamide may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desogestrel,Gabapentin,The metabolism of Desogestrel can be increased when combined with Gabapentin.,increase,no risk
Desogestrel,Ganaxolone,The metabolism of Desogestrel can be increased when combined with Ganaxolone.,increase,no risk
Desogestrel,Gemfibrozil,The metabolism of Desogestrel can be decreased when combined with Gemfibrozil.,decrease,no risk
Desogestrel,Ginkgo biloba,The metabolism of Desogestrel can be decreased when combined with Ginkgo biloba.,decrease,no risk
Desogestrel,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Glofitamab,The serum concentration of Desogestrel can be increased when it is combined with Glofitamab.,increase,no risk
Desogestrel,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Glycerol phenylbutyrate,The metabolism of Desogestrel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Desogestrel,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Golimumab,The metabolism of Desogestrel can be increased when combined with Golimumab.,increase,no risk
Desogestrel,Griseofulvin,The metabolism of Desogestrel can be increased when combined with Griseofulvin.,increase,no risk
Desogestrel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Halothane,The metabolism of Halothane can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Heparin,The risk or severity of adverse effects can be increased when Desogestrel is combined with Heparin.,increase,risk
Desogestrel,Hetacillin,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Hetacillin.,decrease,no risk
Desogestrel,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Desogestrel is combined with Human C1-esterase inhibitor.,increase,risk
Desogestrel,Hydrocortamate,The metabolism of Desogestrel can be increased when combined with Hydrocortamate.,increase,no risk
Desogestrel,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Ketamine,The metabolism of Ketamine can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Ketoconazole,The metabolism of Desogestrel can be decreased when combined with Ketoconazole.,decrease,no risk
Desogestrel,Ketoprofen,The metabolism of Ketoprofen can be increased when combined with Desogestrel.,increase,no risk
Desogestrel,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Octreotide,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Octreotide.,decrease,no risk
Desogestrel,Olanzapine,The metabolism of Desogestrel can be decreased when combined with Olanzapine.,decrease,no risk
Desogestrel,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Olutasidenib,The metabolism of Desogestrel can be increased when combined with Olutasidenib.,increase,no risk
Desogestrel,Omadacycline,The serum concentration of Desogestrel can be decreased when it is combined with Omadacycline.,decrease,no risk
Desogestrel,Omaveloxolone,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Desogestrel,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Oritavancin,The metabolism of Desogestrel can be increased when combined with Oritavancin.,increase,no risk
Desogestrel,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Ox bile extract,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Oxacillin,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Oxacillin.,decrease,no risk
Desogestrel,Oxandrolone,The metabolism of Desogestrel can be decreased when combined with Oxandrolone.,decrease,no risk
Desogestrel,Oxcarbazepine,The metabolism of Desogestrel can be increased when combined with Oxcarbazepine.,increase,no risk
Desogestrel,Oxytetracycline,The serum concentration of Desogestrel can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Desogestrel,Quinidine,The metabolism of Desogestrel can be decreased when combined with Quinidine.,decrease,no risk
Desogestrel,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Ulipristal,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Ulipristal.,decrease,no risk
Desogestrel,Urokinase,The risk or severity of adverse effects can be increased when Desogestrel is combined with Urokinase.,increase,risk
Desogestrel,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Vadadustat,The serum concentration of Desogestrel can be increased when it is combined with Vadadustat.,increase,no risk
Desogestrel,Valdecoxib,The metabolism of Desogestrel can be decreased when combined with Valdecoxib.,decrease,no risk
Desogestrel,Valproic acid,The metabolism of Desogestrel can be increased when combined with Valproic acid.,increase,no risk
Desogestrel,Valsartan,The metabolism of Desogestrel can be decreased when combined with Valsartan.,decrease,no risk
Desogestrel,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Desogestrel.,increase,no risk
Desogestrel,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Vemurafenib,The metabolism of Desogestrel can be increased when combined with Vemurafenib.,increase,no risk
Desogestrel,Venetoclax,The metabolism of Desogestrel can be decreased when combined with Venetoclax.,decrease,no risk
Desogestrel,Verapamil,The metabolism of Desogestrel can be decreased when combined with Verapamil.,decrease,no risk
Desogestrel,Vigabatrin,The metabolism of Desogestrel can be increased when combined with Vigabatrin.,increase,no risk
Desogestrel,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Desogestrel.,decrease,no risk
Desogestrel,Viloxazine,The metabolism of Desogestrel can be decreased when combined with Viloxazine.,decrease,no risk
Desogestrel,Vinblastine,The metabolism of Desogestrel can be increased when combined with Vinblastine.,increase,no risk
Desogestrel,Vitamin A,The therapeutic efficacy of Desogestrel can be decreased when used in combination with Vitamin A.,decrease,no risk
Desogestrel,Vitamin E,The metabolism of Desogestrel can be increased when combined with Vitamin E.,increase,no risk
Desogestrel,Vorapaxar,The risk or severity of adverse effects can be increased when Desogestrel is combined with Vorapaxar.,increase,risk
Desogestrel,Voriconazole,The metabolism of Desogestrel can be decreased when combined with Voriconazole.,decrease,no risk
Desogestrel,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Warfarin,The risk or severity of adverse effects can be increased when Desogestrel is combined with Warfarin.,increase,risk
Desogestrel,Ximelagatran,The risk or severity of adverse effects can be increased when Desogestrel is combined with Ximelagatran.,increase,risk
Desogestrel,Zafirlukast,The metabolism of Desogestrel can be decreased when combined with Zafirlukast.,decrease,no risk
Desogestrel,Zaleplon,The metabolism of Desogestrel can be increased when combined with Zaleplon.,increase,no risk
Desogestrel,Zidovudine,The metabolism of Zidovudine can be increased when combined with Desogestrel.,increase,no risk
Desogestrel,Zileuton,The metabolism of Zileuton can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Zimelidine,The metabolism of Desogestrel can be decreased when combined with Zimelidine.,decrease,no risk
Desogestrel,Ziprasidone,The metabolism of Desogestrel can be decreased when combined with Ziprasidone.,decrease,no risk
Desogestrel,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Desogestrel.,decrease,no risk
Desogestrel,Zonisamide,The metabolism of Desogestrel can be increased when combined with Zonisamide.,increase,no risk
Mitomycin,Gemcitabine,The risk or severity of adverse effects can be increased when Mitomycin is combined with Gemcitabine.,increase,risk
Mitomycin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mitomycin.,increase,risk
Mitomycin,Glatiramer,The risk or severity of adverse effects can be increased when Mitomycin is combined with Glatiramer.,increase,risk
Mitomycin,Golimumab,The risk or severity of adverse effects can be increased when Mitomycin is combined with Golimumab.,increase,risk
Mitomycin,Guselkumab,The risk or severity of adverse effects can be increased when Mitomycin is combined with Guselkumab.,increase,risk
Mitomycin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Mitomycin.,increase,risk
Mitomycin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Mitomycin.,increase,risk
Mitomycin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Mitomycin.,increase,risk
Mitomycin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Mitomycin is combined with Hydrocortisone acetate.,increase,risk
Mitomycin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Mitomycin is combined with Hydrocortisone butyrate.,increase,risk
Mitomycin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Mitomycin is combined with Hydrocortisone succinate.,increase,risk
Mitomycin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Mitomycin.,increase,risk
Mitomycin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Mitomycin is combined with Hydroxychloroquine.,increase,risk
Mitomycin,Hydroxyurea,The risk or severity of adverse effects can be increased when Mitomycin is combined with Hydroxyurea.,increase,risk
Mitomycin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Obinutuzumab,The risk or severity of adverse effects can be increased when Mitomycin is combined with Obinutuzumab.,increase,risk
Mitomycin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Mitomycin.,increase,no risk
Mitomycin,Ofatumumab,The risk or severity of adverse effects can be increased when Mitomycin is combined with Ofatumumab.,increase,risk
Mitomycin,Olaparib,The risk or severity of adverse effects can be increased when Mitomycin is combined with Olaparib.,increase,risk
Mitomycin,Ouabain,Ouabain may decrease the cardiotoxic activities of Mitomycin.,decrease,no risk
Mitomycin,Oxaliplatin,The risk or severity of adverse effects can be increased when Mitomycin is combined with Oxaliplatin.,increase,risk
Mitomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mitomycin is combined with Oxetacaine.,increase,risk
Mitomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mitomycin is combined with Oxybuprocaine.,increase,risk
Mitomycin,Ozanimod,The risk or severity of adverse effects can be increased when Mitomycin is combined with Ozanimod.,increase,risk
Mitomycin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Mitomycin.,increase,risk
Mitomycin,Upadacitinib,The risk or severity of adverse effects can be increased when Mitomycin is combined with Upadacitinib.,increase,risk
Mitomycin,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Mitomycin.,increase,risk
Mitomycin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Mitomycin.,increase,risk
Mitomycin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Vedolizumab,The risk or severity of adverse effects can be increased when Mitomycin is combined with Vedolizumab.,increase,risk
Mitomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mitomycin.,decrease,no risk
Mitomycin,Vilanterol,The risk or severity of adverse effects can be increased when Mitomycin is combined with Vilanterol.,increase,risk
Mitomycin,Vinblastine,"The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vinblastine is combined with Mitomycin.",increase,risk
Mitomycin,Vincristine,"The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vincristine is combined with Mitomycin.",increase,risk
Mitomycin,Vindesine,"The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vindesine is combined with Mitomycin.",increase,risk
Mitomycin,Vinflunine,"The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vinflunine is combined with Mitomycin.",increase,risk
Mitomycin,Vinorelbine,"The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vinorelbine is combined with Mitomycin.",increase,risk
Mitomycin,Voclosporin,The risk or severity of adverse effects can be increased when Mitomycin is combined with Voclosporin.,increase,risk
Mitomycin,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Mitomycin.,increase,risk
Mitomycin,Vorinostat,The risk or severity of adverse effects can be increased when Mitomycin is combined with Vorinostat.,increase,risk
Mitomycin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Mitomycin.,increase,risk
Mitomycin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Mitomycin.,increase,risk
Mitomycin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Mitomycin.,increase,risk
Mitomycin,Zidovudine,The risk or severity of adverse effects can be increased when Mitomycin is combined with Zidovudine.,increase,risk
Bexarotene,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Bimekizumab,The metabolism of Bexarotene can be increased when combined with Bimekizumab.,increase,no risk
Bexarotene,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bexarotene.,increase,risk
Bexarotene,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Bexarotene.,increase,risk
Bexarotene,Blinatumomab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Blinatumomab.,increase,risk
Bexarotene,Boceprevir,The metabolism of Bexarotene can be decreased when combined with Boceprevir.,decrease,no risk
Bexarotene,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Bexarotene.",decrease,no risk
Bexarotene,Bortezomib,The metabolism of Bortezomib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Bosentan,The metabolism of Bexarotene can be increased when combined with Bosentan.,increase,no risk
Bexarotene,Bosutinib,The metabolism of Bosutinib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Brigatinib,The metabolism of Brigatinib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Brodalumab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Brodalumab.,increase,risk
Bexarotene,Budesonide,The risk or severity of adverse effects can be increased when Bexarotene is combined with Budesonide.,increase,risk
Bexarotene,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Bupivacaine.,increase,risk
Bexarotene,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Bupropion,The metabolism of Bupropion can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Busulfan,The metabolism of Busulfan can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Butacaine,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Butacaine.,increase,risk
Bexarotene,Butamben,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Butamben.,increase,risk
Bexarotene,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Gemcitabine,The risk or severity of adverse effects can be increased when Bexarotene is combined with Gemcitabine.,increase,risk
Bexarotene,Gemfibrozil,The metabolism of Bexarotene can be decreased when combined with Gemfibrozil.,decrease,no risk
Bexarotene,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bexarotene.,increase,risk
Bexarotene,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Ginkgo biloba,The metabolism of Bexarotene can be decreased when combined with Ginkgo biloba.,decrease,no risk
Bexarotene,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Glatiramer,The risk or severity of adverse effects can be increased when Bexarotene is combined with Glatiramer.,increase,risk
Bexarotene,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Glimepiride,The metabolism of Bexarotene can be decreased when combined with Glimepiride.,decrease,no risk
Bexarotene,Glipizide,The metabolism of Glipizide can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Glofitamab,The serum concentration of Bexarotene can be increased when it is combined with Glofitamab.,increase,no risk
Bexarotene,Glyburide,The metabolism of Bexarotene can be decreased when combined with Glyburide.,decrease,no risk
Bexarotene,Golimumab,The metabolism of Bexarotene can be increased when combined with Golimumab.,increase,no risk
Bexarotene,Guselkumab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Guselkumab.,increase,risk
Bexarotene,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Bexarotene.,increase,no risk
Bexarotene,Halothane,The metabolism of Halothane can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Bexarotene.,increase,risk
Bexarotene,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Bexarotene.,increase,risk
Bexarotene,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Bexarotene.,increase,risk
Bexarotene,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Bexarotene is combined with Hydrocortisone acetate.,increase,risk
Bexarotene,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Bexarotene is combined with Hydrocortisone butyrate.,increase,risk
Bexarotene,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Bexarotene is combined with Hydrocortisone succinate.,increase,risk
Bexarotene,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Bexarotene.,increase,risk
Bexarotene,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Bexarotene is combined with Hydroxychloroquine.,increase,risk
Bexarotene,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Hydroxyurea,The risk or severity of adverse effects can be increased when Bexarotene is combined with Hydroxyurea.,increase,risk
Bexarotene,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Ketamine,The metabolism of Ketamine can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Ketoconazole,The metabolism of Bexarotene can be decreased when combined with Ketoconazole.,decrease,no risk
Bexarotene,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Obinutuzumab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Obinutuzumab.,increase,risk
Bexarotene,Ocrelizumab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Ocrelizumab.,increase,risk
Bexarotene,Ofatumumab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Ofatumumab.,increase,risk
Bexarotene,Olanzapine,The metabolism of Bexarotene can be decreased when combined with Olanzapine.,decrease,no risk
Bexarotene,Olaparib,The metabolism of Olaparib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Bexarotene.,decrease,no risk
Bexarotene,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Bexarotene is combined with Omadacycline.,increase,risk
Bexarotene,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Oritavancin,The metabolism of Bexarotene can be decreased when combined with Oritavancin.,decrease,no risk
Bexarotene,Osimertinib,The metabolism of Osimertinib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Oxaliplatin,The risk or severity of adverse effects can be increased when Bexarotene is combined with Oxaliplatin.,increase,risk
Bexarotene,Oxandrolone,The metabolism of Bexarotene can be decreased when combined with Oxandrolone.,decrease,no risk
Bexarotene,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Oxetacaine.,increase,risk
Bexarotene,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Oxybuprocaine.,increase,risk
Bexarotene,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Bexarotene is combined with Oxytetracycline.,increase,risk
Bexarotene,Ozanimod,The risk or severity of adverse effects can be increased when Bexarotene is combined with Ozanimod.,increase,risk
Bexarotene,Quinidine,The metabolism of Quinidine can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Quinine,The metabolism of Quinine can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Bexarotene.,increase,risk
Bexarotene,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Bexarotene.,decrease,no risk
Bexarotene,Ulipristal,The metabolism of Ulipristal can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Upadacitinib,The risk or severity of adverse effects can be increased when Bexarotene is combined with Upadacitinib.,increase,risk
Bexarotene,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Bexarotene.,increase,risk
Bexarotene,Vadadustat,The serum concentration of Bexarotene can be increased when it is combined with Vadadustat.,increase,no risk
Bexarotene,Valdecoxib,The metabolism of Bexarotene can be decreased when combined with Valdecoxib.,decrease,no risk
Bexarotene,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Bexarotene.,increase,no risk
Bexarotene,Valsartan,The metabolism of Bexarotene can be decreased when combined with Valsartan.,decrease,no risk
Bexarotene,Vandetanib,The metabolism of Vandetanib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Bexarotene.,increase,risk
Bexarotene,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Vedolizumab,The risk or severity of adverse effects can be increased when Bexarotene is combined with Vedolizumab.,increase,risk
Bexarotene,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Venetoclax,The metabolism of Venetoclax can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Verapamil,The metabolism of Bexarotene can be decreased when combined with Verapamil.,decrease,no risk
Bexarotene,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Bexarotene.,decrease,no risk
Bexarotene,Vilanterol,The risk or severity of adverse effects can be increased when Bexarotene is combined with Vilanterol.,increase,risk
Bexarotene,Viloxazine,The metabolism of Bexarotene can be decreased when combined with Viloxazine.,decrease,no risk
Bexarotene,Vinblastine,The metabolism of Vinblastine can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vincristine,The metabolism of Vincristine can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vindesine,The metabolism of Vindesine can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vinflunine,The metabolism of Vinflunine can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Bexarotene.,increase,risk
Bexarotene,Voclosporin,The metabolism of Voclosporin can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Voriconazole,The metabolism of Bexarotene can be decreased when combined with Voriconazole.,decrease,no risk
Bexarotene,Vorinostat,The risk or severity of adverse effects can be increased when Bexarotene is combined with Vorinostat.,increase,risk
Bexarotene,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Bexarotene.,decrease,no risk
Bexarotene,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Warfarin,The metabolism of Warfarin can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Bexarotene.,increase,risk
Bexarotene,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Bexarotene.,increase,risk
Bexarotene,Zafirlukast,The metabolism of Bexarotene can be decreased when combined with Zafirlukast.,decrease,no risk
Bexarotene,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Zidovudine,The risk or severity of adverse effects can be increased when Bexarotene is combined with Zidovudine.,increase,risk
Bexarotene,Zileuton,The metabolism of Zileuton can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Zimelidine,The metabolism of Bexarotene can be decreased when combined with Zimelidine.,decrease,no risk
Bexarotene,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Bexarotene.,decrease,no risk
Bexarotene,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Bexarotene.,increase,no risk
Bexarotene,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Bexarotene.,decrease,no risk
Ibutilide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ibutilide.,increase,risk
Ibutilide,Budesonide,Ibutilide may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Ibutilide,Bumadizone,Bumadizone may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Bumetanide,Bumetanide may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ibutilide,Bupropion,Ibutilide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Ibutilide,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ibutilide.,increase,risk
Ibutilide,Buspirone,Ibutilide may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Ibutilide,Butabarbital,Butabarbital may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Ibutilide.,increase,risk
Ibutilide,Gabapentin enacarbil,Ibutilide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ibutilide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Ibutilide.,increase,risk
Ibutilide,Gadodiamide,Gadodiamide may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Gadofosveset trisodium,Ibutilide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ibutilide,Gadopentetic acid,Ibutilide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ibutilide,Gadoteric acid,Ibutilide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ibutilide,Gadoteridol,Ibutilide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ibutilide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ibutilide.,increase,risk
Ibutilide,Ganciclovir,Ibutilide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ibutilide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ibutilide.,increase,risk
Ibutilide,Gemcitabine,Ibutilide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ibutilide,Gemfibrozil,Ibutilide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ibutilide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Ibutilide.,increase,risk
Ibutilide,Gentamicin,Ibutilide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ibutilide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Ibutilide.,increase,risk
Ibutilide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Ibutilide.,increase,risk
Ibutilide,Gimeracil,Ibutilide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ibutilide,Givosiran,Givosiran may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Glasdegib,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Glasdegib.,increase,risk
Ibutilide,Glipizide,Ibutilide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ibutilide,Glycerol phenylbutyrate,Ibutilide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ibutilide,Golodirsen,Ibutilide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ibutilide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ibutilide.,increase,risk
Ibutilide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ibutilide.,increase,risk
Ibutilide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Grepafloxacin.,increase,risk
Ibutilide,Guanethidine,Ibutilide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ibutilide,Guanfacine,Ibutilide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ibutilide,Halofantrine,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Halofantrine.,increase,risk
Ibutilide,Haloperidol,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Haloperidol.,increase,risk
Ibutilide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ibutilide.,increase,risk
Ibutilide,Hydralazine,Ibutilide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ibutilide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ibutilide.,increase,risk
Ibutilide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ibutilide,Hydromorphone,Ibutilide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ibutilide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Ibutilide.,increase,risk
Ibutilide,Hydroxyethyl Starch,Ibutilide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ibutilide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Hydroxyzine.,increase,risk
Ibutilide,Hyoscyamine,Ibutilide may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Ibutilide,Kanamycin,Ibutilide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ibutilide,Ketamine,Ibutilide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ibutilide,Ketazolam,Ibutilide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ibutilide,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Ibutilide.,increase,risk
Ibutilide,Ketoprofen,Ketoprofen may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Ketorolac,Ketorolac may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Octinoxate,Ibutilide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ibutilide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ibutilide.,increase,risk
Ibutilide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Ibutilide.,increase,risk
Ibutilide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Ibutilide.,increase,risk
Ibutilide,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ibutilide.,increase,risk
Ibutilide,Olsalazine,Olsalazine may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ibutilide.,increase,risk
Ibutilide,Opium,Ibutilide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ibutilide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ibutilide.,increase,risk
Ibutilide,Oseltamivir,Oseltamivir may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxacillin,Ibutilide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ibutilide.,increase,risk
Ibutilide,Oxaprozin,Oxaprozin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Ibutilide.,increase,risk
Ibutilide,Oxazepam,Ibutilide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxprenolol,Ibutilide may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Ibutilide,Oxybenzone,Ibutilide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxyquinoline,Ibutilide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ibutilide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ibutilide.,increase,risk
Ibutilide,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ibutilide.,increase,risk
Ibutilide,Quinethazone,Quinethazone may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ibutilide,Quinidine,Ibutilide may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Ibutilide,Quinine,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quinine.,increase,risk
Ibutilide,Quizartinib,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quizartinib.,increase,risk
Ibutilide,Vaborbactam,Ibutilide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ibutilide,Valaciclovir,Valaciclovir may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Valbenazine,Ibutilide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ibutilide,Valdecoxib,Valdecoxib may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Valganciclovir,Ibutilide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ibutilide,Valproic acid,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Valproic acid.,increase,risk
Ibutilide,Vancomycin,Ibutilide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ibutilide,Vandetanib,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Vandetanib.,increase,risk
Ibutilide,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ibutilide.,increase,risk
Ibutilide,Varenicline,Ibutilide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ibutilide,Vemurafenib,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Vemurafenib.,increase,risk
Ibutilide,Venlafaxine,Venlafaxine may decrease the excretion rate of Ibutilide which could result in a higher serum level.,decrease,no risk
Ibutilide,Verapamil,Ibutilide may increase the arrhythmogenic activities of Verapamil.,increase,no risk
Ibutilide,Vernakalant,Ibutilide may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Ibutilide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ibutilide.,increase,risk
Ibutilide,Viloxazine,Ibutilide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ibutilide,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Ibutilide.,increase,risk
Ibutilide,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ibutilide.,increase,risk
Ibutilide,Vortioxetine,Ibutilide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ibutilide,Warfarin,Ibutilide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ibutilide,Xylometazoline,Ibutilide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Ibutilide,Zaleplon,Ibutilide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ibutilide,Zanamivir,Ibutilide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ibutilide,Ziconotide,Ibutilide may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Ibutilide,Ziprasidone,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Ziprasidone.,increase,risk
Ibutilide,Zonisamide,Ibutilide may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Ibutilide,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Zuclopenthixol.,increase,risk
Vindesine,Butacaine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Butacaine.,increase,risk
Vindesine,Butalbital,The metabolism of Vindesine can be increased when combined with Butalbital.,increase,no risk
Vindesine,Butamben,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Butamben.,increase,risk
Vindesine,Gemcitabine,The risk or severity of adverse effects can be increased when Vindesine is combined with Gemcitabine.,increase,risk
Vindesine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vindesine.,increase,risk
Vindesine,Gilteritinib,The metabolism of Vindesine can be decreased when combined with Gilteritinib.,decrease,no risk
Vindesine,Ginkgo biloba,The metabolism of Vindesine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vindesine,Glatiramer,The risk or severity of adverse effects can be increased when Vindesine is combined with Glatiramer.,increase,risk
Vindesine,Glecaprevir,The metabolism of Vindesine can be decreased when combined with Glecaprevir.,decrease,no risk
Vindesine,Glofitamab,The serum concentration of Vindesine can be increased when it is combined with Glofitamab.,increase,no risk
Vindesine,Glyburide,The metabolism of Vindesine can be decreased when combined with Glyburide.,decrease,no risk
Vindesine,Glycerol phenylbutyrate,The metabolism of Vindesine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Vindesine,Golimumab,The metabolism of Vindesine can be increased when combined with Golimumab.,increase,no risk
Vindesine,Grapefruit,The serum concentration of Vindesine can be increased when it is combined with Grapefruit.,increase,no risk
Vindesine,Griseofulvin,The metabolism of Vindesine can be increased when combined with Griseofulvin.,increase,no risk
Vindesine,Guselkumab,The risk or severity of adverse effects can be increased when Vindesine is combined with Guselkumab.,increase,risk
Vindesine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Vindesine.,increase,no risk
Vindesine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Vindesine.,increase,risk
Vindesine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Vindesine.,increase,risk
Vindesine,Hydralazine,The serum concentration of Vindesine can be increased when it is combined with Hydralazine.,increase,no risk
Vindesine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Vindesine.,increase,risk
Vindesine,Hydrocortamate,The metabolism of Vindesine can be increased when combined with Hydrocortamate.,increase,no risk
Vindesine,Hydrocortisone,The metabolism of Vindesine can be increased when combined with Hydrocortisone.,increase,no risk
Vindesine,Hydrocortisone acetate,The metabolism of Vindesine can be increased when combined with Hydrocortisone acetate.,increase,no risk
Vindesine,Hydrocortisone butyrate,The metabolism of Vindesine can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Vindesine,Hydrocortisone succinate,The metabolism of Vindesine can be increased when combined with Hydrocortisone succinate.,increase,no risk
Vindesine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Vindesine.,increase,risk
Vindesine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Vindesine is combined with Hydroxychloroquine.,increase,risk
Vindesine,Hydroxyurea,The risk or severity of adverse effects can be increased when Vindesine is combined with Hydroxyurea.,increase,risk
Vindesine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Ketazolam,The serum concentration of Vindesine can be increased when it is combined with Ketazolam.,increase,no risk
Vindesine,Ketoconazole,The metabolism of Vindesine can be decreased when combined with Ketoconazole.,decrease,no risk
Vindesine,Obinutuzumab,The risk or severity of adverse effects can be increased when Vindesine is combined with Obinutuzumab.,increase,risk
Vindesine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Vindesine.,increase,no risk
Vindesine,Octreotide,The serum concentration of Vindesine can be increased when it is combined with Octreotide.,increase,no risk
Vindesine,Ofatumumab,The risk or severity of adverse effects can be increased when Vindesine is combined with Ofatumumab.,increase,risk
Vindesine,Olaparib,The metabolism of Vindesine can be decreased when combined with Olaparib.,decrease,no risk
Vindesine,Olutasidenib,The metabolism of Vindesine can be increased when combined with Olutasidenib.,increase,no risk
Vindesine,Omaveloxolone,The serum concentration of Vindesine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vindesine,Oritavancin,The metabolism of Vindesine can be increased when combined with Oritavancin.,increase,no risk
Vindesine,Orphenadrine,The metabolism of Vindesine can be decreased when combined with Orphenadrine.,decrease,no risk
Vindesine,Osilodrostat,The metabolism of Vindesine can be decreased when combined with Osilodrostat.,decrease,no risk
Vindesine,Osimertinib,The metabolism of Vindesine can be decreased when combined with Osimertinib.,decrease,no risk
Vindesine,Ouabain,Ouabain may decrease the cardiotoxic activities of Vindesine.,decrease,no risk
Vindesine,Oxaliplatin,The risk or severity of adverse effects can be increased when Vindesine is combined with Oxaliplatin.,increase,risk
Vindesine,Oxcarbazepine,The metabolism of Vindesine can be increased when combined with Oxcarbazepine.,increase,no risk
Vindesine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Oxetacaine.,increase,risk
Vindesine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Oxybuprocaine.,increase,risk
Vindesine,Oxybutynin,The serum concentration of Vindesine can be increased when it is combined with Oxybutynin.,increase,no risk
Vindesine,Ozanimod,The risk or severity of adverse effects can be increased when Vindesine is combined with Ozanimod.,increase,risk
Vindesine,Quinidine,The metabolism of Vindesine can be decreased when combined with Quinidine.,decrease,no risk
Vindesine,Quinine,The metabolism of Vindesine can be increased when combined with Quinine.,increase,no risk
Vindesine,Quinupristin,The metabolism of Vindesine can be decreased when combined with Quinupristin.,decrease,no risk
Vindesine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Vindesine.,increase,risk
Vindesine,Upadacitinib,The risk or severity of adverse effects can be increased when Vindesine is combined with Upadacitinib.,increase,risk
Vindesine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Vindesine.,increase,risk
Vindesine,Vadadustat,The serum concentration of Vindesine can be increased when it is combined with Vadadustat.,increase,no risk
Vindesine,Valproic acid,The serum concentration of Vindesine can be increased when it is combined with Valproic acid.,increase,no risk
Vindesine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Vindesine.,increase,risk
Vindesine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Vedolizumab,The risk or severity of adverse effects can be increased when Vindesine is combined with Vedolizumab.,increase,risk
Vindesine,Vemurafenib,The metabolism of Vindesine can be increased when combined with Vemurafenib.,increase,no risk
Vindesine,Venetoclax,The metabolism of Vindesine can be decreased when combined with Venetoclax.,decrease,no risk
Vindesine,Verapamil,The metabolism of Vindesine can be decreased when combined with Verapamil.,decrease,no risk
Vindesine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Vindesine.,decrease,no risk
Vindesine,Vilanterol,The risk or severity of adverse effects can be increased when Vindesine is combined with Vilanterol.,increase,risk
Vindesine,Viloxazine,The metabolism of Vindesine can be decreased when combined with Viloxazine.,decrease,no risk
Vindesine,Vinblastine,The metabolism of Vindesine can be increased when combined with Vinblastine.,increase,no risk
Vindesine,Vincristine,The risk or severity of adverse effects can be increased when Vindesine is combined with Vincristine.,increase,risk
Vindesine,Vinorelbine,The risk or severity of adverse effects can be increased when Vindesine is combined with Vinorelbine.,increase,risk
Vindesine,Vitamin E,The metabolism of Vindesine can be increased when combined with Vitamin E.,increase,no risk
Vindesine,Voclosporin,The risk or severity of adverse effects can be increased when Vindesine is combined with Voclosporin.,increase,risk
Vindesine,Vorapaxar,The metabolism of Vindesine can be decreased when combined with Vorapaxar.,decrease,no risk
Vindesine,Voriconazole,The metabolism of Vindesine can be decreased when combined with Voriconazole.,decrease,no risk
Vindesine,Vorinostat,The risk or severity of adverse effects can be increased when Vindesine is combined with Vorinostat.,increase,risk
Vindesine,Voxelotor,The serum concentration of Vindesine can be increased when it is combined with Voxelotor.,increase,no risk
Vindesine,Warfarin,The metabolism of Vindesine can be increased when combined with Warfarin.,increase,no risk
Vindesine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Vindesine.,increase,risk
Vindesine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Vindesine.,increase,risk
Vindesine,Zafirlukast,The serum concentration of Vindesine can be increased when it is combined with Zafirlukast.,increase,no risk
Vindesine,Zidovudine,The risk or severity of adverse effects can be increased when Vindesine is combined with Zidovudine.,increase,risk
Vindesine,Zimelidine,The metabolism of Vindesine can be decreased when combined with Zimelidine.,decrease,no risk
Vindesine,Ziprasidone,The metabolism of Vindesine can be decreased when combined with Ziprasidone.,decrease,no risk
Vindesine,Zuclopenthixol,The metabolism of Vindesine can be decreased when combined with Zuclopenthixol.,decrease,no risk
Chlorthalidone,Bismuth subgallate,Chlorthalidone may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Bisoprolol,Chlorthalidone may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Bisoxatin,The risk or severity of dehydration can be increased when Chlorthalidone is combined with Bisoxatin.,increase,risk
Chlorthalidone,Bleomycin,Chlorthalidone may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Bosentan,Chlorthalidone may increase the hypotensive activities of Bosentan.,increase,no risk
Chlorthalidone,Bretylium,Chlorthalidone may increase the hypotensive activities of Bretylium.,increase,no risk
Chlorthalidone,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Brimonidine,Brimonidine may increase the antihypertensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Brivaracetam,Chlorthalidone may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Bromazepam,Chlorthalidone may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Brompheniramine,The serum concentration of Chlorthalidone can be increased when it is combined with Brompheniramine.,increase,no risk
Chlorthalidone,Buclizine,The serum concentration of Chlorthalidone can be increased when it is combined with Buclizine.,increase,no risk
Chlorthalidone,Budesonide,Budesonide may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Bumadizone,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Bumadizone.,decrease,no risk
Chlorthalidone,Bumetanide,Chlorthalidone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Chlorthalidone.,increase,risk
Chlorthalidone,Buprenorphine,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Buprenorphine.,decrease,no risk
Chlorthalidone,Bupropion,Chlorthalidone may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Buspirone,Chlorthalidone may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Chlorthalidone.,increase,risk
Chlorthalidone,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Chlorthalidone.,increase,risk
Chlorthalidone,Butobarbital,The serum concentration of Chlorthalidone can be increased when it is combined with Butobarbital.,increase,no risk
Chlorthalidone,Butorphanol,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Butorphanol.,decrease,no risk
Chlorthalidone,Butriptyline,Butriptyline may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Butylscopolamine,The serum concentration of Chlorthalidone can be increased when it is combined with Butylscopolamine.,increase,no risk
Chlorthalidone,Gabapentin enacarbil,Chlorthalidone may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gadobenic acid,Chlorthalidone may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gadodiamide,Chlorthalidone may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gadofosveset trisodium,Chlorthalidone may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gadopentetic acid,Chlorthalidone may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gadoteric acid,Chlorthalidone may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gadoteridol,Chlorthalidone may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gallamine triethiodide,The serum concentration of Chlorthalidone can be increased when it is combined with Gallamine triethiodide.,increase,no risk
Chlorthalidone,Ganciclovir,Chlorthalidone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gemcitabine,Chlorthalidone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gemfibrozil,Chlorthalidone may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gimeracil,Chlorthalidone may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Gluconic Acid,The risk or severity of dehydration can be increased when Chlorthalidone is combined with Gluconic Acid.,increase,risk
Chlorthalidone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Glycerin,The risk or severity of dehydration can be increased when Chlorthalidone is combined with Glycerin.,increase,risk
Chlorthalidone,Glycerol phenylbutyrate,Chlorthalidone may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Glycol salicylate,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Chlorthalidone,Glycopyrronium,The serum concentration of Chlorthalidone can be increased when it is combined with Glycopyrronium.,increase,no risk
Chlorthalidone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Golodirsen,Chlorthalidone may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Goserelin,Chlorthalidone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Guanabenz,Guanabenz may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Guanadrel,Guanadrel may increase the hypotensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Guanethidine,Chlorthalidone may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Guanfacine,Chlorthalidone may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Guanoxan,Chlorthalidone may increase the hypotensive activities of Guanoxan.,increase,no risk
Chlorthalidone,Haloperidol,Chlorthalidone may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Halothane,Halothane may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Hexafluronium,The serum concentration of Chlorthalidone can be increased when it is combined with Hexafluronium.,increase,no risk
Chlorthalidone,Hexocyclium,The serum concentration of Chlorthalidone can be increased when it is combined with Hexocyclium.,increase,no risk
Chlorthalidone,Homatropine methylbromide,The serum concentration of Chlorthalidone can be increased when it is combined with Homatropine methylbromide.,increase,no risk
Chlorthalidone,Hydrochlorothiazide,The therapeutic efficacy of Chlorthalidone can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Chlorthalidone,Hydrocodone,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Hydrocodone.,decrease,no risk
Chlorthalidone,Hydrocortisone,Hydrocortisone may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Hydrocortisone acetate,Hydrocortisone acetate may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Hydrocortisone succinate,Hydrocortisone succinate may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Hydroflumethiazide,The therapeutic efficacy of Chlorthalidone can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Chlorthalidone,Hydromorphone,Chlorthalidone may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Hydroxocobalamin,Chlorthalidone may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Hydroxyethyl Starch,Chlorthalidone may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Hyoscyamine,The serum concentration of Chlorthalidone can be increased when it is combined with Hyoscyamine.,increase,no risk
Chlorthalidone,Ketamine,Chlorthalidone may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Ketazolam,Chlorthalidone may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Chlorthalidone.,increase,risk
Chlorthalidone,Ketorolac,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Ketorolac.,decrease,no risk
Chlorthalidone,Obinutuzumab,Chlorthalidone may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Chlorthalidone,Octinoxate,Chlorthalidone may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Olanzapine,The serum concentration of Chlorthalidone can be increased when it is combined with Olanzapine.,increase,no risk
Chlorthalidone,Oliceridine,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Oliceridine.,decrease,no risk
Chlorthalidone,Olmesartan,Olmesartan may increase the hypotensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Olodaterol,Olodaterol may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Opicapone,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Opicapone.,increase,risk
Chlorthalidone,Opium,Chlorthalidone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Orphenadrine,The serum concentration of Chlorthalidone can be increased when it is combined with Orphenadrine.,increase,no risk
Chlorthalidone,Oseltamivir,Chlorthalidone may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Ouabain,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Ouabain.,increase,risk
Chlorthalidone,Oxacillin,Chlorthalidone may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Oxaprozin,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Oxaprozin.,decrease,no risk
Chlorthalidone,Oxazepam,Chlorthalidone may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Oxcarbazepine,The risk or severity of hyponatremia can be increased when Chlorthalidone is combined with Oxcarbazepine.,increase,risk
Chlorthalidone,Oxprenolol,Chlorthalidone may increase the hypotensive activities of Oxprenolol.,increase,no risk
Chlorthalidone,Oxybenzone,Chlorthalidone may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Oxybutynin,The serum concentration of Chlorthalidone can be increased when it is combined with Oxybutynin.,increase,no risk
Chlorthalidone,Oxycodone,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Oxycodone.,decrease,no risk
Chlorthalidone,Oxymetazoline,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Chlorthalidone,Oxymorphone,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Oxymorphone.,decrease,no risk
Chlorthalidone,Oxyphenbutazone,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Chlorthalidone,Oxyphencyclimine,The serum concentration of Chlorthalidone can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Chlorthalidone,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Chlorthalidone is combined with Oxyphenisatin acetate.,increase,risk
Chlorthalidone,Oxyphenonium,The serum concentration of Chlorthalidone can be increased when it is combined with Oxyphenonium.,increase,no risk
Chlorthalidone,Oxyquinoline,Chlorthalidone may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Quetiapine,Quetiapine may increase the hypotensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Quinapril,The risk or severity of hypotension can be increased when Chlorthalidone is combined with Quinapril.,increase,risk
Chlorthalidone,Quinidine,Chlorthalidone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Quinupramine,Quinupramine may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Udenafil,Udenafil may increase the antihypertensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Umeclidinium,The serum concentration of Chlorthalidone can be increased when it is combined with Umeclidinium.,increase,no risk
Chlorthalidone,Unoprostone,Chlorthalidone may increase the hypotensive activities of Unoprostone.,increase,no risk
Chlorthalidone,Vaborbactam,Chlorthalidone may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Valaciclovir,Chlorthalidone may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Valbenazine,Chlorthalidone may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Valdecoxib,The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Valdecoxib.,decrease,no risk
Chlorthalidone,Valganciclovir,Chlorthalidone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Vamorolone,Vamorolone may increase the hypokalemic activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Vancomycin,Chlorthalidone may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Vardenafil,Vardenafil may increase the antihypertensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Varenicline,Chlorthalidone may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Vecuronium,The serum concentration of Chlorthalidone can be increased when it is combined with Vecuronium.,increase,no risk
Chlorthalidone,Venlafaxine,Chlorthalidone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Verapamil,Chlorthalidone may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Vericiguat,The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Vericiguat.,increase,risk
Chlorthalidone,Vilanterol,Chlorthalidone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Vilazodone,Vilazodone may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Chlorthalidone.,decrease,no risk
Chlorthalidone,Viloxazine,Chlorthalidone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Vitamin D,The risk or severity of hypokalemia can be increased when Vitamin D is combined with Chlorthalidone.,increase,risk
Chlorthalidone,Vortioxetine,Chlorthalidone may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Warfarin,Chlorthalidone may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Xamoterol,Xamoterol may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Yohimbine,Yohimbine may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Zaleplon,Chlorthalidone may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Zanamivir,Chlorthalidone may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorthalidone,Ziconotide,The risk or severity of CNS depression can be increased when Chlorthalidone is combined with Ziconotide.,increase,risk
Chlorthalidone,Zimelidine,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Chlorthalidone.,increase,risk
Chlorthalidone,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Chlorthalidone.,increase,no risk
Chlorthalidone,Zofenopril,The risk or severity of hypotension can be increased when Chlorthalidone is combined with Zofenopril.,increase,risk
Chlorthalidone,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Chlorthalidone.,decrease,no risk
Chlorthalidone,Zonisamide,Chlorthalidone may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gabapentin enacarbil,Ethoxzolamide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gadobenic acid,Ethoxzolamide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gadodiamide,Ethoxzolamide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gadofosveset trisodium,Ethoxzolamide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gadopentetic acid,Ethoxzolamide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gadoteric acid,Ethoxzolamide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gadoteridol,Ethoxzolamide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Ganciclovir,Ethoxzolamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gemcitabine,Ethoxzolamide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gemfibrozil,Ethoxzolamide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gimeracil,Ethoxzolamide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Gluconic Acid,The risk or severity of dehydration can be increased when Ethoxzolamide is combined with Gluconic Acid.,increase,risk
Ethoxzolamide,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Glycerin,The risk or severity of dehydration can be increased when Ethoxzolamide is combined with Glycerin.,increase,risk
Ethoxzolamide,Glycerol phenylbutyrate,Ethoxzolamide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Golodirsen,Ethoxzolamide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Goserelin,Ethoxzolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Ethoxzolamide.,decrease,no risk
Ethoxzolamide,Guanethidine,Ethoxzolamide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Guanfacine,Ethoxzolamide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Haloperidol,Ethoxzolamide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Hydralazine,Ethoxzolamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Hydrocodone,The therapeutic efficacy of Ethoxzolamide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Ethoxzolamide,Hydromorphone,Ethoxzolamide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Hydroxocobalamin,Ethoxzolamide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Hydroxyethyl Starch,Ethoxzolamide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Ketamine,Ethoxzolamide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Ketazolam,Ethoxzolamide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ethoxzolamide.,increase,risk
Ethoxzolamide,Octinoxate,Ethoxzolamide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oliceridine,The therapeutic efficacy of Ethoxzolamide can be decreased when used in combination with Oliceridine.,decrease,no risk
Ethoxzolamide,Olsalazine,The risk or severity of adverse effects can be increased when Olsalazine is combined with Ethoxzolamide.,increase,risk
Ethoxzolamide,Opium,Ethoxzolamide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oseltamivir,Ethoxzolamide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oxacillin,Ethoxzolamide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oxaprozin,Ethoxzolamide may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oxazepam,Ethoxzolamide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oxybenzone,Ethoxzolamide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Oxycodone,The therapeutic efficacy of Ethoxzolamide can be decreased when used in combination with Oxycodone.,decrease,no risk
Ethoxzolamide,Oxymorphone,The therapeutic efficacy of Ethoxzolamide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Ethoxzolamide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Ethoxzolamide is combined with Oxyphenisatin acetate.,increase,risk
Ethoxzolamide,Oxyquinoline,Ethoxzolamide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Quetiapine,Ethoxzolamide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Quinidine,The excretion of Quinidine can be decreased when combined with Ethoxzolamide.,decrease,no risk
Ethoxzolamide,Quinine,The excretion of Quinine can be decreased when combined with Ethoxzolamide.,decrease,no risk
Ethoxzolamide,Vaborbactam,Ethoxzolamide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Valaciclovir,Ethoxzolamide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Valbenazine,Ethoxzolamide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Valganciclovir,Ethoxzolamide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Vancomycin,Ethoxzolamide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Varenicline,Ethoxzolamide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Venlafaxine,Ethoxzolamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Verapamil,Ethoxzolamide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Vilanterol,Ethoxzolamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Ethoxzolamide.,increase,no risk
Ethoxzolamide,Viloxazine,Ethoxzolamide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Vortioxetine,Ethoxzolamide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Warfarin,Ethoxzolamide may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Ethoxzolamide.,decrease,no risk
Ethoxzolamide,Zaleplon,Ethoxzolamide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Zanamivir,Ethoxzolamide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethoxzolamide,Ziconotide,The risk or severity of CNS depression can be increased when Ethoxzolamide is combined with Ziconotide.,increase,risk
Ethoxzolamide,Zidovudine,The excretion of Zidovudine can be decreased when combined with Ethoxzolamide.,decrease,no risk
Ethoxzolamide,Zonisamide,The risk or severity of adverse effects can be increased when Ethoxzolamide is combined with Zonisamide.,increase,risk
Pentobarbital,Bacitracin,Bacitracin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.,increase,no risk
Pentobarbital,Balsalazide,Balsalazide may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Baricitinib,The metabolism of Baricitinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bedaquiline,The serum concentration of Bedaquiline can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Pentobarbital.,decrease,no risk
Pentobarbital,Benazepril,Pentobarbital may increase the hypotensive activities of Benazepril.,increase,no risk
Pentobarbital,Bendroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Pentobarbital is combined with Bendroflumethiazide.,increase,risk
Pentobarbital,Benorilate,Benorilate may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Benperidol,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Benperidol.,increase,risk
Pentobarbital,Benserazide,Pentobarbital may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Pentobarbital,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Pentobarbital.,increase,risk
Pentobarbital,Benzhydrocodone,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Benzhydrocodone.,increase,risk
Pentobarbital,Benznidazole,Pentobarbital may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Pentobarbital,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Benzocaine.,increase,risk
Pentobarbital,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Benzthiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Pentobarbital is combined with Benzthiazide.,increase,risk
Pentobarbital,Benzydamine,Benzydamine may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Benzyl alcohol.,increase,risk
Pentobarbital,Bepotastine,Pentobarbital may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Pentobarbital,Bepridil,The metabolism of Bepridil can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Betaine,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Betaine.,decrease,no risk
Pentobarbital,Betamethasone,The metabolism of Betamethasone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Betaxolol,Pentobarbital may increase the hypotensive activities of Betaxolol.,increase,no risk
Pentobarbital,Bexarotene,The metabolism of Bexarotene can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bezafibrate,The metabolism of Bezafibrate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bicisate,Pentobarbital may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Pentobarbital,Bictegravir,The metabolism of Bictegravir can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bimekizumab,The metabolism of Pentobarbital can be increased when combined with Bimekizumab.,increase,no risk
Pentobarbital,Biperiden,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Biperiden.,increase,risk
Pentobarbital,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Pentobarbital.,decrease,no risk
Pentobarbital,Bismuth subgallate,Pentobarbital may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Pentobarbital,Bisoprolol,The metabolism of Bisoprolol can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bisoxatin,Pentobarbital may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Pentobarbital,Bleomycin,Bleomycin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Boceprevir,The metabolism of Boceprevir can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Borage oil,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Borage oil.,decrease,no risk
Pentobarbital,Bortezomib,The metabolism of Bortezomib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bosentan,The metabolism of Bosentan can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Botulinum toxin type A.,increase,risk
Pentobarbital,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Botulinum toxin type B.,increase,risk
Pentobarbital,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bretylium,Pentobarbital may increase the hypotensive activities of Bretylium.,increase,no risk
Pentobarbital,Brexanolone,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Brexanolone.,increase,risk
Pentobarbital,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Brigatinib,The metabolism of Brigatinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.,increase,no risk
Pentobarbital,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bromazepam,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Bromazepam.,increase,risk
Pentobarbital,Bromocriptine,The metabolism of Bromocriptine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Bromperidol,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Bromperidol.,increase,risk
Pentobarbital,Brompheniramine,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Brompheniramine.,increase,risk
Pentobarbital,Buclizine,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Buclizine.,increase,risk
Pentobarbital,Budesonide,The metabolism of Budesonide can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Bumadizone,Bumadizone may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Bumetanide,Pentobarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Pentobarbital,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Bupivacaine.,increase,risk
Pentobarbital,Buprenorphine,Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Pentobarbital,Bupropion,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Bupropion.,increase,risk
Pentobarbital,Buspirone,The metabolism of Buspirone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Busulfan,The metabolism of Busulfan can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Pentobarbital.,increase,risk
Pentobarbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Butacaine.,increase,risk
Pentobarbital,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Pentobarbital.,increase,risk
Pentobarbital,Butamben,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Butamben.,increase,risk
Pentobarbital,Butaperazine,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Butaperazine.,increase,risk
Pentobarbital,Butobarbital,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Butobarbital.,increase,risk
Pentobarbital,Butorphanol,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Butorphanol.,increase,risk
Pentobarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Butylscopolamine.,increase,risk
Pentobarbital,Gabapentin,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Gabapentin.,increase,risk
Pentobarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Gabapentin enacarbil.,increase,risk
Pentobarbital,Gadobenic acid,Pentobarbital may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gadodiamide,Gadodiamide may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gadofosveset trisodium,Pentobarbital may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gadopentetic acid,Pentobarbital may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gadoteric acid,Pentobarbital may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gadoteridol,Pentobarbital may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Pentobarbital,Galantamine,The metabolism of Galantamine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Gallamine triethiodide.,increase,risk
Pentobarbital,Gamolenic acid,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Pentobarbital,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ganciclovir,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Ganciclovir.,decrease,no risk
Pentobarbital,Gefitinib,The metabolism of Gefitinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Gemcitabine,Pentobarbital may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gemfibrozil,The metabolism of Gemfibrozil can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Gentamicin,Pentobarbital may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pentobarbital,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Gimeracil,Pentobarbital may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pentobarbital,Ginkgo biloba,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Pentobarbital,Givosiran,Givosiran may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Pentobarbital.,decrease,no risk
Pentobarbital,Glipizide,Pentobarbital may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Pentobarbital,Glofitamab,The serum concentration of Pentobarbital can be increased when it is combined with Glofitamab.,increase,no risk
Pentobarbital,Glutethimide,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Glutethimide.,increase,risk
Pentobarbital,Glyburide,The metabolism of Glyburide can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Pentobarbital.,decrease,no risk
Pentobarbital,Glycerol phenylbutyrate,Pentobarbital may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pentobarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Glycopyrronium.,increase,risk
Pentobarbital,Golimumab,The metabolism of Pentobarbital can be increased when combined with Golimumab.,increase,no risk
Pentobarbital,Golodirsen,Pentobarbital may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pentobarbital,Goserelin,Goserelin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Granisetron,The metabolism of Granisetron can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Guanethidine,Pentobarbital may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Pentobarbital,Guanfacine,The metabolism of Guanfacine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Halazepam,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Halazepam.,increase,risk
Pentobarbital,Halofantrine,The metabolism of Halofantrine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pentobarbital.,increase,risk
Pentobarbital,Halothane,The metabolism of Halothane can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Hexafluronium.,increase,risk
Pentobarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Hexocyclium.,increase,risk
Pentobarbital,Homatropine,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Homatropine.,increase,risk
Pentobarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Homatropine methylbromide.,increase,risk
Pentobarbital,Huperzine A,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Pentobarbital,Hydralazine,Pentobarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Pentobarbital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Pentobarbital is combined with Hydrochlorothiazide.,increase,risk
Pentobarbital,Hydrocodone,Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pentobarbital,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Pentobarbital is combined with Hydroflumethiazide.,increase,risk
Pentobarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Hydromorphone.,increase,risk
Pentobarbital,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Hydroxychloroquine,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Pentobarbital,Hydroxyethyl Starch,Pentobarbital may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pentobarbital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.,increase,no risk
Pentobarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Hyoscyamine.,increase,risk
Pentobarbital,Kanamycin,Pentobarbital may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pentobarbital,Ketamine,The metabolism of Ketamine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ketazolam,The metabolism of Ketazolam can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ketoconazole,The metabolism of Ketoconazole can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ketoprofen,Ketoprofen may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Ketorolac,Ketorolac may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Obinutuzumab,Pentobarbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Pentobarbital,Octinoxate,Pentobarbital may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pentobarbital,Olanzapine,Pentobarbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Pentobarbital,Olaparib,The metabolism of Olaparib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pentobarbital is combined with Oliceridine.",increase,risk
Pentobarbital,Olmesartan,Pentobarbital may increase the hypotensive activities of Olmesartan.,increase,no risk
Pentobarbital,Olsalazine,Olsalazine may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Pentobarbital.,decrease,no risk
Pentobarbital,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Pentobarbital.,decrease,no risk
Pentobarbital,Omeprazole,The metabolism of Pentobarbital can be decreased when combined with Omeprazole.,decrease,no risk
Pentobarbital,Ondansetron,The metabolism of Ondansetron can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Opicapone,Pentobarbital may increase the hypotensive activities of Opicapone.,increase,no risk
Pentobarbital,Opium,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Opium.,increase,risk
Pentobarbital,Oritavancin,The metabolism of Pentobarbital can be decreased when combined with Oritavancin.,decrease,no risk
Pentobarbital,Orlistat,Orlistat can cause a decrease in the absorption of Pentobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Pentobarbital,Orphenadrine,Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pentobarbital,Oseltamivir,Oseltamivir may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Osimertinib,The metabolism of Osimertinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ospemifene,The metabolism of Ospemifene can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Oxacillin,Pentobarbital may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Pentobarbital,Oxaprozin,Oxaprozin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Oxazepam,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Oxazepam.,increase,risk
Pentobarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Oxcarbazepine.,increase,risk
Pentobarbital,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Oxetacaine.,increase,risk
Pentobarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Oxitriptan.,increase,risk
Pentobarbital,Oxprenolol,Pentobarbital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Pentobarbital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Oxybenzone,Pentobarbital may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Pentobarbital,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Oxybuprocaine.,increase,risk
Pentobarbital,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Oxycodone,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Oxycodone.,increase,risk
Pentobarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Oxymorphone.,increase,risk
Pentobarbital,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Oxyphencyclimine.,increase,risk
Pentobarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Pentobarbital.,decrease,no risk
Pentobarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pentobarbital.,increase,risk
Pentobarbital,Oxyquinoline,Pentobarbital may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pentobarbital,Quazepam,The metabolism of Quazepam can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Quetiapine,The metabolism of Quetiapine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Quinapril,Pentobarbital may increase the hypotensive activities of Quinapril.,increase,no risk
Pentobarbital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Pentobarbital is combined with Quinethazone.,increase,risk
Pentobarbital,Quinidine,The metabolism of Quinidine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Quinine,The metabolism of Quinine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Udenafil,The metabolism of Udenafil can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Umeclidinium.,increase,risk
Pentobarbital,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Urethane,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Urethane.,increase,risk
Pentobarbital,Vaborbactam,Pentobarbital may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pentobarbital,Valaciclovir,Valaciclovir may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,decrease,no risk
Pentobarbital,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Valganciclovir,The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Valganciclovir.,decrease,no risk
Pentobarbital,Valproic acid,The serum concentration of Pentobarbital can be increased when it is combined with Valproic acid.,increase,no risk
Pentobarbital,Valsartan,Pentobarbital may increase the hypotensive activities of Valsartan.,increase,no risk
Pentobarbital,Vamorolone,The metabolism of Vamorolone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vancomycin,Pentobarbital may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pentobarbital,Vandetanib,The metabolism of Vandetanib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vardenafil,The metabolism of Vardenafil can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Varenicline,Pentobarbital may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Pentobarbital,Vecuronium,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Vecuronium.,increase,risk
Pentobarbital,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Venetoclax,The metabolism of Venetoclax can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Verapamil,The metabolism of Verapamil can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vericiguat,Pentobarbital may increase the hypotensive activities of Vericiguat.,increase,no risk
Pentobarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Vigabatrin.,increase,risk
Pentobarbital,Vilanterol,The metabolism of Vilanterol can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vilazodone,The metabolism of Vilazodone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Viloxazine,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Viloxazine.,increase,risk
Pentobarbital,Vinblastine,The metabolism of Vinblastine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vincristine,The metabolism of Vincristine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vindesine,The metabolism of Vindesine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vinflunine,The metabolism of Vinflunine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vitamin D,The metabolism of Vitamin D can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vitamin E,The metabolism of Vitamin E can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Voclosporin,The metabolism of Voclosporin can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Pentobarbital.,decrease,no risk
Pentobarbital,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Pentobarbital.,decrease,no risk
Pentobarbital,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Warfarin,The metabolism of Warfarin can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Yohimbine,The metabolism of Yohimbine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zafirlukast,The metabolism of Pentobarbital can be decreased when combined with Zafirlukast.,decrease,no risk
Pentobarbital,Zaleplon,The metabolism of Zaleplon can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zanamivir,Pentobarbital may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Pentobarbital,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Ziconotide,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Ziconotide.,increase,risk
Pentobarbital,Zidovudine,The metabolism of Zidovudine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zileuton,The metabolism of Zileuton can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zimelidine,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Zimelidine.,increase,risk
Pentobarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Ziprasidone.,increase,risk
Pentobarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Pentobarbital is combined with Zolmitriptan.,increase,risk
Pentobarbital,Zolpidem,Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pentobarbital,Zonisamide,The metabolism of Zonisamide can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zopiclone,The metabolism of Zopiclone can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zotepine,The metabolism of Zotepine can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Pentobarbital.,increase,no risk
Pentobarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Pentobarbital.,increase,risk
Valproic acid,Balsalazide,The serum concentration of Valproic acid can be increased when it is combined with Balsalazide.,increase,no risk
Valproic acid,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Bedaquiline,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Bedaquiline.,increase,risk
Valproic acid,Belinostat,The metabolism of Belinostat can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Bendazac,The protein binding of Valproic acid can be decreased when combined with Bendazac.,decrease,no risk
Valproic acid,Benorilate,The protein binding of Valproic acid can be decreased when combined with Benorilate.,decrease,no risk
Valproic acid,Benoxaprofen,The protein binding of Valproic acid can be decreased when combined with Benoxaprofen.,decrease,no risk
Valproic acid,Benperidol,The risk or severity of CNS depression can be increased when Valproic acid is combined with Benperidol.,increase,risk
Valproic acid,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Valproic acid.,increase,risk
Valproic acid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Benzocaine.,increase,risk
Valproic acid,Benzoic acid,The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Valproic acid.,decrease,no risk
Valproic acid,Benzphetamine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Benzphetamine.,increase,risk
Valproic acid,Benzydamine,The protein binding of Valproic acid can be decreased when combined with Benzydamine.,decrease,no risk
Valproic acid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Benzyl alcohol.,increase,risk
Valproic acid,Benzylpenicillin,The excretion of Valproic acid can be decreased when combined with Benzylpenicillin.,decrease,no risk
Valproic acid,Bepridil,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Bepridil.,increase,risk
Valproic acid,Berotralstat,The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Valproic acid.,increase,risk
Valproic acid,Betamethasone,The metabolism of Valproic acid can be increased when combined with Betamethasone.,increase,no risk
Valproic acid,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Betulinic Acid,The protein binding of Valproic acid can be decreased when combined with Betulinic Acid.,decrease,no risk
Valproic acid,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Bexarotene,Valproic acid may increase the Pseudotumor Cerebri activities of Bexarotene.,increase,no risk
Valproic acid,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Valproic acid.,increase,risk
Valproic acid,Bimekizumab,The metabolism of Valproic acid can be increased when combined with Bimekizumab.,increase,no risk
Valproic acid,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Bismuth subsalicylate,The serum concentration of Valproic acid can be increased when it is combined with Bismuth subsalicylate.,increase,no risk
Valproic acid,Bleomycin,The serum concentration of Valproic acid can be decreased when it is combined with Bleomycin.,decrease,no risk
Valproic acid,Borage oil,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Borage oil.,decrease,no risk
Valproic acid,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Bosentan,The metabolism of Bosentan can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Valproic acid.,increase,risk
Valproic acid,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Valproic acid.,increase,risk
Valproic acid,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Valproic acid.,increase,risk
Valproic acid,Brexanolone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Brexanolone.,increase,risk
Valproic acid,Brexpiprazole,The risk or severity of CNS depression can be increased when Valproic acid is combined with Brexpiprazole.,increase,risk
Valproic acid,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Valproic acid,Brivaracetam,The risk or severity of CNS depression can be increased when Valproic acid is combined with Brivaracetam.,increase,risk
Valproic acid,Bromazepam,The risk or severity of CNS depression can be increased when Valproic acid is combined with Bromazepam.,increase,risk
Valproic acid,Bromfenac,The protein binding of Valproic acid can be decreased when combined with Bromfenac.,decrease,no risk
Valproic acid,Bromocriptine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Bromocriptine.,increase,risk
Valproic acid,Bromotheophylline,Valproic acid may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valproic acid,Bromperidol,The risk or severity of CNS depression can be increased when Valproic acid is combined with Bromperidol.,increase,risk
Valproic acid,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Valproic acid.,increase,risk
Valproic acid,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Valproic acid.,increase,risk
Valproic acid,Bufexamac,The protein binding of Valproic acid can be decreased when combined with Bufexamac.,decrease,no risk
Valproic acid,Bumadizone,The protein binding of Valproic acid can be decreased when combined with Bumadizone.,decrease,no risk
Valproic acid,Bumetanide,The excretion of Valproic acid can be decreased when combined with Bumetanide.,decrease,no risk
Valproic acid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Bupivacaine.,increase,risk
Valproic acid,Buprenorphine,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Valproic acid,Bupropion,The risk or severity of CNS depression can be increased when Valproic acid is combined with Bupropion.,increase,risk
Valproic acid,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Valproic acid.,increase,risk
Valproic acid,Buspirone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Buspirone.,increase,risk
Valproic acid,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Butabarbital,The serum concentration of Butabarbital can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Butacaine,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Butacaine.,increase,risk
Valproic acid,Butalbital,The serum concentration of Butalbital can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Butamben,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Butamben.,increase,risk
Valproic acid,Butaperazine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Butaperazine.,increase,risk
Valproic acid,Butobarbital,The risk or severity of CNS depression can be increased when Valproic acid is combined with Butobarbital.,increase,risk
Valproic acid,Butorphanol,The risk or severity of CNS depression can be increased when Valproic acid is combined with Butorphanol.,increase,risk
Valproic acid,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Valproic acid.,increase,risk
Valproic acid,Gabapentin,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gabapentin.,increase,risk
Valproic acid,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gabapentin enacarbil.,increase,risk
Valproic acid,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Valproic acid.,increase,risk
Valproic acid,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Valproic acid.,increase,risk
Valproic acid,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gallamine triethiodide.,increase,risk
Valproic acid,Gamolenic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Valproic acid,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Valproic acid is combined with Ganaxolone.",increase,risk
Valproic acid,Ganciclovir,The excretion of Valproic acid can be decreased when combined with Ganciclovir.,decrease,no risk
Valproic acid,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Valproic acid.,increase,risk
Valproic acid,Gemfibrozil,The metabolism of Valproic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Valproic acid,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Valproic acid.,increase,risk
Valproic acid,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Gestrinone,The metabolism of Gestrinone can be increased when combined with Valproic acid.,increase,no risk
Valproic acid,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Valproic acid.,increase,risk
Valproic acid,Ginkgo biloba,The metabolism of Valproic acid can be decreased when combined with Ginkgo biloba.,decrease,no risk
Valproic acid,Glasdegib,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Glasdegib.,increase,risk
Valproic acid,Glecaprevir,The metabolism of Valproic acid can be decreased when combined with Glecaprevir.,decrease,no risk
Valproic acid,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Glipizide,The metabolism of Glipizide can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Glofitamab,The serum concentration of Valproic acid can be increased when it is combined with Glofitamab.,increase,no risk
Valproic acid,Glutethimide,The risk or severity of CNS depression can be increased when Valproic acid is combined with Glutethimide.,increase,risk
Valproic acid,Glyburide,The metabolism of Glyburide can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Valproic acid.,decrease,no risk
Valproic acid,Glycol salicylate,The protein binding of Valproic acid can be decreased when combined with Glycol salicylate.,decrease,no risk
Valproic acid,Golimumab,The metabolism of Valproic acid can be increased when combined with Golimumab.,increase,no risk
Valproic acid,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Valproic acid.,increase,risk
Valproic acid,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Valproic acid.,increase,risk
Valproic acid,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Grepafloxacin.,increase,risk
Valproic acid,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Guanfacine,The serum concentration of Valproic acid can be increased when it is combined with Guanfacine.,increase,no risk
Valproic acid,Guanidine,The excretion of Valproic acid can be decreased when combined with Guanidine.,decrease,no risk
Valproic acid,Halazepam,The risk or severity of CNS depression can be increased when Valproic acid is combined with Halazepam.,increase,risk
Valproic acid,Halofantrine,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Halofantrine.,increase,risk
Valproic acid,Haloperidol,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Haloperidol.,increase,risk
Valproic acid,Halothane,The risk or severity of CNS depression can be increased when Valproic acid is combined with Halothane.,increase,risk
Valproic acid,Hexafluronium,The risk or severity of CNS depression can be increased when Valproic acid is combined with Hexafluronium.,increase,risk
Valproic acid,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Valproic acid.,increase,risk
Valproic acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Hydrocodone,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Valproic acid,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Hydromorphone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Hydromorphone.,increase,risk
Valproic acid,Hydroxychloroquine,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Valproic acid,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Valproic acid.,increase,no risk
Valproic acid,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Hydroxyurea.,increase,risk
Valproic acid,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Hydroxyzine.,increase,risk
Valproic acid,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Valproic acid.,increase,risk
Valproic acid,Ketamine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ketamine.,increase,risk
Valproic acid,Ketazolam,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ketazolam.,increase,risk
Valproic acid,Ketoconazole,The metabolism of Valproic acid can be decreased when combined with Ketoconazole.,decrease,no risk
Valproic acid,Ketoprofen,The protein binding of Valproic acid can be decreased when combined with Ketoprofen.,decrease,no risk
Valproic acid,Ketorolac,The protein binding of Valproic acid can be decreased when combined with Ketorolac.,decrease,no risk
Valproic acid,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Valproic acid.,increase,risk
Valproic acid,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Valproic acid.,increase,risk
Valproic acid,Olanzapine,The serum concentration of Olanzapine can be decreased when it is combined with Valproic acid.,decrease,no risk
Valproic acid,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Valproic acid is combined with Oliceridine.",increase,risk
Valproic acid,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Valproic acid.,increase,risk
Valproic acid,Olsalazine,The serum concentration of Valproic acid can be increased when it is combined with Olsalazine.,increase,no risk
Valproic acid,Ombitasvir,The metabolism of Valproic acid can be decreased when combined with Ombitasvir.,decrease,no risk
Valproic acid,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Valproic acid.,increase,risk
Valproic acid,Opium,The risk or severity of CNS depression can be increased when Valproic acid is combined with Opium.,increase,risk
Valproic acid,Oritavancin,The metabolism of Valproic acid can be decreased when combined with Oritavancin.,decrease,no risk
Valproic acid,Orlistat,Orlistat can cause a decrease in the absorption of Valproic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Valproic acid,Orphenadrine,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Valproic acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Osilodrostat,The metabolism of Valproic acid can be decreased when combined with Osilodrostat.,decrease,no risk
Valproic acid,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Ouabain,The excretion of Valproic acid can be decreased when combined with Ouabain.,decrease,no risk
Valproic acid,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Valproic acid.,increase,risk
Valproic acid,Oxandrolone,The metabolism of Valproic acid can be decreased when combined with Oxandrolone.,decrease,no risk
Valproic acid,Oxaprozin,The protein binding of Valproic acid can be decreased when combined with Oxaprozin.,decrease,no risk
Valproic acid,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Valproic acid.,increase,risk
Valproic acid,Oxazepam,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxazepam.,increase,risk
Valproic acid,Oxcarbazepine,The serum concentration of the active metabolites of Oxcarbazepine can be decreased when Oxcarbazepine is used in combination with Valproic acid.,decrease,no risk
Valproic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Oxetacaine.,increase,risk
Valproic acid,Oxitriptan,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxitriptan.,increase,risk
Valproic acid,Oxprenolol,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxprenolol.,increase,risk
Valproic acid,Oxtriphylline,Valproic acid may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valproic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Oxybuprocaine.,increase,risk
Valproic acid,Oxycodone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxycodone.,increase,risk
Valproic acid,Oxymorphone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxymorphone.,increase,risk
Valproic acid,Oxyphenbutazone,The protein binding of Valproic acid can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Valproic acid,Oxytetracycline,The excretion of Valproic acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Valproic acid,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Valproic acid.,increase,risk
Valproic acid,Quazepam,The risk or severity of CNS depression can be increased when Valproic acid is combined with Quazepam.,increase,risk
Valproic acid,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Valproic acid.,increase,risk
Valproic acid,Quinapril,The excretion of Quinapril can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Quinine,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Quinine.,increase,risk
Valproic acid,Quinupramine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Quinupramine.,increase,risk
Valproic acid,Quizartinib,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Quizartinib.,increase,risk
Valproic acid,Ulipristal,The metabolism of Ulipristal can be increased when combined with Valproic acid.,increase,no risk
Valproic acid,Urethane,The risk or severity of CNS depression can be increased when Valproic acid is combined with Urethane.,increase,risk
Valproic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Valdecoxib,The protein binding of Valproic acid can be decreased when combined with Valdecoxib.,decrease,no risk
Valproic acid,Valganciclovir,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valproic acid,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Valproic acid.,decrease,no risk
Valproic acid,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Valproate bismuth.,increase,risk
Valproic acid,Valsartan,The metabolism of Valsartan can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Vecuronium,The risk or severity of CNS depression can be increased when Valproic acid is combined with Vecuronium.,increase,risk
Valproic acid,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Venlafaxine.,increase,risk
Valproic acid,Verapamil,The metabolism of Verapamil can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Valproic acid.,increase,risk
Valproic acid,Vigabatrin,The risk or severity of CNS depression can be increased when Valproic acid is combined with Vigabatrin.,increase,risk
Valproic acid,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Valproic acid.,increase,risk
Valproic acid,Vilazodone,The risk or severity of CNS depression can be increased when Valproic acid is combined with Vilazodone.,increase,risk
Valproic acid,Viloxazine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Viloxazine.,increase,risk
Valproic acid,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Vitamin A,Valproic acid may increase the Pseudotumor Cerebri activities of Vitamin A.,increase,no risk
Valproic acid,Vonoprazan,The metabolism of Valproic acid can be decreased when combined with Vonoprazan.,decrease,no risk
Valproic acid,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Valproic acid.,increase,risk
Valproic acid,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Valproic acid is combined with Vorinostat.,increase,risk
Valproic acid,Vortioxetine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Vortioxetine.,increase,risk
Valproic acid,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Yohimbine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Yohimbine.,increase,risk
Valproic acid,Zafirlukast,The metabolism of Valproic acid can be decreased when combined with Zafirlukast.,decrease,no risk
Valproic acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Zaleplon,The risk or severity of CNS depression can be increased when Valproic acid is combined with Zaleplon.,increase,risk
Valproic acid,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Ziconotide,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ziconotide.,increase,risk
Valproic acid,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Valproic acid.,increase,no risk
Valproic acid,Zileuton,The metabolism of Zileuton can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Zimelidine,The risk or severity of adverse effects can be increased when Valproic acid is combined with Zimelidine.,increase,risk
Valproic acid,Ziprasidone,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Ziprasidone.,increase,risk
Valproic acid,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Zolpidem,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Valproic acid,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Valproic acid.,increase,risk
Valproic acid,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Valproic acid.,decrease,no risk
Valproic acid,Zotepine,The risk or severity of CNS depression can be increased when Valproic acid is combined with Zotepine.,increase,risk
Valproic acid,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Zuclopenthixol.,increase,risk
Valproic acid,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Valproic acid.,increase,risk
Capreomycin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gadodiamide,Gadodiamide may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gadoteridol,Gadoteridol may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Capreomycin.,increase,no risk
Capreomycin,Ganciclovir,Ganciclovir may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gemcitabine,Gemcitabine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gentamicin,Capreomycin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Capreomycin,Gimeracil,Gimeracil may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Givosiran,Givosiran may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Glipizide,Glipizide may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Capreomycin.,increase,risk
Capreomycin,Golodirsen,Golodirsen may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Goserelin,Goserelin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Guanethidine,Guanethidine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Guanfacine,Guanfacine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Haloperidol,Haloperidol may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Heparin,The therapeutic efficacy of Capreomycin can be decreased when used in combination with Heparin.,decrease,no risk
Capreomycin,Hetacillin,The serum concentration of Capreomycin can be decreased when it is combined with Hetacillin.,decrease,no risk
Capreomycin,Hydralazine,Hydralazine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Capreomycin,Hydromorphone,Hydromorphone may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Kanamycin,Capreomycin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Ketamine,Ketamine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Ketazolam,Ketazolam may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Ketoprofen,Ketoprofen may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Ketorolac,Ketorolac may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Octinoxate,Octinoxate may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Capreomycin is combined with Olsalazine.,increase,risk
Capreomycin,Opium,Opium may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oseltamivir,Oseltamivir may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Ouabain,The risk or severity of adverse effects can be increased when Capreomycin is combined with Ouabain.,increase,risk
Capreomycin,Oxacillin,Oxacillin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Capreomycin.,increase,risk
Capreomycin,Oxaprozin,Oxaprozin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oxazepam,Oxazepam may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Capreomycin is combined with Oxetacaine.,increase,risk
Capreomycin,Oxybenzone,Oxybenzone may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Capreomycin is combined with Oxybuprocaine.,increase,risk
Capreomycin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Oxytetracycline.,increase,risk
Capreomycin,Quetiapine,Quetiapine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Quinethazone,Quinethazone may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Capreomycin,Quinidine,Capreomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Capreomycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Quinine.,increase,risk
Capreomycin,Vaborbactam,Vaborbactam may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Valaciclovir,Valaciclovir may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Valbenazine,Valbenazine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Valdecoxib,Valdecoxib may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Valganciclovir,Valganciclovir may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Vancomycin,Capreomycin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Varenicline,Varenicline may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Capreomycin.,increase,no risk
Capreomycin,Venlafaxine,Venlafaxine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Verapamil,Verapamil may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Capreomycin.,decrease,no risk
Capreomycin,Vilanterol,Vilanterol may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Viloxazine,Viloxazine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Viomycin.,increase,risk
Capreomycin,Vortioxetine,Vortioxetine may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Warfarin,Capreomycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Capreomycin,Zaleplon,Zaleplon may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Zanamivir,Zanamivir may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Capreomycin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Capreomycin is combined with Zoledronic acid.,increase,risk
Capreomycin,Zonisamide,Zonisamide may decrease the excretion rate of Capreomycin which could result in a higher serum level.,decrease,no risk
Zolmitriptan,Butaperazine,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Butaperazine.,increase,risk
Zolmitriptan,Butobarbital,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Butobarbital.,increase,risk
Zolmitriptan,Butorphanol,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Butorphanol.,increase,risk
Zolmitriptan,Butriptyline,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Butriptyline.,increase,risk
Zolmitriptan,Gabapentin,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gabapentin.,increase,risk
Zolmitriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gabapentin enacarbil.,increase,risk
Zolmitriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gallamine triethiodide.,increase,risk
Zolmitriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zolmitriptan is combined with Ganaxolone.",increase,risk
Zolmitriptan,Gatifloxacin,The metabolism of Zolmitriptan can be decreased when combined with Gatifloxacin.,decrease,no risk
Zolmitriptan,Gemfibrozil,The metabolism of Zolmitriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Zolmitriptan,Gemifloxacin,The metabolism of Zolmitriptan can be decreased when combined with Gemifloxacin.,decrease,no risk
Zolmitriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Gilteritinib,The therapeutic efficacy of Zolmitriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Zolmitriptan,Ginkgo biloba,The metabolism of Zolmitriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Zolmitriptan,Givosiran,The serum concentration of Zolmitriptan can be increased when it is combined with Givosiran.,increase,no risk
Zolmitriptan,Glecaprevir,The metabolism of Zolmitriptan can be decreased when combined with Glecaprevir.,decrease,no risk
Zolmitriptan,Glofitamab,The serum concentration of Zolmitriptan can be increased when it is combined with Glofitamab.,increase,no risk
Zolmitriptan,Glutethimide,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Glutethimide.,increase,risk
Zolmitriptan,Golimumab,The metabolism of Zolmitriptan can be increased when combined with Golimumab.,increase,no risk
Zolmitriptan,Granisetron,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Granisetron.,increase,risk
Zolmitriptan,Grepafloxacin,The metabolism of Zolmitriptan can be decreased when combined with Grepafloxacin.,decrease,no risk
Zolmitriptan,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Zolmitriptan.,decrease,no risk
Zolmitriptan,Guanadrel,Zolmitriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Zolmitriptan,Guanethidine,Zolmitriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Zolmitriptan,Guanfacine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Guanfacine.,increase,risk
Zolmitriptan,Guanoxan,Zolmitriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Zolmitriptan,Halazepam,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Halazepam.,increase,risk
Zolmitriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Halothane,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Halothane.,increase,risk
Zolmitriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Hexafluronium.,increase,risk
Zolmitriptan,Hydralazine,Zolmitriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Zolmitriptan,Hydrochlorothiazide,Zolmitriptan may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Zolmitriptan,Hydrocodone,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zolmitriptan,Hydroflumethiazide,Zolmitriptan may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Zolmitriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Hydromorphone.,increase,risk
Zolmitriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Zolmitriptan,Ketamine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ketamine.,increase,risk
Zolmitriptan,Ketazolam,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ketazolam.,increase,risk
Zolmitriptan,Ketoconazole,The metabolism of Zolmitriptan can be decreased when combined with Ketoconazole.,decrease,no risk
Zolmitriptan,Ketoprofen,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ketoprofen.,increase,risk
Zolmitriptan,Ketorolac,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ketorolac.,increase,risk
Zolmitriptan,Obeticholic acid,The metabolism of Zolmitriptan can be decreased when combined with Obeticholic acid.,decrease,no risk
Zolmitriptan,Ofloxacin,The metabolism of Zolmitriptan can be decreased when combined with Ofloxacin.,decrease,no risk
Zolmitriptan,Olanzapine,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Olanzapine.,increase,risk
Zolmitriptan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zolmitriptan is combined with Oliceridine.",increase,risk
Zolmitriptan,Olmesartan,Zolmitriptan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Zolmitriptan,Olodaterol,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Olodaterol.,increase,risk
Zolmitriptan,Ondansetron,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ondansetron.,increase,risk
Zolmitriptan,Opium,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Opium.,increase,risk
Zolmitriptan,Orciprenaline,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Orciprenaline.,increase,risk
Zolmitriptan,Orphenadrine,The metabolism of Zolmitriptan can be decreased when combined with Orphenadrine.,decrease,no risk
Zolmitriptan,Osilodrostat,The metabolism of Zolmitriptan can be decreased when combined with Osilodrostat.,decrease,no risk
Zolmitriptan,Osimertinib,The serum concentration of Zolmitriptan can be decreased when it is combined with Osimertinib.,decrease,no risk
Zolmitriptan,Oxaprozin,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxaprozin.,increase,risk
Zolmitriptan,Oxazepam,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxazepam.,increase,risk
Zolmitriptan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxcarbazepine.,increase,risk
Zolmitriptan,Oxitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxitriptan.,increase,risk
Zolmitriptan,Oxprenolol,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxprenolol.,increase,risk
Zolmitriptan,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Zolmitriptan.,decrease,no risk
Zolmitriptan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxybuprocaine.,increase,risk
Zolmitriptan,Oxycodone,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxycodone.,increase,risk
Zolmitriptan,Oxymetazoline,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxymetazoline.,increase,risk
Zolmitriptan,Oxymorphone,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxymorphone.,increase,risk
Zolmitriptan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxyphenbutazone.,increase,risk
Zolmitriptan,Quazepam,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Quazepam.,increase,risk
Zolmitriptan,Quetiapine,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quetiapine.,increase,risk
Zolmitriptan,Quinapril,Zolmitriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Zolmitriptan,Quinidine,The metabolism of Zolmitriptan can be decreased when combined with Quinidine.,decrease,no risk
Zolmitriptan,Quinine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Quinine.,increase,risk
Zolmitriptan,Quinupramine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Quinupramine.,increase,risk
Zolmitriptan,Urethane,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Urethane.,increase,risk
Zolmitriptan,Valdecoxib,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Valdecoxib.,increase,risk
Zolmitriptan,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Valproate bismuth.,increase,risk
Zolmitriptan,Valproic acid,The metabolism of Zolmitriptan can be decreased when combined with Valproic acid.,decrease,no risk
Zolmitriptan,Valsartan,Zolmitriptan may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Zolmitriptan,Vecuronium,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Vecuronium.,increase,risk
Zolmitriptan,Vemurafenib,The serum concentration of Zolmitriptan can be increased when it is combined with Vemurafenib.,increase,no risk
Zolmitriptan,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Verapamil,The metabolism of Verapamil can be decreased when combined with Zolmitriptan.,decrease,no risk
Zolmitriptan,Vigabatrin,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Vigabatrin.,increase,risk
Zolmitriptan,Vilanterol,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Vilanterol.,increase,risk
Zolmitriptan,Vilazodone,The risk or severity of vasospastic reactions can be increased when Vilazodone is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Viloxazine,The metabolism of Zolmitriptan can be decreased when combined with Viloxazine.,decrease,no risk
Zolmitriptan,Vortioxetine,The risk or severity of vasospastic reactions can be increased when Vortioxetine is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Zolmitriptan.,decrease,no risk
Zolmitriptan,Warfarin,The metabolism of Warfarin can be decreased when combined with Zolmitriptan.,decrease,no risk
Zolmitriptan,Xamoterol,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Xamoterol.,increase,risk
Zolmitriptan,Xylometazoline,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Xylometazoline.,increase,risk
Zolmitriptan,Yohimbine,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Yohimbine.,increase,risk
Zolmitriptan,Zaleplon,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Zaleplon.,increase,risk
Zolmitriptan,Ziconotide,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ziconotide.,increase,risk
Zolmitriptan,Zileuton,The metabolism of Zolmitriptan can be decreased when combined with Zileuton.,decrease,no risk
Zolmitriptan,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Ziprasidone,The risk or severity of vasospastic reactions can be increased when Ziprasidone is combined with Zolmitriptan.,increase,risk
Zolmitriptan,Zofenopril,Zolmitriptan may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Zolmitriptan,Zolpidem,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolmitriptan,Zonisamide,The metabolism of Zolmitriptan can be decreased when combined with Zonisamide.,decrease,no risk
Zolmitriptan,Zopiclone,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zopiclone.,increase,risk
Zolmitriptan,Zotepine,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zotepine.,increase,risk
Zolmitriptan,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zuclopenthixol.,increase,risk
Zolmitriptan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Zolmitriptan.,increase,risk
Acetaminophen,Benznidazole,Acetaminophen may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Acetaminophen,Benzocaine,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Benzocaine.,increase,risk
Acetaminophen,Benzthiazide,Benzthiazide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Acetaminophen,Benzydamine,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Benzydamine.,increase,risk
Acetaminophen,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Benzyl alcohol.,increase,risk
Acetaminophen,Bepotastine,Acetaminophen may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bepridil,The metabolism of Acetaminophen can be decreased when combined with Bepridil.,decrease,no risk
Acetaminophen,Berotralstat,The metabolism of Acetaminophen can be decreased when combined with Berotralstat.,decrease,no risk
Acetaminophen,Betaxolol,The metabolism of Acetaminophen can be decreased when combined with Betaxolol.,decrease,no risk
Acetaminophen,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Bicisate,Acetaminophen may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bifonazole,Bifonazole may increase the hepatotoxic activities of Acetaminophen.,increase,no risk
Acetaminophen,Bimekizumab,The metabolism of Acetaminophen can be increased when combined with Bimekizumab.,increase,no risk
Acetaminophen,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Biperiden,The metabolism of Acetaminophen can be decreased when combined with Biperiden.,decrease,no risk
Acetaminophen,Bismuth subgallate,Acetaminophen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Acetaminophen,Bismuth subsalicylate,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Bismuth subsalicylate.,increase,risk
Acetaminophen,Bisoprolol,Acetaminophen may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bisoxatin,Acetaminophen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bleomycin,Bleomycin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Boceprevir,The metabolism of Acetaminophen can be decreased when combined with Boceprevir.,decrease,no risk
Acetaminophen,Bortezomib,The metabolism of Bortezomib can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Acetaminophen.,increase,no risk
Acetaminophen,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Brigatinib,The metabolism of Brigatinib can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Brivaracetam,Acetaminophen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bromazepam,Bromazepam may increase the hepatotoxic activities of Acetaminophen.,increase,no risk
Acetaminophen,Budesonide,Acetaminophen may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Acetaminophen,Bumadizone,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Bumadizone.,increase,risk
Acetaminophen,Bumetanide,Bumetanide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Acetaminophen,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Bupivacaine.,increase,risk
Acetaminophen,Buprenorphine,The metabolism of Acetaminophen can be decreased when combined with Buprenorphine.,decrease,no risk
Acetaminophen,Bupropion,The metabolism of Acetaminophen can be decreased when combined with Bupropion.,decrease,no risk
Acetaminophen,Buspirone,Acetaminophen may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Acetaminophen,Busulfan,Acetaminophen may decrease the excretion rate of Busulfan which could result in a higher serum level.,decrease,no risk
Acetaminophen,Butabarbital,The metabolism of Acetaminophen can be increased when combined with Butabarbital.,increase,no risk
Acetaminophen,Butacaine,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Butacaine.,increase,risk
Acetaminophen,Butamben,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Butamben.,increase,risk
Acetaminophen,Gabapentin enacarbil,Acetaminophen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gadobenic acid,Acetaminophen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gadodiamide,Gadodiamide may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gadofosveset trisodium,Acetaminophen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gadopentetic acid,Acetaminophen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gadoteric acid,Acetaminophen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gadoteridol,Acetaminophen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Acetaminophen,Galantamine,The metabolism of Galantamine can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Ganciclovir,Acetaminophen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gatifloxacin,The metabolism of Acetaminophen can be decreased when combined with Gatifloxacin.,decrease,no risk
Acetaminophen,Gefitinib,The serum concentration of Acetaminophen can be increased when it is combined with Gefitinib.,increase,no risk
Acetaminophen,Gemcitabine,Acetaminophen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gemfibrozil,The metabolism of Acetaminophen can be decreased when combined with Gemfibrozil.,decrease,no risk
Acetaminophen,Gemifloxacin,The metabolism of Acetaminophen can be decreased when combined with Gemifloxacin.,decrease,no risk
Acetaminophen,Gentamicin,Acetaminophen may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Acetaminophen,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Acetaminophen.,increase,no risk
Acetaminophen,Gestrinone,The metabolism of Gestrinone can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Gilteritinib,The serum concentration of Acetaminophen can be increased when it is combined with Gilteritinib.,increase,no risk
Acetaminophen,Gimeracil,Acetaminophen may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Acetaminophen,Givosiran,The serum concentration of Acetaminophen can be increased when it is combined with Givosiran.,increase,no risk
Acetaminophen,Glecaprevir,The metabolism of Acetaminophen can be decreased when combined with Glecaprevir.,decrease,no risk
Acetaminophen,Glipizide,Acetaminophen may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Acetaminophen,Glofitamab,The serum concentration of Acetaminophen can be increased when it is combined with Glofitamab.,increase,no risk
Acetaminophen,Glycerin,Glycerin may increase the hepatotoxic activities of Acetaminophen.,increase,no risk
Acetaminophen,Glycerol phenylbutyrate,The metabolism of Acetaminophen can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Acetaminophen,Glycol salicylate,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Glycol salicylate.,increase,risk
Acetaminophen,Golimumab,The metabolism of Acetaminophen can be increased when combined with Golimumab.,increase,no risk
Acetaminophen,Golodirsen,Acetaminophen may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Goserelin,Goserelin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Grepafloxacin,The metabolism of Acetaminophen can be decreased when combined with Grepafloxacin.,decrease,no risk
Acetaminophen,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Guanethidine,Acetaminophen may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Guanfacine,Acetaminophen may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Halofantrine,The metabolism of Acetaminophen can be decreased when combined with Halofantrine.,decrease,no risk
Acetaminophen,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Acetaminophen.,increase,no risk
Acetaminophen,Halothane,Halothane may increase the hepatotoxic activities of Acetaminophen.,increase,no risk
Acetaminophen,Hydralazine,Acetaminophen may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Acetaminophen,Hydrocortisone,The metabolism of Acetaminophen can be increased when combined with Hydrocortisone.,increase,no risk
Acetaminophen,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Acetaminophen,Hydromorphone,Acetaminophen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Acetaminophen,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Acetaminophen,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Hydroxychloroquine,The metabolism of Acetaminophen can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Acetaminophen,Hydroxyethyl Starch,Acetaminophen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Acetaminophen,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Hydroxyurea.,increase,risk
Acetaminophen,Kanamycin,Acetaminophen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Acetaminophen,Ketamine,Acetaminophen may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Ketazolam,Acetaminophen may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Acetaminophen,Ketoconazole,The metabolism of Acetaminophen can be decreased when combined with Ketoconazole.,decrease,no risk
Acetaminophen,Ketorolac,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Ketorolac.,increase,risk
Acetaminophen,Obeticholic acid,The metabolism of Acetaminophen can be decreased when combined with Obeticholic acid.,decrease,no risk
Acetaminophen,Octinoxate,Acetaminophen may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Acetaminophen,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Olaparib,The metabolism of Olaparib can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Acetaminophen.,decrease,no risk
Acetaminophen,Olsalazine,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Olsalazine.,increase,risk
Acetaminophen,Omaveloxolone,The serum concentration of Acetaminophen can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Acetaminophen,Ombitasvir,The metabolism of Acetaminophen can be decreased when combined with Ombitasvir.,decrease,no risk
Acetaminophen,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Opium,Acetaminophen may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Acetaminophen,Oritavancin,The metabolism of Acetaminophen can be decreased when combined with Oritavancin.,decrease,no risk
Acetaminophen,Oseltamivir,Oseltamivir may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Osilodrostat,The metabolism of Acetaminophen can be decreased when combined with Osilodrostat.,decrease,no risk
Acetaminophen,Osimertinib,The serum concentration of Acetaminophen can be decreased when it is combined with Osimertinib.,decrease,no risk
Acetaminophen,Ospemifene,The metabolism of Acetaminophen can be decreased when combined with Ospemifene.,decrease,no risk
Acetaminophen,Oxacillin,Acetaminophen may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Acetaminophen,Oxamniquine,The metabolism of Acetaminophen can be decreased when combined with Oxamniquine.,decrease,no risk
Acetaminophen,Oxaprozin,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Oxaprozin.,increase,risk
Acetaminophen,Oxazepam,Acetaminophen may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Acetaminophen,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Oxetacaine.,increase,risk
Acetaminophen,Oxprenolol,The metabolism of Acetaminophen can be decreased when combined with Oxprenolol.,decrease,no risk
Acetaminophen,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Oxybenzone,Acetaminophen may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Acetaminophen,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Oxybuprocaine.,increase,risk
Acetaminophen,Oxybutynin,The metabolism of Acetaminophen can be decreased when combined with Oxybutynin.,decrease,no risk
Acetaminophen,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Oxyphenbutazone.,increase,risk
Acetaminophen,Oxyquinoline,Acetaminophen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Acetaminophen,Quetiapine,Acetaminophen may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Quinethazone,Quinethazone may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Acetaminophen,Quinidine,The metabolism of Quinidine can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Quinine,The metabolism of Acetaminophen can be decreased when combined with Quinine.,decrease,no risk
Acetaminophen,Quizartinib,The serum concentration of Acetaminophen can be increased when it is combined with Quizartinib.,increase,no risk
Acetaminophen,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Acetaminophen.,increase,no risk
Acetaminophen,Ulipristal,The metabolism of Ulipristal can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Vaborbactam,Acetaminophen may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Acetaminophen,Vadadustat,The serum concentration of Acetaminophen can be increased when it is combined with Vadadustat.,increase,no risk
Acetaminophen,Valaciclovir,Valaciclovir may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,decrease,no risk
Acetaminophen,Valbenazine,Acetaminophen may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Acetaminophen,Valdecoxib,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Valdecoxib.,increase,risk
Acetaminophen,Valganciclovir,Acetaminophen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Acetaminophen,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Acetaminophen.,increase,risk
Acetaminophen,Vancomycin,Acetaminophen may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Acetaminophen,Vandetanib,The metabolism of Vandetanib can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Varenicline,Acetaminophen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Acetaminophen,Vayarin,Vayarin may increase the hepatotoxic activities of Acetaminophen.,increase,no risk
Acetaminophen,Vemurafenib,The serum concentration of Acetaminophen can be increased when it is combined with Vemurafenib.,increase,no risk
Acetaminophen,Venetoclax,The metabolism of Venetoclax can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Venlafaxine,The metabolism of Acetaminophen can be decreased when combined with Venlafaxine.,decrease,no risk
Acetaminophen,Verapamil,The metabolism of Acetaminophen can be decreased when combined with Verapamil.,decrease,no risk
Acetaminophen,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Vilanterol,Acetaminophen may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Acetaminophen,Vilazodone,The metabolism of Acetaminophen can be decreased when combined with Vilazodone.,decrease,no risk
Acetaminophen,Viloxazine,The metabolism of Acetaminophen can be decreased when combined with Viloxazine.,decrease,no risk
Acetaminophen,Vinblastine,The metabolism of Vinblastine can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Vincristine,The metabolism of Vincristine can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Vindesine,The metabolism of Vindesine can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Vinflunine,The metabolism of Vinflunine can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Voriconazole,The metabolism of Acetaminophen can be decreased when combined with Voriconazole.,decrease,no risk
Acetaminophen,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Acetaminophen.,increase,no risk
Acetaminophen,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Warfarin,The risk or severity of adverse effects can be increased when Acetaminophen is combined with Warfarin.,increase,risk
Acetaminophen,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Zaleplon,Acetaminophen may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Acetaminophen,Zanamivir,Acetaminophen may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Acetaminophen,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Zileuton,The metabolism of Acetaminophen can be decreased when combined with Zileuton.,decrease,no risk
Acetaminophen,Zimelidine,The metabolism of Acetaminophen can be decreased when combined with Zimelidine.,decrease,no risk
Acetaminophen,Ziprasidone,The metabolism of Acetaminophen can be decreased when combined with Ziprasidone.,decrease,no risk
Acetaminophen,Zolmitriptan,The metabolism of Acetaminophen can be decreased when combined with Zolmitriptan.,decrease,no risk
Acetaminophen,Zolpidem,The metabolism of Zolpidem can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Zonisamide,Zonisamide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Acetaminophen,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Zotepine,The metabolism of Zotepine can be decreased when combined with Acetaminophen.,decrease,no risk
Acetaminophen,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Acetaminophen.,increase,no risk
Acetaminophen,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Acetaminophen.,decrease,no risk
Gefitinib,Galantamine,The metabolism of Galantamine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Gilteritinib,Gilteritinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Gefitinib,Givosiran,The serum concentration of Gefitinib can be increased when it is combined with Givosiran.,increase,no risk
Gefitinib,Glasdegib,Gefitinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Gefitinib,Glecaprevir,Gefitinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Gefitinib,Glofitamab,The serum concentration of Gefitinib can be increased when it is combined with Glofitamab.,increase,no risk
Gefitinib,Glyburide,Gefitinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Gefitinib,Glycerol phenylbutyrate,The metabolism of Gefitinib can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Gefitinib,Golimumab,The metabolism of Gefitinib can be increased when combined with Golimumab.,increase,no risk
Gefitinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Gefitinib,Halofantrine,The metabolism of Gefitinib can be decreased when combined with Halofantrine.,decrease,no risk
Gefitinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Gefitinib.,increase,no risk
Gefitinib,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Gefitinib,Hydroxychloroquine,The metabolism of Gefitinib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Gefitinib,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Hydroxyzine,The metabolism of Gefitinib can be decreased when combined with Hydroxyzine.,decrease,no risk
Gefitinib,Ketoconazole,The metabolism of Gefitinib can be decreased when combined with Ketoconazole.,decrease,no risk
Gefitinib,Olanzapine,Olanzapine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Gefitinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Omaveloxolone,The serum concentration of Gefitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Gefitinib,Ombitasvir,Gefitinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Gefitinib,Omeprazole,Omeprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Gefitinib,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Opium,The metabolism of Opium can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Oritavancin,The metabolism of Gefitinib can be decreased when combined with Oritavancin.,decrease,no risk
Gefitinib,Orphenadrine,The metabolism of Gefitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Gefitinib,Osilodrostat,The metabolism of Gefitinib can be decreased when combined with Osilodrostat.,decrease,no risk
Gefitinib,Osimertinib,Gefitinib may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Gefitinib,Ospemifene,The metabolism of Gefitinib can be decreased when combined with Ospemifene.,decrease,no risk
Gefitinib,Oteseconazole,The serum concentration of Gefitinib can be increased when it is combined with Oteseconazole.,increase,no risk
Gefitinib,Oxaliplatin,Gefitinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Gefitinib,Oxamniquine,The metabolism of Gefitinib can be decreased when combined with Oxamniquine.,decrease,no risk
Gefitinib,Oxcarbazepine,The metabolism of Gefitinib can be increased when combined with Oxcarbazepine.,increase,no risk
Gefitinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Oxetacaine.,increase,risk
Gefitinib,Oxprenolol,The metabolism of Gefitinib can be decreased when combined with Oxprenolol.,decrease,no risk
Gefitinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Oxybuprocaine.,increase,risk
Gefitinib,Oxybutynin,The metabolism of Gefitinib can be decreased when combined with Oxybutynin.,decrease,no risk
Gefitinib,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Ozanimod,Gefitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Gefitinib,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Quinidine,The metabolism of Gefitinib can be decreased when combined with Quinidine.,decrease,no risk
Gefitinib,Quinine,The metabolism of Gefitinib can be decreased when combined with Quinine.,decrease,no risk
Gefitinib,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Gefitinib.,increase,no risk
Gefitinib,Udenafil,The metabolism of Udenafil can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Vadadustat,The serum concentration of Gefitinib can be increased when it is combined with Vadadustat.,increase,no risk
Gefitinib,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Vandetanib,Vandetanib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Gefitinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Velpatasvir,Gefitinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Gefitinib,Vemurafenib,Gefitinib may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Gefitinib,Venetoclax,The metabolism of Gefitinib can be decreased when combined with Venetoclax.,decrease,no risk
Gefitinib,Venlafaxine,The metabolism of Gefitinib can be decreased when combined with Venlafaxine.,decrease,no risk
Gefitinib,Verapamil,The metabolism of Gefitinib can be decreased when combined with Verapamil.,decrease,no risk
Gefitinib,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Vilazodone,The metabolism of Gefitinib can be decreased when combined with Vilazodone.,decrease,no risk
Gefitinib,Viloxazine,The metabolism of Gefitinib can be decreased when combined with Viloxazine.,decrease,no risk
Gefitinib,Vinblastine,The metabolism of Gefitinib can be decreased when combined with Vinblastine.,decrease,no risk
Gefitinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Vinorelbine,Gefitinib may increase the neutropenic activities of Vinorelbine.,increase,no risk
Gefitinib,Vismodegib,Vismodegib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Gefitinib,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Gefitinib,Voriconazole,The serum concentration of Gefitinib can be increased when it is combined with Voriconazole.,increase,no risk
Gefitinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Voxilaprevir,Gefitinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Gefitinib,Warfarin,Gefitinib may increase the anticoagulant activities of Warfarin.,increase,no risk
Gefitinib,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Zidovudine,Gefitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Gefitinib,Zimelidine,The metabolism of Gefitinib can be decreased when combined with Zimelidine.,decrease,no risk
Gefitinib,Ziprasidone,The metabolism of Gefitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Gefitinib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Gefitinib.,decrease,no risk
Gefitinib,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Gefitinib.,decrease,no risk
Codeine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Codeine.,increase,risk
Codeine,Gabapentin,The risk or severity of CNS depression can be increased when Codeine is combined with Gabapentin.,increase,risk
Codeine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Codeine is combined with Gabapentin enacarbil.,increase,risk
Codeine,Galantamine,The metabolism of Galantamine can be decreased when combined with Codeine.,decrease,no risk
Codeine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Codeine.,increase,risk
Codeine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Codeine is combined with Ganaxolone.",increase,risk
Codeine,Ganciclovir,The risk or severity of adverse effects can be increased when Codeine is combined with Ganciclovir.,increase,risk
Codeine,Gefitinib,The metabolism of Codeine can be decreased when combined with Gefitinib.,decrease,no risk
Codeine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Codeine.,increase,risk
Codeine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Codeine.,increase,risk
Codeine,Givosiran,The serum concentration of Codeine can be increased when it is combined with Givosiran.,increase,no risk
Codeine,Glofitamab,The serum concentration of Codeine can be increased when it is combined with Glofitamab.,increase,no risk
Codeine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Codeine.,decrease,no risk
Codeine,Glutethimide,The risk or severity of CNS depression can be increased when Codeine is combined with Glutethimide.,increase,risk
Codeine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Codeine.,decrease,no risk
Codeine,Glycerol phenylbutyrate,The metabolism of Codeine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Codeine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Codeine.,increase,risk
Codeine,Golimumab,The metabolism of Codeine can be increased when combined with Golimumab.,increase,no risk
Codeine,Granisetron,The risk or severity of CNS depression can be increased when Codeine is combined with Granisetron.,increase,risk
Codeine,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Codeine.,decrease,no risk
Codeine,Guanfacine,The risk or severity of CNS depression can be increased when Codeine is combined with Guanfacine.,increase,risk
Codeine,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Codeine.,increase,risk
Codeine,Halazepam,The risk or severity of adverse effects can be increased when Codeine is combined with Halazepam.,increase,risk
Codeine,Halofantrine,The metabolism of Codeine can be decreased when combined with Halofantrine.,decrease,no risk
Codeine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Codeine.,increase,risk
Codeine,Halothane,The risk or severity of CNS depression can be increased when Codeine is combined with Halothane.,increase,risk
Codeine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Codeine.,increase,risk
Codeine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Codeine.,increase,risk
Codeine,Histamine,The risk or severity of adverse effects can be increased when Codeine is combined with Histamine.,increase,risk
Codeine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Codeine.,increase,risk
Codeine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Codeine.,decrease,no risk
Codeine,Hydrocodone,Codeine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Codeine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Codeine.,decrease,no risk
Codeine,Hydromorphone,The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.,increase,risk
Codeine,Hydroxychloroquine,The metabolism of Codeine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Codeine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Codeine.,increase,no risk
Codeine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Codeine.,increase,risk
Codeine,Ketamine,The risk or severity of CNS depression can be increased when Codeine is combined with Ketamine.,increase,risk
Codeine,Ketazolam,The risk or severity of adverse effects can be increased when Codeine is combined with Ketazolam.,increase,risk
Codeine,Ketoconazole,The metabolism of Codeine can be decreased when combined with Ketoconazole.,decrease,no risk
Codeine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Codeine.,increase,risk
Codeine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Codeine is combined with Oliceridine.",increase,risk
Codeine,Omaveloxolone,The serum concentration of Codeine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Codeine,Ondansetron,The risk or severity of CNS depression can be increased when Codeine is combined with Ondansetron.,increase,risk
Codeine,Opium,The risk or severity of adverse effects can be increased when Codeine is combined with Opium.,increase,risk
Codeine,Oritavancin,The metabolism of Codeine can be decreased when combined with Oritavancin.,decrease,no risk
Codeine,Orphenadrine,Codeine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Codeine,Osilodrostat,The metabolism of Codeine can be decreased when combined with Osilodrostat.,decrease,no risk
Codeine,Ospemifene,The metabolism of Codeine can be decreased when combined with Ospemifene.,decrease,no risk
Codeine,Oxamniquine,The metabolism of Codeine can be decreased when combined with Oxamniquine.,decrease,no risk
Codeine,Oxazepam,The risk or severity of adverse effects can be increased when Codeine is combined with Oxazepam.,increase,risk
Codeine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Codeine is combined with Oxcarbazepine.,increase,risk
Codeine,Oxitriptan,The risk or severity of CNS depression can be increased when Codeine is combined with Oxitriptan.,increase,risk
Codeine,Oxprenolol,The risk or severity of CNS depression can be increased when Codeine is combined with Oxprenolol.,increase,risk
Codeine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Codeine is combined with Oxybuprocaine.,increase,risk
Codeine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.,increase,risk
Codeine,Oxycodone,The risk or severity of adverse effects can be increased when Codeine is combined with Oxycodone.,increase,risk
Codeine,Oxymorphone,The risk or severity of adverse effects can be increased when Codeine is combined with Oxymorphone.,increase,risk
Codeine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Codeine.,increase,risk
Codeine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Codeine.,decrease,no risk
Codeine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Codeine.,increase,risk
Codeine,Quazepam,The risk or severity of adverse effects can be increased when Codeine is combined with Quazepam.,increase,risk
Codeine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Codeine.,increase,risk
Codeine,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Codeine.,decrease,no risk
Codeine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Codeine.,increase,risk
Codeine,Quinine,The metabolism of Codeine can be decreased when combined with Quinine.,decrease,no risk
Codeine,Quinupramine,The risk or severity of CNS depression can be increased when Codeine is combined with Quinupramine.,increase,risk
Piperacillin,Gabapentin enacarbil,Piperacillin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Piperacillin,Gadobenic acid,Piperacillin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Piperacillin,Gadodiamide,Gadodiamide may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Gadofosveset trisodium,Piperacillin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Piperacillin,Gadopentetic acid,Piperacillin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Piperacillin,Gadoteric acid,Piperacillin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Piperacillin,Gadoteridol,Piperacillin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Piperacillin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Piperacillin.,increase,no risk
Piperacillin,Ganciclovir,The excretion of Piperacillin can be decreased when combined with Ganciclovir.,decrease,no risk
Piperacillin,Gatifloxacin,The serum concentration of Gatifloxacin can be increased when it is combined with Piperacillin.,increase,no risk
Piperacillin,Gemcitabine,Piperacillin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Piperacillin,Gemfibrozil,The excretion of Piperacillin can be decreased when combined with Gemfibrozil.,decrease,no risk
Piperacillin,Gemifloxacin,The serum concentration of Gemifloxacin can be increased when it is combined with Piperacillin.,increase,no risk
Piperacillin,Gentamicin,Piperacillin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Piperacillin,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Piperacillin.,decrease,no risk
Piperacillin,Gimeracil,Piperacillin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Piperacillin,Givosiran,Givosiran may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Glipizide,Piperacillin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Piperacillin,Glycerol phenylbutyrate,Piperacillin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Piperacillin,Golodirsen,Piperacillin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Piperacillin,Goserelin,Goserelin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Piperacillin.,increase,no risk
Piperacillin,Guanethidine,Piperacillin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Piperacillin,Guanfacine,Piperacillin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Piperacillin,Guanidine,The excretion of Piperacillin can be decreased when combined with Guanidine.,decrease,no risk
Piperacillin,Haloperidol,Piperacillin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Piperacillin,Hydralazine,Piperacillin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Piperacillin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piperacillin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piperacillin,Hydromorphone,Piperacillin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Piperacillin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Hydroxyethyl Starch,Piperacillin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Piperacillin,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Piperacillin.,decrease,no risk
Piperacillin,Kanamycin,Piperacillin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Piperacillin,Ketamine,Piperacillin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Piperacillin,Ketazolam,Piperacillin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Piperacillin,Ketoprofen,The excretion of Piperacillin can be decreased when combined with Ketoprofen.,decrease,no risk
Piperacillin,Ketorolac,Ketorolac may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Octinoxate,Piperacillin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Piperacillin,Ofloxacin,The serum concentration of Ofloxacin can be increased when it is combined with Piperacillin.,increase,no risk
Piperacillin,Olsalazine,Olsalazine may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Omadacycline,The therapeutic efficacy of Piperacillin can be decreased when used in combination with Omadacycline.,decrease,no risk
Piperacillin,Opium,Piperacillin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Piperacillin,Oseltamivir,Oseltamivir may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Ouabain,The excretion of Piperacillin can be decreased when combined with Ouabain.,decrease,no risk
Piperacillin,Oxacillin,Piperacillin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Oxaprozin,Oxaprozin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Oxazepam,Piperacillin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Piperacillin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Piperacillin is combined with Oxetacaine.,increase,risk
Piperacillin,Oxybenzone,Piperacillin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Piperacillin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Piperacillin is combined with Oxybuprocaine.,increase,risk
Piperacillin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Oxyquinoline,Piperacillin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Piperacillin,Oxytetracycline,The therapeutic efficacy of Piperacillin can be decreased when used in combination with Oxytetracycline.,decrease,no risk
Piperacillin,Quetiapine,Piperacillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Piperacillin,Quinethazone,Quinethazone may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piperacillin,Quinidine,Piperacillin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Piperacillin,Quinine,The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Quinine.,increase,risk
Piperacillin,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Piperacillin.,decrease,no risk
Piperacillin,Vaborbactam,Piperacillin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Piperacillin,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Piperacillin.,increase,no risk
Piperacillin,Valaciclovir,Valaciclovir may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Valbenazine,Piperacillin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Piperacillin,Valdecoxib,Valdecoxib may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Valganciclovir,Piperacillin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Piperacillin,Valproic acid,The excretion of Piperacillin can be decreased when combined with Valproic acid.,decrease,no risk
Piperacillin,Vancomycin,Piperacillin may increase the nephrotoxic activities of Vancomycin.,increase,no risk
Piperacillin,Varenicline,Piperacillin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Piperacillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Piperacillin.,increase,no risk
Piperacillin,Venlafaxine,Venlafaxine may decrease the excretion rate of Piperacillin which could result in a higher serum level.,decrease,no risk
Piperacillin,Verapamil,Piperacillin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Piperacillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Piperacillin.,decrease,no risk
Piperacillin,Vilanterol,Piperacillin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Piperacillin,Viloxazine,Piperacillin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Piperacillin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Viomycin.,increase,risk
Piperacillin,Vortioxetine,Piperacillin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Piperacillin,Warfarin,Piperacillin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Piperacillin,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Piperacillin.,decrease,no risk
Piperacillin,Zaleplon,Piperacillin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Piperacillin,Zanamivir,Piperacillin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Piperacillin,Zidovudine,The excretion of Piperacillin can be decreased when combined with Zidovudine.,decrease,no risk
Piperacillin,Zonisamide,Zonisamide may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dihydroergotamine,Bosentan,The metabolism of Dihydroergotamine can be increased when combined with Bosentan.,increase,no risk
Dihydroergotamine,Bosutinib,The metabolism of Dihydroergotamine can be decreased when combined with Bosutinib.,decrease,no risk
Dihydroergotamine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Dihydroergotamine.,increase,risk
Dihydroergotamine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Dihydroergotamine.,increase,risk
Dihydroergotamine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Bretylium,Dihydroergotamine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Dihydroergotamine,Brexanolone,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Brexanolone.,increase,risk
Dihydroergotamine,Brexpiprazole,The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Brexpiprazole.,decrease,risk
Dihydroergotamine,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dihydroergotamine.,increase,no risk
Dihydroergotamine,Brivaracetam,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Brivaracetam.,increase,risk
Dihydroergotamine,Bromazepam,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Bromazepam.,increase,risk
Dihydroergotamine,Bromocriptine,The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Bromocriptine.,decrease,risk
Dihydroergotamine,Bromperidol,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bromperidol.,increase,risk
Dihydroergotamine,Brompheniramine,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Brompheniramine.,increase,risk
Dihydroergotamine,Budesonide,The metabolism of Dihydroergotamine can be increased when combined with Budesonide.,increase,no risk
Dihydroergotamine,Bumadizone,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Bumadizone.,increase,risk
Dihydroergotamine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Dihydroergotamine.,increase,risk
Dihydroergotamine,Buprenorphine,Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Dihydroergotamine,Bupropion,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Bupropion.,increase,risk
Dihydroergotamine,Buspirone,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Buspirone.,increase,risk
Dihydroergotamine,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Dihydroergotamine.,increase,risk
Dihydroergotamine,Butalbital,The metabolism of Dihydroergotamine can be increased when combined with Butalbital.,increase,no risk
Dihydroergotamine,Butaperazine,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Butaperazine.,increase,risk
Dihydroergotamine,Butobarbital,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Butobarbital.,increase,risk
Dihydroergotamine,Butorphanol,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Butorphanol.,increase,risk
Dihydroergotamine,Butriptyline,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Butriptyline.,increase,risk
Dihydroergotamine,Gabapentin,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Gabapentin.,increase,risk
Dihydroergotamine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Gabapentin enacarbil.,increase,risk
Dihydroergotamine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Gallamine triethiodide.,increase,risk
Dihydroergotamine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dihydroergotamine is combined with Ganaxolone.",increase,risk
Dihydroergotamine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Gilteritinib,The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Dihydroergotamine,Ginkgo biloba,The metabolism of Dihydroergotamine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dihydroergotamine,Glecaprevir,The metabolism of Dihydroergotamine can be decreased when combined with Glecaprevir.,decrease,no risk
Dihydroergotamine,Glofitamab,The serum concentration of Dihydroergotamine can be increased when it is combined with Glofitamab.,increase,no risk
Dihydroergotamine,Glutethimide,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Glutethimide.,increase,risk
Dihydroergotamine,Glyburide,The metabolism of Dihydroergotamine can be decreased when combined with Glyburide.,decrease,no risk
Dihydroergotamine,Glycerol phenylbutyrate,The metabolism of Dihydroergotamine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Dihydroergotamine,Golimumab,The metabolism of Dihydroergotamine can be increased when combined with Golimumab.,increase,no risk
Dihydroergotamine,Granisetron,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Granisetron.,increase,risk
Dihydroergotamine,Grapefruit,The serum concentration of Dihydroergotamine can be increased when it is combined with Grapefruit.,increase,no risk
Dihydroergotamine,Griseofulvin,The metabolism of Dihydroergotamine can be increased when combined with Griseofulvin.,increase,no risk
Dihydroergotamine,Guanabenz,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Dihydroergotamine,Guanadrel,Dihydroergotamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Dihydroergotamine,Guanethidine,Dihydroergotamine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Dihydroergotamine,Guanfacine,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Dihydroergotamine,Guanoxan,Dihydroergotamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Dihydroergotamine,Halazepam,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Halazepam.,increase,risk
Dihydroergotamine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dihydroergotamine.,increase,risk
Dihydroergotamine,Halothane,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Halothane.,increase,risk
Dihydroergotamine,Hexafluronium,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Hexafluronium.,increase,risk
Dihydroergotamine,Hydralazine,The serum concentration of Dihydroergotamine can be increased when it is combined with Hydralazine.,increase,no risk
Dihydroergotamine,Hydrochlorothiazide,Dihydroergotamine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Dihydroergotamine,Hydrocodone,Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dihydroergotamine,Hydrocortamate,The metabolism of Dihydroergotamine can be increased when combined with Hydrocortamate.,increase,no risk
Dihydroergotamine,Hydrocortisone,The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone.,increase,no risk
Dihydroergotamine,Hydrocortisone acetate,The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone acetate.,increase,no risk
Dihydroergotamine,Hydrocortisone butyrate,The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Dihydroergotamine,Hydrocortisone succinate,The metabolism of Dihydroergotamine can be increased when combined with Hydrocortisone succinate.,increase,no risk
Dihydroergotamine,Hydroflumethiazide,Dihydroergotamine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Dihydroergotamine,Hydromorphone,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Hydromorphone.,increase,risk
Dihydroergotamine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dihydroergotamine.,increase,no risk
Dihydroergotamine,Ketamine,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Ketamine.,increase,risk
Dihydroergotamine,Ketazolam,The serum concentration of Dihydroergotamine can be increased when it is combined with Ketazolam.,increase,no risk
Dihydroergotamine,Ketoconazole,The metabolism of Dihydroergotamine can be decreased when combined with Ketoconazole.,decrease,no risk
Dihydroergotamine,Ketoprofen,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ketoprofen.,increase,risk
Dihydroergotamine,Ketorolac,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Ketorolac.,increase,risk
Dihydroergotamine,Octreotide,The serum concentration of Dihydroergotamine can be increased when it is combined with Octreotide.,increase,no risk
Dihydroergotamine,Olanzapine,"Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Olanzapine.",increase,no risk
Dihydroergotamine,Olaparib,The metabolism of Dihydroergotamine can be decreased when combined with Olaparib.,decrease,no risk
Dihydroergotamine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dihydroergotamine is combined with Oliceridine.",increase,risk
Dihydroergotamine,Olmesartan,Dihydroergotamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Dihydroergotamine,Olodaterol,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Dihydroergotamine,Olutasidenib,The metabolism of Dihydroergotamine can be increased when combined with Olutasidenib.,increase,no risk
Dihydroergotamine,Omaveloxolone,The serum concentration of Dihydroergotamine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dihydroergotamine,Ondansetron,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Ondansetron.,increase,risk
Dihydroergotamine,Opium,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Opium.,increase,risk
Dihydroergotamine,Orciprenaline,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Dihydroergotamine,Oritavancin,The metabolism of Dihydroergotamine can be increased when combined with Oritavancin.,increase,no risk
Dihydroergotamine,Orphenadrine,Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dihydroergotamine,Osilodrostat,The metabolism of Dihydroergotamine can be decreased when combined with Osilodrostat.,decrease,no risk
Dihydroergotamine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Oxaprozin,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Oxaprozin.,increase,risk
Dihydroergotamine,Oxazepam,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Oxazepam.,increase,risk
Dihydroergotamine,Oxcarbazepine,The metabolism of Dihydroergotamine can be increased when combined with Oxcarbazepine.,increase,no risk
Dihydroergotamine,Oxitriptan,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Oxitriptan.,increase,risk
Dihydroergotamine,Oxprenolol,Oxprenolol may increase the vasoconstricting activities of Dihydroergotamine.,increase,no risk
Dihydroergotamine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Oxybuprocaine.,increase,risk
Dihydroergotamine,Oxybutynin,The serum concentration of Dihydroergotamine can be increased when it is combined with Oxybutynin.,increase,no risk
Dihydroergotamine,Oxycodone,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Oxycodone.,increase,risk
Dihydroergotamine,Oxymetazoline,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Dihydroergotamine,Oxymorphone,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Oxymorphone.,increase,risk
Dihydroergotamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Oxyphenbutazone.,increase,risk
Dihydroergotamine,Oxytocin,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Oxytocin.,increase,risk
Dihydroergotamine,Quazepam,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Quazepam.,increase,risk
Dihydroergotamine,Quetiapine,"Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Dihydroergotamine,Quinagolide,The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Quinagolide.,decrease,risk
Dihydroergotamine,Quinapril,Dihydroergotamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Dihydroergotamine,Quinidine,"Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Dihydroergotamine,Quinine,The metabolism of Dihydroergotamine can be increased when combined with Quinine.,increase,no risk
Dihydroergotamine,Quinupramine,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Quinupramine.,increase,risk
Dihydroergotamine,Quinupristin,The metabolism of Dihydroergotamine can be decreased when combined with Quinupristin.,decrease,no risk
Dihydroergotamine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Dihydroergotamine.,increase,risk
Dihydroergotamine,Urethane,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Urethane.,increase,risk
Dihydroergotamine,Vadadustat,The serum concentration of Dihydroergotamine can be increased when it is combined with Vadadustat.,increase,no risk
Dihydroergotamine,Valdecoxib,The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Valdecoxib.,increase,risk
Dihydroergotamine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Valproate bismuth.,increase,risk
Dihydroergotamine,Valproic acid,The serum concentration of Dihydroergotamine can be increased when it is combined with Valproic acid.,increase,no risk
Dihydroergotamine,Valsartan,Dihydroergotamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Dihydroergotamine,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dihydroergotamine.,decrease,no risk
Dihydroergotamine,Vecuronium,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Vecuronium.,increase,risk
Dihydroergotamine,Vemurafenib,The metabolism of Dihydroergotamine can be increased when combined with Vemurafenib.,increase,no risk
Dihydroergotamine,Venetoclax,The metabolism of Dihydroergotamine can be decreased when combined with Venetoclax.,decrease,no risk
Dihydroergotamine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Venlafaxine.,increase,risk
Dihydroergotamine,Verapamil,The metabolism of Dihydroergotamine can be decreased when combined with Verapamil.,decrease,no risk
Dihydroergotamine,Vibegron,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Dihydroergotamine,Vigabatrin,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Vigabatrin.,increase,risk
Dihydroergotamine,Vilanterol,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Dihydroergotamine,Vilazodone,Dihydroergotamine may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Dihydroergotamine,Viloxazine,The metabolism of Dihydroergotamine can be decreased when combined with Viloxazine.,decrease,no risk
Dihydroergotamine,Vinblastine,The metabolism of Dihydroergotamine can be increased when combined with Vinblastine.,increase,no risk
Dihydroergotamine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Vitamin E,The metabolism of Dihydroergotamine can be increased when combined with Vitamin E.,increase,no risk
Dihydroergotamine,Vorapaxar,The metabolism of Dihydroergotamine can be decreased when combined with Vorapaxar.,decrease,no risk
Dihydroergotamine,Voriconazole,The serum concentration of Dihydroergotamine can be increased when it is combined with Voriconazole.,increase,no risk
Dihydroergotamine,Vortioxetine,Dihydroergotamine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Dihydroergotamine,Voxelotor,The serum concentration of Dihydroergotamine can be increased when it is combined with Voxelotor.,increase,no risk
Dihydroergotamine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Xamoterol,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Dihydroergotamine,Xylometazoline,Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Dihydroergotamine,Yohimbine,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Yohimbine.,increase,risk
Dihydroergotamine,Zafirlukast,The serum concentration of Dihydroergotamine can be increased when it is combined with Zafirlukast.,increase,no risk
Dihydroergotamine,Zaleplon,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Zaleplon.,increase,risk
Dihydroergotamine,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Dihydroergotamine.,increase,no risk
Dihydroergotamine,Ziconotide,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Ziconotide.,increase,risk
Dihydroergotamine,Zimelidine,The metabolism of Dihydroergotamine can be decreased when combined with Zimelidine.,decrease,no risk
Dihydroergotamine,Ziprasidone,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ziprasidone.,increase,risk
Dihydroergotamine,Zofenopril,Dihydroergotamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Dihydroergotamine,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Dihydroergotamine is combined with Zolmitriptan.,increase,risk
Dihydroergotamine,Zolpidem,Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dihydroergotamine,Zonisamide,The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Zonisamide.,increase,risk
Dihydroergotamine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dihydroergotamine.,decrease,no risk
Dihydroergotamine,Zotepine,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Zotepine.,increase,risk
Dihydroergotamine,Zuclopenthixol,"Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Dihydroergotamine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dihydroergotamine.,increase,risk
Amitriptyline,Bacitracin,Bacitracin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Baclofen,The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Amitriptyline.,increase,risk
Amitriptyline,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Balsalazide.,increase,risk
Amitriptyline,Baricitinib,Amitriptyline may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Amitriptyline,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Beclomethasone dipropionate,The metabolism of Amitriptyline can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Amitriptyline,Bedaquiline,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Bedaquiline.,increase,risk
Amitriptyline,Belinostat,The metabolism of Belinostat can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Amitriptyline.,increase,risk
Amitriptyline,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Amitriptyline.,increase,no risk
Amitriptyline,Benazepril,Amitriptyline may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Amitriptyline,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Bendazac,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Bendazac.,increase,risk
Amitriptyline,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Benorilate.,increase,risk
Amitriptyline,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Benoxaprofen.,increase,risk
Amitriptyline,Benperidol,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benperidol.,increase,risk
Amitriptyline,Benserazide,Amitriptyline may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Amitriptyline,Benzatropine,The metabolism of Amitriptyline can be decreased when combined with Benzatropine.,decrease,no risk
Amitriptyline,Benzhydrocodone,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benzhydrocodone.,increase,risk
Amitriptyline,Benznidazole,Amitriptyline may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Amitriptyline,Benzocaine,The metabolism of Amitriptyline can be decreased when combined with Benzocaine.,decrease,no risk
Amitriptyline,Benzphetamine,Benzphetamine may decrease the sedative activities of Amitriptyline.,decrease,no risk
Amitriptyline,Benzthiazide,Benzthiazide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Benzydamine.,increase,risk
Amitriptyline,Benzyl alcohol,The metabolism of Amitriptyline can be decreased when combined with Benzyl alcohol.,decrease,no risk
Amitriptyline,Benzylpenicilloyl polylysine,Amitriptyline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Amitriptyline,Bepotastine,Amitriptyline may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Amitriptyline,Bepridil,The metabolism of Amitriptyline can be decreased when combined with Bepridil.,decrease,no risk
Amitriptyline,Berotralstat,The serum concentration of Amitriptyline can be increased when it is combined with Berotralstat.,increase,no risk
Amitriptyline,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Betaine,The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Betaine.,decrease,no risk
Amitriptyline,Betamethasone,The metabolism of Amitriptyline can be increased when combined with Betamethasone.,increase,no risk
Amitriptyline,Betamethasone phosphate,The metabolism of Amitriptyline can be increased when combined with Betamethasone phosphate.,increase,no risk
Amitriptyline,Betaxolol,The metabolism of Amitriptyline can be decreased when combined with Betaxolol.,decrease,no risk
Amitriptyline,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Betulinic Acid,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Betulinic Acid.,increase,risk
Amitriptyline,Bexagliflozin,Amitriptyline may decrease the hypoglycemic activities of Bexagliflozin.,decrease,no risk
Amitriptyline,Bexarotene,The metabolism of Amitriptyline can be decreased when combined with Bexarotene.,decrease,no risk
Amitriptyline,Bezafibrate,The metabolism of Amitriptyline can be decreased when combined with Bezafibrate.,decrease,no risk
Amitriptyline,Bicalutamide,The metabolism of Amitriptyline can be decreased when combined with Bicalutamide.,decrease,no risk
Amitriptyline,Bicisate,Amitriptyline may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Amitriptyline,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Amitriptyline.,increase,risk
Amitriptyline,Bimekizumab,The metabolism of Amitriptyline can be increased when combined with Bimekizumab.,increase,no risk
Amitriptyline,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Biperiden,The metabolism of Amitriptyline can be decreased when combined with Biperiden.,decrease,no risk
Amitriptyline,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Bismuth subcitrate potassium,Amitriptyline may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Amitriptyline,Bismuth subgallate,Amitriptyline may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Amitriptyline,Bismuth subnitrate,Amitriptyline may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Amitriptyline,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Amitriptyline.,increase,no risk
Amitriptyline,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Bleomycin,Bleomycin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Boceprevir,The metabolism of Amitriptyline can be decreased when combined with Boceprevir.,decrease,no risk
Amitriptyline,Bortezomib,The metabolism of Amitriptyline can be decreased when combined with Bortezomib.,decrease,no risk
Amitriptyline,Bosentan,The metabolism of Amitriptyline can be increased when combined with Bosentan.,increase,no risk
Amitriptyline,Bosutinib,The metabolism of Amitriptyline can be decreased when combined with Bosutinib.,decrease,no risk
Amitriptyline,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Botulinum toxin type A.,increase,risk
Amitriptyline,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Botulinum toxin type B.,increase,risk
Amitriptyline,Bretylium,Amitriptyline may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Amitriptyline,Brexanolone,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Brexanolone.,increase,risk
Amitriptyline,Brexpiprazole,"Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Amitriptyline,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.,increase,no risk
Amitriptyline,Brivaracetam,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Brivaracetam.,increase,risk
Amitriptyline,Bromazepam,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Bromazepam.,increase,risk
Amitriptyline,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Bromfenac.,increase,risk
Amitriptyline,Bromocriptine,"Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Amitriptyline,Bromotheophylline,Bromotheophylline may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Bromperidol,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bromperidol.,increase,risk
Amitriptyline,Brompheniramine,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Brompheniramine.,increase,risk
Amitriptyline,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Amitriptyline.,increase,risk
Amitriptyline,Budesonide,The metabolism of Amitriptyline can be increased when combined with Budesonide.,increase,no risk
Amitriptyline,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Bufexamac.,increase,risk
Amitriptyline,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Bumadizone.,increase,risk
Amitriptyline,Bumetanide,Bumetanide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Bupivacaine,The metabolism of Amitriptyline can be decreased when combined with Bupivacaine.,decrease,no risk
Amitriptyline,Buprenorphine,Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Amitriptyline,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Amitriptyline.,increase,risk
Amitriptyline,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Amitriptyline.,increase,risk
Amitriptyline,Buspirone,The metabolism of Amitriptyline can be decreased when combined with Buspirone.,decrease,no risk
Amitriptyline,Butabarbital,The metabolism of Amitriptyline can be increased when combined with Butabarbital.,increase,no risk
Amitriptyline,Butalbital,The metabolism of Amitriptyline can be increased when combined with Butalbital.,increase,no risk
Amitriptyline,Butaperazine,The serum concentration of Amitriptyline can be increased when it is combined with Butaperazine.,increase,no risk
Amitriptyline,Butobarbital,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Butobarbital.,increase,risk
Amitriptyline,Butorphanol,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Butorphanol.,increase,risk
Amitriptyline,Butriptyline,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Butriptyline.,increase,risk
Amitriptyline,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Amitriptyline.,increase,risk
Amitriptyline,Gabapentin,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Gabapentin.,increase,risk
Amitriptyline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Gabapentin enacarbil.,increase,risk
Amitriptyline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Gadobenic acid.,increase,risk
Amitriptyline,Gadodiamide,Gadodiamide may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gadofosveset trisodium,Amitriptyline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gadopentetic acid,Amitriptyline may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gadoteric acid,Amitriptyline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gadoteridol,Amitriptyline may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Amitriptyline,Galantamine,The metabolism of Amitriptyline can be decreased when combined with Galantamine.,decrease,no risk
Amitriptyline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Gallamine triethiodide.,increase,risk
Amitriptyline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Amitriptyline is combined with Ganaxolone.",increase,risk
Amitriptyline,Ganciclovir,Amitriptyline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gatifloxacin,Gatifloxacin may increase the QTc-prolonging activities of Amitriptyline.,increase,no risk
Amitriptyline,Gefitinib,The metabolism of Amitriptyline can be decreased when combined with Gefitinib.,decrease,no risk
Amitriptyline,Gemcitabine,Amitriptyline may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gemfibrozil,The metabolism of Amitriptyline can be decreased when combined with Gemfibrozil.,decrease,no risk
Amitriptyline,Gemifloxacin,Gemifloxacin may increase the QTc-prolonging activities of Amitriptyline.,increase,no risk
Amitriptyline,Gentamicin,Amitriptyline may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Amitriptyline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Amitriptyline.,increase,risk
Amitriptyline,Gilteritinib,The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Gilteritinib.,decrease,no risk
Amitriptyline,Gimeracil,Amitriptyline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Amitriptyline,Ginkgo biloba,The metabolism of Amitriptyline can be decreased when combined with Ginkgo biloba.,decrease,no risk
Amitriptyline,Givosiran,The serum concentration of Amitriptyline can be increased when it is combined with Givosiran.,increase,no risk
Amitriptyline,Glasdegib,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Glasdegib.,increase,risk
Amitriptyline,Gliclazide,Amitriptyline may decrease the hypoglycemic activities of Gliclazide.,decrease,no risk
Amitriptyline,Glimepiride,Amitriptyline may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Amitriptyline,Glipizide,Amitriptyline may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Amitriptyline,Gliquidone,Amitriptyline may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Amitriptyline,Glofitamab,The serum concentration of Amitriptyline can be increased when it is combined with Glofitamab.,increase,no risk
Amitriptyline,Glucagon,Amitriptyline may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Amitriptyline,Glutethimide,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Glutethimide.,increase,risk
Amitriptyline,Glyburide,Amitriptyline may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Amitriptyline,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Glycerol phenylbutyrate,The metabolism of Amitriptyline can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Amitriptyline,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Glycol salicylate.,increase,risk
Amitriptyline,Glycopyrronium,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Glycopyrronium.,increase,risk
Amitriptyline,Glymidine,Amitriptyline may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Amitriptyline,Golimumab,The metabolism of Amitriptyline can be increased when combined with Golimumab.,increase,no risk
Amitriptyline,Golodirsen,Amitriptyline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Amitriptyline,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amitriptyline.,increase,risk
Amitriptyline,Granisetron,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Granisetron.,increase,risk
Amitriptyline,Grepafloxacin,Grepafloxacin may increase the QTc-prolonging activities of Amitriptyline.,increase,no risk
Amitriptyline,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Guanadrel,Amitriptyline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Amitriptyline,Guanethidine,Amitriptyline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Amitriptyline,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Guanoxan,Amitriptyline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Amitriptyline,Halazepam,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Halazepam.,increase,risk
Amitriptyline,Halofantrine,The metabolism of Amitriptyline can be decreased when combined with Halofantrine.,decrease,no risk
Amitriptyline,Haloperidol,The serum concentration of Amitriptyline can be increased when it is combined with Haloperidol.,increase,no risk
Amitriptyline,Halothane,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Halothane.,increase,risk
Amitriptyline,Hexafluronium,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Hexafluronium.,increase,risk
Amitriptyline,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Amitriptyline.,increase,risk
Amitriptyline,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Amitriptyline.,increase,risk
Amitriptyline,Homatropine,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Homatropine.,increase,risk
Amitriptyline,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Amitriptyline.,increase,risk
Amitriptyline,Huperzine A,The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Huperzine A.,decrease,no risk
Amitriptyline,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Hydralazine,Amitriptyline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Amitriptyline,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Hydrocodone,Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Amitriptyline,Hydrocortisone,The metabolism of Amitriptyline can be increased when combined with Hydrocortisone.,increase,no risk
Amitriptyline,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Hydromorphone,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Hydromorphone.,increase,risk
Amitriptyline,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Hydroxychloroquine,The metabolism of Amitriptyline can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Amitriptyline,Hydroxyethyl Starch,Amitriptyline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Amitriptyline,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Hydroxyurea,The metabolism of Amitriptyline can be decreased when combined with Hydroxyurea.,decrease,no risk
Amitriptyline,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Hydroxyzine.,increase,risk
Amitriptyline,Hyoscyamine,Amitriptyline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Amitriptyline,Kanamycin,Amitriptyline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Amitriptyline,Ketamine,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Ketamine.,increase,risk
Amitriptyline,Ketazolam,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Ketazolam.,increase,risk
Amitriptyline,Ketoconazole,The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.,decrease,no risk
Amitriptyline,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Ketoprofen.,increase,risk
Amitriptyline,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Ketorolac.,increase,risk
Amitriptyline,Obeticholic acid,The metabolism of Amitriptyline can be decreased when combined with Obeticholic acid.,decrease,no risk
Amitriptyline,Octinoxate,Amitriptyline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Amitriptyline,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Amitriptyline.,increase,risk
Amitriptyline,Ofloxacin,Ofloxacin may increase the QTc-prolonging activities of Amitriptyline.,increase,no risk
Amitriptyline,Olanzapine,"Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Olanzapine.",increase,no risk
Amitriptyline,Olaparib,The metabolism of Olaparib can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Amitriptyline is combined with Oliceridine.",increase,risk
Amitriptyline,Olmesartan,Amitriptyline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Amitriptyline,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Olsalazine,Olsalazine may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Omaveloxolone,The serum concentration of Amitriptyline can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Amitriptyline,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Omeprazole,The metabolism of Amitriptyline can be decreased when combined with Omeprazole.,decrease,no risk
Amitriptyline,Ondansetron,The metabolism of Amitriptyline can be decreased when combined with Ondansetron.,decrease,no risk
Amitriptyline,Opium,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Opium.,increase,risk
Amitriptyline,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Oritavancin,The metabolism of Amitriptyline can be decreased when combined with Oritavancin.,decrease,no risk
Amitriptyline,Orphenadrine,The metabolism of Amitriptyline can be decreased when combined with Orphenadrine.,decrease,no risk
Amitriptyline,Oseltamivir,Oseltamivir may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Osilodrostat,The metabolism of Amitriptyline can be decreased when combined with Osilodrostat.,decrease,no risk
Amitriptyline,Osimertinib,The serum concentration of Amitriptyline can be decreased when it is combined with Osimertinib.,decrease,no risk
Amitriptyline,Ospemifene,The metabolism of Amitriptyline can be decreased when combined with Ospemifene.,decrease,no risk
Amitriptyline,Oxacillin,Amitriptyline may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Amitriptyline,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amitriptyline.,increase,risk
Amitriptyline,Oxamniquine,The metabolism of Amitriptyline can be decreased when combined with Oxamniquine.,decrease,no risk
Amitriptyline,Oxandrolone,The metabolism of Amitriptyline can be decreased when combined with Oxandrolone.,decrease,no risk
Amitriptyline,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Oxaprozin.,increase,risk
Amitriptyline,Oxatomide,The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Oxatomide.,increase,risk
Amitriptyline,Oxazepam,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Oxazepam.,increase,risk
Amitriptyline,Oxcarbazepine,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Oxcarbazepine.,increase,risk
Amitriptyline,Oxitriptan,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Oxitriptan.,increase,risk
Amitriptyline,Oxprenolol,The metabolism of Amitriptyline can be decreased when combined with Oxprenolol.,decrease,no risk
Amitriptyline,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Oxybenzone,Amitriptyline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Amitriptyline,Oxybuprocaine,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Oxybuprocaine.,increase,risk
Amitriptyline,Oxybutynin,The metabolism of Amitriptyline can be decreased when combined with Oxybutynin.,decrease,no risk
Amitriptyline,Oxycodone,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxycodone.,increase,risk
Amitriptyline,Oxymetazoline,Amitriptyline may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Amitriptyline,Oxymetholone,The metabolism of Amitriptyline can be decreased when combined with Oxymetholone.,decrease,no risk
Amitriptyline,Oxymorphone,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxymorphone.,increase,risk
Amitriptyline,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Oxyphenbutazone.,increase,risk
Amitriptyline,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Amitriptyline.,increase,risk
Amitriptyline,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Amitriptyline.,decrease,no risk
Amitriptyline,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Amitriptyline.,increase,risk
Amitriptyline,Oxyquinoline,Amitriptyline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Amitriptyline,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amitriptyline.,increase,risk
Amitriptyline,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Amitriptyline.,decrease,no risk
Amitriptyline,Quazepam,The risk or severity of CNS depression can be increased when Amitriptyline is combined with Quazepam.,increase,risk
Amitriptyline,Quetiapine,"Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Amitriptyline,Quinapril,Amitriptyline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Amitriptyline,Quinestrol,The serum concentration of Amitriptyline can be increased when it is combined with Quinestrol.,increase,no risk
Amitriptyline,Quinethazone,Quinethazone may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amitriptyline,Quinidine,The metabolism of Amitriptyline can be decreased when combined with Quinidine.,decrease,no risk
Floxuridine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Benorilate,Benorilate may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Benserazide,Floxuridine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Floxuridine,Benzatropine,Benzatropine may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Benznidazole,Floxuridine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Floxuridine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Benzocaine.,increase,risk
Floxuridine,Benzthiazide,Benzthiazide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Benzydamine,Benzydamine may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Benzyl alcohol.,increase,risk
Floxuridine,Bepotastine,Floxuridine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Floxuridine,Betamethasone,The risk or severity of adverse effects can be increased when Floxuridine is combined with Betamethasone.,increase,risk
Floxuridine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Floxuridine.,increase,risk
Floxuridine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Floxuridine.,increase,risk
Floxuridine,Bicisate,Floxuridine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Floxuridine,Bimekizumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Bimekizumab.,increase,risk
Floxuridine,Bismuth subgallate,Floxuridine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Floxuridine,Bisoprolol,Floxuridine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Floxuridine,Bisoxatin,Floxuridine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Floxuridine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Floxuridine.,increase,risk
Floxuridine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Floxuridine.,increase,risk
Floxuridine,Blinatumomab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Blinatumomab.,increase,risk
Floxuridine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Floxuridine.",decrease,no risk
Floxuridine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Floxuridine.,increase,risk
Floxuridine,Bosentan,The metabolism of Bosentan can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Bosutinib,The risk or severity of adverse effects can be increased when Floxuridine is combined with Bosutinib.,increase,risk
Floxuridine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Floxuridine is combined with Brentuximab vedotin.,increase,risk
Floxuridine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Brodalumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Brodalumab.,increase,risk
Floxuridine,Bromazepam,Floxuridine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Floxuridine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Budesonide,The risk or severity of adverse effects can be increased when Floxuridine is combined with Budesonide.,increase,risk
Floxuridine,Bumadizone,Bumadizone may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Bumetanide,Bumetanide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Bupivacaine.,increase,risk
Floxuridine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Bupropion,The metabolism of Bupropion can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Buspirone,Floxuridine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Floxuridine,Busulfan,The risk or severity of adverse effects can be increased when Floxuridine is combined with Busulfan.,increase,risk
Floxuridine,Butabarbital,Butabarbital may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Butacaine,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Butacaine.,increase,risk
Floxuridine,Butamben,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Butamben.,increase,risk
Floxuridine,Gabapentin enacarbil,Floxuridine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Floxuridine,Gadobenic acid,Floxuridine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Floxuridine,Gadodiamide,Gadodiamide may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Gadofosveset trisodium,Floxuridine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Floxuridine,Gadopentetic acid,Floxuridine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Floxuridine,Gadoteric acid,Floxuridine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Floxuridine,Gadoteridol,Floxuridine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Floxuridine,Ganciclovir,Floxuridine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Floxuridine,Gemcitabine,The risk or severity of adverse effects can be increased when Floxuridine is combined with Gemcitabine.,increase,risk
Floxuridine,Gemfibrozil,Floxuridine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Floxuridine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Floxuridine.,increase,risk
Floxuridine,Gentamicin,Floxuridine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Floxuridine,Gimeracil,Floxuridine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Floxuridine,Givosiran,Givosiran may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Glatiramer,The risk or severity of adverse effects can be increased when Floxuridine is combined with Glatiramer.,increase,risk
Floxuridine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Glipizide,The metabolism of Glipizide can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Glyburide,The metabolism of Glyburide can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Glycerol phenylbutyrate,Floxuridine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Floxuridine,Golimumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Golimumab.,increase,risk
Floxuridine,Golodirsen,Floxuridine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Floxuridine,Goserelin,Goserelin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Guanethidine,Floxuridine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Floxuridine,Guanfacine,Floxuridine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Floxuridine,Guselkumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Guselkumab.,increase,risk
Floxuridine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Halothane,The metabolism of Halothane can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Floxuridine.,increase,risk
Floxuridine,Hydralazine,Floxuridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Floxuridine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Floxuridine is combined with Hydrocortisone acetate.,increase,risk
Floxuridine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Floxuridine is combined with Hydrocortisone butyrate.,increase,risk
Floxuridine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Floxuridine is combined with Hydrocortisone succinate.,increase,risk
Floxuridine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Floxuridine is combined with Hydroxychloroquine.,increase,risk
Floxuridine,Hydroxyethyl Starch,Floxuridine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Floxuridine,Hydroxyurea,The risk or severity of adverse effects can be increased when Floxuridine is combined with Hydroxyurea.,increase,risk
Floxuridine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Kanamycin,Floxuridine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Floxuridine,Ketamine,The metabolism of Ketamine can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Ketazolam,Floxuridine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Floxuridine,Ketoprofen,Ketoprofen may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Obinutuzumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Obinutuzumab.,increase,risk
Floxuridine,Ocrelizumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Ocrelizumab.,increase,risk
Floxuridine,Octinoxate,Floxuridine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Floxuridine,Ofatumumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Ofatumumab.,increase,risk
Floxuridine,Olaparib,The risk or severity of adverse effects can be increased when Floxuridine is combined with Olaparib.,increase,risk
Floxuridine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Olsalazine,Olsalazine may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Opium,Floxuridine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Floxuridine,Oseltamivir,Oseltamivir may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Oxacillin,Floxuridine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Floxuridine,Oxaliplatin,The risk or severity of adverse effects can be increased when Floxuridine is combined with Oxaliplatin.,increase,risk
Floxuridine,Oxaprozin,Oxaprozin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Oxazepam,Floxuridine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Floxuridine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Oxetacaine.,increase,risk
Floxuridine,Oxybenzone,Floxuridine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Floxuridine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Oxybuprocaine.,increase,risk
Floxuridine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Oxyquinoline,Floxuridine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Floxuridine,Ozanimod,The risk or severity of adverse effects can be increased when Floxuridine is combined with Ozanimod.,increase,risk
Floxuridine,Quetiapine,Floxuridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Floxuridine,Quinethazone,Quinethazone may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Quinidine,Floxuridine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Floxuridine,Quinine,The metabolism of Quinine can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Floxuridine.,increase,risk
Floxuridine,Upadacitinib,The risk or severity of adverse effects can be increased when Floxuridine is combined with Upadacitinib.,increase,risk
Floxuridine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Floxuridine.,increase,risk
Floxuridine,Vaborbactam,Floxuridine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Floxuridine,Valaciclovir,Valaciclovir may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Valbenazine,Floxuridine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Floxuridine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Valganciclovir,Floxuridine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Floxuridine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Valsartan,The metabolism of Valsartan can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Vancomycin,Floxuridine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Floxuridine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Varenicline,Floxuridine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Floxuridine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Floxuridine.,increase,risk
Floxuridine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Vedolizumab,The risk or severity of adverse effects can be increased when Floxuridine is combined with Vedolizumab.,increase,risk
Floxuridine,Venlafaxine,Venlafaxine may decrease the excretion rate of Floxuridine which could result in a higher serum level.,decrease,no risk
Floxuridine,Verapamil,Floxuridine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Floxuridine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Floxuridine.,decrease,no risk
Floxuridine,Vilanterol,The risk or severity of adverse effects can be increased when Floxuridine is combined with Vilanterol.,increase,risk
Floxuridine,Viloxazine,Floxuridine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Floxuridine,Vinblastine,The risk or severity of adverse effects can be increased when Floxuridine is combined with Vinblastine.,increase,risk
Floxuridine,Vincristine,The risk or severity of adverse effects can be increased when Floxuridine is combined with Vincristine.,increase,risk
Floxuridine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Floxuridine.,increase,risk
Floxuridine,Vinorelbine,The risk or severity of adverse effects can be increased when Floxuridine is combined with Vinorelbine.,increase,risk
Floxuridine,Voclosporin,The risk or severity of adverse effects can be increased when Floxuridine is combined with Voclosporin.,increase,risk
Floxuridine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Floxuridine.,increase,risk
Floxuridine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Vorinostat,The risk or severity of adverse effects can be increased when Floxuridine is combined with Vorinostat.,increase,risk
Floxuridine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Warfarin,The metabolism of Warfarin can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Floxuridine.,increase,risk
Floxuridine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Zaleplon,Floxuridine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Floxuridine,Zanamivir,Floxuridine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Floxuridine,Zidovudine,The risk or severity of adverse effects can be increased when Floxuridine is combined with Zidovudine.,increase,risk
Floxuridine,Zileuton,The metabolism of Zileuton can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Floxuridine.,decrease,no risk
Floxuridine,Zonisamide,Zonisamide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Floxuridine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Floxuridine.,decrease,no risk
Tolcapone,Bisoprolol,The risk or severity of adverse effects can be increased when Tolcapone is combined with Bisoprolol.,increase,risk
Tolcapone,Bisoxatin,Tolcapone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tolcapone,Bleomycin,Bleomycin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Bosentan,Tolcapone may increase the hypotensive activities of Bosentan.,increase,no risk
Tolcapone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Tolcapone.,increase,risk
Tolcapone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Tolcapone.,increase,risk
Tolcapone,Bretylium,The risk or severity of adverse effects can be increased when Tolcapone is combined with Bretylium.,increase,risk
Tolcapone,Brexanolone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Brexanolone.,increase,risk
Tolcapone,Brexpiprazole,The therapeutic efficacy of Tolcapone can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Tolcapone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.,increase,no risk
Tolcapone,Brivaracetam,The risk or severity of CNS depression can be increased when Tolcapone is combined with Brivaracetam.,increase,risk
Tolcapone,Bromazepam,The risk or severity of CNS depression can be increased when Tolcapone is combined with Bromazepam.,increase,risk
Tolcapone,Bromocriptine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Bromocriptine.,increase,risk
Tolcapone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolcapone,Bromperidol,The risk or severity of CNS depression can be increased when Tolcapone is combined with Bromperidol.,increase,risk
Tolcapone,Brompheniramine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Brompheniramine.,increase,risk
Tolcapone,Budesonide,Tolcapone may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Tolcapone,Bumadizone,Bumadizone may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Bumetanide,Bumetanide may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolcapone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Tolcapone.,increase,risk
Tolcapone,Buprenorphine,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Tolcapone,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Tolcapone.,increase,risk
Tolcapone,Buspirone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Buspirone.,increase,risk
Tolcapone,Butabarbital,Butabarbital may increase the hypotensive activities of Tolcapone.,increase,no risk
Tolcapone,Butalbital,Butalbital may increase the hypotensive activities of Tolcapone.,increase,no risk
Tolcapone,Butaperazine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Butaperazine.,increase,risk
Tolcapone,Butobarbital,The risk or severity of CNS depression can be increased when Tolcapone is combined with Butobarbital.,increase,risk
Tolcapone,Butorphanol,The risk or severity of CNS depression can be increased when Tolcapone is combined with Butorphanol.,increase,risk
Tolcapone,Butriptyline,The risk or severity of CNS depression can be increased when Tolcapone is combined with Butriptyline.,increase,risk
Tolcapone,Gabapentin,The risk or severity of CNS depression can be increased when Tolcapone is combined with Gabapentin.,increase,risk
Tolcapone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tolcapone is combined with Gabapentin enacarbil.,increase,risk
Tolcapone,Gadobenic acid,Tolcapone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Tolcapone,Gadodiamide,Gadodiamide may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Gadofosveset trisodium,Tolcapone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tolcapone,Gadopentetic acid,Tolcapone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Tolcapone,Gadoteric acid,Tolcapone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tolcapone,Gadoteridol,Tolcapone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Tolcapone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Tolcapone is combined with Gallamine triethiodide.,increase,risk
Tolcapone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tolcapone is combined with Ganaxolone.",increase,risk
Tolcapone,Ganciclovir,Tolcapone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tolcapone,Gemcitabine,Tolcapone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Tolcapone,Gemfibrozil,Tolcapone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Tolcapone,Gentamicin,Tolcapone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tolcapone,Gepirone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Gepirone.,increase,risk
Tolcapone,Gimeracil,Tolcapone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tolcapone,Givosiran,Givosiran may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Glipizide,Tolcapone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tolcapone,Glutethimide,The risk or severity of CNS depression can be increased when Tolcapone is combined with Glutethimide.,increase,risk
Tolcapone,Glycerol phenylbutyrate,Tolcapone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tolcapone,Golodirsen,Tolcapone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tolcapone,Goserelin,Goserelin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Granisetron,The risk or severity of CNS depression can be increased when Tolcapone is combined with Granisetron.,increase,risk
Tolcapone,Guanabenz,Tolcapone may increase the hypotensive activities of Guanabenz.,increase,no risk
Tolcapone,Guanadrel,Tolcapone may increase the hypotensive activities of Guanadrel.,increase,no risk
Tolcapone,Guanethidine,Tolcapone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tolcapone,Guanfacine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Guanfacine.,increase,risk
Tolcapone,Guanoxan,Tolcapone may increase the hypotensive activities of Guanoxan.,increase,no risk
Tolcapone,Halazepam,The risk or severity of CNS depression can be increased when Tolcapone is combined with Halazepam.,increase,risk
Tolcapone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tolcapone.,increase,risk
Tolcapone,Halothane,The risk or severity of CNS depression can be increased when Tolcapone is combined with Halothane.,increase,risk
Tolcapone,Hexafluronium,The risk or severity of CNS depression can be increased when Tolcapone is combined with Hexafluronium.,increase,risk
Tolcapone,Hydralazine,The risk or severity of adverse effects can be increased when Tolcapone is combined with Hydralazine.,increase,risk
Tolcapone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolcapone,Hydrocodone,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tolcapone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolcapone,Hydromorphone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Hydromorphone.,increase,risk
Tolcapone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Hydroxyethyl Starch,Tolcapone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tolcapone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.,increase,no risk
Tolcapone,Kanamycin,Tolcapone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tolcapone,Ketamine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Ketamine.,increase,risk
Tolcapone,Ketazolam,The risk or severity of CNS depression can be increased when Tolcapone is combined with Ketazolam.,increase,risk
Tolcapone,Ketoprofen,Ketoprofen may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Ketorolac,Ketorolac may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Obinutuzumab,The risk or severity of adverse effects can be increased when Tolcapone is combined with Obinutuzumab.,increase,risk
Tolcapone,Octinoxate,Tolcapone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tolcapone,Olanzapine,The therapeutic efficacy of Tolcapone can be decreased when used in combination with Olanzapine.,decrease,no risk
Tolcapone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tolcapone is combined with Oliceridine.",increase,risk
Tolcapone,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Tolcapone.,increase,risk
Tolcapone,Olsalazine,Olsalazine may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Ondansetron,The risk or severity of CNS depression can be increased when Tolcapone is combined with Ondansetron.,increase,risk
Tolcapone,Opicapone,The risk or severity of adverse effects can be increased when Tolcapone is combined with Opicapone.,increase,risk
Tolcapone,Opium,The risk or severity of CNS depression can be increased when Tolcapone is combined with Opium.,increase,risk
Tolcapone,Orphenadrine,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tolcapone,Oseltamivir,Oseltamivir may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Oxacillin,Tolcapone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Tolcapone,Oxaprozin,Oxaprozin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Oxazepam,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxazepam.,increase,risk
Tolcapone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxcarbazepine.,increase,risk
Tolcapone,Oxitriptan,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxitriptan.,increase,risk
Tolcapone,Oxprenolol,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxprenolol.,increase,risk
Tolcapone,Oxybenzone,Tolcapone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tolcapone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxybuprocaine.,increase,risk
Tolcapone,Oxycodone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxycodone.,increase,risk
Tolcapone,Oxymorphone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Oxymorphone.,increase,risk
Tolcapone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Oxyquinoline,Tolcapone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tolcapone,Quazepam,The risk or severity of CNS depression can be increased when Tolcapone is combined with Quazepam.,increase,risk
Tolcapone,Quetiapine,The therapeutic efficacy of Tolcapone can be decreased when used in combination with Quetiapine.,decrease,no risk
Tolcapone,Quinapril,The risk or severity of adverse effects can be increased when Tolcapone is combined with Quinapril.,increase,risk
Tolcapone,Quinethazone,Quinethazone may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolcapone,Quinidine,Tolcapone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tolcapone,Quinine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Quinine.,increase,risk
Tolcapone,Quinupramine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Quinupramine.,increase,risk
Tolcapone,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Tolcapone.,increase,risk
Tolcapone,Urethane,The risk or severity of CNS depression can be increased when Tolcapone is combined with Urethane.,increase,risk
Tolcapone,Vaborbactam,Tolcapone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tolcapone,Valaciclovir,Valaciclovir may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Valbenazine,Tolcapone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tolcapone,Valdecoxib,Valdecoxib may decrease the excretion rate of Tolcapone which could result in a higher serum level.,decrease,no risk
Tolcapone,Valganciclovir,Tolcapone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tolcapone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tolcapone.,increase,risk
Tolcapone,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Tolcapone.,increase,risk
Tolcapone,Vancomycin,Tolcapone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tolcapone,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Tolcapone.,increase,risk
Tolcapone,Varenicline,Tolcapone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tolcapone,Vecuronium,The risk or severity of CNS depression can be increased when Tolcapone is combined with Vecuronium.,increase,risk
Tolcapone,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tolcapone.,increase,risk
Tolcapone,Verapamil,The risk or severity of adverse effects can be increased when Tolcapone is combined with Verapamil.,increase,risk
Tolcapone,Vericiguat,The risk or severity of adverse effects can be increased when Tolcapone is combined with Vericiguat.,increase,risk
Tolcapone,Vigabatrin,The risk or severity of CNS depression can be increased when Tolcapone is combined with Vigabatrin.,increase,risk
Tolcapone,Vilanterol,Tolcapone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Tolcapone,Vilazodone,The risk or severity of CNS depression can be increased when Tolcapone is combined with Vilazodone.,increase,risk
Tolcapone,Viloxazine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Viloxazine.,increase,risk
Tolcapone,Vortioxetine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Vortioxetine.,increase,risk
Tolcapone,Warfarin,Tolcapone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Tolcapone,Yohimbine,The risk or severity of CNS depression can be increased when Tolcapone is combined with Yohimbine.,increase,risk
Tolcapone,Zaleplon,The risk or severity of CNS depression can be increased when Tolcapone is combined with Zaleplon.,increase,risk
Tolcapone,Zanamivir,Tolcapone may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Tolcapone,Ziconotide,The risk or severity of CNS depression can be increased when Tolcapone is combined with Ziconotide.,increase,risk
Tolcapone,Zimelidine,The risk or severity of adverse effects can be increased when Tolcapone is combined with Zimelidine.,increase,risk
Tolcapone,Ziprasidone,The risk or severity of adverse effects can be increased when Tolcapone is combined with Ziprasidone.,increase,risk
Tolcapone,Zofenopril,Tolcapone may increase the hypotensive activities of Zofenopril.,increase,no risk
Tolcapone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tolcapone.,increase,risk
Tolcapone,Zolpidem,Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tolcapone,Zonisamide,The risk or severity of CNS depression can be increased when Tolcapone is combined with Zonisamide.,increase,risk
Tolcapone,Zopiclone,The risk or severity of adverse effects can be increased when Tolcapone is combined with Zopiclone.,increase,risk
Tolcapone,Zotepine,The therapeutic efficacy of Tolcapone can be decreased when used in combination with Zotepine.,decrease,no risk
Tolcapone,Zuclopenthixol,The therapeutic efficacy of Tolcapone can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Tolcapone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tolcapone.,increase,risk
Fluorometholone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Gemcitabine,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Gemcitabine.,increase,risk
Fluorometholone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluorometholone.,increase,risk
Fluorometholone,Gestrinone,The serum concentration of Fluorometholone can be increased when it is combined with Gestrinone.,increase,no risk
Fluorometholone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Glatiramer,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Glatiramer.,increase,risk
Fluorometholone,Gliclazide,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Gliclazide.,increase,risk
Fluorometholone,Glimepiride,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Glimepiride.,increase,risk
Fluorometholone,Glipizide,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Glipizide.,increase,risk
Fluorometholone,Gliquidone,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Gliquidone.,increase,risk
Fluorometholone,Glofitamab,The serum concentration of Fluorometholone can be increased when it is combined with Glofitamab.,increase,no risk
Fluorometholone,Glyburide,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Glyburide.,increase,risk
Fluorometholone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Glycol salicylate.,increase,risk
Fluorometholone,Glymidine,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Glymidine.,increase,risk
Fluorometholone,Golimumab,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Golimumab.,increase,risk
Fluorometholone,Guselkumab,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Guselkumab.,increase,risk
Fluorometholone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fluorometholone.,increase,no risk
Fluorometholone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Fluorometholone.,increase,risk
Fluorometholone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Fluorometholone is combined with Hydrochlorothiazide.,increase,risk
Fluorometholone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Hydrocortisone acetate.,increase,risk
Fluorometholone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Hydrocortisone butyrate.,increase,risk
Fluorometholone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Hydrocortisone succinate.,increase,risk
Fluorometholone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Fluorometholone is combined with Hydroflumethiazide.,increase,risk
Fluorometholone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Hydroxychloroquine.,increase,risk
Fluorometholone,Hydroxyprogesterone caproate,The serum concentration of Fluorometholone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Fluorometholone,Hydroxyurea,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Hydroxyurea.,increase,risk
Fluorometholone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Ketoprofen.,increase,risk
Fluorometholone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Ketorolac.,increase,risk
Fluorometholone,Obinutuzumab,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Obinutuzumab.,increase,risk
Fluorometholone,Ocrelizumab,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Ocrelizumab.,increase,risk
Fluorometholone,Ofatumumab,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Ofatumumab.,increase,risk
Fluorometholone,Olaparib,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Olaparib.,increase,risk
Fluorometholone,Olodaterol,The risk or severity of hypokalemia can be increased when Fluorometholone is combined with Olodaterol.,increase,risk
Fluorometholone,Omaveloxolone,The serum concentration of Fluorometholone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Fluorometholone,Orciprenaline,The risk or severity of hypokalemia can be increased when Fluorometholone is combined with Orciprenaline.,increase,risk
Fluorometholone,Oxaliplatin,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Oxaliplatin.,increase,risk
Fluorometholone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Oxaprozin.,increase,risk
Fluorometholone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Oxyphenbutazone.,increase,risk
Fluorometholone,Ozanimod,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Ozanimod.,increase,risk
Fluorometholone,Quinethazone,Fluorometholone may increase the hypokalemic activities of Quinethazone.,increase,no risk
Fluorometholone,Quinine,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Quinine.,increase,risk
Fluorometholone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Fluorometholone.,increase,risk
Fluorometholone,Ulipristal,The serum concentration of Fluorometholone can be increased when it is combined with Ulipristal.,increase,no risk
Fluorometholone,Upadacitinib,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Upadacitinib.,increase,risk
Fluorometholone,Vadadustat,The serum concentration of Fluorometholone can be increased when it is combined with Vadadustat.,increase,no risk
Fluorometholone,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Valdecoxib.,increase,risk
Fluorometholone,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Fluorometholone.,increase,risk
Fluorometholone,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluorometholone.,increase,risk
Fluorometholone,Vedolizumab,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vedolizumab.,increase,risk
Fluorometholone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Vilanterol,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vilanterol.,increase,risk
Fluorometholone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Vildagliptin.,increase,risk
Fluorometholone,Viloxazine,The metabolism of Fluorometholone can be decreased when combined with Viloxazine.,decrease,no risk
Fluorometholone,Vinblastine,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vinblastine.,increase,risk
Fluorometholone,Vincristine,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vincristine.,increase,risk
Fluorometholone,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Fluorometholone.,increase,risk
Fluorometholone,Vinorelbine,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vinorelbine.,increase,risk
Fluorometholone,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Fluorometholone.,decrease,no risk
Fluorometholone,Voclosporin,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Voclosporin.,increase,risk
Fluorometholone,Voriconazole,The serum concentration of Fluorometholone can be increased when it is combined with Voriconazole.,increase,no risk
Fluorometholone,Vorinostat,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vorinostat.,increase,risk
Fluorometholone,Warfarin,Fluorometholone may increase the anticoagulant activities of Warfarin.,increase,no risk
Fluorometholone,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Fluorometholone.,increase,risk
Fluorometholone,Zidovudine,The risk or severity of adverse effects can be increased when Fluorometholone is combined with Zidovudine.,increase,risk
Nitroprusside,Brivaracetam,Nitroprusside may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nitroprusside,Bromazepam,Nitroprusside may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Nitroprusside,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Nitroprusside,Bromotheophylline,Bromotheophylline may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nitroprusside,Budesonide,Nitroprusside may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Nitroprusside,Bumadizone,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Bumadizone.,decrease,no risk
Nitroprusside,Bumetanide,Bumetanide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nitroprusside,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Nitroprusside.,increase,risk
Nitroprusside,Bupropion,Nitroprusside may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Nitroprusside,Buspirone,Buspirone may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Nitroprusside,Butabarbital,Butabarbital may increase the hypotensive activities of Nitroprusside.,increase,no risk
Nitroprusside,Butalbital,Butalbital may increase the hypotensive activities of Nitroprusside.,increase,no risk
Nitroprusside,Butriptyline,Butriptyline may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Nitroprusside,Gabapentin enacarbil,Nitroprusside may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gadobenic acid,Nitroprusside may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gadodiamide,Gadodiamide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gadofosveset trisodium,Nitroprusside may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gadopentetic acid,Nitroprusside may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gadoteric acid,Nitroprusside may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gadoteridol,Nitroprusside may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Nitroprusside,Ganciclovir,Nitroprusside may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gatifloxacin,Nitroprusside can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nitroprusside,Gemcitabine,Nitroprusside may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gemfibrozil,Nitroprusside may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gemifloxacin,Nitroprusside can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nitroprusside,Gentamicin,Nitroprusside may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nitroprusside,Gimeracil,Nitroprusside may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nitroprusside,Givosiran,Givosiran may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Nitroprusside,Glipizide,Nitroprusside may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Nitroprusside,Glycerol phenylbutyrate,Nitroprusside may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nitroprusside,Glycol salicylate,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Nitroprusside,Golodirsen,Nitroprusside may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nitroprusside,Goserelin,Goserelin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Nitroprusside,Grepafloxacin,Nitroprusside can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nitroprusside,Guanabenz,Guanabenz may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Nitroprusside,Guanadrel,Guanadrel may increase the hypotensive activities of Nitroprusside.,increase,no risk
Nitroprusside,Guanethidine,Nitroprusside may increase the hypotensive activities of Guanethidine.,increase,no risk
Nitroprusside,Guanfacine,Guanfacine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Nitroprusside,Guanoxan,Nitroprusside may increase the hypotensive activities of Guanoxan.,increase,no risk
Nitroprusside,Haloperidol,Nitroprusside may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Nitroprusside,Halothane,Halothane may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Nitroprusside,Hydralazine,Nitroprusside may increase the hypotensive activities of Hydralazine.,increase,no risk
Nitroprusside,Hydrochlorothiazide,The therapeutic efficacy of Nitroprusside can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Nitroprusside,Hydroflumethiazide,The therapeutic efficacy of Nitroprusside can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Nitroprusside,Hydromorphone,Nitroprusside may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Nitroprusside,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,decrease,no risk
Nitroprusside,Hydroxyethyl Starch,Nitroprusside may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nitroprusside,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Hydroxyurea.,increase,risk
Nitroprusside,Kanamycin,Nitroprusside may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nitroprusside,Ketamine,Nitroprusside may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Nitroprusside,Ketazolam,Nitroprusside may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nitroprusside,Ketoprofen,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Ketoprofen.,decrease,no risk
Nitroprusside,Ketorolac,The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Ketorolac.,decrease,no risk
Calcium glucoheptonate,Quinethazone,Quinethazone may decrease the excretion rate of Calcium glucoheptonate which could result in a higher serum level.,decrease,no risk
Calcium glucoheptonate,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium glucoheptonate.,decrease,no risk
Calcium glucoheptonate,Vitamin D,The risk or severity of adverse effects can be increased when Vitamin D is combined with Calcium glucoheptonate.,increase,risk
Calcium glucoheptonate,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Calcium glucoheptonate.,decrease,no risk
Calcium glucoheptonate,Ziconotide,The therapeutic efficacy of Ziconotide can be decreased when used in combination with Calcium glucoheptonate.,decrease,no risk
Calcium glucoheptonate,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium glucoheptonate.,decrease,no risk
Calcium glucoheptonate,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Calcium glucoheptonate.,decrease,no risk
Hydromorphone,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Benperidol,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Benperidol.,increase,risk
Hydromorphone,Benserazide,Hydromorphone may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Hydromorphone,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Hydromorphone.,increase,risk
Hydromorphone,Benzhydrocodone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Benzhydrocodone.,increase,risk
Hydromorphone,Benznidazole,Hydromorphone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Hydromorphone,Benzocaine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Benzocaine.,increase,risk
Hydromorphone,Benzphetamine,Benzphetamine may increase the analgesic activities of Hydromorphone.,increase,no risk
Hydromorphone,Benzthiazide,Benzthiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydromorphone,Benzydamine,Benzydamine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Benzyl alcohol,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Benzyl alcohol.,increase,risk
Hydromorphone,Bepotastine,Hydromorphone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bexarotene,The metabolism of Hydromorphone can be decreased when combined with Bexarotene.,decrease,no risk
Hydromorphone,Bicisate,Hydromorphone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bimekizumab,The metabolism of Hydromorphone can be increased when combined with Bimekizumab.,increase,no risk
Hydromorphone,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Hydromorphone.,increase,risk
Hydromorphone,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hydromorphone.,decrease,no risk
Hydromorphone,Bismuth subgallate,Hydromorphone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bisoprolol,Hydromorphone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Hydromorphone.,decrease,no risk
Hydromorphone,Bleomycin,Bleomycin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bortezomib,The metabolism of Hydromorphone can be decreased when combined with Bortezomib.,decrease,no risk
Hydromorphone,Bosentan,The metabolism of Hydromorphone can be increased when combined with Bosentan.,increase,no risk
Hydromorphone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Hydromorphone.,increase,risk
Hydromorphone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Hydromorphone.,increase,risk
Hydromorphone,Brexanolone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Brexanolone.,increase,risk
Hydromorphone,Brexpiprazole,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Brexpiprazole.,increase,risk
Hydromorphone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Hydromorphone,Brivaracetam,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Brivaracetam.,increase,risk
Hydromorphone,Bromazepam,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bromazepam.,increase,risk
Hydromorphone,Bromocriptine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Bromocriptine.,increase,risk
Hydromorphone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydromorphone,Bromperidol,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Bromperidol.,increase,risk
Hydromorphone,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Hydromorphone.,increase,risk
Hydromorphone,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Hydromorphone.,increase,risk
Hydromorphone,Budesonide,Hydromorphone may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bumadizone,Bumadizone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Bumetanide,Bumetanide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydromorphone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Hydromorphone.,increase,risk
Hydromorphone,Buprenorphine,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Hydromorphone,Bupropion,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Bupropion.,increase,risk
Hydromorphone,Buspirone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Buspirone.,increase,risk
Hydromorphone,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Hydromorphone.,increase,risk
Hydromorphone,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Hydromorphone.,increase,risk
Hydromorphone,Butaperazine,The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Hydromorphone.,increase,risk
Hydromorphone,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Hydromorphone.,increase,risk
Hydromorphone,Butorphanol,The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Butorphanol.,decrease,no risk
Hydromorphone,Butriptyline,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Butriptyline.,increase,risk
Hydromorphone,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Hydromorphone.,increase,risk
Hydromorphone,Gabapentin,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Gabapentin.,increase,risk
Hydromorphone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Gabapentin enacarbil.,increase,risk
Hydromorphone,Gadobenic acid,Hydromorphone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gadodiamide,Gadodiamide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gadofosveset trisodium,Hydromorphone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gadopentetic acid,Hydromorphone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gadoteric acid,Hydromorphone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gadoteridol,Hydromorphone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Hydromorphone.,increase,risk
Hydromorphone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Hydromorphone is combined with Ganaxolone.",increase,risk
Hydromorphone,Ganciclovir,Hydromorphone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gemcitabine,Hydromorphone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gemfibrozil,The metabolism of Hydromorphone can be decreased when combined with Gemfibrozil.,decrease,no risk
Hydromorphone,Gentamicin,Hydromorphone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Hydromorphone.,increase,risk
Hydromorphone,Gimeracil,Hydromorphone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Hydromorphone,Ginkgo biloba,The metabolism of Hydromorphone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Hydromorphone,Givosiran,Givosiran may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Hydromorphone.,decrease,no risk
Hydromorphone,Glimepiride,The metabolism of Hydromorphone can be decreased when combined with Glimepiride.,decrease,no risk
Hydromorphone,Glipizide,Hydromorphone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Hydromorphone,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Hydromorphone.,decrease,no risk
Hydromorphone,Glofitamab,The serum concentration of Hydromorphone can be increased when it is combined with Glofitamab.,increase,no risk
Hydromorphone,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Hydromorphone.,decrease,no risk
Hydromorphone,Glutethimide,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Glutethimide.,increase,risk
Hydromorphone,Glyburide,The metabolism of Hydromorphone can be decreased when combined with Glyburide.,decrease,no risk
Hydromorphone,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hydromorphone.,decrease,no risk
Hydromorphone,Glycerol phenylbutyrate,Hydromorphone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Hydromorphone,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hydromorphone.,increase,risk
Hydromorphone,Golimumab,The metabolism of Hydromorphone can be increased when combined with Golimumab.,increase,no risk
Hydromorphone,Golodirsen,Hydromorphone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Hydromorphone,Goserelin,Goserelin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Granisetron,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Granisetron.,increase,risk
Hydromorphone,Guanethidine,Hydromorphone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Hydromorphone,Guanfacine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Guanfacine.,increase,risk
Hydromorphone,Halazepam,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Halazepam.,increase,risk
Hydromorphone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Hydromorphone.,increase,risk
Hydromorphone,Halothane,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Halothane.,increase,risk
Hydromorphone,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Hydromorphone.,increase,risk
Hydromorphone,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Hydromorphone.,increase,risk
Hydromorphone,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Hydromorphone.,increase,risk
Hydromorphone,Hydralazine,Hydromorphone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydromorphone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydromorphone,Hydrocodone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydromorphone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydromorphone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Hydroxyethyl Starch,Hydromorphone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Hydromorphone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Hydromorphone,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hydromorphone.,increase,risk
Hydromorphone,Kanamycin,Hydromorphone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Hydromorphone,Ketamine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ketamine.,increase,risk
Hydromorphone,Ketazolam,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ketazolam.,increase,risk
Hydromorphone,Ketoconazole,The metabolism of Hydromorphone can be decreased when combined with Ketoconazole.,decrease,no risk
Hydromorphone,Ketoprofen,Ketoprofen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Ketorolac,Ketorolac may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Octinoxate,Hydromorphone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Hydromorphone,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Hydromorphone.,increase,risk
Hydromorphone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hydromorphone is combined with Oliceridine.",increase,risk
Hydromorphone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Hydromorphone.,decrease,no risk
Hydromorphone,Olsalazine,Olsalazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Ondansetron,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ondansetron.,increase,risk
Hydromorphone,Opium,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Opium.,increase,risk
Hydromorphone,Oritavancin,The metabolism of Hydromorphone can be decreased when combined with Oritavancin.,decrease,no risk
Hydromorphone,Orphenadrine,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Hydromorphone,Oseltamivir,Oseltamivir may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Hydromorphone.,decrease,no risk
Hydromorphone,Oxacillin,Hydromorphone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Hydromorphone,Oxandrolone,The metabolism of Hydromorphone can be decreased when combined with Oxandrolone.,decrease,no risk
Hydromorphone,Oxaprozin,Oxaprozin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Oxazepam,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxazepam.,increase,risk
Hydromorphone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Oxcarbazepine.,increase,risk
Hydromorphone,Oxitriptan,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Oxitriptan.,increase,risk
Hydromorphone,Oxprenolol,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Oxprenolol.,increase,risk
Hydromorphone,Oxybenzone,Hydromorphone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Oxybuprocaine.,increase,risk
Hydromorphone,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hydromorphone.,increase,risk
Hydromorphone,Oxycodone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxycodone.,increase,risk
Hydromorphone,Oxymorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxymorphone.,increase,risk
Hydromorphone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydromorphone,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hydromorphone.,increase,risk
Hydromorphone,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hydromorphone.,decrease,no risk
Hydromorphone,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hydromorphone.,increase,risk
Hydromorphone,Oxyquinoline,Hydromorphone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Indomethacin,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Indomethacin.,increase,risk
Indomethacin,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Indomethacin.,increase,risk
Indomethacin,Bacitracin,The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Bacitracin.,increase,risk
Indomethacin,Baclofen,Indomethacin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Indomethacin,Balsalazide,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Indomethacin.,increase,no risk
Indomethacin,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Indomethacin.,increase,risk
Indomethacin,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Indomethacin.,increase,risk
Indomethacin,Beclomethasone dipropionate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Indomethacin.,increase,risk
Indomethacin,Belantamab mafodotin,Indomethacin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Indomethacin,Belatacept,The risk or severity of adverse effects can be increased when Indomethacin is combined with Belatacept.,increase,risk
Indomethacin,Belimumab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Belimumab.,increase,risk
Indomethacin,Belinostat,The metabolism of Belinostat can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Belumosudil,The risk or severity of adverse effects can be increased when Indomethacin is combined with Belumosudil.,increase,risk
Indomethacin,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Indomethacin.,increase,no risk
Indomethacin,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Bemiparin.,increase,risk
Indomethacin,Bempedoic acid,The metabolism of Bempedoic acid can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Benazepril.",increase,risk
Indomethacin,Bendamustine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Bendamustine.,increase,risk
Indomethacin,Bendazac,The risk or severity of adverse effects can be increased when Indomethacin is combined with Bendazac.,increase,risk
Indomethacin,Bendroflumethiazide,The therapeutic efficacy of Indomethacin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Indomethacin,Benorilate,The risk or severity of adverse effects can be increased when Indomethacin is combined with Benorilate.,increase,risk
Indomethacin,Benoxaprofen,The risk or severity of adverse effects can be increased when Indomethacin is combined with Benoxaprofen.,increase,risk
Indomethacin,Benserazide,Indomethacin may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Indomethacin,Benzatropine,Indomethacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Indomethacin,Benznidazole,Indomethacin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Indomethacin,Benzoic acid,The excretion of Indomethacin can be decreased when combined with Benzoic acid.,decrease,no risk
Indomethacin,Benzphetamine,The risk or severity of hypertension can be increased when Indomethacin is combined with Benzphetamine.,increase,risk
Indomethacin,Benzthiazide,The therapeutic efficacy of Indomethacin can be decreased when used in combination with Benzthiazide.,decrease,no risk
Indomethacin,Benzydamine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Benzydamine.,increase,risk
Indomethacin,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Bepotastine,Indomethacin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Indomethacin,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Indomethacin.,increase,risk
Indomethacin,Betaxolol,Indomethacin may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Indomethacin,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Indomethacin.,increase,risk
Indomethacin,Betulinic Acid,The risk or severity of adverse effects can be increased when Indomethacin is combined with Betulinic Acid.,increase,risk
Indomethacin,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Bexagliflozin.,increase,risk
Indomethacin,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Indomethacin.,increase,risk
Indomethacin,Bicisate,Indomethacin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Indomethacin,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Bimekizumab,The metabolism of Indomethacin can be increased when combined with Bimekizumab.,increase,no risk
Indomethacin,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Bismuth subgallate,Indomethacin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Indomethacin,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Bisoprolol,Indomethacin may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Indomethacin,Bisoxatin,Indomethacin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Indomethacin,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Bivalirudin.,increase,risk
Indomethacin,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Indomethacin.,increase,risk
Indomethacin,Blinatumomab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Blinatumomab.,increase,risk
Indomethacin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Indomethacin.",decrease,no risk
Indomethacin,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Indomethacin.,increase,risk
Indomethacin,Bosentan,Bosentan may decrease the excretion rate of Indomethacin which could result in a higher serum level.,decrease,no risk
Indomethacin,Bosutinib,The risk or severity of adverse effects can be increased when Indomethacin is combined with Bosutinib.,increase,risk
Indomethacin,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Indomethacin is combined with Brentuximab vedotin.,increase,risk
Indomethacin,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Brexpiprazole,The risk or severity of hypertension can be increased when Indomethacin is combined with Brexpiprazole.,increase,risk
Indomethacin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Indomethacin.,increase,no risk
Indomethacin,Brivaracetam,Indomethacin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Indomethacin,Brodalumab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Brodalumab.,increase,risk
Indomethacin,Bromazepam,Indomethacin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Indomethacin,Bromfenac,The risk or severity of adverse effects can be increased when Indomethacin is combined with Bromfenac.,increase,risk
Indomethacin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Bromocriptine.,increase,risk
Indomethacin,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Indomethacin.,increase,risk
Indomethacin,Bufexamac,The risk or severity of adverse effects can be increased when Indomethacin is combined with Bufexamac.,increase,risk
Indomethacin,Bumadizone,The risk or severity of adverse effects can be increased when Indomethacin is combined with Bumadizone.,increase,risk
Indomethacin,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Bupropion,Indomethacin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Indomethacin,Buspirone,The risk or severity of hypertension can be increased when Indomethacin is combined with Buspirone.,increase,risk
Indomethacin,Busulfan,The risk or severity of adverse effects can be increased when Indomethacin is combined with Busulfan.,increase,risk
Indomethacin,Butabarbital,Indomethacin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Indomethacin,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Indomethacin.,increase,risk
Indomethacin,Gabapentin enacarbil,Indomethacin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadobenic acid,Indomethacin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadodiamide,Indomethacin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadofosveset trisodium,Indomethacin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadopentetic acid,Indomethacin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadoteric acid,Indomethacin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadoteridol,Indomethacin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Indomethacin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Ganciclovir,The excretion of Indomethacin can be decreased when combined with Ganciclovir.,decrease,no risk
Indomethacin,Gatifloxacin,Indomethacin may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Indomethacin,Gemcitabine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Gemcitabine.,increase,risk
Indomethacin,Gemfibrozil,The metabolism of Indomethacin can be decreased when combined with Gemfibrozil.,decrease,no risk
Indomethacin,Gemifloxacin,Indomethacin may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Indomethacin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Indomethacin.,increase,risk
Indomethacin,Gentamicin,Indomethacin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Indomethacin,Gimeracil,Indomethacin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Indomethacin,Ginkgo biloba,The metabolism of Indomethacin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Indomethacin,Givosiran,The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Givosiran.,increase,risk
Indomethacin,Glatiramer,The risk or severity of adverse effects can be increased when Indomethacin is combined with Glatiramer.,increase,risk
Indomethacin,Glecaprevir,The metabolism of Indomethacin can be decreased when combined with Glecaprevir.,decrease,no risk
Indomethacin,Gliclazide,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Gliclazide.,increase,risk
Indomethacin,Glimepiride,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Glimepiride.,increase,risk
Indomethacin,Glipizide,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Glipizide.,increase,risk
Indomethacin,Gliquidone,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Gliquidone.,increase,risk
Indomethacin,Glofitamab,The serum concentration of Indomethacin can be increased when it is combined with Glofitamab.,increase,no risk
Indomethacin,Glucagon,The therapeutic efficacy of Glucagon can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Glyburide,Glyburide may decrease the excretion rate of Indomethacin which could result in a higher serum level.,decrease,no risk
Indomethacin,Glycerol phenylbutyrate,Indomethacin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Indomethacin,Glycol salicylate,The risk or severity of adverse effects can be increased when Indomethacin is combined with Glycol salicylate.,increase,risk
Indomethacin,Glycyrrhizic acid,Indomethacin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Indomethacin,Glymidine,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Glymidine.,increase,risk
Indomethacin,Golimumab,The metabolism of Indomethacin can be increased when combined with Golimumab.,increase,no risk
Indomethacin,Golodirsen,Indomethacin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Indomethacin,Goserelin,Indomethacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Indomethacin,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Grepafloxacin,Indomethacin may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Indomethacin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Guanidine,The excretion of Indomethacin can be decreased when combined with Guanidine.,decrease,no risk
Indomethacin,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Guselkumab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Guselkumab.,increase,risk
Indomethacin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Indomethacin.,increase,no risk
Indomethacin,Halothane,The risk or severity of hypertension can be increased when Indomethacin is combined with Halothane.,increase,risk
Indomethacin,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Heparin.,increase,risk
Indomethacin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Indomethacin.,increase,risk
Indomethacin,Hydralazine,Indomethacin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Indomethacin,Hydrochlorothiazide,The therapeutic efficacy of Indomethacin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Indomethacin,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Indomethacin.,increase,risk
Indomethacin,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Indomethacin.,increase,risk
Indomethacin,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Indomethacin.,increase,risk
Indomethacin,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Indomethacin.,increase,risk
Indomethacin,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Indomethacin.,increase,risk
Indomethacin,Hydroflumethiazide,The therapeutic efficacy of Indomethacin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Indomethacin,Hydromorphone,Indomethacin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Indomethacin,Hydroxocobalamin,Indomethacin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Indomethacin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Hydroxychloroquine.,increase,risk
Indomethacin,Hydroxyethyl Starch,Indomethacin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Indomethacin,Hydroxyurea,The risk or severity of adverse effects can be increased when Indomethacin is combined with Hydroxyurea.,increase,risk
Indomethacin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Kanamycin,Indomethacin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Indomethacin,Ketamine,Indomethacin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Indomethacin,Ketazolam,Indomethacin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Indomethacin,Ketoconazole,Ketoconazole may decrease the excretion rate of Indomethacin which could result in a higher serum level.,decrease,no risk
Indomethacin,Ketoprofen,The risk or severity of adverse effects can be increased when Indomethacin is combined with Ketoprofen.,increase,risk
Indomethacin,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Indomethacin.,increase,risk
Indomethacin,Obinutuzumab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Obinutuzumab.,increase,risk
Indomethacin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Indomethacin.,increase,no risk
Indomethacin,Octinoxate,Indomethacin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Indomethacin,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Indomethacin.,increase,risk
Indomethacin,Ofatumumab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Ofatumumab.,increase,risk
Indomethacin,Ofloxacin,Indomethacin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Indomethacin,Olanzapine,The metabolism of Indomethacin can be decreased when combined with Olanzapine.,decrease,no risk
Indomethacin,Olaparib,The risk or severity of adverse effects can be increased when Indomethacin is combined with Olaparib.,increase,risk
Indomethacin,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Indomethacin.",increase,risk
Indomethacin,Olodaterol,The risk or severity of hypertension can be increased when Indomethacin is combined with Olodaterol.,increase,risk
Indomethacin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Olsalazine.,increase,risk
Indomethacin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Indomethacin is combined with Omacetaxine mepesuccinate.,increase,risk
Indomethacin,Ombitasvir,The metabolism of Indomethacin can be decreased when combined with Ombitasvir.,decrease,no risk
Indomethacin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Opium,Indomethacin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Indomethacin,Orciprenaline,The risk or severity of hypertension can be increased when Indomethacin is combined with Orciprenaline.,increase,risk
Indomethacin,Oritavancin,The metabolism of Indomethacin can be decreased when combined with Oritavancin.,decrease,no risk
Indomethacin,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Ouabain,The excretion of Indomethacin can be decreased when combined with Ouabain.,decrease,no risk
Indomethacin,Oxacillin,Indomethacin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Indomethacin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Indomethacin.,increase,risk
Indomethacin,Oxandrolone,The metabolism of Indomethacin can be decreased when combined with Oxandrolone.,decrease,no risk
Indomethacin,Oxaprozin,The risk or severity of adverse effects can be increased when Indomethacin is combined with Oxaprozin.,increase,risk
Indomethacin,Oxazepam,Indomethacin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Indomethacin,Oxprenolol,Indomethacin may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Indomethacin,Oxybenzone,Indomethacin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Indomethacin,Oxymetazoline,The risk or severity of hypertension can be increased when Indomethacin is combined with Oxymetazoline.,increase,risk
Indomethacin,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Indomethacin is combined with Oxyphenbutazone.,increase,risk
Indomethacin,Oxyquinoline,Indomethacin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Indomethacin,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Ozanimod,The risk or severity of adverse effects can be increased when Indomethacin is combined with Ozanimod.,increase,risk
Indomethacin,Quetiapine,The risk or severity of hypertension can be increased when Indomethacin is combined with Quetiapine.,increase,risk
Indomethacin,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Quinapril.",increase,risk
Indomethacin,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Quinidine,Indomethacin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Indomethacin,Quinine,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Quinine.,increase,risk
Indomethacin,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Indomethacin.,increase,risk
Indomethacin,Quizartinib,The metabolism of Indomethacin can be decreased when combined with Quizartinib.,decrease,no risk
Indomethacin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Ubidecarenone.,increase,risk
Indomethacin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Indomethacin.,increase,risk
Indomethacin,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Upadacitinib,The risk or severity of adverse effects can be increased when Indomethacin is combined with Upadacitinib.,increase,risk
Indomethacin,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Urokinase.,increase,risk
Indomethacin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Indomethacin which could result in a higher serum level.,decrease,no risk
Indomethacin,Vaborbactam,Indomethacin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Indomethacin,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Indomethacin.,increase,no risk
Indomethacin,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Valbenazine,Indomethacin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Indomethacin,Valdecoxib,The risk or severity of adverse effects can be increased when Indomethacin is combined with Valdecoxib.,increase,risk
Indomethacin,Valganciclovir,Indomethacin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Indomethacin,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Indomethacin.",increase,risk
Indomethacin,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Indomethacin.,increase,risk
Indomethacin,Vancomycin,Indomethacin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Indomethacin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Varenicline,Indomethacin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Indomethacin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Indomethacin.,increase,risk
Indomethacin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Vasopressin,Indomethacin may increase the cardiodepressant activities of Vasopressin.,increase,no risk
Indomethacin,Vedolizumab,The risk or severity of adverse effects can be increased when Indomethacin is combined with Vedolizumab.,increase,risk
Indomethacin,Vemurafenib,The metabolism of Indomethacin can be decreased when combined with Vemurafenib.,decrease,no risk
Indomethacin,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Indomethacin.,increase,no risk
Indomethacin,Verapamil,Indomethacin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Indomethacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Indomethacin.,decrease,no risk
Indomethacin,Vilanterol,The risk or severity of adverse effects can be increased when Indomethacin is combined with Vilanterol.,increase,risk
Indomethacin,Vilazodone,The risk or severity of hypertension can be increased when Indomethacin is combined with Vilazodone.,increase,risk
Indomethacin,Vildagliptin,The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Vildagliptin.,increase,risk
Indomethacin,Viloxazine,Indomethacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Indomethacin,Vinblastine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinblastine.,increase,risk
Indomethacin,Vincristine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Vincristine.,increase,risk
Indomethacin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Indomethacin.,increase,risk
Indomethacin,Vinorelbine,The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinorelbine.,increase,risk
Indomethacin,Voclosporin,The risk or severity of adverse effects can be increased when Indomethacin is combined with Voclosporin.,increase,risk
Indomethacin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Vorapaxar.,increase,risk
Indomethacin,Voriconazole,The serum concentration of Indomethacin can be increased when it is combined with Voriconazole.,increase,no risk
Indomethacin,Vorinostat,The risk or severity of adverse effects can be increased when Indomethacin is combined with Vorinostat.,increase,risk
Indomethacin,Vortioxetine,The risk or severity of hypertension can be increased when Indomethacin is combined with Vortioxetine.,increase,risk
Indomethacin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Warfarin.,increase,risk
Indomethacin,Xamoterol,The risk or severity of hypertension can be increased when Indomethacin is combined with Xamoterol.,increase,risk
Indomethacin,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Ximelagatran.,increase,risk
Indomethacin,Xylometazoline,The risk or severity of hypertension can be increased when Indomethacin is combined with Xylometazoline.,increase,risk
Indomethacin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Indomethacin.,increase,risk
Indomethacin,Yohimbine,The risk or severity of hypertension can be increased when Indomethacin is combined with Yohimbine.,increase,risk
Indomethacin,Zafirlukast,The metabolism of Indomethacin can be decreased when combined with Zafirlukast.,decrease,no risk
Indomethacin,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Zaleplon,Indomethacin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Indomethacin,Zanamivir,Indomethacin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Indomethacin,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Indomethacin.,increase,risk
Indomethacin,Zileuton,The metabolism of Zileuton can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Indomethacin.,increase,risk
Indomethacin,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Indomethacin.,increase,risk
Indomethacin,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Zofenopril.",increase,risk
Indomethacin,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Zoledronic acid.,increase,risk
Indomethacin,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indomethacin.,increase,risk
Indomethacin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Indomethacin.,decrease,no risk
Indomethacin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Indomethacin.,decrease,no risk
Ethambutol,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Bicisate,Ethambutol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ethambutol,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Bismuth subgallate,Ethambutol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ethambutol,Bisoprolol,Ethambutol may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Ethambutol,Bisoxatin,Ethambutol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ethambutol,Bleomycin,Bleomycin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Bosentan,The metabolism of Bosentan can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Brivaracetam,Ethambutol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Ethambutol,Bromazepam,Ethambutol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Ethambutol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethambutol,Budesonide,Ethambutol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Ethambutol,Bumadizone,Bumadizone may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Bumetanide,Bumetanide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethambutol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Bupivacaine.,increase,risk
Ethambutol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Bupropion,Ethambutol may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Ethambutol,Buspirone,Ethambutol may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Ethambutol,Busulfan,The metabolism of Busulfan can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Butabarbital,Butabarbital may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Butacaine,The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Butacaine.,increase,risk
Ethambutol,Butamben,The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Butamben.,increase,risk
Ethambutol,Gabapentin enacarbil,Ethambutol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ethambutol,Gadobenic acid,Ethambutol may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ethambutol,Gadodiamide,Gadodiamide may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Gadofosveset trisodium,Ethambutol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ethambutol,Gadopentetic acid,Ethambutol may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ethambutol,Gadoteric acid,Ethambutol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ethambutol,Gadoteridol,Ethambutol may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ethambutol,Galantamine,The metabolism of Galantamine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Ganciclovir,Ethambutol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ethambutol,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Gemcitabine,Ethambutol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ethambutol,Gemfibrozil,Ethambutol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ethambutol,Gentamicin,Ethambutol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ethambutol,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Gimeracil,Ethambutol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ethambutol,Givosiran,Givosiran may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Glipizide,Ethambutol may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ethambutol,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Glyburide,The metabolism of Glyburide can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Glycerol phenylbutyrate,Ethambutol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ethambutol,Golodirsen,Ethambutol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ethambutol,Goserelin,Goserelin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Guanethidine,Ethambutol may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ethambutol,Guanfacine,Ethambutol may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ethambutol,Haloperidol,Ethambutol may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ethambutol,Halothane,The metabolism of Halothane can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Hydralazine,Ethambutol may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ethambutol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethambutol,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethambutol,Hydromorphone,Hydromorphone may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Hydroxyethyl Starch,Ethambutol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ethambutol,Kanamycin,Ethambutol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ethambutol,Ketamine,Ethambutol may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ethambutol,Ketazolam,Ethambutol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ethambutol,Ketoprofen,Ketoprofen may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Ketorolac,Ketorolac may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Octinoxate,Ethambutol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ethambutol,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Olaparib,The metabolism of Olaparib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Olsalazine,Olsalazine may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Opium,Ethambutol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ethambutol,Oseltamivir,Oseltamivir may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Oxacillin,Ethambutol may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ethambutol,Oxaprozin,Oxaprozin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Oxazepam,Ethambutol may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ethambutol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Oxetacaine.,increase,risk
Ethambutol,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Oxybenzone,Ethambutol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ethambutol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Oxybuprocaine.,increase,risk
Ethambutol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Oxyquinoline,Ethambutol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ethambutol,Quetiapine,Ethambutol may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ethambutol,Quinethazone,Quinethazone may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethambutol,Quinidine,The metabolism of Quinidine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Quinine,The metabolism of Quinine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ethambutol.,increase,no risk
Ethambutol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vaborbactam,Ethambutol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ethambutol,Valaciclovir,Valaciclovir may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Valbenazine,Ethambutol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ethambutol,Valdecoxib,Valdecoxib may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Valganciclovir,Ethambutol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ethambutol,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Valsartan,The metabolism of Valsartan can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vancomycin,Ethambutol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ethambutol,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Varenicline,Ethambutol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ethambutol,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Venlafaxine,Venlafaxine may decrease the excretion rate of Ethambutol which could result in a higher serum level.,decrease,no risk
Ethambutol,Verapamil,Ethambutol may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ethambutol,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ethambutol.,decrease,no risk
Ethambutol,Vilanterol,Ethambutol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ethambutol,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Viloxazine,Ethambutol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ethambutol,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vincristine,The metabolism of Vincristine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vindesine,The metabolism of Vindesine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Warfarin,The metabolism of Warfarin can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zaleplon,Ethambutol may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ethambutol,Zanamivir,Ethambutol may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ethambutol,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zileuton,The metabolism of Zileuton can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zonisamide,Zonisamide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ethambutol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zotepine,The metabolism of Zotepine can be decreased when combined with Ethambutol.,decrease,no risk
Ethambutol,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ethambutol.,decrease,no risk
Metformin,Bupropion,The excretion of Metformin can be decreased when combined with Bupropion.,decrease,no risk
Metformin,Buserelin,The therapeutic efficacy of Metformin can be decreased when used in combination with Buserelin.,decrease,no risk
Metformin,Buspirone,Metformin may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Metformin,Butabarbital,Butabarbital may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Metformin.,decrease,no risk
Metformin,Gabapentin enacarbil,Metformin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Metformin,Gadobenic acid,Metformin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Metformin,Gadodiamide,Gadodiamide may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Gadofosveset trisodium,Metformin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Metformin,Gadopentetic acid,Metformin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Metformin,Gadoteric acid,Metformin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Metformin,Gadoteridol,Metformin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Metformin,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Metformin.,decrease,no risk
Metformin,Gatifloxacin,The therapeutic efficacy of Metformin can be increased when used in combination with Gatifloxacin.,increase,no risk
Metformin,Gefapixant,The therapeutic efficacy of Metformin can be increased when used in combination with Gefapixant.,increase,no risk
Metformin,Gemcitabine,Metformin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Metformin,Gemfibrozil,Metformin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Metformin,Gemifloxacin,The therapeutic efficacy of Metformin can be increased when used in combination with Gemifloxacin.,increase,no risk
Metformin,Gentamicin,Metformin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Metformin,Gilteritinib,The excretion of Metformin can be decreased when combined with Gilteritinib.,decrease,no risk
Metformin,Gimeracil,Metformin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Metformin,Givosiran,Givosiran may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Glasdegib,The excretion of Metformin can be decreased when combined with Glasdegib.,decrease,no risk
Metformin,Gliquidone,The risk or severity of hypoglycemia can be increased when Metformin is combined with Gliquidone.,increase,risk
Metformin,Glycerol phenylbutyrate,Metformin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Metformin,Glycopyrronium,The serum concentration of Metformin can be increased when it is combined with Glycopyrronium.,increase,no risk
Metformin,Glymidine,The therapeutic efficacy of Metformin can be increased when used in combination with Glymidine.,increase,no risk
Metformin,Golodirsen,Metformin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Metformin,Goserelin,The therapeutic efficacy of Metformin can be decreased when used in combination with Goserelin.,decrease,no risk
Metformin,Grepafloxacin,The therapeutic efficacy of Metformin can be increased when used in combination with Grepafloxacin.,increase,no risk
Metformin,Guanethidine,Metformin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Metformin,Guanfacine,Metformin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Metformin,Guanidine,The serum concentration of Metformin can be increased when it is combined with Guanidine.,increase,no risk
Metformin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Metformin.,increase,risk
Metformin,Haloperidol,The therapeutic efficacy of Metformin can be decreased when used in combination with Haloperidol.,decrease,no risk
Metformin,Histamine,The serum concentration of Histamine can be increased when it is combined with Metformin.,increase,no risk
Metformin,Histrelin,The therapeutic efficacy of Metformin can be decreased when used in combination with Histrelin.,decrease,no risk
Metformin,Hydralazine,Metformin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Metformin,Hydrochlorothiazide,The therapeutic efficacy of Metformin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Metformin,Hydrocortisone,The therapeutic efficacy of Metformin can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Metformin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Metformin.,increase,risk
Metformin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Metformin.,increase,risk
Metformin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Metformin.,increase,risk
Metformin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Metformin.,increase,risk
Metformin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Metformin.,increase,risk
Metformin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Metformin.,increase,risk
Metformin,Hydroflumethiazide,The therapeutic efficacy of Metformin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Metformin,Hydromorphone,Hydromorphone may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Hydroxychloroquine,The therapeutic efficacy of Metformin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Metformin,Hydroxyethyl Starch,Metformin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Metformin,Hydroxyprogesterone caproate,The therapeutic efficacy of Metformin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Metformin,Kanamycin,Metformin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Metformin,Ketamine,Metformin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Metformin,Ketazolam,Metformin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Metformin,Ketoprofen,Ketoprofen may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Ketorolac,Ketorolac may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Metformin is combined with Ketotifen.,increase,risk
Metformin,Octinoxate,Metformin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Metformin,Octreotide,The therapeutic efficacy of Metformin can be decreased when used in combination with Octreotide.,decrease,no risk
Metformin,Ofloxacin,The therapeutic efficacy of Metformin can be increased when used in combination with Ofloxacin.,increase,no risk
Metformin,Olanzapine,The therapeutic efficacy of Metformin can be decreased when used in combination with Olanzapine.,decrease,no risk
Metformin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Metformin.,increase,no risk
Metformin,Opium,Metformin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Metformin,Oseltamivir,Oseltamivir may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Oxacillin,Metformin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Metformin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Metformin.,increase,no risk
Metformin,Oxaprozin,Oxaprozin may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Oxazepam,Metformin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Metformin,Oxprenolol,The therapeutic efficacy of Metformin can be increased when used in combination with Oxprenolol.,increase,no risk
Metformin,Oxybenzone,Metformin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Metformin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Metformin.,increase,no risk
Metformin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Metformin which could result in a higher serum level.,decrease,no risk
Metformin,Oxyquinoline,Metformin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Metformin,Quetiapine,The therapeutic efficacy of Metformin can be decreased when used in combination with Quetiapine.,decrease,no risk
Metformin,Quinapril,The risk or severity of lactic acidosis can be increased when Quinapril is combined with Metformin.,increase,risk
Metformin,Quinethazone,The therapeutic efficacy of Metformin can be decreased when used in combination with Quinethazone.,decrease,no risk
Metformin,Quinidine,Metformin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Metformin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Metformin.,increase,risk
Metformin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Metformin.,decrease,no risk
Ipratropium,Galantamine,The therapeutic efficacy of Ipratropium can be decreased when used in combination with Galantamine.,decrease,no risk
Ipratropium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Ipratropium.,increase,risk
Ipratropium,Ginkgo biloba,The therapeutic efficacy of Ipratropium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Ipratropium,Glucagon,Ipratropium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Ipratropium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Ipratropium.,decrease,no risk
Ipratropium,Glycopyrronium,The risk or severity of adverse effects can be increased when Ipratropium is combined with Glycopyrronium.,increase,risk
Ipratropium,Guanabenz,The risk or severity of Tachycardia can be increased when Ipratropium is combined with Guanabenz.,increase,risk
Ipratropium,Guanfacine,The risk or severity of Tachycardia can be increased when Ipratropium is combined with Guanfacine.,increase,risk
Ipratropium,Hexafluronium,The risk or severity of adverse effects can be increased when Ipratropium is combined with Hexafluronium.,increase,risk
Ipratropium,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Ipratropium.,increase,risk
Ipratropium,Homatropine,The risk or severity of adverse effects can be increased when Ipratropium is combined with Homatropine.,increase,risk
Ipratropium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Ipratropium.,increase,risk
Ipratropium,Huperzine A,The therapeutic efficacy of Ipratropium can be decreased when used in combination with Huperzine A.,decrease,no risk
Ipratropium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Ipratropium.,increase,no risk
Ipratropium,Hydrocodone,The risk or severity of adverse effects can be increased when Ipratropium is combined with Hydrocodone.,increase,risk
Ipratropium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Ipratropium.,increase,no risk
Ipratropium,Hydromorphone,The risk or severity of adverse effects can be increased when Ipratropium is combined with Hydromorphone.,increase,risk
Ipratropium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Ipratropium.,increase,risk
Ipratropium,Ketamine,The therapeutic efficacy of Ipratropium can be decreased when used in combination with Ketamine.,decrease,no risk
Ipratropium,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Ipratropium.,increase,risk
Ipratropium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Ipratropium is combined with Oliceridine.",increase,risk
Ipratropium,Olodaterol,The risk or severity of Tachycardia can be increased when Ipratropium is combined with Olodaterol.,increase,risk
Ipratropium,Opium,The risk or severity of adverse effects can be increased when Ipratropium is combined with Opium.,increase,risk
Ipratropium,Orciprenaline,The risk or severity of Tachycardia can be increased when Ipratropium is combined with Orciprenaline.,increase,risk
Ipratropium,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Ipratropium.,increase,risk
Ipratropium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Ipratropium.,increase,risk
Ipratropium,Oxycodone,The risk or severity of adverse effects can be increased when Ipratropium is combined with Oxycodone.,increase,risk
Ipratropium,Oxymetazoline,The absorption of Ipratropium can be decreased when combined with Oxymetazoline.,decrease,no risk
Ipratropium,Oxymorphone,The risk or severity of adverse effects can be increased when Ipratropium is combined with Oxymorphone.,increase,risk
Ipratropium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Ipratropium.,increase,risk
Ipratropium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Ipratropium.,decrease,no risk
Ipratropium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Ipratropium.,increase,risk
Ipratropium,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Ipratropium.,increase,risk
Ipratropium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Ipratropium.,increase,no risk
Ipratropium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Ipratropium.,increase,risk
Ipratropium,Quinupramine,The risk or severity of adverse effects can be increased when Ipratropium is combined with Quinupramine.,increase,risk
Ipratropium,Umeclidinium,The risk or severity of adverse effects can be increased when Ipratropium is combined with Umeclidinium.,increase,risk
Ipratropium,Vecuronium,The risk or severity of adverse effects can be increased when Ipratropium is combined with Vecuronium.,increase,risk
Ipratropium,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Ipratropium.,increase,risk
Ipratropium,Vilanterol,The risk or severity of Tachycardia can be increased when Ipratropium is combined with Vilanterol.,increase,risk
Ipratropium,Xamoterol,The risk or severity of Tachycardia can be increased when Ipratropium is combined with Xamoterol.,increase,risk
Ipratropium,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Ipratropium.,increase,risk
Methadone,Bacitracin,Bacitracin may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Baclofen,The risk or severity of adverse effects can be increased when Methadone is combined with Baclofen.,increase,risk
Methadone,Balsalazide,Balsalazide may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Baricitinib,Methadone may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Methadone,Bedaquiline,The risk or severity of QTc prolongation can be increased when Methadone is combined with Bedaquiline.,increase,risk
Methadone,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Methadone.,increase,risk
Methadone,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Methadone.,decrease,no risk
Methadone,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Benorilate,Benorilate may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Benperidol,The risk or severity of adverse effects can be increased when Methadone is combined with Benperidol.,increase,risk
Methadone,Benserazide,Methadone may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Methadone,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Methadone.,increase,risk
Methadone,Benzhydrocodone,The risk or severity of adverse effects can be increased when Methadone is combined with Benzhydrocodone.,increase,risk
Methadone,Benznidazole,Methadone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Methadone,Benzocaine,The risk or severity of adverse effects can be increased when Methadone is combined with Benzocaine.,increase,risk
Methadone,Benzphetamine,The risk or severity of adverse effects can be increased when Methadone is combined with Benzphetamine.,increase,risk
Methadone,Benzthiazide,Benzthiazide may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Benzydamine,Benzydamine may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Benzyl alcohol,The risk or severity of adverse effects can be increased when Methadone is combined with Benzyl alcohol.,increase,risk
Methadone,Bepotastine,Methadone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Methadone,Bepridil,The risk or severity of QTc prolongation can be increased when Methadone is combined with Bepridil.,increase,risk
Methadone,Berotralstat,The metabolism of Methadone can be decreased when combined with Berotralstat.,decrease,no risk
Methadone,Betaine,The therapeutic efficacy of Methadone can be decreased when used in combination with Betaine.,decrease,no risk
Methadone,Betamethasone,The metabolism of Methadone can be increased when combined with Betamethasone.,increase,no risk
Methadone,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Methadone.,decrease,no risk
Methadone,Bexarotene,The metabolism of Methadone can be decreased when combined with Bexarotene.,decrease,no risk
Methadone,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Methadone.,increase,no risk
Methadone,Bicisate,Methadone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Methadone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Methadone.,increase,risk
Methadone,Bimekizumab,The metabolism of Methadone can be increased when combined with Bimekizumab.,increase,no risk
Methadone,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Methadone.,increase,risk
Methadone,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Methadone.,decrease,no risk
Methadone,Bismuth subgallate,Methadone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Methadone,Bisoprolol,Methadone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Methadone,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Methadone.,decrease,no risk
Methadone,Bleomycin,Bleomycin may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Boceprevir,The metabolism of Methadone can be decreased when combined with Boceprevir.,decrease,no risk
Methadone,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Bosentan,The metabolism of Methadone can be increased when combined with Bosentan.,increase,no risk
Methadone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Methadone is combined with Botulinum toxin type A.,increase,risk
Methadone,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Methadone is combined with Botulinum toxin type B.,increase,risk
Methadone,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Methadone.,increase,no risk
Methadone,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Methadone.,increase,risk
Methadone,Brexanolone,The risk or severity of adverse effects can be increased when Methadone is combined with Brexanolone.,increase,risk
Methadone,Brexpiprazole,The risk or severity of adverse effects can be increased when Methadone is combined with Brexpiprazole.,increase,risk
Methadone,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methadone.,increase,no risk
Methadone,Brivaracetam,The risk or severity of adverse effects can be increased when Methadone is combined with Brivaracetam.,increase,risk
Methadone,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.,increase,no risk
Methadone,Bromocriptine,The risk or severity of adverse effects can be increased when Methadone is combined with Bromocriptine.,increase,risk
Methadone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Bromperidol,The risk or severity of adverse effects can be increased when Methadone is combined with Bromperidol.,increase,risk
Methadone,Brompheniramine,The risk or severity of adverse effects can be increased when Methadone is combined with Brompheniramine.,increase,risk
Methadone,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Methadone.,increase,risk
Methadone,Budesonide,Methadone may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Methadone,Bumadizone,Bumadizone may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Bumetanide,Bumetanide may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Bupivacaine,The risk or severity of adverse effects can be increased when Methadone is combined with Bupivacaine.,increase,risk
Methadone,Buprenorphine,The risk or severity of adverse effects can be increased when Methadone is combined with Buprenorphine.,increase,risk
Methadone,Bupropion,The risk or severity of adverse effects can be increased when Methadone is combined with Bupropion.,increase,risk
Methadone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Methadone.,increase,risk
Methadone,Buspirone,The risk or severity of adverse effects can be increased when Methadone is combined with Buspirone.,increase,risk
Methadone,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Methadone.,increase,no risk
Methadone,Butabarbital,The risk or severity of adverse effects can be increased when Methadone is combined with Butabarbital.,increase,risk
Methadone,Butalbital,The risk or severity of adverse effects can be increased when Methadone is combined with Butalbital.,increase,risk
Methadone,Butaperazine,The risk or severity of adverse effects can be increased when Methadone is combined with Butaperazine.,increase,risk
Methadone,Butobarbital,The risk or severity of adverse effects can be increased when Methadone is combined with Butobarbital.,increase,risk
Methadone,Butorphanol,The risk or severity of adverse effects can be increased when Methadone is combined with Butorphanol.,increase,risk
Methadone,Butriptyline,The risk or severity of adverse effects can be increased when Methadone is combined with Butriptyline.,increase,risk
Methadone,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Methadone.,increase,risk
Methadone,Gabapentin,The risk or severity of adverse effects can be increased when Methadone is combined with Gabapentin.,increase,risk
Methadone,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Methadone is combined with Gabapentin enacarbil.,increase,risk
Methadone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Methadone is combined with Gadobenic acid.,increase,risk
Methadone,Gadodiamide,Gadodiamide may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Gadofosveset trisodium,Methadone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Methadone,Gadopentetic acid,Methadone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Methadone,Gadoteric acid,Methadone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Methadone,Gadoteridol,Methadone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Methadone,Galantamine,The metabolism of Galantamine can be decreased when combined with Methadone.,decrease,no risk
Methadone,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Methadone is combined with Gallamine triethiodide.,increase,risk
Methadone,Ganaxolone,The risk or severity of adverse effects can be increased when Methadone is combined with Ganaxolone.,increase,risk
Methadone,Ganciclovir,Methadone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Methadone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Methadone.,increase,risk
Methadone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Methadone.,decrease,no risk
Methadone,Gemcitabine,Methadone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Methadone,Gemfibrozil,The metabolism of Methadone can be decreased when combined with Gemfibrozil.,decrease,no risk
Methadone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Methadone is combined with Gemifloxacin.,increase,risk
Methadone,Gentamicin,Methadone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Methadone,Gepirone,The risk or severity of adverse effects can be increased when Methadone is combined with Gepirone.,increase,risk
Methadone,Gilteritinib,The therapeutic efficacy of Methadone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Methadone,Gimeracil,Methadone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Methadone,Ginkgo biloba,The metabolism of Methadone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Methadone,Givosiran,The serum concentration of Methadone can be increased when it is combined with Givosiran.,increase,no risk
Methadone,Glasdegib,The risk or severity of QTc prolongation can be increased when Methadone is combined with Glasdegib.,increase,risk
Methadone,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Methadone.,decrease,no risk
Methadone,Glimepiride,The metabolism of Methadone can be decreased when combined with Glimepiride.,decrease,no risk
Methadone,Glipizide,Methadone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Methadone,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Methadone.,decrease,no risk
Methadone,Glofitamab,The serum concentration of Methadone can be increased when it is combined with Glofitamab.,increase,no risk
Methadone,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Methadone.,decrease,no risk
Methadone,Glutethimide,The risk or severity of adverse effects can be increased when Methadone is combined with Glutethimide.,increase,risk
Methadone,Glyburide,The metabolism of Glyburide can be decreased when combined with Methadone.,decrease,no risk
Methadone,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Methadone.,decrease,no risk
Methadone,Glycerol phenylbutyrate,The metabolism of Methadone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Methadone,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Methadone.,increase,risk
Methadone,Golimumab,The metabolism of Methadone can be increased when combined with Golimumab.,increase,no risk
Methadone,Golodirsen,Methadone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Methadone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Methadone.,increase,risk
Methadone,Granisetron,The risk or severity of adverse effects can be increased when Methadone is combined with Granisetron.,increase,risk
Methadone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Methadone is combined with Grepafloxacin.,increase,risk
Methadone,Guanethidine,Methadone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Methadone,Guanfacine,The risk or severity of adverse effects can be increased when Methadone is combined with Guanfacine.,increase,risk
Methadone,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.,increase,no risk
Methadone,Halofantrine,The risk or severity of QTc prolongation can be increased when Methadone is combined with Halofantrine.,increase,risk
Methadone,Haloperidol,The risk or severity of adverse effects can be increased when Methadone is combined with Haloperidol.,increase,risk
Methadone,Halothane,The risk or severity of adverse effects can be increased when Methadone is combined with Halothane.,increase,risk
Methadone,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Methadone.,decrease,no risk
Methadone,Hexafluronium,The risk or severity of adverse effects can be increased when Methadone is combined with Hexafluronium.,increase,risk
Methadone,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Methadone.,increase,risk
Methadone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Methadone.,increase,risk
Methadone,Homatropine,The risk or severity of adverse effects can be increased when Methadone is combined with Homatropine.,increase,risk
Methadone,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Methadone.,increase,risk
Methadone,Huperzine A,The therapeutic efficacy of Methadone can be decreased when used in combination with Huperzine A.,decrease,no risk
Methadone,Hydralazine,Methadone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Methadone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Hydrocodone,The risk or severity of adverse effects can be increased when Methadone is combined with Hydrocodone.,increase,risk
Methadone,Hydrocortisone,The metabolism of Methadone can be increased when combined with Hydrocortisone.,increase,no risk
Methadone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Hydromorphone,The risk or severity of adverse effects can be increased when Methadone is combined with Hydromorphone.,increase,risk
Methadone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Methadone.,decrease,no risk
Methadone,Hydroxyethyl Starch,Methadone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Methadone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Methadone is combined with Hydroxyzine.,increase,risk
Methadone,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methadone.,increase,risk
Methadone,Kanamycin,Methadone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Methadone,Ketamine,The risk or severity of adverse effects can be increased when Methadone is combined with Ketamine.,increase,risk
Methadone,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone.,increase,no risk
Methadone,Ketoconazole,The metabolism of Methadone can be decreased when combined with Ketoconazole.,decrease,no risk
Methadone,Ketoprofen,Ketoprofen may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Ketorolac,Ketorolac may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Octinoxate,Methadone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Methadone,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Methadone.,increase,risk
Methadone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Methadone is combined with Ofloxacin.,increase,risk
Methadone,Olanzapine,The risk or severity of adverse effects can be increased when Methadone is combined with Olanzapine.,increase,risk
Methadone,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Oliceridine,The risk or severity of adverse effects can be increased when Methadone is combined with Oliceridine.,increase,risk
Methadone,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Methadone.,increase,risk
Methadone,Olsalazine,Olsalazine may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Omaveloxolone,The serum concentration of Methadone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Methadone,Omeprazole,The metabolism of Methadone can be decreased when combined with Omeprazole.,decrease,no risk
Methadone,Ondansetron,The risk or severity of adverse effects can be increased when Methadone is combined with Ondansetron.,increase,risk
Methadone,Opium,The risk or severity of adverse effects can be increased when Methadone is combined with Opium.,increase,risk
Methadone,Oritavancin,The metabolism of Methadone can be decreased when combined with Oritavancin.,decrease,no risk
Methadone,Orphenadrine,The risk or severity of adverse effects can be increased when Methadone is combined with Orphenadrine.,increase,risk
Methadone,Oseltamivir,Oseltamivir may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Osilodrostat,The metabolism of Methadone can be decreased when combined with Osilodrostat.,decrease,no risk
Methadone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Methadone.,decrease,no risk
Methadone,Oxacillin,Methadone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Methadone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Methadone.,increase,risk
Methadone,Oxamniquine,The metabolism of Methadone can be decreased when combined with Oxamniquine.,decrease,no risk
Methadone,Oxandrolone,The metabolism of Methadone can be decreased when combined with Oxandrolone.,decrease,no risk
Methadone,Oxaprozin,Oxaprozin may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Oxatomide,The risk or severity of QTc prolongation can be increased when Methadone is combined with Oxatomide.,increase,risk
Methadone,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.,increase,no risk
Methadone,Oxcarbazepine,The risk or severity of adverse effects can be increased when Methadone is combined with Oxcarbazepine.,increase,risk
Methadone,Oxitriptan,The risk or severity of adverse effects can be increased when Methadone is combined with Oxitriptan.,increase,risk
Methadone,Oxprenolol,The risk or severity of adverse effects can be increased when Methadone is combined with Oxprenolol.,increase,risk
Methadone,Oxybenzone,Methadone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Methadone,Oxybuprocaine,The risk or severity of adverse effects can be increased when Methadone is combined with Oxybuprocaine.,increase,risk
Methadone,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Methadone.,increase,risk
Methadone,Oxycodone,The risk or severity of adverse effects can be increased when Methadone is combined with Oxycodone.,increase,risk
Methadone,Oxymorphone,The risk or severity of adverse effects can be increased when Methadone is combined with Oxymorphone.,increase,risk
Methadone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Methadone.,increase,risk
Methadone,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Methadone.,decrease,no risk
Methadone,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methadone.,increase,risk
Methadone,Oxyquinoline,Methadone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Methadone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Methadone.,increase,risk
Methadone,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.,increase,no risk
Methadone,Quetiapine,The risk or severity of adverse effects can be increased when Methadone is combined with Quetiapine.,increase,risk
Methadone,Quinethazone,Quinethazone may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methadone,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Methadone.,increase,risk
Methadone,Quinine,The risk or severity of adverse effects can be increased when Methadone is combined with Quinine.,increase,risk
Methadone,Quinupramine,The risk or severity of adverse effects can be increased when Methadone is combined with Quinupramine.,increase,risk
Methadone,Quizartinib,The risk or severity of QTc prolongation can be increased when Methadone is combined with Quizartinib.,increase,risk
Methadone,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Methadone.,increase,risk
Methadone,Urethane,The risk or severity of adverse effects can be increased when Methadone is combined with Urethane.,increase,risk
Methadone,Vaborbactam,Methadone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Methadone,Vadadustat,The serum concentration of Methadone can be decreased when it is combined with Vadadustat.,decrease,no risk
Methadone,Valaciclovir,Valaciclovir may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Methadone.,decrease,no risk
Methadone,Valdecoxib,Valdecoxib may decrease the excretion rate of Methadone which could result in a higher serum level.,decrease,no risk
Methadone,Valganciclovir,Methadone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Methadone,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Methadone is combined with Valproate bismuth.,increase,risk
Methadone,Valproic acid,The risk or severity of adverse effects can be increased when Methadone is combined with Valproic acid.,increase,risk
Methadone,Valsartan,The metabolism of Methadone can be decreased when combined with Valsartan.,decrease,no risk
Methadone,Vancomycin,Methadone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Methadone,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Methadone.,decrease,no risk
Methadone,Varenicline,Methadone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Methadone,Vecuronium,The risk or severity of adverse effects can be increased when Methadone is combined with Vecuronium.,increase,risk
Methadone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Methadone.,decrease,no risk
Methadone,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Methadone.,increase,no risk
Methadone,Venlafaxine,The risk or severity of adverse effects can be increased when Methadone is combined with Venlafaxine.,increase,risk
Methadone,Verapamil,The metabolism of Methadone can be decreased when combined with Verapamil.,decrease,no risk
Methadone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Methadone.,decrease,no risk
Methadone,Vigabatrin,The risk or severity of adverse effects can be increased when Methadone is combined with Vigabatrin.,increase,risk
Methadone,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Methadone.,increase,risk
Methadone,Vilazodone,The risk or severity of adverse effects can be increased when Methadone is combined with Vilazodone.,increase,risk
Methadone,Viloxazine,The risk or severity of adverse effects can be increased when Methadone is combined with Viloxazine.,increase,risk
Methadone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Methadone.,increase,no risk
Methadone,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Methadone.,increase,no risk
Methadone,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Methadone.,increase,no risk
Methadone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Methadone.,increase,no risk
Methadone,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Methadone.,increase,no risk
Methadone,Vonoprazan,The metabolism of Methadone can be decreased when combined with Vonoprazan.,decrease,no risk
Methadone,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Methadone.,decrease,no risk
Methadone,Voriconazole,The serum concentration of Methadone can be increased when it is combined with Voriconazole.,increase,no risk
Methadone,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Methadone.,increase,risk
Methadone,Vortioxetine,The risk or severity of adverse effects can be increased when Methadone is combined with Vortioxetine.,increase,risk
Methadone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Methadone.,increase,no risk
Methadone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Methadone.,increase,no risk
Methadone,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Methadone.,decrease,no risk
Methadone,Yohimbine,The risk or severity of adverse effects can be increased when Methadone is combined with Yohimbine.,increase,risk
Methadone,Zafirlukast,The metabolism of Methadone can be decreased when combined with Zafirlukast.,decrease,no risk
Methadone,Zaleplon,The risk or severity of adverse effects can be increased when Methadone is combined with Zaleplon.,increase,risk
Methadone,Zanamivir,Methadone may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Methadone,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Methadone.,increase,no risk
Methadone,Ziconotide,The risk or severity of adverse effects can be increased when Methadone is combined with Ziconotide.,increase,risk
Methadone,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Methadone.,increase,no risk
Methadone,Zileuton,The metabolism of Zileuton can be decreased when combined with Methadone.,decrease,no risk
Methadone,Zimelidine,The risk or severity of adverse effects can be increased when Methadone is combined with Zimelidine.,increase,risk
Methadone,Ziprasidone,The risk or severity of adverse effects can be increased when Methadone is combined with Ziprasidone.,increase,risk
Methadone,Zolmitriptan,The risk or severity of adverse effects can be increased when Methadone is combined with Zolmitriptan.,increase,risk
Methadone,Zolpidem,The risk or severity of adverse effects can be increased when Methadone is combined with Zolpidem.,increase,risk
Methadone,Zonisamide,The risk or severity of adverse effects can be increased when Methadone is combined with Zonisamide.,increase,risk
Methadone,Zopiclone,The risk or severity of adverse effects can be increased when Methadone is combined with Zopiclone.,increase,risk
Methadone,Zotepine,The risk or severity of adverse effects can be increased when Methadone is combined with Zotepine.,increase,risk
Methadone,Zuclopenthixol,The risk or severity of adverse effects can be increased when Methadone is combined with Zuclopenthixol.,increase,risk
Methadone,Zuranolone,The risk or severity of adverse effects can be increased when Methadone is combined with Zuranolone.,increase,risk
Olanzapine,Benperidol,The risk or severity of CNS depression can be increased when Olanzapine is combined with Benperidol.,increase,risk
Olanzapine,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Benzatropine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Benzatropine.,increase,risk
Olanzapine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Olanzapine is combined with Benzhydrocodone.,increase,risk
Olanzapine,Benzocaine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Benzocaine.,increase,risk
Olanzapine,Benzphetamine,Benzphetamine may decrease the sedative activities of Olanzapine.,decrease,no risk
Olanzapine,Benzthiazide,The serum concentration of Benzthiazide can be increased when it is combined with Olanzapine.,increase,no risk
Olanzapine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Olanzapine is combined with Benzyl alcohol.,increase,risk
Olanzapine,Benzylpenicilloyl polylysine,Olanzapine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Olanzapine,Bepridil,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Bepridil.,increase,risk
Olanzapine,Berotralstat,The metabolism of Olanzapine can be decreased when combined with Berotralstat.,decrease,no risk
Olanzapine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Betaine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Betaine.,decrease,no risk
Olanzapine,Betaxolol,Betaxolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Olanzapine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Olanzapine.,decrease,no risk
Olanzapine,Bifonazole,Olanzapine can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Olanzapine,Bilastine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Bilastine.,increase,risk
Olanzapine,Bimekizumab,The metabolism of Olanzapine can be increased when combined with Bimekizumab.,increase,no risk
Olanzapine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Olanzapine.,decrease,no risk
Olanzapine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Olanzapine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Bortezomib,The metabolism of Olanzapine can be decreased when combined with Bortezomib.,decrease,no risk
Olanzapine,Bosentan,The metabolism of Bosentan can be decreased when combined with Olanzapine.,decrease,no risk
Olanzapine,Bosutinib,Olanzapine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Olanzapine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum toxin type A.,increase,risk
Olanzapine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum toxin type B.,increase,risk
Olanzapine,Bretylium,The risk or severity of adverse effects can be increased when Olanzapine is combined with Bretylium.,increase,risk
Olanzapine,Brexanolone,The risk or severity of CNS depression can be increased when Olanzapine is combined with Brexanolone.,increase,risk
Olanzapine,Brexpiprazole,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Olanzapine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Olanzapine,Brivaracetam,The risk or severity of CNS depression can be increased when Olanzapine is combined with Brivaracetam.,increase,risk
Olanzapine,Bromazepam,The risk or severity of CNS depression can be increased when Olanzapine is combined with Bromazepam.,increase,risk
Olanzapine,Bromocriptine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Olanzapine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Olanzapine.,decrease,no risk
Olanzapine,Bromperidol,The risk or severity of CNS depression can be increased when Olanzapine is combined with Bromperidol.,increase,risk
Olanzapine,Brompheniramine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Brompheniramine.,increase,risk
Olanzapine,Buclizine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Buclizine.,increase,risk
Olanzapine,Budesonide,Olanzapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Olanzapine,Bumetanide,The risk or severity of adverse effects can be increased when Olanzapine is combined with Bumetanide.,increase,risk
Olanzapine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Olanzapine.,increase,risk
Olanzapine,Buprenorphine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Olanzapine,Bupropion,The metabolism of Olanzapine can be decreased when combined with Bupropion.,decrease,no risk
Olanzapine,Buserelin,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Buserelin.,increase,risk
Olanzapine,Buspirone,The risk or severity of CNS depression can be increased when Olanzapine is combined with Buspirone.,increase,risk
Olanzapine,Butabarbital,Butabarbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Olanzapine,Butalbital,Butalbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Olanzapine,Butaperazine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Butaperazine.,increase,risk
Olanzapine,Butobarbital,The risk or severity of CNS depression can be increased when Olanzapine is combined with Butobarbital.,increase,risk
Olanzapine,Butorphanol,The risk or severity of adverse effects can be increased when Olanzapine is combined with Butorphanol.,increase,risk
Olanzapine,Butriptyline,The risk or severity of CNS depression can be increased when Olanzapine is combined with Butriptyline.,increase,risk
Olanzapine,Butylscopolamine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Butylscopolamine.,increase,risk
Olanzapine,Gabapentin,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gabapentin.,increase,risk
Olanzapine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gabapentin enacarbil.,increase,risk
Olanzapine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Gadobenic acid.,increase,risk
Olanzapine,Galantamine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Galantamine.,decrease,no risk
Olanzapine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gallamine triethiodide.,increase,risk
Olanzapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Olanzapine is combined with Ganaxolone.",increase,risk
Olanzapine,Gatifloxacin,The metabolism of Olanzapine can be decreased when combined with Gatifloxacin.,decrease,no risk
Olanzapine,Gefitinib,Olanzapine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Olanzapine,Gemfibrozil,The metabolism of Olanzapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Olanzapine,Gemifloxacin,The metabolism of Olanzapine can be decreased when combined with Gemifloxacin.,decrease,no risk
Olanzapine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Olanzapine.,increase,risk
Olanzapine,Gilteritinib,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Olanzapine,Ginkgo biloba,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Olanzapine,Givosiran,The serum concentration of Olanzapine can be increased when it is combined with Givosiran.,increase,no risk
Olanzapine,Glasdegib,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Glasdegib.,increase,risk
Olanzapine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Glofitamab,The serum concentration of Olanzapine can be increased when it is combined with Glofitamab.,increase,no risk
Olanzapine,Glucagon,Olanzapine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Olanzapine,Glutethimide,The risk or severity of CNS depression can be increased when Olanzapine is combined with Glutethimide.,increase,risk
Olanzapine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Glycerol phenylbutyrate,The metabolism of Olanzapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Olanzapine,Glycopyrronium,The risk or severity of adverse effects can be increased when Olanzapine is combined with Glycopyrronium.,increase,risk
Olanzapine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Olanzapine.,decrease,no risk
Olanzapine,Golimumab,The metabolism of Olanzapine can be increased when combined with Golimumab.,increase,no risk
Atenolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Atenolol.,increase,risk
Atenolol,Bretylium,Atenolol may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Atenolol,Brexpiprazole,Atenolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Atenolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Atenolol.,increase,no risk
Atenolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Atenolol is combined with Bromotheophylline.,increase,risk
Atenolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Atenolol.,increase,risk
Atenolol,Budesonide,Atenolol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Atenolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Bumetanide,The risk or severity of adverse effects can be increased when Atenolol is combined with Bumetanide.,increase,risk
Atenolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Atenolol.,increase,no risk
Atenolol,Buprenorphine,The metabolism of Atenolol can be decreased when combined with Buprenorphine.,decrease,no risk
Atenolol,Bupropion,The metabolism of Atenolol can be decreased when combined with Bupropion.,decrease,no risk
Atenolol,Buspirone,Buspirone may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Butabarbital,Butabarbital may increase the hypotensive activities of Atenolol.,increase,no risk
Atenolol,Butalbital,Butalbital may increase the hypotensive activities of Atenolol.,increase,no risk
Atenolol,Butaperazine,The serum concentration of Atenolol can be increased when it is combined with Butaperazine.,increase,no risk
Atenolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Galantamine,Galantamine may increase the bradycardic activities of Atenolol.,increase,no risk
Atenolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Atenolol.,increase,no risk
Atenolol,Gefitinib,The metabolism of Atenolol can be decreased when combined with Gefitinib.,decrease,no risk
Atenolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Atenolol.,increase,no risk
Atenolol,Givosiran,The serum concentration of Atenolol can be increased when it is combined with Givosiran.,increase,no risk
Atenolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Glucagon,The therapeutic efficacy of Atenolol can be decreased when used in combination with Glucagon.,decrease,no risk
Atenolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Glycerol phenylbutyrate,The metabolism of Atenolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Atenolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Glycopyrronium,The bioavailability of Atenolol can be increased when combined with Glycopyrronium.,increase,no risk
Atenolol,Glycyrrhizic acid,Atenolol may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Atenolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Golimumab,The metabolism of Atenolol can be increased when combined with Golimumab.,increase,no risk
Atenolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Guanadrel,Guanadrel may increase the hypotensive activities of Atenolol.,increase,no risk
Atenolol,Guanethidine,Guanethidine may increase the hypotensive activities of Atenolol.,increase,no risk
Atenolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Guanoxan,Atenolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Atenolol,Halofantrine,The metabolism of Atenolol can be decreased when combined with Halofantrine.,decrease,no risk
Atenolol,Haloperidol,The serum concentration of Atenolol can be increased when it is combined with Haloperidol.,increase,no risk
Atenolol,Halothane,Halothane may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Heparin,The risk or severity of hyperkalemia can be increased when Atenolol is combined with Heparin.,increase,risk
Atenolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Atenolol.,increase,no risk
Atenolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Atenolol.,increase,risk
Atenolol,Huperzine A,Huperzine A may increase the bradycardic activities of Atenolol.,increase,no risk
Atenolol,Hydroflumethiazide,The therapeutic efficacy of Atenolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Atenolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Atenolol.,decrease,risk
Atenolol,Hydroxyzine,The metabolism of Atenolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Atenolol,Hyoscyamine,Atenolol may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Atenolol,Ketamine,Ketamine may increase the bradycardic activities of Atenolol.,increase,no risk
Atenolol,Ketoconazole,The metabolism of Atenolol can be decreased when combined with Ketoconazole.,decrease,no risk
Atenolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Atenolol.,increase,risk
Atenolol,Obinutuzumab,Atenolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Atenolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Atenolol.,increase,no risk
Atenolol,Ofloxacin,Atenolol may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Atenolol,Olanzapine,Atenolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Atenolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Olmesartan,Olmesartan may decrease the excretion rate of Atenolol which could result in a higher serum level.,decrease,no risk
Atenolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Opicapone,The risk or severity of adverse effects can be increased when Atenolol is combined with Opicapone.,increase,risk
Atenolol,Opium,The metabolism of Opium can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Oritavancin,The metabolism of Atenolol can be decreased when combined with Oritavancin.,decrease,no risk
Atenolol,Orphenadrine,The metabolism of Atenolol can be decreased when combined with Orphenadrine.,decrease,no risk
Atenolol,Osilodrostat,The metabolism of Atenolol can be decreased when combined with Osilodrostat.,decrease,no risk
Atenolol,Ospemifene,The metabolism of Atenolol can be decreased when combined with Ospemifene.,decrease,no risk
Atenolol,Ouabain,Atenolol may increase the bradycardic activities of Ouabain.,increase,no risk
Atenolol,Oxamniquine,The metabolism of Atenolol can be decreased when combined with Oxamniquine.,decrease,no risk
Atenolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Oxprenolol,Atenolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Atenolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Atenolol is combined with Oxtriphylline.,increase,risk
Atenolol,Oxybutynin,The metabolism of Atenolol can be decreased when combined with Oxybutynin.,decrease,no risk
Atenolol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Oxymetazoline,The therapeutic efficacy of Atenolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Atenolol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Quetiapine,Quetiapine may increase the hypotensive activities of Atenolol.,increase,no risk
Atenolol,Quinapril,Atenolol may increase the hypotensive activities of Quinapril.,increase,no risk
Atenolol,Quinidine,Atenolol may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Atenolol,Quinine,The metabolism of Atenolol can be decreased when combined with Quinine.,decrease,no risk
Atenolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Udenafil,Udenafil may increase the antihypertensive activities of Atenolol.,increase,no risk
Atenolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Unoprostone,Atenolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Atenolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Atenolol.,increase,risk
Atenolol,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Atenolol which could result in a higher serum level.,decrease,no risk
Atenolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Valsartan,Valsartan may increase the hypotensive activities of Atenolol.,increase,no risk
Atenolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Atenolol.,increase,no risk
Atenolol,Varenicline,The risk or severity of adverse effects can be increased when Atenolol is combined with Varenicline.,increase,risk
Atenolol,Vemurafenib,The metabolism of Atenolol can be decreased when combined with Vemurafenib.,decrease,no risk
Atenolol,Venlafaxine,The metabolism of Atenolol can be decreased when combined with Venlafaxine.,decrease,no risk
Atenolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Atenolol.,increase,risk
Atenolol,Vericiguat,The risk or severity of adverse effects can be increased when Atenolol is combined with Vericiguat.,increase,risk
Atenolol,Vernakalant,Atenolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Atenolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Vilazodone,The metabolism of Atenolol can be decreased when combined with Vilazodone.,decrease,no risk
Atenolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Atenolol.,increase,no risk
Atenolol,Viloxazine,The metabolism of Atenolol can be decreased when combined with Viloxazine.,decrease,no risk
Atenolol,Vinblastine,Vinblastine may decrease the excretion rate of Atenolol which could result in a higher serum level.,decrease,no risk
Atenolol,Vincristine,Atenolol may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Atenolol,Vinorelbine,The metabolism of Atenolol can be decreased when combined with Vinorelbine.,decrease,no risk
Atenolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Atenolol.,decrease,no risk
Atenolol,Xylometazoline,Atenolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Atenolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Ziconotide,Atenolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Atenolol,Zimelidine,The serum concentration of Atenolol can be increased when it is combined with Zimelidine.,increase,no risk
Atenolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Atenolol.,increase,no risk
Atenolol,Zofenopril,Atenolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Atenolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Atenolol.,decrease,no risk
Atenolol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Atenolol.,decrease,no risk
Atenolol,Zonisamide,Atenolol may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Atenolol,Zuclopenthixol,Atenolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Pimecrolimus,Gemcitabine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gemcitabine.,increase,risk
Pimecrolimus,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gemtuzumab ozogamicin.,increase,risk
Pimecrolimus,Glatiramer,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Glatiramer.,increase,risk
Pimecrolimus,Glofitamab,The serum concentration of Pimecrolimus can be increased when it is combined with Glofitamab.,increase,no risk
Pimecrolimus,Golimumab,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Golimumab.,increase,risk
Pimecrolimus,Guselkumab,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Guselkumab.,increase,risk
Pimecrolimus,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Pimecrolimus.,increase,no risk
Pimecrolimus,Hydrocortisone,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone.,increase,risk
Pimecrolimus,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone acetate.,increase,risk
Pimecrolimus,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone butyrate.,increase,risk
Pimecrolimus,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone succinate.,increase,risk
Pimecrolimus,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydroxychloroquine.,increase,risk
Pimecrolimus,Hydroxyurea,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydroxyurea.,increase,risk
Pimecrolimus,Obinutuzumab,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Obinutuzumab.,increase,risk
Pimecrolimus,Ocrelizumab,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ocrelizumab.,increase,risk
Pimecrolimus,Ofatumumab,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ofatumumab.,increase,risk
Pimecrolimus,Olaparib,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Olaparib.,increase,risk
Pimecrolimus,Oxaliplatin,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Oxaliplatin.,increase,risk
Pimecrolimus,Ozanimod,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ozanimod.,increase,risk
Pimecrolimus,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Pimecrolimus.,increase,risk
Pimecrolimus,Upadacitinib,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Upadacitinib.,increase,risk
Pimecrolimus,Vadadustat,The serum concentration of Pimecrolimus can be increased when it is combined with Vadadustat.,increase,no risk
Pimecrolimus,Vedolizumab,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vedolizumab.,increase,risk
Pimecrolimus,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pimecrolimus.,decrease,no risk
Pimecrolimus,Vilanterol,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vilanterol.,increase,risk
Pimecrolimus,Viloxazine,The metabolism of Pimecrolimus can be decreased when combined with Viloxazine.,decrease,no risk
Pimecrolimus,Vinblastine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vinblastine.,increase,risk
Pimecrolimus,Vincristine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vincristine.,increase,risk
Pimecrolimus,Vindesine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vindesine.,increase,risk
Pimecrolimus,Vinorelbine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vinorelbine.,increase,risk
Pimecrolimus,Voclosporin,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Voclosporin.,increase,risk
Pimecrolimus,Vorinostat,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vorinostat.,increase,risk
Pimecrolimus,Zidovudine,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zidovudine.,increase,risk
Omeprazole,Gefitinib,Omeprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Omeprazole,Gemfibrozil,The metabolism of Omeprazole can be decreased when combined with Gemfibrozil.,decrease,no risk
Omeprazole,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Glofitamab,The serum concentration of Omeprazole can be increased when it is combined with Glofitamab.,increase,no risk
Omeprazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Golimumab,The metabolism of Omeprazole can be increased when combined with Golimumab.,increase,no risk
Omeprazole,Ketoconazole,Omeprazole can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Omeprazole,Octreotide,Omeprazole can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Omeprazole,Olanzapine,The metabolism of Omeprazole can be decreased when combined with Olanzapine.,decrease,no risk
Omeprazole,Oritavancin,The metabolism of Omeprazole can be decreased when combined with Oritavancin.,decrease,no risk
Omeprazole,Osilodrostat,The metabolism of Omeprazole can be decreased when combined with Osilodrostat.,decrease,no risk
Omeprazole,Oxcarbazepine,The metabolism of Omeprazole can be decreased when combined with Oxcarbazepine.,decrease,no risk
Omeprazole,Quinine,The metabolism of Quinine can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Valproic acid,The metabolism of Omeprazole can be decreased when combined with Valproic acid.,decrease,no risk
Omeprazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Vonoprazan,The metabolism of Omeprazole can be decreased when combined with Vonoprazan.,decrease,no risk
Omeprazole,Voriconazole,The serum concentration of Omeprazole can be increased when it is combined with Voriconazole.,increase,no risk
Omeprazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Zafirlukast,The metabolism of Omeprazole can be decreased when combined with Zafirlukast.,decrease,no risk
Omeprazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Omeprazole.,decrease,no risk
Omeprazole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Omeprazole.,decrease,no risk
Pyrazinamide,Gabapentin enacarbil,Pyrazinamide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gadobenic acid,Pyrazinamide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gadodiamide,Gadodiamide may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gadofosveset trisodium,Pyrazinamide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gadopentetic acid,Pyrazinamide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gadoteric acid,Pyrazinamide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gadoteridol,Pyrazinamide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Ganciclovir,Pyrazinamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gemcitabine,Pyrazinamide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gemfibrozil,Pyrazinamide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gentamicin,Pyrazinamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Gimeracil,Pyrazinamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Givosiran,Givosiran may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Glipizide,Pyrazinamide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Glycerol phenylbutyrate,Pyrazinamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Golodirsen,Pyrazinamide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Goserelin,Goserelin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Guanethidine,Pyrazinamide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Guanfacine,Pyrazinamide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Haloperidol,Pyrazinamide may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Hydralazine,Pyrazinamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pyrazinamide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pyrazinamide,Hydromorphone,Hydromorphone may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Hydroxyethyl Starch,Pyrazinamide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Kanamycin,Pyrazinamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Ketamine,Pyrazinamide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Ketazolam,Pyrazinamide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Ketoprofen,Ketoprofen may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Ketorolac,Ketorolac may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Octinoxate,Pyrazinamide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Olsalazine,Olsalazine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Opium,Pyrazinamide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oseltamivir,Oseltamivir may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oxacillin,Pyrazinamide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oxaprozin,Oxaprozin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oxazepam,Pyrazinamide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pyrazinamide is combined with Oxetacaine.,increase,risk
Pyrazinamide,Oxybenzone,Pyrazinamide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pyrazinamide is combined with Oxybuprocaine.,increase,risk
Pyrazinamide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Oxyquinoline,Pyrazinamide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Quetiapine,Pyrazinamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Quinethazone,Quinethazone may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pyrazinamide,Quinidine,Pyrazinamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Vaborbactam,Pyrazinamide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Valaciclovir,Valaciclovir may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Valbenazine,Pyrazinamide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Valdecoxib,Valdecoxib may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Valganciclovir,Pyrazinamide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Pyrazinamide.,decrease,no risk
Pyrazinamide,Vancomycin,Pyrazinamide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Varenicline,Pyrazinamide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Venlafaxine,Venlafaxine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Verapamil,Pyrazinamide may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pyrazinamide.,decrease,no risk
Pyrazinamide,Vilanterol,Pyrazinamide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Viloxazine,Pyrazinamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Vortioxetine,Pyrazinamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Warfarin,Pyrazinamide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Zaleplon,Pyrazinamide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Zanamivir,Pyrazinamide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Pyrazinamide,Zonisamide,Zonisamide may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metixene,Galantamine,The therapeutic efficacy of Metixene can be decreased when used in combination with Galantamine.,decrease,no risk
Metixene,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Metixene is combined with Gallamine triethiodide.,increase,risk
Metixene,Ginkgo biloba,The therapeutic efficacy of Metixene can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Metixene,Glucagon,Metixene may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Metixene,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Metixene.,decrease,no risk
Metixene,Glycopyrronium,The risk or severity of adverse effects can be increased when Metixene is combined with Glycopyrronium.,increase,risk
Metixene,Guanabenz,The risk or severity of Tachycardia can be increased when Metixene is combined with Guanabenz.,increase,risk
Metixene,Guanfacine,The risk or severity of Tachycardia can be increased when Metixene is combined with Guanfacine.,increase,risk
Metixene,Haloperidol,The therapeutic efficacy of Metixene can be decreased when used in combination with Haloperidol.,decrease,no risk
Metixene,Hexafluronium,The risk or severity of adverse effects can be increased when Metixene is combined with Hexafluronium.,increase,risk
Metixene,Hexocyclium,The risk or severity of adverse effects can be increased when Metixene is combined with Hexocyclium.,increase,risk
Metixene,Homatropine,The risk or severity of adverse effects can be increased when Metixene is combined with Homatropine.,increase,risk
Metixene,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Metixene is combined with Homatropine methylbromide.,increase,risk
Metixene,Huperzine A,The therapeutic efficacy of Metixene can be decreased when used in combination with Huperzine A.,decrease,no risk
Metixene,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Metixene.,increase,no risk
Metixene,Hydrocodone,The risk or severity of adverse effects can be increased when Metixene is combined with Hydrocodone.,increase,risk
Metixene,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Metixene.,increase,no risk
Metixene,Hydromorphone,The risk or severity of adverse effects can be increased when Metixene is combined with Hydromorphone.,increase,risk
Metixene,Hyoscyamine,The risk or severity of adverse effects can be increased when Metixene is combined with Hyoscyamine.,increase,risk
Metixene,Ketamine,The therapeutic efficacy of Metixene can be decreased when used in combination with Ketamine.,decrease,no risk
Metixene,Olanzapine,The therapeutic efficacy of Metixene can be decreased when used in combination with Olanzapine.,decrease,no risk
Metixene,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Metixene is combined with Oliceridine.",increase,risk
Metixene,Olodaterol,The risk or severity of Tachycardia can be increased when Metixene is combined with Olodaterol.,increase,risk
Metixene,Opium,The risk or severity of adverse effects can be increased when Metixene is combined with Opium.,increase,risk
Metixene,Orciprenaline,The risk or severity of Tachycardia can be increased when Metixene is combined with Orciprenaline.,increase,risk
Metixene,Orphenadrine,The risk or severity of adverse effects can be increased when Metixene is combined with Orphenadrine.,increase,risk
Metixene,Oxybutynin,The risk or severity of adverse effects can be increased when Metixene is combined with Oxybutynin.,increase,risk
Metixene,Oxycodone,The risk or severity of adverse effects can be increased when Metixene is combined with Oxycodone.,increase,risk
Metixene,Oxymetazoline,The risk or severity of Tachycardia can be increased when Metixene is combined with Oxymetazoline.,increase,risk
Metixene,Oxymorphone,The risk or severity of adverse effects can be increased when Metixene is combined with Oxymorphone.,increase,risk
Metixene,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Metixene is combined with Oxyphencyclimine.,increase,risk
Metixene,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Metixene.,decrease,no risk
Metixene,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Metixene.,increase,risk
Metixene,Quetiapine,The therapeutic efficacy of Metixene can be decreased when used in combination with Quetiapine.,decrease,no risk
Metixene,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Metixene.,increase,no risk
Metixene,Quinidine,The risk or severity of adverse effects can be increased when Metixene is combined with Quinidine.,increase,risk
Metixene,Quinupramine,The risk or severity of adverse effects can be increased when Metixene is combined with Quinupramine.,increase,risk
Metixene,Umeclidinium,The risk or severity of adverse effects can be increased when Metixene is combined with Umeclidinium.,increase,risk
Metixene,Vecuronium,The risk or severity of adverse effects can be increased when Metixene is combined with Vecuronium.,increase,risk
Metixene,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Metixene.,increase,risk
Metixene,Vilanterol,The risk or severity of Tachycardia can be increased when Metixene is combined with Vilanterol.,increase,risk
Metixene,Xamoterol,The risk or severity of Tachycardia can be increased when Metixene is combined with Xamoterol.,increase,risk
Metixene,Xylometazoline,The risk or severity of Tachycardia can be increased when Metixene is combined with Xylometazoline.,increase,risk
Metixene,Ziprasidone,The therapeutic efficacy of Metixene can be decreased when used in combination with Ziprasidone.,decrease,no risk
Metixene,Zotepine,The therapeutic efficacy of Metixene can be decreased when used in combination with Zotepine.,decrease,no risk
Metixene,Zuclopenthixol,The therapeutic efficacy of Metixene can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Cetirizine,Berotralstat,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Berotralstat.,increase,risk
Cetirizine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Cetirizine.,decrease,no risk
Cetirizine,Bicisate,Cetirizine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Cetirizine,Bilastine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Bilastine.,increase,risk
Cetirizine,Biperiden,Biperiden may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Bismuth subgallate,Cetirizine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Cetirizine,Bisoprolol,Cetirizine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Cetirizine,Bisoxatin,Cetirizine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Cetirizine,Bleomycin,Bleomycin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Cetirizine.,increase,risk
Cetirizine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Cetirizine.,increase,risk
Cetirizine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Cetirizine.,increase,risk
Cetirizine,Bretylium,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Bretylium.,increase,risk
Cetirizine,Brexanolone,The risk or severity of CNS depression can be increased when Cetirizine is combined with Brexanolone.,increase,risk
Cetirizine,Brexpiprazole,The risk or severity of CNS depression can be increased when Cetirizine is combined with Brexpiprazole.,increase,risk
Cetirizine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cetirizine.,increase,no risk
Cetirizine,Brivaracetam,The risk or severity of CNS depression can be increased when Cetirizine is combined with Brivaracetam.,increase,risk
Cetirizine,Bromazepam,The risk or severity of CNS depression can be increased when Cetirizine is combined with Bromazepam.,increase,risk
Cetirizine,Bromocriptine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Bromocriptine.,increase,risk
Cetirizine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cetirizine,Bromperidol,The risk or severity of CNS depression can be increased when Cetirizine is combined with Bromperidol.,increase,risk
Cetirizine,Brompheniramine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Brompheniramine.,increase,risk
Cetirizine,Buclizine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Buclizine.,increase,risk
Cetirizine,Budesonide,Cetirizine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Cetirizine,Bumadizone,Bumadizone may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Bumetanide,Bumetanide may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cetirizine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Cetirizine.,increase,risk
Cetirizine,Buprenorphine,Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Cetirizine,Bupropion,The risk or severity of CNS depression can be increased when Cetirizine is combined with Bupropion.,increase,risk
Cetirizine,Buserelin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Buserelin.,increase,risk
Cetirizine,Buspirone,The risk or severity of CNS depression can be increased when Cetirizine is combined with Buspirone.,increase,risk
Cetirizine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Cetirizine.,increase,risk
Cetirizine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Cetirizine.,increase,risk
Cetirizine,Butaperazine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Butaperazine.,increase,risk
Cetirizine,Butobarbital,The risk or severity of CNS depression can be increased when Cetirizine is combined with Butobarbital.,increase,risk
Cetirizine,Butorphanol,The risk or severity of CNS depression can be increased when Cetirizine is combined with Butorphanol.,increase,risk
Cetirizine,Butriptyline,The risk or severity of CNS depression can be increased when Cetirizine is combined with Butriptyline.,increase,risk
Cetirizine,Butylscopolamine,Butylscopolamine may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Gabapentin,The risk or severity of CNS depression can be increased when Cetirizine is combined with Gabapentin.,increase,risk
Cetirizine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cetirizine is combined with Gabapentin enacarbil.,increase,risk
Cetirizine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Gadobenic acid.,increase,risk
Cetirizine,Gadodiamide,Gadodiamide may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Gadofosveset trisodium,Cetirizine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cetirizine,Gadopentetic acid,Cetirizine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cetirizine,Gadoteric acid,Cetirizine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cetirizine,Gadoteridol,Cetirizine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cetirizine,Galantamine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Galantamine.,increase,risk
Cetirizine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Cetirizine is combined with Gallamine triethiodide.,increase,risk
Cetirizine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cetirizine is combined with Ganaxolone.",increase,risk
Cetirizine,Ganciclovir,Cetirizine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cetirizine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Gatifloxacin.,increase,risk
Cetirizine,Gemcitabine,Cetirizine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cetirizine,Gemfibrozil,Cetirizine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cetirizine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Gemifloxacin.,increase,risk
Cetirizine,Gentamicin,Cetirizine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cetirizine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Cetirizine.,increase,risk
Cetirizine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Gilteritinib.,increase,risk
Cetirizine,Gimeracil,Cetirizine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cetirizine,Givosiran,Givosiran may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Glasdegib,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Glasdegib.,increase,risk
Cetirizine,Glipizide,Cetirizine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cetirizine,Glutethimide,The risk or severity of CNS depression can be increased when Cetirizine is combined with Glutethimide.,increase,risk
Cetirizine,Glycerol phenylbutyrate,Cetirizine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cetirizine,Glycopyrronium,Glycopyrronium may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Golodirsen,Cetirizine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cetirizine,Goserelin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Goserelin.,increase,risk
Cetirizine,Granisetron,The risk or severity of CNS depression can be increased when Cetirizine is combined with Granisetron.,increase,risk
Cetirizine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Grepafloxacin.,increase,risk
Cetirizine,Guanethidine,Cetirizine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cetirizine,Guanfacine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Guanfacine.,increase,risk
Cetirizine,Halazepam,The risk or severity of CNS depression can be increased when Cetirizine is combined with Halazepam.,increase,risk
Cetirizine,Halofantrine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Halofantrine.,increase,risk
Cetirizine,Haloperidol,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Haloperidol.,increase,risk
Cetirizine,Halothane,The risk or severity of CNS depression can be increased when Cetirizine is combined with Halothane.,increase,risk
Cetirizine,Hexafluronium,The risk or severity of CNS depression can be increased when Cetirizine is combined with Hexafluronium.,increase,risk
Cetirizine,Hexocyclium,Hexocyclium may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Histrelin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Histrelin.,increase,risk
Cetirizine,Homatropine methylbromide,Homatropine methylbromide may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cetirizine.,decrease,no risk
Cetirizine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Cetirizine.,decrease,no risk
Cetirizine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Cetirizine.,decrease,no risk
Cetirizine,Hydralazine,Cetirizine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cetirizine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cetirizine,Hydrocodone,Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cetirizine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cetirizine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cetirizine.,increase,risk
Cetirizine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Hydroxychloroquine.,increase,risk
Cetirizine,Hydroxyethyl Starch,Cetirizine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cetirizine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Hydroxyzine.,increase,risk
Cetirizine,Hyoscyamine,Cetirizine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Cetirizine,Kanamycin,Cetirizine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cetirizine,Ketamine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Ketamine.,increase,risk
Cetirizine,Ketazolam,The risk or severity of CNS depression can be increased when Cetirizine is combined with Ketazolam.,increase,risk
Cetirizine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ketoconazole.,increase,risk
Cetirizine,Ketoprofen,Ketoprofen may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Ketorolac,Ketorolac may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Octinoxate,Cetirizine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cetirizine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Cetirizine.,increase,risk
Cetirizine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ofloxacin.,increase,risk
Cetirizine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cetirizine.,increase,risk
Cetirizine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cetirizine is combined with Oliceridine.",increase,risk
Cetirizine,Olodaterol,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Olodaterol.,increase,risk
Cetirizine,Olsalazine,Olsalazine may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Ondansetron,The risk or severity of CNS depression can be increased when Cetirizine is combined with Ondansetron.,increase,risk
Cetirizine,Opium,The risk or severity of CNS depression can be increased when Cetirizine is combined with Opium.,increase,risk
Cetirizine,Orphenadrine,Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cetirizine,Oseltamivir,Oseltamivir may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Oxacillin,Cetirizine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cetirizine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cetirizine.,increase,risk
Cetirizine,Oxaprozin,Oxaprozin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Oxatomide,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Oxatomide.,increase,risk
Cetirizine,Oxazepam,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxazepam.,increase,risk
Cetirizine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxcarbazepine.,increase,risk
Cetirizine,Oxitriptan,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxitriptan.,increase,risk
Cetirizine,Oxprenolol,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxprenolol.,increase,risk
Cetirizine,Oxybenzone,Cetirizine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cetirizine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxybuprocaine.,increase,risk
Cetirizine,Oxybutynin,Oxybutynin may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Oxycodone,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxycodone.,increase,risk
Cetirizine,Oxymorphone,The risk or severity of CNS depression can be increased when Cetirizine is combined with Oxymorphone.,increase,risk
Cetirizine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Oxyphencyclimine,Oxyphencyclimine may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Oxyphenonium,Oxyphenonium may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Oxyquinoline,Cetirizine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cetirizine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cetirizine.,increase,risk
Cetirizine,Quazepam,The risk or severity of CNS depression can be increased when Cetirizine is combined with Quazepam.,increase,risk
Cetirizine,Quetiapine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Quetiapine.,increase,risk
Cetirizine,Quinethazone,Quinethazone may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cetirizine,Quinidine,Cetirizine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cetirizine,Quinine,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Quinine.,increase,risk
Cetirizine,Quinupramine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Quinupramine.,increase,risk
Cetirizine,Quizartinib,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Quizartinib.,increase,risk
Cetirizine,Umeclidinium,Umeclidinium may increase the anticholinergic activities of Cetirizine.,increase,no risk
Cetirizine,Urethane,The risk or severity of CNS depression can be increased when Cetirizine is combined with Urethane.,increase,risk
Cetirizine,Vaborbactam,Cetirizine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cetirizine,Valaciclovir,Valaciclovir may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Valbenazine,Cetirizine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cetirizine,Valdecoxib,Valdecoxib may decrease the excretion rate of Cetirizine which could result in a higher serum level.,decrease,no risk
Cetirizine,Valganciclovir,Cetirizine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cetirizine,Valproic acid,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Valproic acid.,increase,risk
Cetirizine,Vancomycin,Cetirizine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cetirizine,Vandetanib,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vandetanib.,increase,risk
Cetirizine,Vardenafil,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vardenafil.,increase,risk
Cetirizine,Varenicline,Cetirizine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cetirizine,Vecuronium,The risk or severity of CNS depression can be increased when Cetirizine is combined with Vecuronium.,increase,risk
Cetirizine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Cetirizine.,increase,risk
Cetirizine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Cetirizine.,increase,risk
Cetirizine,Verapamil,Cetirizine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cetirizine,Vernakalant,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vernakalant.,increase,risk
Cetirizine,Vigabatrin,The risk or severity of CNS depression can be increased when Cetirizine is combined with Vigabatrin.,increase,risk
Cetirizine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cetirizine.,increase,risk
Cetirizine,Vilazodone,The risk or severity of CNS depression can be increased when Cetirizine is combined with Vilazodone.,increase,risk
Cetirizine,Viloxazine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Viloxazine.,increase,risk
Cetirizine,Voriconazole,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Voriconazole.,increase,risk
Cetirizine,Vorinostat,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vorinostat.,increase,risk
Cetirizine,Vortioxetine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Vortioxetine.,increase,risk
Cetirizine,Warfarin,Cetirizine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cetirizine,Yohimbine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Yohimbine.,increase,risk
Cetirizine,Zaleplon,The risk or severity of CNS depression can be increased when Cetirizine is combined with Zaleplon.,increase,risk
Cetirizine,Zanamivir,Cetirizine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cetirizine,Ziconotide,The risk or severity of CNS depression can be increased when Cetirizine is combined with Ziconotide.,increase,risk
Cetirizine,Zimelidine,The risk or severity of adverse effects can be increased when Cetirizine is combined with Zimelidine.,increase,risk
Cetirizine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ziprasidone.,increase,risk
Cetirizine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Cetirizine.,increase,risk
Cetirizine,Zolpidem,Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cetirizine,Zonisamide,The risk or severity of CNS depression can be increased when Cetirizine is combined with Zonisamide.,increase,risk
Cetirizine,Zopiclone,The risk or severity of adverse effects can be increased when Cetirizine is combined with Zopiclone.,increase,risk
Cetirizine,Zotepine,The risk or severity of CNS depression can be increased when Cetirizine is combined with Zotepine.,increase,risk
Cetirizine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Zuclopenthixol.,increase,risk
Cetirizine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cetirizine.,increase,risk
Terfenadine,Bepridil,The metabolism of Bepridil can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Berotralstat,The metabolism of Terfenadine can be decreased when combined with Berotralstat.,decrease,no risk
Terfenadine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Terfenadine.,decrease,no risk
Terfenadine,Betaine,The therapeutic efficacy of Terfenadine can be decreased when used in combination with Betaine.,decrease,no risk
Terfenadine,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bicalutamide,The serum concentration of Terfenadine can be increased when it is combined with Bicalutamide.,increase,no risk
Terfenadine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bifonazole,The metabolism of Terfenadine can be decreased when combined with Bifonazole.,decrease,no risk
Terfenadine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Terfenadine.,increase,risk
Terfenadine,Bimekizumab,The metabolism of Terfenadine can be increased when combined with Bimekizumab.,increase,no risk
Terfenadine,Biperiden,The metabolism of Terfenadine can be decreased when combined with Biperiden.,decrease,no risk
Terfenadine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Terfenadine.,decrease,no risk
Terfenadine,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Terfenadine.,decrease,no risk
Terfenadine,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bosentan,The metabolism of Bosentan can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Terfenadine is combined with Botulinum toxin type A.,increase,risk
Terfenadine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Terfenadine is combined with Botulinum toxin type B.,increase,risk
Terfenadine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Terfenadine.,increase,risk
Terfenadine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Terfenadine.,increase,risk
Terfenadine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Terfenadine.,increase,risk
Terfenadine,Budesonide,The metabolism of Budesonide can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Bupropion,The metabolism of Terfenadine can be decreased when combined with Bupropion.,decrease,no risk
Terfenadine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Terfenadine.,increase,risk
Terfenadine,Buspirone,The metabolism of Buspirone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Busulfan,The metabolism of Busulfan can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Terfenadine.,increase,risk
Terfenadine,Butalbital,The metabolism of Terfenadine can be increased when combined with Butalbital.,increase,no risk
Terfenadine,Butobarbital,The risk or severity of adverse effects can be increased when Terfenadine is combined with Butobarbital.,increase,risk
Terfenadine,Butorphanol,The risk or severity of adverse effects can be increased when Terfenadine is combined with Butorphanol.,increase,risk
Terfenadine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Terfenadine.,increase,risk
Terfenadine,Butylscopolamine,The risk or severity of adverse effects can be increased when Terfenadine is combined with Butylscopolamine.,increase,risk
Terfenadine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Terfenadine.,increase,risk
Terfenadine,Galantamine,The metabolism of Galantamine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Terfenadine is combined with Gallamine triethiodide.,increase,risk
Terfenadine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Terfenadine.,increase,risk
Terfenadine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Terfenadine.,increase,risk
Terfenadine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ginkgo biloba,The therapeutic efficacy of Terfenadine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Terfenadine,Givosiran,The serum concentration of Terfenadine can be increased when it is combined with Givosiran.,increase,no risk
Terfenadine,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Glecaprevir,The metabolism of Terfenadine can be decreased when combined with Glecaprevir.,decrease,no risk
Terfenadine,Glimepiride,Glimepiride may decrease the excretion rate of Terfenadine which could result in a higher serum level.,decrease,no risk
Terfenadine,Glipizide,Terfenadine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Terfenadine,Glofitamab,The serum concentration of Terfenadine can be increased when it is combined with Glofitamab.,increase,no risk
Terfenadine,Glucagon,Terfenadine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Terfenadine,Glyburide,The metabolism of Glyburide can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Terfenadine.,decrease,no risk
Terfenadine,Glycerol phenylbutyrate,The metabolism of Terfenadine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Terfenadine,Glycopyrronium,The risk or severity of adverse effects can be increased when Terfenadine is combined with Glycopyrronium.,increase,risk
Terfenadine,Glycyrrhizic acid,Terfenadine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Terfenadine,Golimumab,The metabolism of Terfenadine can be increased when combined with Golimumab.,increase,no risk
Terfenadine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terfenadine.,increase,risk
Terfenadine,Granisetron,The metabolism of Granisetron can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Grapefruit,The metabolism of Terfenadine can be decreased when combined with Grapefruit.,decrease,no risk
Terfenadine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Griseofulvin,The metabolism of Terfenadine can be increased when combined with Griseofulvin.,increase,no risk
Terfenadine,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Haloperidol,The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Haloperidol.,increase,risk
Terfenadine,Hexafluronium,The risk or severity of adverse effects can be increased when Terfenadine is combined with Hexafluronium.,increase,risk
Terfenadine,Hexocyclium,The risk or severity of adverse effects can be increased when Terfenadine is combined with Hexocyclium.,increase,risk
Terfenadine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Terfenadine.,increase,risk
Terfenadine,Homatropine,The risk or severity of adverse effects can be increased when Terfenadine is combined with Homatropine.,increase,risk
Terfenadine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Terfenadine is combined with Homatropine methylbromide.,increase,risk
Terfenadine,Huperzine A,The therapeutic efficacy of Terfenadine can be decreased when used in combination with Huperzine A.,decrease,no risk
Terfenadine,Hydralazine,The metabolism of Terfenadine can be decreased when combined with Hydralazine.,decrease,no risk
Terfenadine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Terfenadine.,increase,risk
Terfenadine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydrocortamate,The metabolism of Terfenadine can be increased when combined with Hydrocortamate.,increase,no risk
Terfenadine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Hydromorphone,The risk or severity of adverse effects can be increased when Terfenadine is combined with Hydromorphone.,increase,risk
Terfenadine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Hydroxyzine.,increase,risk
Terfenadine,Hyoscyamine,Terfenadine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Terfenadine,Ketamine,The metabolism of Ketamine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Terfenadine.,increase,risk
Terfenadine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Terfenadine.,increase,risk
Terfenadine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Olaparib,The metabolism of Olaparib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Olmesartan,Olmesartan may decrease the excretion rate of Terfenadine which could result in a higher serum level.,decrease,no risk
Terfenadine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Terfenadine.,increase,risk
Terfenadine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Opium,The metabolism of Opium can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oritavancin,The metabolism of Terfenadine can be increased when combined with Oritavancin.,increase,no risk
Terfenadine,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Terfenadine.,increase,risk
Terfenadine,Oxamniquine,The metabolism of Terfenadine can be decreased when combined with Oxamniquine.,decrease,no risk
Terfenadine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Terfenadine.,increase,risk
Terfenadine,Oxcarbazepine,The metabolism of Terfenadine can be increased when combined with Oxcarbazepine.,increase,no risk
Terfenadine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Terfenadine is combined with Oxyphencyclimine.,increase,risk
Terfenadine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Terfenadine.,decrease,no risk
Terfenadine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Terfenadine.,increase,risk
Terfenadine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Terfenadine.,increase,risk
Terfenadine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Quazepam,The metabolism of Quazepam can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Quinidine,The metabolism of Quinidine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Quinine,The metabolism of Quinine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Quinupramine,The risk or severity of adverse effects can be increased when Terfenadine is combined with Quinupramine.,increase,risk
Terfenadine,Quinupristin,The metabolism of Terfenadine can be decreased when combined with Quinupristin.,decrease,no risk
Terfenadine,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Udenafil,The metabolism of Udenafil can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Umeclidinium,The risk or severity of adverse effects can be increased when Terfenadine is combined with Umeclidinium.,increase,risk
Terfenadine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Terfenadine which could result in a higher serum level.,decrease,no risk
Terfenadine,Vadadustat,The serum concentration of Terfenadine can be increased when it is combined with Vadadustat.,increase,no risk
Terfenadine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Terfenadine.,increase,risk
Terfenadine,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vecuronium,The risk or severity of adverse effects can be increased when Terfenadine is combined with Vecuronium.,increase,risk
Terfenadine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Verapamil,The metabolism of Verapamil can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Viloxazine,The metabolism of Terfenadine can be decreased when combined with Viloxazine.,decrease,no risk
Terfenadine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vincristine,The metabolism of Vincristine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vindesine,The metabolism of Vindesine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Terfenadine.,increase,risk
Terfenadine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Terfenadine.,increase,no risk
Terfenadine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Warfarin,The metabolism of Warfarin can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zafirlukast,The metabolism of Terfenadine can be decreased when combined with Zafirlukast.,decrease,no risk
Terfenadine,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zileuton,The metabolism of Zileuton can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zimelidine,The metabolism of Terfenadine can be decreased when combined with Zimelidine.,decrease,no risk
Terfenadine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Ziprasidone.,increase,risk
Terfenadine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zotepine,The metabolism of Zotepine can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Terfenadine.,decrease,no risk
Terfenadine,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Terfenadine.,increase,no risk
Diltiazem,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Diltiazem.,increase,risk
Diltiazem,Balsalazide,The risk or severity of bleeding can be increased when Diltiazem is combined with Balsalazide.,increase,risk
Diltiazem,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bedaquiline,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Bedaquiline.,increase,risk
Diltiazem,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bemiparin,The risk or severity of hyperkalemia can be increased when Diltiazem is combined with Bemiparin.,increase,risk
Diltiazem,Benazepril,Diltiazem may increase the hypotensive activities of Benazepril.,increase,no risk
Diltiazem,Bendroflumethiazide,The therapeutic efficacy of Diltiazem can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Diltiazem,Benorilate,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Benorilate.,decrease,no risk
Diltiazem,Benoxaprofen,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Diltiazem,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Diltiazem.,increase,risk
Diltiazem,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Benzthiazide,The therapeutic efficacy of Diltiazem can be increased when used in combination with Benzthiazide.,increase,no risk
Diltiazem,Benzydamine,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Benzydamine.,decrease,no risk
Diltiazem,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bepridil,Diltiazem may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Diltiazem,Beractant,Diltiazem may increase the bradycardic activities of Beractant.,increase,no risk
Diltiazem,Berotralstat,The metabolism of Diltiazem can be decreased when combined with Berotralstat.,decrease,no risk
Diltiazem,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Diltiazem.,increase,no risk
Diltiazem,Bethanidine,Bethanidine may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Bexagliflozin.,increase,risk
Diltiazem,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Diltiazem.,increase,no risk
Diltiazem,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Diltiazem.,increase,risk
Diltiazem,Bimatoprost,Diltiazem may increase the hypotensive activities of Bimatoprost.,increase,no risk
Diltiazem,Bimekizumab,The metabolism of Diltiazem can be increased when combined with Bimekizumab.,increase,no risk
Diltiazem,Bioallethrin,Diltiazem may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Diltiazem,Biperiden,The metabolism of Diltiazem can be decreased when combined with Biperiden.,decrease,no risk
Diltiazem,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Diltiazem.,decrease,no risk
Diltiazem,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Diltiazem is combined with Bismuth subsalicylate.,increase,risk
Diltiazem,Bisoprolol,The therapeutic efficacy of Diltiazem can be increased when used in combination with Bisoprolol.,increase,no risk
Diltiazem,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Diltiazem.,decrease,no risk
Diltiazem,Boceprevir,The serum concentration of Diltiazem can be increased when it is combined with Boceprevir.,increase,no risk
Diltiazem,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bosentan,The metabolism of Bosentan can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bretylium,Diltiazem may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Diltiazem,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Brimonidine,Brimonidine may increase the antihypertensive activities of Diltiazem.,increase,no risk
Diltiazem,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Diltiazem.,increase,risk
Diltiazem,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Diltiazem.,increase,risk
Diltiazem,Budesonide,The metabolism of Budesonide can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bumadizone,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Bumadizone.,decrease,no risk
Diltiazem,Bumetanide,The risk or severity of adverse effects can be increased when Diltiazem is combined with Bumetanide.,increase,risk
Diltiazem,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Bupropion,The metabolism of Diltiazem can be decreased when combined with Bupropion.,decrease,no risk
Diltiazem,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Diltiazem.,increase,risk
Diltiazem,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Busulfan,The metabolism of Busulfan can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Butabarbital,Butabarbital may increase the hypotensive activities of Diltiazem.,increase,no risk
Diltiazem,Butalbital,Butalbital may increase the hypotensive activities of Diltiazem.,increase,no risk
Diltiazem,Butriptyline,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Butriptyline.,increase,risk
Diltiazem,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Gadobenic acid.,increase,risk
Diltiazem,Galantamine,The metabolism of Galantamine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Gallamine triethiodide,Diltiazem may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Diltiazem,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Diltiazem.,increase,risk
Diltiazem,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Gemfibrozil,The metabolism of Diltiazem can be decreased when combined with Gemfibrozil.,decrease,no risk
Diltiazem,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Gemifloxacin.,increase,risk
Diltiazem,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Gilteritinib,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Gilteritinib.,increase,risk
Diltiazem,Ginkgo biloba,The metabolism of Diltiazem can be decreased when combined with Ginkgo biloba.,decrease,no risk
Diltiazem,Givosiran,The serum concentration of Diltiazem can be increased when it is combined with Givosiran.,increase,no risk
Diltiazem,Glasdegib,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Glasdegib.,increase,risk
Diltiazem,Gliclazide,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Gliclazide.,increase,risk
Diltiazem,Glimepiride,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Glimepiride.,increase,risk
Diltiazem,Glipizide,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Glipizide.,increase,risk
Diltiazem,Gliquidone,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Gliquidone.,increase,risk
Diltiazem,Glofitamab,The serum concentration of Diltiazem can be increased when it is combined with Glofitamab.,increase,no risk
Diltiazem,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Diltiazem.,decrease,no risk
Diltiazem,Glyburide,The metabolism of Glyburide can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Diltiazem.,decrease,no risk
Diltiazem,Glycerol phenylbutyrate,The metabolism of Diltiazem can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Diltiazem,Glycol salicylate,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Diltiazem,Glymidine,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Glymidine.,increase,risk
Diltiazem,Golimumab,The metabolism of Diltiazem can be increased when combined with Golimumab.,increase,no risk
Diltiazem,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Diltiazem.,increase,risk
Diltiazem,Granisetron,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Granisetron.,increase,risk
Diltiazem,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Grepafloxacin.,increase,risk
Diltiazem,Guanabenz,Guanabenz may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Guanadrel,Guanadrel may increase the hypotensive activities of Diltiazem.,increase,no risk
Diltiazem,Guanethidine,Diltiazem may increase the hypotensive activities of Guanethidine.,increase,no risk
Diltiazem,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Guanoxan,Diltiazem may increase the hypotensive activities of Guanoxan.,increase,no risk
Diltiazem,Halofantrine,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Halofantrine.,increase,risk
Diltiazem,Haloperidol,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Haloperidol.,increase,risk
Diltiazem,Halothane,Halothane may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Heparin,The risk or severity of hyperkalemia can be increased when Diltiazem is combined with Heparin.,increase,risk
Diltiazem,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Diltiazem.,increase,risk
Diltiazem,Hydralazine,Diltiazem may increase the hypotensive activities of Hydralazine.,increase,no risk
Diltiazem,Hydrochlorothiazide,The therapeutic efficacy of Diltiazem can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Diltiazem,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydroflumethiazide,The therapeutic efficacy of Diltiazem can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Diltiazem,Hydromorphone,The metabolism of Diltiazem can be decreased when combined with Hydromorphone.,decrease,no risk
Diltiazem,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Diltiazem.,increase,risk
Diltiazem,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Hydroxyzine.,increase,risk
Diltiazem,Hyoscyamine,Diltiazem may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Diltiazem,Ketamine,The metabolism of Ketamine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Ketoconazole,The metabolism of Diltiazem can be decreased when combined with Ketoconazole.,decrease,no risk
Diltiazem,Ketoprofen,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Ketoprofen.,decrease,no risk
Diltiazem,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Obinutuzumab,Diltiazem may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Diltiazem,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Diltiazem.,increase,no risk
Diltiazem,Ofloxacin,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Ofloxacin.,increase,risk
Diltiazem,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Diltiazem.,increase,risk
Diltiazem,Olaparib,The metabolism of Olaparib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Olmesartan,Olmesartan may increase the hypotensive activities of Diltiazem.,increase,no risk
Diltiazem,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Olsalazine,The risk or severity of bleeding can be increased when Diltiazem is combined with Olsalazine.,increase,risk
Diltiazem,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Opicapone,The risk or severity of adverse effects can be increased when Diltiazem is combined with Opicapone.,increase,risk
Diltiazem,Opium,The metabolism of Opium can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Oritavancin,The metabolism of Diltiazem can be decreased when combined with Oritavancin.,decrease,no risk
Diltiazem,Orphenadrine,The metabolism of Diltiazem can be decreased when combined with Orphenadrine.,decrease,no risk
Diltiazem,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Diltiazem.,increase,no risk
Diltiazem,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Diltiazem.,increase,risk
Diltiazem,Oxamniquine,The metabolism of Diltiazem can be decreased when combined with Oxamniquine.,decrease,no risk
Diltiazem,Oxandrolone,The metabolism of Diltiazem can be decreased when combined with Oxandrolone.,decrease,no risk
Diltiazem,Oxaprozin,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Oxaprozin.,decrease,no risk
Diltiazem,Oxatomide,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Oxatomide.,increase,risk
Diltiazem,Oxcarbazepine,The metabolism of Diltiazem can be increased when combined with Oxcarbazepine.,increase,no risk
Diltiazem,Oxprenolol,Diltiazem may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Diltiazem,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Oxymetazoline,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Diltiazem,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Oxyphenbutazone,The therapeutic efficacy of Diltiazem can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Diltiazem,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Diltiazem.,decrease,no risk
Diltiazem,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Diltiazem.,increase,risk
Diltiazem,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Quazepam,The metabolism of Quazepam can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Quetiapine,Quetiapine may increase the hypotensive activities of Diltiazem.,increase,no risk
Diltiazem,Quinapril,Diltiazem may increase the hypotensive activities of Quinapril.,increase,no risk
Diltiazem,Quinidine,Diltiazem may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Diltiazem,Quinine,The metabolism of Diltiazem can be decreased when combined with Quinine.,decrease,no risk
Diltiazem,Quinupramine,Quinupramine may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Quizartinib,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Quizartinib.,increase,risk
Diltiazem,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Udenafil,The metabolism of Udenafil can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Unoprostone,Diltiazem may increase the hypotensive activities of Unoprostone.,increase,no risk
Diltiazem,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vadadustat,The serum concentration of Diltiazem can be increased when it is combined with Vadadustat.,increase,no risk
Diltiazem,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Valproic acid,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Valproic acid.,increase,risk
Diltiazem,Valsartan,The metabolism of Diltiazem can be decreased when combined with Valsartan.,decrease,no risk
Diltiazem,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vecuronium,Diltiazem may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Diltiazem,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Venlafaxine,The metabolism of Diltiazem can be decreased when combined with Venlafaxine.,decrease,no risk
Diltiazem,Verapamil,Diltiazem may increase the arrhythmogenic activities of Verapamil.,increase,no risk
Diltiazem,Vericiguat,The risk or severity of adverse effects can be increased when Diltiazem is combined with Vericiguat.,increase,risk
Diltiazem,Vernakalant,Diltiazem may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Diltiazem,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Diltiazem.,increase,risk
Diltiazem,Vilazodone,The metabolism of Diltiazem can be decreased when combined with Vilazodone.,decrease,no risk
Diltiazem,Vildagliptin,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Vildagliptin.,increase,risk
Diltiazem,Viloxazine,The metabolism of Diltiazem can be decreased when combined with Viloxazine.,decrease,no risk
Diltiazem,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vincristine,The metabolism of Vincristine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vindesine,The metabolism of Vindesine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Voriconazole,The metabolism of Diltiazem can be decreased when combined with Voriconazole.,decrease,no risk
Diltiazem,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Diltiazem.,increase,risk
Diltiazem,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Diltiazem.,increase,no risk
Diltiazem,Xamoterol,Xamoterol may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Xylometazoline,Diltiazem may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Diltiazem,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zafirlukast,The metabolism of Diltiazem can be decreased when combined with Zafirlukast.,decrease,no risk
Diltiazem,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Ziconotide,Diltiazem may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Diltiazem,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zileuton,The metabolism of Zileuton can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zimelidine,The metabolism of Diltiazem can be decreased when combined with Zimelidine.,decrease,no risk
Diltiazem,Ziprasidone,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Ziprasidone.,increase,risk
Diltiazem,Zofenopril,Diltiazem may increase the hypotensive activities of Zofenopril.,increase,no risk
Diltiazem,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Diltiazem.,decrease,no risk
Diltiazem,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zonisamide,Diltiazem may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Diltiazem,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zotepine,The metabolism of Zotepine can be decreased when combined with Diltiazem.,decrease,no risk
Diltiazem,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Zuclopenthixol.,increase,risk
Diltiazem,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Diltiazem.,decrease,no risk
Protriptyline,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.,increase,no risk
Protriptyline,Brivaracetam,The risk or severity of CNS depression can be increased when Protriptyline is combined with Brivaracetam.,increase,risk
Protriptyline,Bromazepam,The risk or severity of CNS depression can be increased when Protriptyline is combined with Bromazepam.,increase,risk
Protriptyline,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Bromfenac.,increase,risk
Protriptyline,Bromocriptine,Protriptyline may increase the vasopressor activities of Bromocriptine.,increase,no risk
Protriptyline,Bromperidol,The risk or severity of adverse effects can be increased when Protriptyline is combined with Bromperidol.,increase,risk
Protriptyline,Brompheniramine,The risk or severity of CNS depression can be increased when Protriptyline is combined with Brompheniramine.,increase,risk
Protriptyline,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Protriptyline.,increase,risk
Protriptyline,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Bufexamac.,increase,risk
Protriptyline,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Bumadizone.,increase,risk
Protriptyline,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Protriptyline.,increase,risk
Protriptyline,Buprenorphine,Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Protriptyline,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Protriptyline.,increase,risk
Protriptyline,Buserelin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Buserelin.,increase,risk
Protriptyline,Buspirone,The risk or severity of CNS depression can be increased when Protriptyline is combined with Buspirone.,increase,risk
Protriptyline,Butabarbital,The metabolism of Protriptyline can be increased when combined with Butabarbital.,increase,no risk
Protriptyline,Butalbital,The metabolism of Protriptyline can be increased when combined with Butalbital.,increase,no risk
Protriptyline,Butaperazine,The serum concentration of Protriptyline can be increased when it is combined with Butaperazine.,increase,no risk
Protriptyline,Butobarbital,The risk or severity of CNS depression can be increased when Protriptyline is combined with Butobarbital.,increase,risk
Protriptyline,Butorphanol,The risk or severity of CNS depression can be increased when Protriptyline is combined with Butorphanol.,increase,risk
Protriptyline,Butriptyline,The risk or severity of CNS depression can be increased when Protriptyline is combined with Butriptyline.,increase,risk
Protriptyline,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Protriptyline.,increase,risk
Protriptyline,Gabapentin,The risk or severity of CNS depression can be increased when Protriptyline is combined with Gabapentin.,increase,risk
Protriptyline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Protriptyline is combined with Gabapentin enacarbil.,increase,risk
Protriptyline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Gadobenic acid.,increase,risk
Protriptyline,Galantamine,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Galantamine.,increase,risk
Protriptyline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Protriptyline is combined with Gallamine triethiodide.,increase,risk
Protriptyline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Protriptyline is combined with Ganaxolone.",increase,risk
Protriptyline,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Gatifloxacin.,increase,risk
Protriptyline,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Gemifloxacin.,increase,risk
Protriptyline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Protriptyline.,increase,risk
Protriptyline,Gilteritinib,The therapeutic efficacy of Protriptyline can be decreased when used in combination with Gilteritinib.,decrease,no risk
Protriptyline,Glasdegib,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Glasdegib.,increase,risk
Protriptyline,Gliclazide,Protriptyline may decrease the hypoglycemic activities of Gliclazide.,decrease,no risk
Protriptyline,Glimepiride,Protriptyline may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Protriptyline,Glipizide,Protriptyline may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Protriptyline,Gliquidone,Protriptyline may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Protriptyline,Glutethimide,The risk or severity of CNS depression can be increased when Protriptyline is combined with Glutethimide.,increase,risk
Protriptyline,Glyburide,Protriptyline may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Protriptyline,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Glycol salicylate.,increase,risk
Protriptyline,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Protriptyline.,increase,risk
Protriptyline,Glymidine,Protriptyline may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Protriptyline,Goserelin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Goserelin.,increase,risk
Protriptyline,Granisetron,The risk or severity of CNS depression can be increased when Protriptyline is combined with Granisetron.,increase,risk
Protriptyline,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Grepafloxacin.,increase,risk
Protriptyline,Guanabenz,The risk or severity of hypertension can be increased when Protriptyline is combined with Guanabenz.,increase,risk
Protriptyline,Guanadrel,Protriptyline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Protriptyline,Guanethidine,Protriptyline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Protriptyline,Guanfacine,The risk or severity of hypertension can be increased when Protriptyline is combined with Guanfacine.,increase,risk
Protriptyline,Guanoxan,Protriptyline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Protriptyline,Halazepam,The risk or severity of CNS depression can be increased when Protriptyline is combined with Halazepam.,increase,risk
Protriptyline,Halofantrine,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Halofantrine.,increase,risk
Protriptyline,Haloperidol,The serum concentration of Protriptyline can be increased when it is combined with Haloperidol.,increase,no risk
Protriptyline,Halothane,The risk or severity of CNS depression can be increased when Protriptyline is combined with Halothane.,increase,risk
Protriptyline,Hexafluronium,The risk or severity of CNS depression can be increased when Protriptyline is combined with Hexafluronium.,increase,risk
Protriptyline,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Protriptyline.,increase,risk
Protriptyline,Histrelin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Histrelin.,increase,risk
Protriptyline,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Protriptyline.,increase,risk
Protriptyline,Hydralazine,Protriptyline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Protriptyline,Hydrochlorothiazide,Protriptyline may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Protriptyline,Hydrocodone,Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Protriptyline,Hydroflumethiazide,Protriptyline may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Protriptyline,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Protriptyline.,increase,risk
Protriptyline,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Protriptyline.,increase,risk
Protriptyline,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Hydroxyzine.,increase,risk
Protriptyline,Hyoscyamine,Protriptyline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Protriptyline,Ketamine,The risk or severity of CNS depression can be increased when Protriptyline is combined with Ketamine.,increase,risk
Protriptyline,Ketazolam,The risk or severity of CNS depression can be increased when Protriptyline is combined with Ketazolam.,increase,risk
Protriptyline,Ketoconazole,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Ketoconazole.,increase,risk
Protriptyline,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Ketoprofen.,increase,risk
Protriptyline,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Ketorolac.,increase,risk
Protriptyline,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Protriptyline.,increase,risk
Protriptyline,Ofloxacin,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Ofloxacin.,increase,risk
Protriptyline,Olanzapine,The risk or severity of adverse effects can be increased when Protriptyline is combined with Olanzapine.,increase,risk
Protriptyline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Protriptyline is combined with Oliceridine.",increase,risk
Protriptyline,Olmesartan,Protriptyline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Protriptyline,Olodaterol,The risk or severity of hypertension can be increased when Protriptyline is combined with Olodaterol.,increase,risk
Protriptyline,Ondansetron,The risk or severity of CNS depression can be increased when Protriptyline is combined with Ondansetron.,increase,risk
Protriptyline,Opium,The risk or severity of CNS depression can be increased when Protriptyline is combined with Opium.,increase,risk
Protriptyline,Orciprenaline,The risk or severity of hypertension can be increased when Protriptyline is combined with Orciprenaline.,increase,risk
Protriptyline,Orphenadrine,Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Protriptyline,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Protriptyline.,increase,risk
Protriptyline,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Oxaprozin.,increase,risk
Protriptyline,Oxatomide,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Oxatomide.,increase,risk
Protriptyline,Oxazepam,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxazepam.,increase,risk
Protriptyline,Oxcarbazepine,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxcarbazepine.,increase,risk
Protriptyline,Oxitriptan,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxitriptan.,increase,risk
Protriptyline,Oxprenolol,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxprenolol.,increase,risk
Protriptyline,Oxybuprocaine,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxybuprocaine.,increase,risk
Protriptyline,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Protriptyline.,increase,risk
Protriptyline,Oxycodone,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxycodone.,increase,risk
Protriptyline,Oxymetazoline,Protriptyline may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Protriptyline,Oxymorphone,The risk or severity of CNS depression can be increased when Protriptyline is combined with Oxymorphone.,increase,risk
Protriptyline,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Oxyphenbutazone.,increase,risk
Protriptyline,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Protriptyline.,increase,risk
Protriptyline,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Protriptyline.,increase,risk
Protriptyline,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Protriptyline.,increase,risk
Protriptyline,Quazepam,The risk or severity of CNS depression can be increased when Protriptyline is combined with Quazepam.,increase,risk
Protriptyline,Quetiapine,The risk or severity of adverse effects can be increased when Protriptyline is combined with Quetiapine.,increase,risk
Protriptyline,Quinapril,Protriptyline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Protriptyline,Quinestrol,The serum concentration of Protriptyline can be increased when it is combined with Quinestrol.,increase,no risk
Protriptyline,Quinidine,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Quinidine.,increase,risk
Protriptyline,Quinine,Protriptyline may decrease the hypoglycemic activities of Quinine.,decrease,no risk
Protriptyline,Quinupramine,The risk or severity of CNS depression can be increased when Protriptyline is combined with Quinupramine.,increase,risk
Protriptyline,Quizartinib,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Quizartinib.,increase,risk
Protriptyline,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Protriptyline.,increase,risk
Protriptyline,Urethane,The risk or severity of CNS depression can be increased when Protriptyline is combined with Urethane.,increase,risk
Protriptyline,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Valdecoxib.,increase,risk
Protriptyline,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Protriptyline is combined with Valproate bismuth.,increase,risk
Protriptyline,Valproic acid,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Valproic acid.,increase,risk
Protriptyline,Valsartan,Protriptyline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Protriptyline,Vandetanib,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Vandetanib.,increase,risk
Protriptyline,Vardenafil,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Vardenafil.,increase,risk
Protriptyline,Vasopressin,Protriptyline may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Protriptyline,Vecuronium,The risk or severity of CNS depression can be increased when Protriptyline is combined with Vecuronium.,increase,risk
Protriptyline,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Protriptyline.,increase,risk
Protriptyline,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Protriptyline is combined with Venlafaxine.,increase,risk
Protriptyline,Vernakalant,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Vernakalant.,increase,risk
Protriptyline,Vibegron,The risk or severity of hypertension can be increased when Protriptyline is combined with Vibegron.,increase,risk
Protriptyline,Vigabatrin,The risk or severity of CNS depression can be increased when Protriptyline is combined with Vigabatrin.,increase,risk
Protriptyline,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Protriptyline.,increase,risk
Protriptyline,Vilazodone,The risk or severity of adverse effects can be increased when Protriptyline is combined with Vilazodone.,increase,risk
Protriptyline,Vildagliptin,Protriptyline may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Protriptyline,Viloxazine,The risk or severity of CNS depression can be increased when Protriptyline is combined with Viloxazine.,increase,risk
Protriptyline,Vincristine,Protriptyline may increase the neurotoxic activities of Vincristine.,increase,no risk
Protriptyline,Vinorelbine,Protriptyline may increase the neurotoxic activities of Vinorelbine.,increase,no risk
Protriptyline,Viomycin,Protriptyline may increase the neurotoxic activities of Viomycin.,increase,no risk
Protriptyline,Voriconazole,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Voriconazole.,increase,risk
Protriptyline,Vorinostat,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Vorinostat.,increase,risk
Protriptyline,Vortioxetine,The risk or severity of adverse effects can be increased when Protriptyline is combined with Vortioxetine.,increase,risk
Protriptyline,Warfarin,The risk or severity of bleeding can be increased when Protriptyline is combined with Warfarin.,increase,risk
Protriptyline,Xamoterol,The risk or severity of hypertension can be increased when Protriptyline is combined with Xamoterol.,increase,risk
Protriptyline,Xylometazoline,Protriptyline may increase the vasopressor activities of Xylometazoline.,increase,no risk
Protriptyline,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Protriptyline.,increase,no risk
Protriptyline,Zaleplon,The risk or severity of CNS depression can be increased when Protriptyline is combined with Zaleplon.,increase,risk
Protriptyline,Ziconotide,The risk or severity of CNS depression can be increased when Protriptyline is combined with Ziconotide.,increase,risk
Protriptyline,Zimelidine,The risk or severity of adverse effects can be increased when Protriptyline is combined with Zimelidine.,increase,risk
Protriptyline,Ziprasidone,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Ziprasidone.,increase,risk
Protriptyline,Zofenopril,Protriptyline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Protriptyline,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Protriptyline.,increase,risk
Protriptyline,Zolpidem,Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Protriptyline,Zonisamide,The risk or severity of CNS depression can be increased when Protriptyline is combined with Zonisamide.,increase,risk
Protriptyline,Zopiclone,The risk or severity of adverse effects can be increased when Protriptyline is combined with Zopiclone.,increase,risk
Protriptyline,Zotepine,The risk or severity of adverse effects can be increased when Protriptyline is combined with Zotepine.,increase,risk
Protriptyline,Zuclopenthixol,The risk or severity of adverse effects can be increased when Protriptyline is combined with Zuclopenthixol.,increase,risk
Protriptyline,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Protriptyline.,increase,risk
Aminohippuric acid,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Ganciclovir,The excretion of Aminohippuric acid can be decreased when combined with Ganciclovir.,decrease,no risk
Aminohippuric acid,Gemfibrozil,The excretion of Aminohippuric acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Aminohippuric acid,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Aminohippuric acid.,increase,no risk
Aminohippuric acid,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Glyburide,The excretion of Aminohippuric acid can be decreased when combined with Glyburide.,decrease,no risk
Aminohippuric acid,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Guanidine,The excretion of Aminohippuric acid can be decreased when combined with Guanidine.,decrease,no risk
Aminohippuric acid,Histamine,The serum concentration of Histamine can be increased when it is combined with Aminohippuric acid.,increase,no risk
Aminohippuric acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Ketoprofen,The excretion of Aminohippuric acid can be decreased when combined with Ketoprofen.,decrease,no risk
Aminohippuric acid,Ofloxacin,The excretion of Aminohippuric acid can be decreased when combined with Ofloxacin.,decrease,no risk
Aminohippuric acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Ouabain,The excretion of Aminohippuric acid can be decreased when combined with Ouabain.,decrease,no risk
Aminohippuric acid,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Aminohippuric acid.,increase,no risk
Aminohippuric acid,Oxyphenbutazone,The excretion of Aminohippuric acid can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Aminohippuric acid,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Quinapril,The excretion of Quinapril can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Quinidine,The excretion of Aminohippuric acid can be decreased when combined with Quinidine.,decrease,no risk
Aminohippuric acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Aminohippuric acid.,increase,no risk
Aminohippuric acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Valproic acid,The excretion of Valproic acid can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Valsartan,The excretion of Valsartan can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Varenicline,The excretion of Varenicline can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Aminohippuric acid.,decrease,no risk
Aminohippuric acid,Zidovudine,The excretion of Zidovudine can be decreased when combined with Aminohippuric acid.,decrease,no risk
Alfuzosin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Gadobenic acid.,increase,risk
Alfuzosin,Galantamine,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Galantamine.,increase,risk
Alfuzosin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Gatifloxacin.,increase,risk
Alfuzosin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Gemifloxacin.,increase,risk
Alfuzosin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Alfuzosin.,increase,risk
Alfuzosin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Gilteritinib.,increase,risk
Alfuzosin,Glasdegib,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Glasdegib.,increase,risk
Alfuzosin,Glofitamab,The serum concentration of Alfuzosin can be increased when it is combined with Glofitamab.,increase,no risk
Alfuzosin,Glyburide,The metabolism of Alfuzosin can be decreased when combined with Glyburide.,decrease,no risk
Alfuzosin,Goserelin,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Goserelin.,increase,risk
Alfuzosin,Granisetron,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Granisetron.,increase,risk
Alfuzosin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Grepafloxacin.,increase,risk
Alfuzosin,Guanabenz,Alfuzosin may increase the hypotensive activities of Guanabenz.,increase,no risk
Alfuzosin,Guanadrel,Alfuzosin may increase the hypotensive activities of Guanadrel.,increase,no risk
Alfuzosin,Guanethidine,Alfuzosin may increase the hypotensive activities of Guanethidine.,increase,no risk
Alfuzosin,Guanfacine,Alfuzosin may increase the hypotensive activities of Guanfacine.,increase,no risk
Alfuzosin,Guanoxan,Alfuzosin may increase the hypotensive activities of Guanoxan.,increase,no risk
Alfuzosin,Halofantrine,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Halofantrine.,increase,risk
Alfuzosin,Haloperidol,The metabolism of Alfuzosin can be decreased when combined with Haloperidol.,decrease,no risk
Alfuzosin,Histrelin,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Histrelin.,increase,risk
Alfuzosin,Hydralazine,The metabolism of Alfuzosin can be decreased when combined with Hydralazine.,decrease,no risk
Alfuzosin,Hydrochlorothiazide,Alfuzosin may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Alfuzosin,Hydroflumethiazide,Alfuzosin may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Alfuzosin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Hydroxychloroquine.,increase,risk
Alfuzosin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Hydroxyzine.,increase,risk
Alfuzosin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Hyoscyamine.,increase,risk
Alfuzosin,Ketazolam,The metabolism of Alfuzosin can be decreased when combined with Ketazolam.,decrease,no risk
Alfuzosin,Ketoconazole,The metabolism of Alfuzosin can be decreased when combined with Ketoconazole.,decrease,no risk
Alfuzosin,Octreotide,The metabolism of Alfuzosin can be decreased when combined with Octreotide.,decrease,no risk
Alfuzosin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Ofloxacin.,increase,risk
Alfuzosin,Olanzapine,Olanzapine may increase the hypotensive activities of Alfuzosin.,increase,no risk
Alfuzosin,Olaparib,The metabolism of Alfuzosin can be decreased when combined with Olaparib.,decrease,no risk
Alfuzosin,Olmesartan,Alfuzosin may increase the hypotensive activities of Olmesartan.,increase,no risk
Alfuzosin,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Alfuzosin.,decrease,no risk
Alfuzosin,Omaveloxolone,The serum concentration of Alfuzosin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Alfuzosin,Ondansetron,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Ondansetron.,increase,risk
Alfuzosin,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Alfuzosin.,decrease,no risk
Alfuzosin,Orphenadrine,The metabolism of Alfuzosin can be decreased when combined with Orphenadrine.,decrease,no risk
Alfuzosin,Osilodrostat,The metabolism of Alfuzosin can be decreased when combined with Osilodrostat.,decrease,no risk
Alfuzosin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Alfuzosin.,increase,risk
Alfuzosin,Oxatomide,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Oxatomide.,increase,risk
Alfuzosin,Oxetacaine,The metabolism of Alfuzosin can be decreased when combined with Oxetacaine.,decrease,no risk
Alfuzosin,Oxprenolol,Alfuzosin may increase the hypotensive activities of Oxprenolol.,increase,no risk
Alfuzosin,Oxybutynin,The metabolism of Alfuzosin can be decreased when combined with Oxybutynin.,decrease,no risk
Alfuzosin,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Alfuzosin.,decrease,no risk
Alfuzosin,Oxymetholone,The metabolism of Alfuzosin can be decreased when combined with Oxymetholone.,decrease,no risk
Alfuzosin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Alfuzosin.,increase,risk
Alfuzosin,Quetiapine,Quetiapine may increase the hypotensive activities of Alfuzosin.,increase,no risk
Alfuzosin,Quinapril,Alfuzosin may increase the hypotensive activities of Quinapril.,increase,no risk
Alfuzosin,Quinidine,Quinidine may increase the hypotensive activities of Alfuzosin.,increase,no risk
Alfuzosin,Quinine,The metabolism of Alfuzosin can be decreased when combined with Quinine.,decrease,no risk
Alfuzosin,Quinupristin,The metabolism of Alfuzosin can be decreased when combined with Quinupristin.,decrease,no risk
Alfuzosin,Quizartinib,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Quizartinib.,increase,risk
Alfuzosin,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Alfuzosin.,increase,risk
Alfuzosin,Vadadustat,The serum concentration of Alfuzosin can be increased when it is combined with Vadadustat.,increase,no risk
Alfuzosin,Valproic acid,The metabolism of Alfuzosin can be decreased when combined with Valproic acid.,decrease,no risk
Alfuzosin,Valsartan,Alfuzosin may increase the hypotensive activities of Valsartan.,increase,no risk
Alfuzosin,Vandetanib,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Vandetanib.,increase,risk
Alfuzosin,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Alfuzosin.,increase,risk
Alfuzosin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Alfuzosin.,increase,risk
Alfuzosin,Venetoclax,The metabolism of Alfuzosin can be decreased when combined with Venetoclax.,decrease,no risk
Alfuzosin,Verapamil,Verapamil may increase the hypotensive activities of Alfuzosin.,increase,no risk
Alfuzosin,Vernakalant,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Vernakalant.,increase,risk
Alfuzosin,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Alfuzosin.,decrease,no risk
Alfuzosin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Alfuzosin.,increase,risk
Alfuzosin,Viloxazine,The metabolism of Alfuzosin can be decreased when combined with Viloxazine.,decrease,no risk
Alfuzosin,Vinblastine,The metabolism of Alfuzosin can be decreased when combined with Vinblastine.,decrease,no risk
Alfuzosin,Voriconazole,The metabolism of Alfuzosin can be decreased when combined with Voriconazole.,decrease,no risk
Alfuzosin,Vorinostat,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Vorinostat.,increase,risk
Alfuzosin,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Alfuzosin.,decrease,no risk
Alfuzosin,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Alfuzosin.,decrease,no risk
Alfuzosin,Yohimbine,Yohimbine may increase the hypotensive activities of Alfuzosin.,increase,no risk
Alfuzosin,Zafirlukast,The metabolism of Alfuzosin can be decreased when combined with Zafirlukast.,decrease,no risk
Alfuzosin,Ziconotide,The risk or severity of hypotension can be increased when Alfuzosin is combined with Ziconotide.,increase,risk
Alfuzosin,Zimelidine,The metabolism of Alfuzosin can be decreased when combined with Zimelidine.,decrease,no risk
Alfuzosin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Ziprasidone.,increase,risk
Alfuzosin,Zofenopril,Alfuzosin may increase the hypotensive activities of Zofenopril.,increase,no risk
Alfuzosin,Zonisamide,The risk or severity of hypotension can be increased when Alfuzosin is combined with Zonisamide.,increase,risk
Alfuzosin,Zuclopenthixol,Zuclopenthixol may increase the hypotensive activities of Alfuzosin.,increase,no risk
Trimethadione,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trimethadione.,increase,no risk
Trimethadione,Balsalazide,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Balsalazide.,increase,risk
Trimethadione,Bedaquiline,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Bedaquiline.,increase,risk
Trimethadione,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Bemiparin,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Bemiparin.,increase,risk
Trimethadione,Benazepril,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Benazepril.,increase,risk
Trimethadione,Bendroflumethiazide,Trimethadione may increase the bradycardic activities of Bendroflumethiazide.,increase,no risk
Trimethadione,Benorilate,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Benorilate.,increase,risk
Trimethadione,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Benoxaprofen.,increase,risk
Trimethadione,Benperidol,The risk or severity of CNS depression can be increased when Trimethadione is combined with Benperidol.,increase,risk
Trimethadione,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Trimethadione.,increase,risk
Trimethadione,Benzocaine,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Benzocaine.,increase,risk
Trimethadione,Benzphetamine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Benzphetamine.,increase,risk
Trimethadione,Benzydamine,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Benzydamine.,increase,risk
Trimethadione,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Benzyl alcohol.,increase,risk
Trimethadione,Bepridil,Trimethadione may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Trimethadione,Beractant,Trimethadione may increase the bradycardic activities of Beractant.,increase,no risk
Trimethadione,Berotralstat,The metabolism of Trimethadione can be decreased when combined with Berotralstat.,decrease,no risk
Trimethadione,Betamethasone,The metabolism of Trimethadione can be increased when combined with Betamethasone.,increase,no risk
Trimethadione,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Trimethadione.,increase,no risk
Trimethadione,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Bexagliflozin.,increase,risk
Trimethadione,Bexarotene,The metabolism of Trimethadione can be decreased when combined with Bexarotene.,decrease,no risk
Trimethadione,Bezafibrate,The metabolism of Trimethadione can be decreased when combined with Bezafibrate.,decrease,no risk
Trimethadione,Bifonazole,The metabolism of Trimethadione can be decreased when combined with Bifonazole.,decrease,no risk
Trimethadione,Bilastine,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Bilastine.,increase,risk
Trimethadione,Bimekizumab,The metabolism of Trimethadione can be increased when combined with Bimekizumab.,increase,no risk
Trimethadione,Bioallethrin,Trimethadione may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Trimethadione,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Trimethadione.,decrease,no risk
Trimethadione,Bisoprolol,The therapeutic efficacy of Trimethadione can be increased when used in combination with Bisoprolol.,increase,no risk
Trimethadione,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Trimethadione.,decrease,no risk
Trimethadione,Boceprevir,The serum concentration of Trimethadione can be increased when it is combined with Boceprevir.,increase,no risk
Trimethadione,Borage oil,The therapeutic efficacy of Trimethadione can be decreased when used in combination with Borage oil.,decrease,no risk
Trimethadione,Bortezomib,The metabolism of Trimethadione can be decreased when combined with Bortezomib.,decrease,no risk
Trimethadione,Bosentan,The metabolism of Trimethadione can be increased when combined with Bosentan.,increase,no risk
Trimethadione,Bosutinib,The metabolism of Trimethadione can be decreased when combined with Bosutinib.,decrease,no risk
Trimethadione,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Trimethadione.,increase,risk
Trimethadione,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Trimethadione.,increase,risk
Trimethadione,Bretylium,Trimethadione may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Trimethadione,Brexanolone,The risk or severity of CNS depression can be increased when Trimethadione is combined with Brexanolone.,increase,risk
Trimethadione,Brexpiprazole,The risk or severity of CNS depression can be increased when Trimethadione is combined with Brexpiprazole.,increase,risk
Trimethadione,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Trimethadione.,increase,no risk
Trimethadione,Brivaracetam,The risk or severity of CNS depression can be increased when Trimethadione is combined with Brivaracetam.,increase,risk
Trimethadione,Bromazepam,The risk or severity of CNS depression can be increased when Trimethadione is combined with Bromazepam.,increase,risk
Trimethadione,Bromocriptine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Bromocriptine.,increase,risk
Trimethadione,Bromotheophylline,Trimethadione may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimethadione,Bromperidol,The risk or severity of CNS depression can be increased when Trimethadione is combined with Bromperidol.,increase,risk
Trimethadione,Brompheniramine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Brompheniramine.,increase,risk
Trimethadione,Buclizine,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Buclizine.,increase,risk
Trimethadione,Bumadizone,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Bumadizone.,increase,risk
Trimethadione,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Bupivacaine.,increase,risk
Trimethadione,Buprenorphine,Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Trimethadione,Bupropion,The risk or severity of CNS depression can be increased when Trimethadione is combined with Bupropion.,increase,risk
Trimethadione,Buserelin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Buserelin.,increase,risk
Trimethadione,Buspirone,The risk or severity of CNS depression can be increased when Trimethadione is combined with Buspirone.,increase,risk
Trimethadione,Butabarbital,The metabolism of Trimethadione can be increased when combined with Butabarbital.,increase,no risk
Trimethadione,Butacaine,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Butacaine.,increase,risk
Trimethadione,Butalbital,The metabolism of Trimethadione can be increased when combined with Butalbital.,increase,no risk
Trimethadione,Butamben,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Butamben.,increase,risk
Trimethadione,Butaperazine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Butaperazine.,increase,risk
